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ABSTRACT
The most widespread image of people who use illegal drugs is that they manifest a 
range of problems due to their dependence. But some people who use illegal drugs 
represent themselves as “recreational” users who differ from this stereotype. This 
research investigates a group of polydrug users who called themselves 
“recreational” users when I first met them in 1989. I study how they have fared 
over the nine years I have had contact with them. In 1989, their use was associated 
with fun, most obviously displayed in the spoof worship of “Saint Oswald”, the 
“Patron Saint” of drug use. For obvious reasons, the members of this group call 
themselves “Oswaldians.”
My first hypothesis was that, not only was the invention of this “Saint” unique, but 
that group members were different from other users of illegal drugs, both in their 
approach to drug using and also in realms such as education, their extensive 
polydrug use, their strong friendship links and their limited involvement with 
serious crime. After an examination of the literature, which indicated that there are 
more non-dependent than dependent heroin users, my second hypothesis was that 
the Oswaldians’ “recreational” use of heroin would persist longterm.
To test these hypotheses, I interviewed both Oswaldians and non-Oswaldians, and 
1 also considered it important to conduct two rounds of interviews in order to 
measure changes over time. I interviewed 139 Canberra-based users of illegal 
drugs during 1992 and, during 1993 and 1994, I reinterviewed 97 of these people, 
40 of whom were Oswaldians. Both qualitative and quantitative data were 
collected on sociodemographic characteristics, drug use, health and crime. The 
baseline data obtained at the first interview and the prospective data on a variety of 
changes which occurred between interviews were used to explore differences 
between Oswaldians and non-Oswaldians.
Most people I interviewed had completed their Higher School Certificate and many 
were involved in tertiary education. A history of extensive polydrug use was 
common. The majority had strong social support networks. A few IDUs were still 
sharing needles and syringes. There was a high incidence of unsafe sex. Between 
interviews, several IDUs had been diagnosed with hepatitis B and/or C. There was 
very little involvement in serious crime and very few people had been incarcerated.
Whilst there were some differences between the total population I studied and 
some other studies of people who use illegal drugs, I found very little evidence to 
support my hypothesis that the Oswaldians were different from other users of
illegal drugs. Very few were able to maintain all their drug use at a “recreational” 
level. Over the years, many Oswaldians have become dependent on heroin and 
this precipitated their first treatment. Others had ceased or decreased their use of 
illegal drugs, including heroin.
Amongst the total sample, there was a significant increase in the number of people 
with a history of treatment at the second interview. I also found a significant 
relationship between treatment status and both age and duration of heroin use. 
These findings lead me to question previously held wisdom about the ratios of 
dependent to non-dependent heroin users. I suggest that, in contemporary 
Australia, long term non-dependent heroin may be possible for only a minority. 
My findings are derived from only a small sample. I recommend, therefore, a 
longitudinal study of a larger sample of heroin users in order to better estimate 
Australian ratios of dependent and non-dependent heroin use.
I was also interested in gender differences but found only a few, most notably in 
women’s riskier sexual behaviours. I also compared those who went on to present 
for the second interview with those interviewed only once. The latter were 
significantly younger and it is possible, therefore, that their experiences between 
interviews would have been different from those who presented twice.
Partly as a consequence of an expansion of places in the Methadone Program, there 
were significantly more people in treatment at the second interview than at the 
first. There was a significant reduction in the number of drugs used between 
interviews. Many people linked their changes in drug use to their health. Between 
interviews, there was a significant improvement in physical health which is 
probably related to the overall reduction in drug use. Several respondents cited 
personal changes, such as entering into new relationships, or becoming parents for 
the first time, as reasons for changes in drug use. The changes in some drug 
patterns were due simply to availability. These changes affected both Oswaldians 
and non-Oswaldians. Although many of my findings question stereotypical images 
of people who use illegal drugs, the problems some people experienced confirm 
that part of the image which suggests that drug use may have detrimental health 
effects. Based on these findings, the thesis concludes with some suggestions for 
further harm minimisation strategies.
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CHAPTER 1: INTRODUCTION
1.1: Background to the research
Most known human societies, as well as some non-human societies, have used 
psychotropic substances (Plant, 1975; Davies, 1986; Mugford and Cohen, 1989; Siegel, 
1989; Fraillon, 1990). People have been using these substances for a long historical 
period of at least 8 thousand years (Lang, 1998). In more recent times, it has become 
apparent that such use may lead to harm. My interest is largely in the prevention of 
health problems among people who use illegal drugs. This interest evolved throughout 
a nursing career which taught me that, where possible, prevention rather than treatment 
of disease should be the primary goal of health professionals. My philosophy towards 
the use of drugs came, therefore, to be based on the harm minimisation approach. This 
is defined by The National Drug Strategy (NDS) (abbreviations and acronyms are also 
included as Appendix 1) Committee for the Ministerial Council on Drug Strategy as “an 
approach that aims to reduce the adverse health, social and economic consequences of 
alcohol and other drugs by minimising or limiting the harms and hazards of drug use for 
both the community and the individual without necessarily eliminating use” (1994:4).
My involvement with research among people who use illegal drugs began in 1989. I 
begin this chapter with an overview of the genesis of the further research discussed in 
this thesis. I then present the general hypotheses generated by the 1989 research. I go 
on to outline the research conducted for this thesis, the structure of the thesis, and define 
some of the associated terminology. The chapter continues with a summary of the main 
findings.
1.2: Genesis of the research
My research into illegal drug use began in 1989 when, as part of my Honours degree in 
Sociology at the Australian National University (ANU), I become involved in data 
collection for two ongoing research projects. The first project was the Australian 
National AIDS and Injecting Drug Use Study (ANAIDUS). The aim of this research 
was to “determine the variables associated with the risk of HIV (human immuno­
deficiency virus) infection in Australian injecting drug users” (ANAIDUS, 1991: 
unnumbered page, executive summary)1. The second project was the Australian Capital 
Territory’s (ACT) Drug Indicators Project (DIP), a three year research initiative funded 
by the then National Campaign Against Drug Abuse (NCADA). This was set up to 
“develop and refine methodologies for estimating the incidence, prevalence and character 
of drug use in local communities” (Stevens and Wardlaw, 1994:21). My task for both 
these projects was to find Canberra-based “recreational” injecting drug users (IDUs).
1 The ACT data were not used for this report.
At that time I knew no IDUs, and in order to gain access I was advised by my then 
supervisor, Stephen Mugford, to ask all of my friends and acquaintances if they knew 
anyone who injected drugs. I asked about 50 people without success until I found 
Roger (pseudonyms are used throughout) whom I first met when he came along to a 
meeting of an organisation to which I belonged. The following description of accessing 
the group of which Roger is a member, as well as the description of the group, is 
synthesised from previous publications (Dance, 1989; Dance, 1991a; Dance, 1991b; 
Dance, 1992a; Dance and Mugford, 1992). Two of these publications are included as 
Appendices 2 and 3 (Dance, 1991a; Dance and Mugford, 1992).
After our second meeting with Roger, my partner and I invited him home for dinner. 
By the end of the evening I had told Roger of my project. After questioning my 
attitudes toward the use and legalisation of illegal drugs, he told me he was a 
“recreational” injecting drug user, and enthusiastically insisted that he be the first person 
I interviewed:
It's about time someone got interested in us. All anyone has done so far is 
research addicts and we're not addicts [1 ’ve got] thirty to forty friends who 
are recreational users ... they're from mostly middle class backgrounds and 
we're not idiots. Whatever you do, don't treat us like idiots.
Roger said that he would get as many as possible of his friends to come to me for 
interview, and for the 1989 ANAIDUS and DIP research he was the nucleus of a 
snowball for 13 of his friends whom I also interviewed. The link with Roger, who had 
been around the Canberra drug scene for thirteen years, was crucial in encouraging his 
friends to present for interview. Since Roger was an influential group member, a 
“recreational” illegal drug user of many years standing, respected and trusted by his 
friends, I benefited from the “halo effect.” Fetterman describes this as a process 
whereby the greater the trust which the group places in the intermediary, the greater the 
trust extended to the researcher (1989). During the ethnographic work, which was not 
planned but which evolved during the 1989 research, the closeness and reciprocal 
friendship with Roger led people to relax in my presence, permitting a study of people 
who use illegal drugs in their “native habitats” (Becker, 1970:33). The “halo effect” 
was also a crucial factor in encouraging Roger's friends to present for interview. Not 
only did Roger see me as a friend, we both belonged to an organisation that had 
excellent credibility in his eyes and this fortified his personal trust in me.
In order to plot networks of the friendship, needle sharing and sexual links among 
Roger’s group of friends, I conducted more research in the second half of 1989. At that 
time, I reinterviewed 8 group members and a further 14 people from the group. During 
1989 I interviewed a total of 36 people who use illegal drugs: 27 were group members
and the other people were all only once removed from Roger. During the networking 
research, details of a further 25 group members were given to me by the group- 
members. Because some members of the group invented “Saint Oswald” the “Patron 
Saint of drug use, group members often call themselves the “Oswaldians.” I 
subsequently use this term when referring to them.
1.3: The Oswaldians
At the core of the Oswaldian group are many people who have known each other since 
schooldays. Several belong to the same families. During the 1989 interviews Sarah 
prompted the first real awareness that these people were, in the strict sociological 
meaning of the term, a group, not merely an aggregate:
This is a strange lot here in Canberra, they'll use anything. I don't know 
anywhere else like it. We get on each other's nerves; we all know 
everything about each other, do things together and we all sleep with each 
other. We have to get away sometimes, but we all come back.
Similar tantalising comments were coming through as I conducted the ANAIDUS and 
DIP interviews. For example, Patrick said: “We're a close knit group, I guess you 
could call us incestuous.” Jackie made a similar comment: “We're incestuous, we've 
really slept with everyone in the group. If we've not actually slept with them we've at 
least slept with someone who has.” Drew-11 said “I tried Uni’ at Wollongong but 
couldn't fit in. They're a bit rough there. They think we're intellectuals in Canberra, 
and I guess our group is.”
Based on interview data from 1989, and data from the interviews for the research 
described here, as well as my ethnographic work, I consider the core group of 
Oswaldians to contain 36 people. I have interviewed all but five of these Oswaldians at 
some stage and have interacted with all of them during ethnographic work. I have also, 
over the years, interviewed 22 people I consider to be peripheral or transitory group 
members. Some Oswaldians have presented for all four interviews I have conducted 
since I first made contact with them.
The requirements for entry into the Oswaldian group are not tightly based on such 
factors as gender or age, and even though the majority come from middle class 
backgrounds such values are eschewed and are not a basis for group entry. The 
individuals in the group, though largely from Anglo-Celtic backgrounds, also include 
those from Aboriginal and other non-Anglo-Celtic backgrounds. The ratio of women to 
men is fairly even and members represent a wide variety of occupations including
1 The method of allocating pseudonyms is discussed in the following chapter.
tertiary students, health professionals, academics and public servants. Many 
Oswaldians are, however, unemployed.
Although there is no universality concerning characteristics such as those described 
above, there are other characteristics which are both common and highly valued. The 
patterns of use and routes of administration vary considerably, but the consumption of 
alcohol and the use of illegal drugs is common to all group members. The 1989 
interview data, and my ethnographic work, led to Stephen Mugford and myself coining 
the phrase “drug enthusiasts” to describe both the variety and intensity of the drug use 
by group members (Appendix 3). We concluded that much of the group organisation 
revolves around drug consumption, both legal and illegal.
There are group norms other than illegal drug use, such as belonging to the left of the 
political spectrum (best described as non-violent anarchism). As Drew-1, a 
longstanding core-Oswaldian, had pointed out, erudition is another valued group norm. 
His claim to intellectualism has been validated by my ethnographic work where I have 
frequently observed boardgames such as Scrabble, Goh and chess being played. Most 
Oswaldians are well read and are informed and articulate about current affairs. There are 
also expectations that group members will be interesting and friendly. Other researchers 
have noted that people who use illegal drugs not only share the drug using experience, 
they also “share many valued things such as housing, food, money, clothing and 
childcare” (Grund et al, 1992:383). Similarly, I found that the Oswaldians share their 
problems, look after each others' children, play sport together and have fun together. 
One of the most fun things they share is the participation in the spoof “worship” of 
“Saint Oswald”, the “Patron Saint” of drug use. This “Patron Saint” was invented in 
1981 by three group members and is one of the bonds which unites them. The 
celebrations revolve around a yearly ceremony for “Saint Oswald's Day”, as well as 
frequent references to this imaginary figure at other social occasions (Appendix 3).
Although most Oswaldians had been involved in crime other than illegal drug use, 
generally they had restricted these activities to shop stealing1 and selling illegal drugs. 
Very few Oswaldians had been apprehended by law enforcement agencies, and none 
had been incarcerated. A few peripheral group members had previously been in 
treatment for their opioid use, but at the time of the 1989 interviews they considered 
themselves to have become “recreational” users.
1 In Australian Jurisdictions, the term “shoplifting” has been abandoned in favour of “shop-stealing.”
1.4: General hypotheses
During my 1989 research I had serendipitously discovered a group of people who use 
illegal drugs. The Oswaldian group structure differs from the people Zinberg studied 
since he found “controlled” heroin users “huddled together in small isolated groups.” 
The groups he described were “fragile and drug-centred ... because it is difficult to find 
controlled users who would make compatible friends” (1984:153). My discovery, as 
well as the specific features of the Oswaldians, stimulated a desire to undertake further 
work with the group, to observe and record their behaviours longitudinally, and to make 
comparisons between them and other people who use illegal drugs.
My first general hypothesis, which emerged from the 1989 research findings, was that 
the Oswaldians were very different from most samples of people who use illegal drugs 
which are usually derived from “captive” populations (Becker, 1970:33). Becker coined 
this term to describe those in drug treatment or law enforcement institutions and from 
whom, he argued, most samples of people who use illegal drugs at that time were 
drawn. (Since the advent of HIV/AIDS, there have been several successful attempts to 
access illegal drug users not in treatment. Some of these studies are described in other 
parts of the thesis.) I hypothesised that not only was the invention of “Saint Oswald” 
unique to the group, the Oswaldians would be different from other illegal drug users I 
studied in variables such as their education, their extensive polydrug use, their strong 
friendship links and their marginal involvement with serious crime.
According to the Commonwealth Department of Community Services and Health 
(CDCSH), Australia has up to two non-dependent heroin users for every one that is 
dependent (1988a). Upon reading of this ratio put forward by a government body, I 
then hypothesised that the Oswaldians who used heroin would be able to maintain their 
use at a non-dependent level.
The ratio put forward by the CDCSH appears to be derived from the one proposed by 
Hartnoll and colleagues in the United Kingdom. Opioid users were asked by these 
researchers to nominate friends who were regular opioid users and to indicate whether 
or not they had attended a clinic in the past year. This ratio was then used to extrapolate 
the total hidden population. For every regular opioid user nominated by respondents, 
there were typically 2 to 3 people whom they knew to use occasionally or intermittently 
(1985). In addition, for every nominated opioid user who had received treatment in the 
previous year, 6 to 10 who had not were nominated.
Bammer and Sengoz cite a personal communication from Reuter who “suggests that the 
ratio is very sensitive to the stage of the “epidemic” of heroin use and that it is currently 
much lower than that suggested by Hartnoll and colleagues” (1994:5). As the research
6progressed, I learnt of several respondents whose heroin use was increasing and of 
several who had entered into treatment. These changes affected both Oswaldians and 
non-Oswaldians. I use longitudinal data, particularly those from the Oswaldians, to 
discuss ratios of dependent to non-dependant heroin users. In so doing, I recognise that 
making a direct comparison between my findings and previous studies of ratios 
dependent to non-dependant heroin users is problematic since my conclusions are based 
on a longitudinal study whilst previous studies have been cross-sectional.
1.5: Overview of the research
To test my hypotheses, I interviewed 139 Canberra-based users of illegal drugs during 
1992. During 1993 and 1994, I reinterviewed 97 of these people. Forty were 
Oswaldians and 57 were not. One of my major interests was in changes over time. 
Unless otherwise specified, the findings are, therefore, based on the people who were 
interviewed twice.
Since the majority of Oswaldians had not been in treatment and none had been 
incarcerated, I wanted to compare them with similar people. I consequently made 
attempts to access as many people as possible who used illegal drugs who did not have a 
history of treatment or incarceration. I was only partially successful. Considering both 
Oswaldians and non-Oswaldians, 7 respondents were in treatment at the first interview 
and a further 21 had a previous history of treatment. A further 5 people without a 
treatment history had also been incarcerated, all for a short period of time. As I go on to 
show in Chapter 5, there was a significant increase in the number of people with a 
history of treatment at the second interview and I also found a significant relationship 
between treatment status and both age and duration of heroin use.
Because the Oswaldian group contained both IDUs and non-IDUs, I wanted the 
comparative subset to be of a similar composition. At the first round of interviews, 81.8 
per cent of Oswaldians (n=36) and an almost identical proportion (74.7%, n=71) of 
non-Oswaldians were current IDUs. (When used in relation to the first interview, 
“current/ly” means during the 12 months prior to interview, and when used in relation to 
the second interview, it means the period between interviews. These definitions are also 
included in Table 1 in Appendix 4.) There was some attrition at the second interview 
(this is fully discussed in Chapter 2) but these proportions were little changed when 
82.5 per cent of Oswaldians (n=33) and 80.7 per cent of non-Oswaldians (n=46) were 
current IDUs.
I compared the 40 Oswaldians and the 57 non-Oswaldians and I further subdivided the 
Oswaldians into 26 core-Oswaldians and 14 non-core-Oswaldians. For other 
comparisons, I grouped the 14 non-core-Oswaldians with the non-Oswaldians into a
7subset of 71, which I refer to as the “Remainder”, whom I compared with the core- 
Oswaldians. (The definitions of these and other subsets are included in Table 2 in 
Appendix 4.) I also looked to see if there had been any significant changes between the 
two interviews for the total sample, as well as all the subsets. Whilst the thrust of the 
thesis is on the findings from the 97 people who were interviewed twice, I also used the 
data from the first interview to compare those who went on to present for the second 
interview with those who did not. Where possible, I compare my findings for the total 
sample with other, mostly Australian, studies of people who use illegal drugs.
Adler has hypothesised that women’s and men’s behaviours are converging. This 
convergence includes similarities in “their profile of physical diseases, their 
psychological configurations, their criminal deviances, and their addictive patterns” 
(1975:132). This hypothesis has been the subject of some debate in the drug literature 
(reviewed by Robbins, 1989). Several researchers have argued that women have been 
rendered invisible by drug researchers (for example, Gomberg, 1986; Hser et al, 1987; 
Stevens, 1991). Wodak believes that “the combination of intoxication and risk taking is 
predominantly a male prerogative”, adding that men “also account for a far greater 
proportion of the adverse health and social consequences associated with alcohol and 
drugs” (1992:108). Broom notes that the kinds of suffering experienced by men and 
women may be qualitatively different, and she gives as an example the fact that though 
more men drink alcohol, women are damaged more quickly by excessive alcohol 
consumption (1994). Whilst far more men than women in the Western world have 
contracted HIV, Treichler has persuasively argued that, in most issues related to 
HIV/AIDS, women have been relegated to the place of “Other”1 (1989:194). Given this 
debate, I looked to see if there were any gender differences among the people I 
interviewed. Those I found are discussed in the relevant parts of the thesis.
As early as 1940, Lindesmith argued that many so called “dope fiends” maintain their 
self-respect and social status: “it is not the effect of the drug that produces the alleged 
deterioration of character in the addict, but rather the social situation into which he is 
forced by the law and by the public’s conception of addiction which does the damage” 
(1940:202-3). More recently, Dole also argued against the myth of the stereotype of the 
“narcotics addict” (1994:4). Still, the stereotypes persist such that people who use 
illegal drugs are still seen as “mad (addicted) or bad (criminal)” (Newcombe, 1993).
Users fear the discrimination which emanates from such stereotypes and many have 
experienced losing their job or children or have suffered discrimination by pharmacists, 
members of the police forces and professionals such as doctors and solicitors who may
1 Treichler has drawn this phrase from de Beauvoir who asks “why is woman the other?” (de Beauvoir, 
1949 [1987 ed]:69).
8refuse to have them as clients (Newcombe, 1993). Not surprisingly, the people who 
use illegal drugs I got to know dislike these images and many live in fear of the possible 
ramifications of their illegal drug use being discovered. They see one of my important 
roles as telling the ‘“ true story’ (which will get) to the public through [the researcher’s] 
report” (Becker, 1970:30). Fetterman describes “advocate ethnography” as a process 
whereby participants “define their reality (and) consider their view about the ideal 
solution to their problem” (1989:126). The task of the ethnographer is, however, not 
only to describe the respondents and their world as their respondents see it, but also as 
they see it themselves (Walters, 1980). However sympathetic the ethnographer’s view 
may be, it may not always accord with the opinions of the people they study, who may, 
indeed, differ among themselves.
I attempt to fulfil this dual role by presenting qualitative and quantitative data on the lives 
of people who use illegal drugs in aspects related to their illegal activities as well as the 
many normal aspects of their lives. This has been made possible, not only by the 
interview data, but also by several respondents inviting me into their everyday lives.
1.6: Overview of the thesis
The thesis is presented in two volumes. Volume I contains the text, and the chapters are 
constructed so that the relevant literature review, specific hypotheses and research 
questions are covered in each chapter. These are woven into my research findings thus 
making each chapter relatively self contained. In the second Chapter, I present an 
overview of the research design and the methodology. Chapter 3 sets the drug use 
patterns of the people I interviewed in context by presenting the sociodemographic 
findings. In Chapter 4 , 1 document the drug use histories before going on in Chapter 5 
to discuss in detail the changes in drug use which occurred between interviews. Chapter 
6 is concerned with general physical, psychological and social health whilst Chapter 7 
focuses on bloodborne viruses (BBVs) and sexual and genital health. Criminal 
behaviours are outlined in Chapter 8. The concluding Chapter includes a summary of 
the main findings and, suggestions for future research, as well as possible further harm 
minimisation strategies.
The pagination from Volume 1 is continued in Volume II which contains the appendices. 
Some of the appendices are attached documents and their original page numbers have 
been erased. The Opiate Treatment Index (OTI), one of the instruments I used for the 
interviews, is included as Appendix 10. I sometimes make reference to the page 
numbers in the OTI. These page numbers refer to those in the Appendix rather than the 
original OTI.
1.7: Definitions related to drug use
In this thesis, “drug use”, means all drug use, from the legal and commonly used drugs, 
most notably tobacco and alcohol, to illegal drugs such as marijuana and heroin. 
Prescribed drugs may be used strictly according to a physician’s prescription, or they 
may be used in other ways by the individual who is prescribed them. They may also be 
given to, or obtained from, friends and acquaintances. There are also drugs which are 
obtained over the counter, or bought in supermarkets, such as nitrous oxide (available in 
bulbs containing meringue, described more fully in Chapter 4) as well as a range of 
drugs, most commonly mushrooms and poppy seeds, which users simply go out and 
gather, or purchase, but whose use is still prohibited. Thus, I use the term “drug use” 
to denote the use of both legal and illegal drugs, and the term “illegal drug use” to denote 
the illegal use of any substance even if the substance is not prohibited.
Drug users are often classed as “dependent” or “non-dependent.” Dependent users are 
those who use frequently and regularly (CDCSH, 1988a). Dependence has been 
defined as “a cluster of cognitive, behavioral and physiological symptoms indicating that 
the individual continues use of the substance despite significant substance-related 
problems” (American Psychiatric Association, 1994:178). Recently, it has been 
recognised that neuroadaption, “an altered physiological state ... produced by the 
repeated administration of a drug”, occurs when people become dependent (Whelan, 
1998:22). Non-dependent users are those who use occasionally, or in particular 
contexts (CDCSH, 1988a). For the sake of convenience I use the terms “dependent” 
and “non-dependent”, but as Edwards and colleagues note “no sharp cut-off point can 
be identified for distinguishing dependence from non-dependent but recurrent use” 
(1981:230). As my findings demonstrate, levels of use may also vary considerably over 
time.
As I found, and as Stowe and Ross also indicate, “recreational use” is a term used by 
people who use illegal drugs (nd:3). To that we might add that the terms “junkie” and 
“addicts” are commonly used by those who use illegal drugs, but they should no longer 
be used by professionals. I have abandoned the use of the term “recreational” use 
(which I used to describe the people I accessed in 1989), in favour of “non-dependent” 
use.
1.8: Conclusion
Whilst finding some differences between the people I interviewed and some other 
studies of people who use illegal drugs, I found very little evidence to support my 
hypothesis that the Oswaldians were different from other users of illegal drugs. With 
the hindsight of following the Oswaldians for almost 10 years, it is possible that there 
was some observer bias in my previous descriptions of these people as non-dependent
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users who had experienced little pathology with their drug use. I was looking for 
“recreational” IDUs and this is how the people I first contacted described themselves. 
The drug use histories, however, corresponded with this self description and I am as 
confident as I can be that this was a true self description.
Findings from both Oswaldians and non-Oswaldians lead me to question previously 
held wisdom about the ratios of dependent to non-dependent heroin users. Previous 
ratios have been derived from cross-sectional studies. I suggest that, in contemporary 
Australia, long term non-dependent heroin use may be possible for only a minority and 
that, in order to appreciate what happens to drug consumption patterns over time, it is 
necessary to conduct longitudinal studies. Since my findings are derived from only a 
small sample, I recommend a further longitudinal study of a larger sample of heroin 
users. This would provide a better estimate of ratios of dependent and non-dependent 
heroin use in Australia than the one currently used. A longitudinal study of a larger 
sample would, like my study, measure what happens to non-dependent heroin users 
over time and would demonstrate how generalisable my findings were.
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CHAPTER 2: METHODOLOGICAL APPROACH 
2.1: Introduction
With the advent of HIV/AIDS, there have been several longitudinal studies of people 
who use illegal drugs (for example, Plant et al, 1988; Power, 1989; Skidmore et al, 
1989; Morrison, 1991; Nicolosi et al, 1991; Vlahov et al, 1991; Loxley and Marsh, 
1992). Because I wanted to evaluate changes in a range of behaviours, I also conducted 
a longitudinal study.
Below, I present an outline of the sampling system, the integrated methodology, the 
instruments used for the interviews and a description of the way the interviews were 
conducted. I go on to discuss ethical considerations, possible sources of bias and issues 
of validity and reliability. The chapter then outlines the way in which the data were 
analysed, and the way the results are presented.
2.2: Sampling
I wanted tö compare the Oswaldians with other people who use illegal drugs in terms of 
these other people being similar in having a history of minimal contact with treatment 
and law enforcement agencies. These people are sometimes referred to as “hidden 
users.” Becker says that these are people who participate in an activity which is both 
stigmatised and illegal so that “those who engage in it do not make that face publicly 
known or easily available” (1970:30). This description most closely approximates the 
group I found in 1989 and the population from which I was hoping to seek more 
respondents.
Several other researchers have successfully collected data from non-treatment 
populations (or example, Feldman and Biernacki, 1988; Power, 1988; Wiebel, 1988; 
McKeganey et al, 1989; Watters and Biernacki, 1989; Darke et al, 1990; Rhodes et al, 
1990; Marsh and Loxley, 1992; Meandzi et al, 1994; Needle and Mills, 1994; Rezza et 
al, 1994 ; Baker et al, 1995). Our knowledge of people who use illegal drugs is still, 
however, largely confined to those easily accessible for research through agencies such 
as drug treatment settings and the law courts (Becker, 1970; Watters and Biernacki, 
1989; Moore et al, 1992; Grund et al, 1993). As Becker notes, “When you believe you 
know nothing and have no contacts (this is) the only sure method of getting at least 
some beginning information” (1970:32). These people, he terms as “captives”, are 
almost certainly dependent users. Becker draws attention to the fact that they differ 
greatly from the more successful non-captive population, adding that samples taken 
from them are not only unrepresentative but that people drawn from them do not behave 
as they might in their “native habitats” (1970:33).
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A criterion of probability sampling is a population with high visibility (Biernacki and 
Waldorf, 1981). Given that my aim was to find people engaged in illegal activities, and, 
moreover, to find as many as possible of those “hidden users”, my target group did not 
meet this criterion. Alternative sampling methods, therefore, had to be found. The most 
important of these was snowballing, which had also proved to be successful for my 
1989 research. This is a method of sampling through referrals made among people 
“who share or know of others who possess some characteristics of research interest.” It 
is particularly applicable when the focus of study is a sensitive issue (Biernacki and 
Waldorf, 1981:141), and when exploring populations about whom we know little 
(Kaplan et al, 1987). Although some researchers are disparaging about snowballing 
(Barnes, for example, says that “for most purposes this is a poor way of sampling” 
[1972:23]) the method has been widely used for obtaining samples of people who use 
illegal drugs (Plant and Reeves, 1976; Zinberg, 1984; Power, 1988; Power, 1989; 
Watters and Biernacki, 1989; Goldstein et al, 1990; ANAIDUS, 1991; Morrison, 1991; 
Fitzgerald, 1993; Pivnick et al, 1994).
I prepared flyers (Appendix 5) containing details of the interview and my mobile phone 
number. Table 2.1 shows the results of the sampling for all respondents at both 
interviews. For the first round of interviews, 60 flyers were sent to the Needle 
Exchange Program (NEP) in the nearby town of Queanbeyan, 40 were taken by an ACT 
Refuge worker and I placed 140 in the paper bags used to distribute injecting 
paraphernalia for IDU clients of the AIDS Bus1. I gave 21 to peer outreach workers and 
a further 288 were taken by 50 respondents to hand out to their contacts. A majority of 
interview referrals (68.3%) were from other respondents, mainly prompted by the 
flyers. Other researchers have also found this method of referral to be an effective 
method of recruitment where out-of-treatment samples of people who use illegal drugs 
have been sought (Nelson et al, 1991; Marsh and Loxley, 1992).
Some respondents whose only illegal drug was marijuana, and that very occasionally, 
passed the flyers on to respondents who injected heroin and amphetamines, thus 
indicating that a variety of drug use patterns may exist within a drug-using network. 
Through my ethnographic work, I was able to ask 21 people directly for an interview 
and many self referrals were also made in this context. Although only 5 respondents 
presented for interview after picking up flyers on the AIDS Bus, most of these referred 
several other respondents. Similarly, the Junkmail article (a journal for IDUs and their 
service providers) (Dance, 1992a), yielded only one phone call but this person referred 
10 people directly to me and most of these people referred others too.
1 The AIDS Bus travels to different locations in Canberra. Workers exchange needles and syringes, and 
also offer a range of other appropriate services.
There were 28 occasions when people did not show up for their scheduled first 
interview. Six of these people recontacted me and were interviewed later.
At the end of the first interview, I asked respondents if they would be willing to present 
for a follow-up interview. Though one person declined, he still appeared for a second 
interview. I asked people for means of contacting them. Most gave me a phone 
number; some said they wanted me to phone someone mutually known and a few people 
said they would prefer to be recontacted via a flyer on the AIDS Bus.
For the second round of interviews, I left 100 flyers on the AIDS Bus and placed 
advertisements at the ACT Drug Referral and Information Centre (DRIC)1 and at the 
ACT Intravenous League (ACT IV League)2. Because I was aware that some 
respondents were in methadone treatment, I also placed a total of 90 flyers in the two 
ACT outlets. Thirty six people took 150 flyers for the second interview. The most 
successful way of reaccessing people for the second round of interviews was by 
personal contact (66.0%).
Table 2.1: Sampling for all respondents at both interviews
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First interview Second interview 
Method____________________  n % n %
Referral by respondents 95 68.3 24 24.7
Direct request by me 21 15.1 64 66.0
Self referral 14 10.1 0 0.0
AIDS Bus “flyers” 5 3.4 4 4.1
Junkm ail article 1 0.7 NA NA
Referral by non-respondents 3 2.2 0 0.0
Methadone Clinic - - 5 5.2
Total 139 _ 97
Of the 139 people originally interviewed, 44 (31.6%) were Oswaldians and I consider 
28 of these people to be core-Oswaldians. Nine Oswaldians I interviewed during 1989 
did not present for interview. One had stopped all illegal drug use and had disassociated 
herself from most group members, 5 had left the ACT, and the other two offered 
themselves for interview only after I had commenced the second round of interviews.
1 This is a community based organisation which offers a range of services for drug users and their 
families including advice, counselling, information and education.
2 This is a peer-based organisation which offers services to IDUs, including education, information and 
needle exchange.
I started the first round of interviews in January 1992 and finished it in September of 
that year. The second round of interviews began in November 1993 and was completed 
in April 1994. There was an average length of 18.3 months between the interviews with 
a range of 11-24 months. Ninety seven of the 139 people interviewed during 1992 
made themselves available for reinterview (Table 2.2). This represents a follow-up rate 
of almost 70 per cent. Particularly given this timespan between interviews, the follow­
up rate compares favourably with other longitudinal studies. Plant and colleagues, for 
example, report a follow-up rate of 56 per cent over a six month period for their study of 
drug users in Sydney (1988). Over a similar timeframe, Robertson and colleagues 
report a follow-up rate of 80 per cent in their British study of IDUs (1988).
Given my continued ethnographic contact with the Oswaldians, these people were the 
easiest to reaccess for the second interview. Forty of the people who presented for the 
second interview were Oswaldians (41.2% of the sample, 90.9% of Oswaldians 
interviewed at the first interview). Of the 4 Oswaldians who were not reinterviewed, 
two peripheral group members had left the ACT and two core-Oswaldians were having 
personal problems. Fifty seven non-Oswaldians (58.8% of the sample, 60.0% of non- 
Oswaldians interviewed at the first interview) presented for the second interview.
Table 2.2 demonstrates the sampling bias at the second interview. Proportionately more 
non-Oswaldian IDUs (35.2%) and non-Oswaldian non-IDUs (54.2%) than Oswaldian 
IDUs (8.3%) and Oswaldian non-IDUs (12.5%) were lost to attrition. Although the 
attrition rate for the non-Oswaldians may impact on the major findings, the attrition rate 
for the Oswaldians was low. It is, therefore, unlikely that the attrition rate for this 
subset will affect the conclusions based on their findings.
Table 2.2: Direction of sampling bias
Presented for 1st 
interview
n %
Went on to 
present for 2nd 
interview 
n %
Attrition
n
Oswaldian IDUs 36 81.8 33 82.5 3 8.3
Oswaldian non-IDUs 8 18.2 7 17.5 1 12.5
Total 44 100 40 100 4 9.1
non-Oswaldian IDUs 71 74.7 46 80.7 25 35.2
non-Oswaldian non-IDUs 24 25.3 11 19.3 13 54.2
Total 95 100 57 100 38 40.0
r'  v  i  ______A,. • .....;.I ..' ..■...J.L < .._  ..
Cumulative total 139 100 97 100 42 30.2
1 This is a percentage of the number of people who presented for the first interview.
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Table 2.3 shows what is known about the people who did not present for a second 
interview. In the majority of cases, the people concerned had simply moved out of 
Canberra. This was ascertained either from ethnographic work or from people these 
respondents said I could communicate with as a means of recontacting them. I was able 
to contact a further two people who had moved to Sydney and I reinterviewed them on a 
visit there. Even though I used a variety of strategies to recontact respondents, 
including making several phone calls, writing letters or making contact with someone 
mutually known, in some cases this was to no avail. I made personal contact with 3 
people who then did not appear for interview. Evidence from a variety of sources, 
including the media and ethnographic work, shows that at least 5 of those who did not 
present for the second interview had legal problems and a further two had family 
problems. Using the data obtained at the first interview, I discuss the differences found 
between those who did and did not present for the second interview in the results 
chapters (Chapters 3-8).
The question of what is meant by treatment has become controversial since the 
introduction of NEPs (Power, R. London. 1996, September 9, pers comm). For the 
purposes of my research, and in common with other Australian researchers (ANAIDUS, 
1991; Darke et al, 1992a), I did not consider clients of needle exchange outlets as being 
in contact with treatment services. Most of the people I interviewed who were not in 
treatment for their drug use had some contact with health professionals. I also did not 
consider these people to be in treatment.
16
T able 2.3: R easons for  resp on d en ts not p resen tin g  for the second in terv iew
R eason n %
M oved  o u t o f  the A C T 19 45 .2
F lyer passed  on but responden t d id  no t p resen t fo r interview 5 11.9
P ersonal con tac t and request fo r in terv iew  bu t no further contact 3 7.1
A  m u tua l con tac t had m oved  ou t o f  C anberra  and had lost touch 2 4 .8
P hone d isconnec ted , no o ther fo rm  o f  contact 2 4 .8
N o t k n ow n  if  f lyer w as passed  on 1 2 .4
N o t k n ow n  if  f lyer w as passed  on, p lus m oved  in terstate 1 2 .4
F am ily  p ro b lem s 2 4.8
P resen ted  for in terv iew  at responden t's  house, respondent ill and did 
not reconnect 1 2 .4
Phone d isconnec ted , m essage  le ft w ith  con tac t, not know n if 
m essage passed on 1 2 .4
M oved  and  no other form  o f  con tac t 1 2 .4
L etter re tu rned  (from  interstate) 1 2 .4
L etter to  in terstate address, no response 1 2 .4
U nknow n 2 4 .8
T otal 42 _
Whilst specifying too few eligibility criteria can create problems related to screening, 
specifying too many can result in verification problems (Biemacki and Waldorf, 1981). 
Because of the potential criticism that respondents will tell the interviewer what s/he 
wants to hear, I did not stipulate a particular type or history of illegal drug use on the 
flyer (Appendix 5). Because of the possibility of phone-tapping, I did not ask any 
questions that might be incriminating when people phoned to book an interview. 
Furthermore, it would not have been wise to ask about drug treatment and criminal 
histories as soon as I met someone and then refuse to interview those who had these 
histories and who had taken the time and trouble to present for interview. Had I acted in 
that way it is also possible that subsequent respondents might not have divulged these 
histories. Since these are particularly sensitive areas, I needed to establish some rapport 
and it was not until well into the interview that I asked these questions. I found 
Goldstein and colleagues to be correct in their perception that the problem is seldom how 
to recruit people but rather how to reject those who, for one reason or another, do not 
meet the criteria for participation (1990). It was inevitable, therefore, that my sample 
did contain people with a history of treatment or incarceration.
Some strategies were, however, used to maximise the number of respondents without a 
history of treatment or incarceration. At the end of the first interview, I told respondents
who were willing to pass on flyers that though I was interested in all drug use 
behaviours, “hidden users” were, by definition, the most difficult to access and I would 
be grateful if they could give the flyers to any of these people. I also gave this 
information to people during the process of my ethnographic work, as well as to the 
ACT IV League and NEP staff. The article I wrote for Junkmail outlined my research 
interests and my major target group for research.
Table 2.4 shows the results of these strategies, demonstrating that 11 people were in 
treatment at the first interview and 128 were not. A further 24 people had a history of 
drug treatment. Seven people with a history of treatment also had a history of 
imprisonment and 7 people who did not, had also been imprisoned. We are thus left 
with 95 people (69.3%) who had never been in treatment or incarcerated. Fifty nine 
(43.1%) were current heroin users.
A markedly greater proportion of people who went on to present for the second 
interview had a history of treatment for drug use. This may affect some of the 
findings discussed in subsequent chapters, particularly the significant increase in the 
number of people presently in treatment at the second interview, which included 
some people with a previous history of treatment.
Table 2.4: Treatment and imprisonment history for all respondents
at the first interview
Presented only for 
1st interview
Went on to present 
for 2nd interview
Total
History n % n % n %
Present treatment 4 9.5 7 7.4 11 8.0
Previous treatment 3 7.1 21 22.1 24 17.5
Previous imprisonment, 
no treatment 2 4.7 5 5.3 7 5.1
No treatment or 
imprisonment 33 78.6 62 65.3 95 69.3
Total3 42 - 95 . 137 -
a There are 2 missing values for imprisonment history for those who went on to present for 
the second interview.
2.3: Integrated methodology
The guiding philosophy of this research was that of harm minimisation. The techniques 
I used were grounded not only in my training as a sociologist but also in my 25 years 
experience as a health professional.
In order to maximise the benefits of the interview I collected both qualitative and 
quantitative data. Their relative merits have long been debated but, as several authors
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have indicated, both methods have their weaknesses which, to some extent, may be 
compensated for by the strengths of the other (Watters and Biemacki, 1989; Lambert 
and Wiebel, 1990; Steckler et al, 1992). The strengths of quantitative methods are that 
they produce “factual, reliable outcome data that are usually generalisable to some larger 
population” and the strengths of qualitative methods are that they “generate rich, 
detailed, valid process data that usually leave the study participants' perspectives intact” 
(Steckler et al, 1992:2). Steckler and colleagues go on to say that “social interventions 
are complex phenomena which require the application of multiple methodologies in 
order to properly understand or evaluate them” (1992:4). Other researchers in the drug 
field are now combining both qualitative and quantitative research methods (for 
example, Wiebel, 1988; Goldstein et al, 1990; Marshall, 1990; Morrison, 1991; Barnard 
and Frischer, 1995).
Ethnography was one component of the qualitative methodology. This has been defined 
as “the art and science of describing a group or culture from their perspective” 
(Fetterman, 1989:11). Although it has traditionally been seen as the domain of social 
anthropologists, it is a methodology which has also been used by other people 
researching drug use per se (for example, Becker, 1963; Preble and Casey, 1969; Plant, 
1975; Moore, 1990; Grund, 1991; Maher, 1996) and also by those working specifically 
on ways of preventing HIV among IDUs (for example, Feldman and Biernacki, 1988; 
Wiebel, 1988; Power, 1989; Williams, 1990; Grund et al, 1991; Rivera-Beckman, 
1992).
My involvement with ethnographic work was an unplanned consequence of the initial 
1989 research. (This process is fully discussed in the publications attached as 
Appendices 2 and 3.) During the research described here I have, in addition, undertaken 
some ethnographic work with non-Oswaldians. I have seen 14 people from this subset 
(definitions of the subsets are included in Table 2 in Appendix 4) in a social setting at 
least once and have had more intense interactions with 8 of them.
Participant observation is a major component of the ethnographic method. It has 
evolved from anthropological studies where ones peers approve of participation in a 
strange culture (Plant and Reeves, 1976). But as Plant and Reeves go on to say, 
participation in deviant groups is a “much more vexed question” (1976:157). According 
to Becker, “Researchers often feel that if they want fully to understand the deviants they 
study they should partake themselves of the forbidden activity”, but he disagrees: “I 
think it indisputable that one need not engage in an activity to understand it. In spite of 
the romantic yearnings and the earnest ideological assurances of some deviants, 
scientific requirements do not force us to join in deviant activities” (1970:47). Some
respondents did ask about my drug-taking activities, but no one tried to pressure me into 
participating in illegal drug use.
One of the rules of participant observation is that the researcher must, as far as possible, 
not influence events but endeavour to record them as they occur. This is an 
unacceptable luxury to ethnographers who may be observing potentially harmful 
behaviours. Power concludes that “in the current climate research objectivity may at 
times have to take a back seat to health education and risk reduction” (1989:50). Marsh 
and Loxley also believe that rigid separation between research and intervention is 
inappropriate in the HIV/AIDS area (1992).
Whilst the continued ethnographic work allowed closer contact with many respondents 
than that allowed by relying only on contact at interview, there was very little 
information gleaned from this contact which shed any light on further harm minimisation 
strategies. I have as a consequence used very few of these data in the thesis. The 
papers included as Appendices 2 and 3 describe previous ethnographic work in more 
detail.
Before commencing the interviews, I undertook a health education course at the ACT 
NEP, and became qualified to exchange injecting equipment and distribute condoms. I 
also gained practical experience by working several shifts on the AIDS Bus, I trained as 
a volunteer at ACT AIDS Action Inc and I worked as a nurse in the ACT Sexually 
Transmitted Disease Clinic/AIDS Reference Centre.
2.4: Instruments used for interviews
The ANAIDUS and AIC questionnaires influenced the interview guide I drafted 
(Appendix 6). I also examined other questionnaires. Some questions were suggested 
by Oswaldians and some by service providers. Many of the qualitative questions were 
stimulated by the 1989 research when it was apparent that respondents found it difficult 
to confine themselves to pre-coded responses concerned with the complex behaviours 
associated with drug use, needle use and sexuality. They were, however, very willing 
to talk about these matters in detail. Other questions flowed from my ethnographic 
work, as well as my literature review.
The final interview guide contained structured and semi-structured questions on 
sociodemographic variables, drug use behaviours, needle use behaviours, general 
health, sexual behaviours, criminal behaviours and networks (networks are not 
discussed in this thesis). The interview guide (Appendix 7) for the second interview 
concentrated on changes which occurred between interviews. The specifics of the 
various sections of the interview guides are discussed with the relevant findings in the
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results chapters. Not all of the quantitative questions were pre-coded. The codes I used 
for the quantitative data at the first round of interviews are attached as Appendix 8. 
Those for the second interview are attached as Appendix 9.
At both interviews, I also employed the Opiate Treatment Index (OTI) (Appendix 10). 
As Darke and colleagues indicate, a major problem in most drug-related research is the 
inability to compare results (1991a; 1992a). Where possible I compare my results with 
those from other researchers who have also used the OTI. The OTI was developed in 
Sydney for both research and clinical applications (Darke et al, 1991a). The NDS has 
recommend its use (1993). One of the functions of the OTI is to assess the impact of 
treatment over time and it has been used in this way by other researchers (Macleod et al, 
1996). I also used it to assess the changes that occurred between interviews. The OTI 
has been used for people both in and out of treatment (Darke et al, 1991a) and also 
solely for those not in treatment (Baker et al, 1994). It has also been administered to 
people whose primary drug was amphetamine (Hall and Hando, 1994). Where 
possible, I use these findings from other researchers to make comparisons with the 
people I interviewed.
The OTI has been found to be both reliable and valid (Darke et al, 1991a; Darke et al, 
1991b; Darke et al, 1992a; Adelekan et al, 1996; Deering and Sellman, 1996). It has 
been structured so that the higher the score, the greater the degree of indicated 
dysfunction. During the development of the OTI, results obtained in the HIV risk 
behaviour scores (HRBS), and the social, criminal, physical, and psychological health 
domains, were divided by Darke and colleagues into quintiles. This, then, allows for a 
clinical interpretation of the degree of dysfunction for each of these domains. The 
degrees of dysfunction were classified by the researchers as High, Above Average, 
Average, Below Average and Low (Darke et al, 199la:23-24). I also analysed my data 
according to these degrees of dysfunction (also defined in Table 3, Appendix 4) but the 
results must be viewed with some caution since, as Dark and colleagues indicate, the 
degrees of dysfunction are based solely on the distribution of the scores of respondents 
interviewed during the development of the OTI and they are continuing their work “to 
provide more comprehensive norms” (1991a:24).
The General Health Questionnaire-60 (GHQ-60) was developed by Goldberg with the 
aim of detecting people with a current diagnosable non-psychotic psychiatric illness 
(1972). Several scaled versions were subsequently designed including the GHQ-28 
(Goldberg and Hiller, 1979). This has been found to be a valid and reliable instrument 
for measuring psychopathology (Goldberg and Hiller 1979; Goodchild and Duncan 
Jones, 1985). Since it is incorporated into the OTI (Appendix 10:393-5), I used it to 
measure psychological health.
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Goldberg and Hiller broke items in the GHQ-28 down into a somatic symptoms area, an 
anxiety area, a social dysfunctional area and a depression area. Each area has seven 
self-completed questions and respondents are informed that the questions relate to 
“medical complaints, and how your health has been in general over the past few weeks” 
(1979:143). There are four possible responses to each of these questions (Appendix 
10:393-5). Either of the first two responses are scored as zero, and either of the second 
two responses are scored as one (Goldberg and Hiller, 1979).
The GHQ-60 item version has been tested within an Australian population of general 
practice clients by Tennant. Each respondent’s score was also re-calculated for the 12-, 
20- and 30-item versions. Tennant found all four to be reliable and valid (1977). Darke 
and colleagues found a high Pearson correlation coefficient of 0.88 for the GHQ-28 
score among 50 opioid users who were retested one week after their initial interview 
(1991a).
Although these findings give room for optimism that the GHQ-28 is a valid and reliable 
instrument for one-off testing, Radovanovfc and colleagues document a problem they 
found when they looked at the test-retest validity of the GHQ-60. When using this 
version of the GHQ, they found a marked decrease in the mean GHQ scores of both 
men and women when they administered the questionnaire to a sample of medical 
students three times with an interval of two years between each test (1988). In order to 
examine the sensitivity of the GHQ-60, respondents were also interviewed by a 
psychiatrist who based his assessment solely on the use of the Standardised Psychiatric 
Interview. Over time, a fall in sensitivity to 64.7 per cent was found. No sensitivity 
tests were possible in my study, and even though Radovanovi'c and colleagues used a 
different version of the GHQ, and were able to identify the confounding factors of an 
attempt by students to hide their symptoms and the inability of the psychiatrist to 
completely ignore the knowledge obtained at previous interviews, their finding is of 
some concern and needs to be considered when looking at my longitudinal findings.
2.5: The interviews
The first interviews ranged from 1 hour 20 minutes to 7 hours and 45 minutes with an 
average of about three hours; the second interviews ranged from 50 minutes to 2 hours 
and 45 minutes with an average length of about 1 hour and 20 minutes.
Eleven of the first, and 12 of the second, interviews were conducted in respondents’ 
homes. Nine of the first and three of the second interviews were conducted at my 
home. These were generally with people I had got to know through ethnographic work 
and who had previously visited my home. The rest of the interviews were conducted in 
a discretely located office.
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Once we were in the interview venue, a consent form (Appendix 11) was read out to 
prospective respondents who were then asked to read through it themselves to ensure 
they were properly informed. In order to preserve anonymity, and with the approval of 
the ANU’s Ethics in Human Experimentation Committee, the consent form was signed 
by me once I was confident the participant had given their informed consent.
Everyone granted permission for the qualitative data in the first interview to be 
audiotaped. I instructed the people who transcribed the tapes to return them immediately 
if they recognised anyone’s voices. This did not prove to be necessary. The audiotapes 
were a source of some concern to some respondents and once they were transcribed and 
the transcriptions checked, I wiped the tapes. Due to financial constraints, the 
qualitative data in the second interview were not audiotaped.
2.6: Ethical considerations
I attempted to get my research gazetted under the Commonwealth Epidemiological 
Studies (Confidentiality) Act 1981. This Act helps ensure the confidentiality of data 
provided by respondents. Both the 1989 ANAIDUS and AIC research were gazetted 
under this Act, and this proved to be useful in encouraging respondents to present for 
interview. I was unable to have my research covered as the Act covers only research 
instigated by the Commonwealth. I eventually commenced interviewing without legal 
protection. This meant that strenuous efforts had to be undertaken to ensure that 
everything possible was done to protect the respondents from prosecution resulting from 
the data collection. These measures were approved by the ANU’s Ethics In Human 
Experimentation Committee. Completed questionnaires were locked in a secure place 
and data keyed into the computer were placed in a locked partition.
The first 94 people at the first interview were told there was no legal protection of their 
data (Appendix 11: consent form 1). Michael Moore (an Independent Member of the 
ACT Legislative Assembly) was instrumental in drawing up an Epidemiological Studies 
(Confidentiality) Act in 1992 for the ACT1 (Appendix 12). The Act protects the 
respondents by stipulating punishment in the form of imprisonment and/or a fine if the 
researcher divulges any information which might identify them. When my research was 
gazetted under this Act, which contained a clause to protect the data already collected, 
subsequent respondents were informed of this protection (Appendix 11: consent form 
2). I also wrote a small article for the ACTIV League newsletter which included this 
information (Dance, 1992b). Until Simon Bronitt conducted some research on legal 
issues for the Feasibility Research into the Controlled Availability of Opioids, I believed 
the information I gave in both this consent form, and the consent form for the second
1 The impetus for this Act was primarily to protect data collected by the research team for the 
Feasibility Research into the Controlled Availability of Opioids.
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interview (Appendix 11: consent form 3) to be correct. I now know that although “The 
Act does not... permit the disclosure of information ... simply because the information 
is reasonably necessary for the enforcement of the criminal law ... disclosure is 
permitted in special circumstances including ... where [it] has been expressly authorised 
by the Minister” (Bronitt, 1995:42).
I recorded only given names and the first three letters of respondents’ surnames. I had 
already given pseudonyms to respondents from the 1989 research, as well as to the 
earlier new respondents for the research under discussion. After several disparaging 
comments about the pseudonyms I had chosen, I asked subsequent respondents to 
choose their own. The result was happier respondents but, as will be seen, there was 
some duplication of choices, for example, a James-1, James-2 and James-3. There 
were also some unusual choices such as “Mishima” and “Snork.”
The ANU’s Ethics Committee had concerns about me interviewing people under the age 
of consent. Since many adolescent drug users are no longer living in the parental home 
it was not possible to seek parental consent. In addition, full names of respondents 
were not asked for so it was not possible, nor would it have been ethical, to get parental 
consent. The ANU’s Ethics Committee gave me permission to interview young people 
once these points were put to them. As it transpired, I interviewed only one person 
under the age of 16.
Other researchers have raised the question of reciprocity, recognising that the researcher 
takes up a lot of their respondents’ time (Fetterman, 1989; Power, 1989). I provided 
respondents with an honorarium of $40.00 for each interview. This may have been one 
of the reasons people, particularly younger people, presented for interview. There has 
been some debate on the ethics of paying respondents, but, as Cannell points out, we do 
not “really know what effect they have and what is good and bad about them. We have 
a folklore but not the data” (1985:49). Several other Australian researchers have used 
honoraria (Mugford and Cohen, 1989; Darke et al, 1991a; Ross et al, 1993a; Spooner 
and Flaherty, 1993; Dobinson and Poletti, nd). It is possible, however that payment is a 
form of coercion and it is also possible that this payment biased the sample by attracting 
those with low incomes. These are more likely to be younger people.
During the interviews I provided tea, coffee, biscuits and cigarettes. For some of the 
longer interviews I also provided lunch or dinner. I handed out educational leaflets and 
booklets related to illegal drug use and HIV to interested respondents. Respondents 
were asked if they wanted feedback from the interview and for those (the majority) who 
did, I gave education about unsafe drug use, needle use and sexual behaviours. I 
supplied condoms and exchanged needles and syringes, and where necessary, supplied
referrals to people who solicited help or information or whom I thought needed 
professional help.
All my research findings so far have been directed back to as many respondents as 
possible and I offered copies of my publications to everyone I interviewed. Most 
respondents took some, or all, of my publications. The paper on the “Saint Oswald’s 
Day” celebrations proved the most popular (Appendix 3). Largely as a consequence of 
this, there were many more participants in the 1992 celebrations than in previous years. 
This caused me some angst, but Oswaldians considered this to have been a very 
successful “Saint Oswald's Day” and non-Oswaldians did not appear at subsequent 
celebrations.
Other researchers have demonstrated a correlation between illegal drug use and physical 
and sexual abuse (Dembo et al, 1988; Howard, 1993a; Howard, 1993b). After careful 
consideration, and with the rationale that I did not want to resurrect such painful 
memories, I decided not to include questions relating to abuse. Nevertheless, several 
people talked spontaneously about their physical, sexual or emotional abuse. Some time 
after the interviews, I was criticised by one young man because of his recollection of the 
way I had conducted the interview. His memory was that I had asked him questions 
relating to his childhood abuse and then not discussed them with him. Only by going 
through the transcripts with him was I able to convince him that I had not. The fact 
remains that the interview triggered some painful memories and I did not deal with his 
feelings adequately. I remain concerned that there are other people I have similarly hurt. 
One of the harm minimisation recommendations I make (Chapter 9) is related to the 
importance of interviewers being prepared to deal with issues of abuse.
Given my continued closeness to some Oswaldians, these are the people that the thesis 
is most likely to reach. This poses ethical problems since giving too much detail will 
identify the individuals being discussed. In those cases where I was in doubt about 
disclosing information of a sensitive nature, and which could possibly also reveal the 
identity of the respondent involved, I showed what I had written to the person 
concerned. In instances where respondents expressed any misgivings, these findings 
were removed from the written work.
2.7: Sources of bias
The people with whom I conducted ethnographic work became friends. There are 
negative implications of this. I did not have the same degree of rapport with everyone I 
interviewed and this may be reflected in my research findings.
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I became aware that it takes some time to stop looking through the eyes of respondents. 
The researcher is surprised and happy with all the things that they (contrary to 
expectations) can identify with and have in common with a culture which is different 
from their own and this colours their vision. There follows a kind of transformation, 
for in order to be able to look at the data objectively the researcher must reimpose some 
distance from it1.
Another possible source of bias in this research is that, from its inception, its design was 
guided by only some of the people that I interviewed. This happened first during the 
1989 interviews when Sarah indicated to me that there was a group structure, later 
informing me that there had been profound changes amongst the drug use patterns of 
some Oswaldians and that these should be studied. Some group members, as well as 
service providers, made suggestions regarding the structure of the interview guides and, 
because I respected their knowledge and their ability to give me constructive comments, 
some respondents were deliberately chosen for the pilot interviews. Their views may 
not be representative of everyone I interviewed.
Lastly, only a finite number of illegal drug users are willing to be interviewed, 
particularly for such a long and penetrating interview as mine, and their self-selection, as 
well as my selection of some respondents, may also bias the findings.
2.8: Reliability and validity
Several studies have been conducted on the reliability and validity of data obtained from 
illegal drug users. These have relied largely on treatment samples where the respondent 
is already a known drug user, or on surveys from probability samples of households or 
schools. Following comparisons between data collected at interview from 59 “narcotic 
drug addicts” with their hospital and FBI records, and urine samples Ball concluded that 
the results indicated “a rather surprising veracity ... the data were quite reliable and 
valid” (1967:653). He went on to suggest that the method of interviewing affects the 
respondent’s motivation to be either “candid, equivocal or deceitful” (1967:654). Willie 
also found the data he collected from formerly dependent opioid users to be valid and 
reliable (1983). Some researchers have also looked at the data on HIV risk behaviours 
collected from people who use illegal drugs and also found them to be reliable (Gibson 
and Young, 1994; Des Jarlais et al, 1996).
In their small sample of heroin users who were interviewed face to face, Davies and 
Baker found major differences dependent upon whether the interviewer was a known 
heroin user or a “straight” interviewer: respondents presented themselves as more
1 I am grateful to Dr Leslie Devereaux (a social anthropologist) for elucidating this concept to me.
26
‘“ addicted”’ to the ‘“ straight” ’ interviewer. Davies and Baker concluded that it was not 
possible to know which version was more truthful (1987). A national probability 
survey of high school students’ drug use reported by Bachman and O’Malley found 
marked discrepancies between drug use reported during the previous month and that 
reported during the previous year. Blaming recall bias, they suggest that much of the 
discrepancy was due to an under-reporting of drug use in the past 12 months (1981).
The evidence is, therefore, somewhat equivocal, but there are ways in which the 
interviewer can maximise the validity of data collected at interview. Several are outlined 
by Nurco (1985:8-9). Firstly, he discusses the issue of assuring confidentiality of the 
data. I did my best to ensure this, but having prior legal protection for the data would 
have been even more reassuring to those respondents who had to be told that there was a 
possibility that the data could be subpoenaed.
Nurco recognises the establishment of rapport as another important element. Becker 
believes that deviants and non-deviants are each outsiders to the other (1963). Adler is 
even more pessimistic in her belief that “deviants are more difficult to locate, befriend 
and investigate than other subject populations” (1990:97). Although Tam Stewart is 
writing about new heroin users contacting current users, some of her more optimistic 
insight is also apposite for researchers. My experience is similar to Stewart’s who 
maintains that, in many respects, users want you to be “like them ... to prove they are 
not weird outsiders after all. Against their better judgement, they want your acceptance, 
involvement and approval.” It is not, however, necessary for researchers to “share [all 
users’] experiences” (1987:12). Further advice which assisted my interaction with 
respondents was provided by Roger, who at that first discussion back in 1989 had told 
me “We're not idiots, whatever you do don't treat us like idiots.”
Nurco also identifies the need to concentrate on recent events as being a major issue. In 
my pilot interviews I did ask several questions relating to early drug use, but most were 
removed when I realised the problem of recall. The final relevant issue discussed by 
Nurco is related to making questions less specific. For example, from the pilot 
interviews I conducted, it became obvious that most people, particularly those whose 
drug consumption patterns were high, could not tell me how many times they had used a 
drug in the 12 months prior to interview. Instead, I then asked for some sort of range 
from the maximum number of times they had used a drug in the given period, to the 
minimum number of times they had used it.
My integrated methodology also helped maximise validity since this allows the checking 
of some of the interview data against ethnographic observations (Plant and Reeves,
1976; Fetterman, 1989). The prospective nature of this data collection also enabled me 
to check on the validity of data collected at the first interview.
I used several ways of maximising the reliability of the questions I asked. Firstly, I was 
the only interviewer for the data collection so I was sure that the questions were always 
asked in the same way. After reading The Opiate Treatment Index (OTI) Manual (Darke 
et al, 1991a), I contacted Shane Darke on several occasions to ensure that I understood 
the questions. Having designed the interview guides myself and having conducted all 
the interviews, I was conversant with the rationale for the questions being asked, and 
the questions were all asked in a similar way. The interview guides for the first round 
of interviews were piloted with 23 respondents (both Oswaldians and non-Oswaldians). 
The major changes that occurred took the form of shortening questions and removing 
those that either did not work or were repetitive. The interview guides for the second 
round of interviews were piloted with 10 respondents. The data from the pilot 
interviews were included in the analyses but, as a consequence, there are some missing 
values.
Because of financial constraints I was the only person who coded the qualitative data. 
Having other people also code the same data would have been another way of 
maximising the reliability of the findings.
2.9: Data analysis
Qualitative analysis requires the researcher to search the transcribed text and explore and 
interpret its meaning (Richards, 1990). The transcripts of my qualitative data were 
searched in this way, then coded and analysed with the Non-Numerical Unstructured 
Data Indexing, Searching and Theorising (NUDTST) computer program.
Analysis of the descriptive quantitative data was largely achieved with the StatView 
program. Because there were no normal distributions in any of the variables discussed, 
I relied on non-parametric statistics for analysing the ordinal data. Where there were 
more than 20 people represented in a given numerical variable, I performed comparative 
tests and worked out the medians, ranges and interquartile ranges. In variables which 
involved fewer than 20 people, comparative tests were not performed and only the range 
is presented. I used the Chi2 test for comparisons of nominal variables at each 
interview. The McNemar test was used to examine the significance of changes in 
nominal variables between the two interviews. Since the StatView program does not 
include the McNemar test, I worked out these analyses with the aid of a calculator. 
Where there were ordinal data, non-parametric statistics were also used for making 
comparisons between subsets. The Mann-Whitney U test was used for comparing
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subsets within each interview and the Wilcoxon matched-pairs signed-ranks test was 
used for examining changes between interviews.
Most tables are attached separately as appendices. I present only the median numbers in 
the text where I also refer to tables which include ranges and interquartile ranges. The 
results of the significance tests are presented in the text rather than the tables since the 
size required for most tables precluded their inclusion there. When working out the 
percentages, very few of the totals reached a round 100 per cent and these totals are 
usually left blank. . . . . . .
I used the data from the first interview to compare those who presented only for this 
interview with those who went on to present for the second interview. I also made 
gender comparisons, and comparisons between the Oswaldian subsets and their 
opposite subsets at both interviews. Unless otherwise indicated, no significant 
differences were found and I have only tabled the results of the subsets separately where 
I did find significant differences.
As determined by Fisher, probability (p) tests are usually set at the 0.05 level of 
significance (Blalock, 1979). According to Rothman, many statisticians have been 
concerned about the interpretation of p values when multiple comparisons are made, and 
they have suggested that this should be corrected for by dividing 0.05 by the number of 
tests performed in order to obtain a nominal significance level (1986). Rothman, 
however, questions this by asking at what point a researcher should stop making these 
adjustments, for example should it be at the level of one question, or should it be all the 
tests ever performed by a particular researcher?
I checked to see what would be the effect on my p values of correcting for multiple tests. 
If, for example, I take one variable and divide 0.05 by 4, the largest number of 
comparative tests performed on a variable (that is between all the subsets at the first 
interview), a p of 0.0125 is obtained. If 0.05 is divided by 3 (the most comparative 
tests performed on a variable at the second interview) a p of 0.0167 is obtained. Taking 
this further by, for example, looking at the 12 variables in the OTI Social Domain, 
which results in 48 comparative tests at the first interview, a p of 0.00104 (0.05 divided 
by 48) is obtained. I took this even further and divided 0.05 by all the comparative tests 
done for all the variables in the OTI and obtained a p of 0.00047. I concluded that there 
obviously comes a point at which correcting for multiple testing, particularly when there 
is a small number of respondents as in my sample, means that the power to test anything 
is lost. I decided to set the p at 0.01, that is, approximately according to the number of 
tests performed on each variable. Given the debate in the literature surrounding the 
issue of multiple comparative tests, and given that I set the p value at 0.01, lower than
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that determined by Fisher, I also note where any differences approached the level of 
significance I set. I acknowledge that there may, therefore, be Type A errors but I have 
also noted where differences approached significance because my research was 
exploratory and the intention was that is should be hypothesis generating. I have also 
noted when my findings were different from those obtained from other samples of 
people who use illegal drugs.
Though it was possible to fill in some of their missing values from the interview guide, 
there are two missing values for most of the OTI findings from the people I interviewed 
because two people did not have enough time to complete the OTI at the first interview. 
In these cases, and also in other instances where there were missing data from one 
interview, and where comparative tests were made between the two interviews, the 
corresponding values were also treated as missing.
Where possible, I also made comparisons between my results and previous relevant 
results collected from (mostly Australian) people who use illegal drugs. When making 
comparisons between my sample and samples that were solely composed of IDUs, I 
also looked separately at the subsets of IDUs I interviewed. Since I used non- 
parametric statistics, while most results from other samples were obtained by parametric 
statistics, direct comparisons were not possible. The comparisons do, however, give 
some indication of how the people I interviewed compare with other samples of people 
who use illegal drugs.
2.10: Summary
This chapter has covered the methods I used to obtain and analyse the data for the 
findings discussed in Chapters 3-8. The discussion in these chapters show that though 
some of my findings are similar to those reported by other researchers, there are also 
some differences. In these results chapters, I also discuss problems associated with the 
attrition rate and the, often quite profound, changes which occurred between the two 
interviews.
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CHAPTER 3: SOCIODEMOGRAPHIC PROFILES
3.1: Introduction
Before going on in subsequent chapters to discuss aspects of the respondents’ lives 
related to their drug use, I set these in context by presenting here the sociodemographic 
profiles of the people I interviewed. In addition to other comparisons, where possible, I 
also compare my findings with the results from the 1992 ACT Census of the general 
population in Canberra.
The sociodemographic results, related to residential stability, gender, age, country of 
birth, religion and secondary and tertiary education, are prefaced with an overview of 
some of the features of the geographical location of the research.
3.2: Characteristics of the ACT
Canberra is the national capital of Australia and is part of the ACT which, when the 
research began in 1992, had a population of around 296 000 (Jacobs, 1993). Canberra 
is a planned city and was created in 1911 to house both a Federal Parliament and a 
Commonwealth Public Service. As a result, Canberra has more than half of its work 
force in the public sector, compared to less than a third nationally (ACT Community and 
Health Service, 1988), resulting in what may be described as a government company 
town.
The ACT is an “island” within the south east of New South Wales (NSW). It is situated 
between Sydney (the state capital of NSW), which is 320 kilometres away from 
Canberra, and Melbourne (the state capital of Victoria), which is 640 kilometres away. 
Both these cities are important sources of illegal drugs The small adjacent city of 
Queanbeyan, which is in NSW, functions, in part, as a suburb of Canberra since 
residents treat the cities as an extension of one another for services such as housing and 
shopping. Nor is it unusual for people seeking illegal drugs to travel from one city to 
the other to obtain them.
3.3: Residential stability
At the first round of interviews, everyone gave an ACT post code. In spite of the 
population of the ACT being considered to have a “traditional volatility of interstate 
arrivals and departures” (Jacobs, 1993:25), the majority of respondents had been 
Canberra residents for at least 11 years (Table 1, Appendix 13). Other research has 
found that people who use illegal drugs tend to be more mobile than those I studied. 
The researchers in the ANAIDUS study, for example, concluded that the respondents in 
their survey had “a substantial degree of mobility” (1991:16).
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Those who went on to also present for the second interview had lived in Canberra for a 
median of 13 years (range one month-31 years, interquartile range 5-23 years) compared 
to a median of 4 years (range one month-30 years, interquartile range 10 months-17 
years) for those who presented only for the first interview (Z -3.422, p < 0.001).
3.4: Gender
There were 38 women (39.2%) and 59 men (60.8%) in the sample. The gender 
distributions for current IDUs were similar at both interviews to that of the total sample, 
as were the gender distributions for the Oswaldian and non-Oswaldian subsets 
(definitions of the subsets are included in Table 2 in Appendix 4) (Table 2, Appendix 
13).
Some other samples show a smaller proportion of women than found in my sample. 
The ACT DIP drew all of its sample from treatment settings and corrective agencies and 
29 per cent of their sample were women (Stevens and Wardlaw, 1994). In the national 
ANAIDUS project, where 57.8 per cent of people had been in treatment and 35.6 per 
cent had been in prison, 31.9 per cent of the respondents were women (1991). The OTI 
study included 230 people receiving opioid treatment, as well as 60 who were not, and 
these researchers found a “male to female ratio of approximately 2:1” (Darke et al, 
1992a: 735). A census conducted of treatment agencies in Australia during March 1992 
found that only 27.9 per cent of clients were women (Chen et al, 1993). (This survey 
excluded clients receiving only methadone and no other services.) Of the 716 
respondents in Crofts and Aitken’s’ cohort of IDUs from Victoria (Australia), 39 per 
cent were women and 60 per cent were men (one respondent was transsexual) (1997). 
This gender distribution was, therefore, almost identical to that found in my sample. In 
their study of “recreational” cocaine users Mugford and Cohen found a slightly larger 
proportion of 44 per cent of women than that found in my study (1989), as did Maher in 
her ethnographic work where 45 per cent of the sample were women (1996).
The possibility that women are more likely to present for interview where the 
interviewer is also a woman is not supported by the research on “recreational” cocaine 
users reported by Mugford and Cohen where the interviewers were male and a large 
proportion of respondents were female (1989). The majority of people in my sample 
had never been in treatment or in prison. The different gender distribution, compared to 
those drawn from treatment or prison settings, may be due to the fact that men are more 
likely than women to go into treatment or be incarcerated. Some Australian researchers 
maintain that women are under-represented in most drug treatment programs (Walby, 
1988; Stevens, 1989; Hamilton, 1993). These authors believe that women-centred 
services are required in order to both attract and retain women with health problems due 
to drug use. Based on her experiences as a co-ordinator of a Therapeutic Centre which
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provides childcare, Major-Blatch has found that the provision of this service leads to an 
increase in the number of women using the service (1994).
3.5: Age
Figure 3.1 shows that at the first interview this was a young sample of respondents with 
a median age of 24. Those who presented only for the first interview had a younger 
median age of 19 (range 15-37, interquartile range 18-25) than those who went on to 
present for the second interview (Z -2.854, p < 0.01).
Figure 3.1: Age distribution at first interview
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By the time of the second interview, the median age was 26 (Table 3, Appendix 13). 
Mugford and Cohen found the same median age in their sample of “recreational” cocaine 
users (1989). The respondents in the ACT DIP had a similar mean age of 26.5 
(Stevens, 1990), as did the ANAIDUS respondents who had a mean age of 27 (1991). 
Darke and colleagues report a slightly higher mean age of 29.7 among respondents 
interviewed for the development of the OTI (1992a). The census data reported by Chen 
and colleagues found an even higher mean age of 34.3 for clients of treatment services 
(1993). Maher’s ethnographic work in Sydney uncovered a very young sample with a 
mean age of 20 (1996).
Because it is a comparatively new city, Canberra has a younger age profile than 
Australia as a whole. The 1991 Census of population and housing found the greatest 
number of ACT residents in the 20-24 age group (9.8%), whilst Australia in general had 
a greater number of people aged between 30-34. The median age of people living in the 
ACT was 29.7 at the 1992 census compared to an Australian median of 32.2 (Jacobs,
1993). This may partly explain the younger age at their first interview of the people I 
interviewed compared to some other samples. Unlike most other samples, the majority 
of people had not been in treatment at the time of the first interview (as will be seen in 
Chapter 5, there were profound changes in treatment status between interviews). It is 
probable that age and a longer history of drug use are correlated, which, in turn, 
correlates with a need for treatment.
There are other possible reasons for the low median age in my sample. Quite 
unplanned, my interviewing room turned out to be situated next door to a “squat”1. 
Sara, one of the young people living there, picked up one of my flyers from the AIDS 
Bus and made an appointment for interview. She passed flyers on to her friends in the 
“squat” who used illegal drugs. Most then presented for interview. It was obvious that 
the honorarium was a major incentive. In addition, Cliff, a core-Oswaldian, passed on 
one of my flyers to his sister Annabel who was still at school. Annabel presented for 
interview and was then the source of a snowball for her network of friends, the majority 
of whom were also still at school. As previously detailed (in Chapter 2), one of my 
ethnographic areas is a venue frequented by (mostly young) tertiary students. This led 
to several introductions with students who then made interview appointments.
There was a median age of 23 at the first interview for women, compared to a median 
age of 25 for men (Table 3, Appendix 13). By the second interview, there was a 
median age of 25 for women and a median age of 26 for men. At both interviews, these 
differences approached significance (at the first interview: Z -2.329, p = 0.0198, at the 
second interview: Z -2.24, p = 0.0250).
Similar gender differences in age are not restricted to my sample. The ACT DIP study 
(Stevens and Wardlaw, 1994), Maher’s ethnographic study (1996) and the Australian 
Study of HIV and Injecting Drug Use (ASHIDU) (Loxley et al, 1995) also found that 
women were younger than men. The ANAIDUS research (1991), the census of clients 
of treatment services (Chen et al, 1993), a study of clients in methadone maintenance in 
Adelaide (Dyer et al, 1992) and studies from the USA of clients in methadone 
maintenance (Hser et al, 1987) all found this difference to be significant.
Table 3 in Appendix 13 also shows the ages of the IDUs and the ages of the people in 
the other subsets revealing only marginal differences between any of the subsets.
T A “squat is an abandoned building which is utilised as a dwelling place without payment or rent. 
“Squats” are often used by homeless people, particularly young people. These dwellings are usually 
occupied on a temporary basis.
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3.6: Country of birth
Seventy six people (78.4%) were Australian born (Table 4, Appendix 13). Two of 
these people were Aborigines. Fifteen of the other respondents were bom in an Anglo- 
Celtic country. Of the 6 who were not, only one woman (bom in Argentina) and one 
man (bom in Japan) were of non-Anglo-Celtic parentage. Most of the 21 people bom 
outside of Australia were long term Australian residents since 16 had arrived before 
1975. A further 4 people had arrived during 1976 to 1987 and one had arrived quite 
recently, since 1990.
The profile for country of birth is very similar to the 1992 treatment census reported by 
Chen and colleagues, in which 75.1 per cent of clients were Australian born non- 
Aborigines (1993). It is also like the ANAIDUS sample, where 80.1 per cent were 
Australian bom (1991) and approximates that of the 1992 ACT census which showed 
that 74.6 per cent of the ACT population was Australian bom (Jacobs, 1993).
Only three (3.1%) of the people I interviewed said that a language other that English was 
spoken at home. This is somewhat different from the 1992 ACT census which found 
about 15 per cent of people over the age of 4 in this category; the languages most 
commonly spoken were Italian at 10.8 per cent, one of the Chinese languages at 9.5 per 
cent, and both Greek and Croatian at 8.3 per cent (Jacobs, 1993). Only 11 of the people 
I interviewed (11.3%) had one or both parents who were of non-Anglo-Celtic origin. 
None of these people had either Italian or Greek parents. There was only one 
Australian-bom person who had a parent bom in a country where Chinese languages 
were commonly spoken. Another Australian-born person had one parent who 
originated from Croatia. Part of the difference in my sample, compared to that of the 
census, could be attributed to the fact that only people who were proficient and confident 
with their English speaking skills felt comfortable about presenting for a long face to 
face interview. Other factors might include differentials in illegal drug use consumption 
between ethnic groups, or a greater fear of illegal drug use being discovered among 
some ethnic groups.
3.7: Religion
At the first interview, most people (n=78, 80.4%) said they did not belong to an 
orthodox religion and only 6 people (6.2%) said that they belonged to a Christian 
religion (Table 5, Appendix 13). Thirteen people nominated a non-Christian religion: 5 
were core-Oswaldians who laughingly responded that “Oswaldianism” (Appendix 3) 
was their religion.
The low incidence of affiliation with orthodox religions is similar to Mugford and 
Cohen’s finding that only 5 of their 73 “recreational” cocaine users identified themselves
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with any organised religion (1989). My finding supports Plant’s opinion, based on his 
research with people who use illegal drugs, that “many drug takers identify themselves 
as agnostic, atheist, or as having adopted Oriental forms of belief ... Many belong to 
recently formed sects” (1976:40). The finding is, however, very different to the overall 
population in Canberra where in the 1991 census 71.1 per cent of people identified 
themselves as Christian (Jacobs, 1993).
3.8: Secondary education
At 62.1 per cent for the first interview (n=59), and 66.3 per cent for the second 
interview (n=62) (Table 6, Appendix 13), there was a high proportion of people who 
had completed their secondary education by attaining a Higher School Certificate (HSC) 
in year 12. In order to make a better comparison with studies which have focused on 
IDUs, I looked separately at the IDUs in my sample and found the proportions of 
completed HSC to be similar to those of the total population I interviewed. At the first 
interview 61.6 per cent of current IDUs (n=45) had achieved their HSC. There was 
only a minimal change at the second interview when 61.8 per cent of the then current 
EDUs (n=47) had achieved this level of secondary education.
According to Plant, “Drug takers are more likely than non-drug-takers to report that they 
have stayed on at school after the minimum leaving age (1976:39). Several Australian 
studies have, however, shown a smaller proportion of people who have completed their 
HSC than found in my sample. The ANAIDUS researchers report that 19.7 per cent of 
their sample nominated having completed secondary education as their highest level of 
education attained. An additional 11.4 per cent had undertaken some tertiary education 
and a further 8.8 per cent had completed tertiary education (1991). It is probable than 
those in the latter two categories had also completed their secondary education, giving a 
likely overall proportion of 39.9 per cent who had reached this level of education. In 
Lenton and Tan-Quigley’s Western Australian study, 23.8 per cent of their sample 
nominated completion of “Senior High School” as their highest level of education 
(1997:23). An additional 6.8 per cent had completed university or college and 3.7 per 
cent were enrolled in this form of tertiary education and could, therefore, be also 
expected to have completed high school. This gives a probable overall percentage of
34.3 per cent who had completed high school. The ASHIDU finding was similar since
27.4 per cent of their national sample had “Completed year 12” (Loxley et al, 1995:21). 
Spooner and colleagues found a higher proportion. Forty nine per cent of the 581 
young people (described as occasional illegal drug users) they interviewed had “at least” 
their HSC (1993:161).
As shown in the following section of this chapter, a large proportion of the people I 
interviewed were university students who were likely to have completed their HSC.
The higher level of HSC found in my sample, compared to others cited may also partly 
be explained by Canberra having higher school retention rates than the national average 
(Jacobs, 1993). Other evidence that some people who use illegal drugs do achieve 
higher levels of education was found in a United States study of secondary students 
where 70 per cent of the academically successful reported some type of drug use (Evans 
and Skager, 1992). The findings to be reported in Chapter 5 reveal a significant 
reduction in the numbers of drugs used between the first and second interviews, and 
also show that many people had reduced their levels of intake. In a study of 422 heroin 
users, Waldorf found that those who had remained in high school had more resources to 
support long abstentions compared to those who did not (1970). Though this finding 
may bode well for the people in my sample who had completed their HSC, and who 
wished to control their drug use, it is not an optimistic finding for the less academically 
successful.
At 62.8 per cent (n=59), those who went on to present for the second interview had a 
larger proportion of people who had completed their HSC at the time of the first 
interview than the proportion of 28.6 per cent (n=12) for those who were only 
interviewed once (Z -3.553, p < 0.0005). One of the most difficult subsets of people to 
relocate were those still at school at the first interview and who could not, by definition, 
have completed their HSC. This would explain much of this difference.
Although I found no significant educational difference between women and men at either 
interview, other Australian studies of people who use illegal drugs have found that 
women had achieved a significantly higher level of education than men (ANAIDUS, 
1991; Loxley et al, 1995).
During my 1989 research, I found that most Oswaldians I interviewed had attained their 
HSC and hypothesised that, compared with the other illegal drug users I interviewed, 
there would be a higher proportion of those who completed HSC among the 
Oswaldians. At the first interview, 71.1 per cent of Oswaldians (n=27) had obtained 
their HSC compared to 57.1 per cent of non-Oswaldians (n=32). At the second 
interview, there had been no change in the number of Oswaldians with their HSC but 
three non-Oswaldians had obtained their HSC between interviews so that a total of 62.5 
per cent of non-Oswaldians (n=35) had their HSC.
At the first interview, 80 per cent of core-Oswaldians (n=20) had obtained their HSC 
compared to 56.5 per cent of the Remainder (n=39). These differences approached 
significance (Z -2.293, p = 0.0220). By the second interview, there had been no 
change in the number of core-Oswaldians who had obtained their HSC but 3 people in 
the Remainder subset had attained their HSC between interviews thus increasing their
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proportion to 69.8 per cent (n=42). This difference in educational level no longer 
approached significance. There is, therefore, insufficient evidence to support my 
hypothesis.
3.9: Tertiary education
The proportion of people previously or presently involved with tertiary education was 
high (Table 7, Appendix 13). Of those who were eligible by age, there were only 36.0 
per cent at the first interview and 31.9 per cent at the second who had no tertiary 
education. Only small numbers had, however, completed a degree or diploma. At the 
first interview 10 people (11.6% of those eligible by age) had completed an 
undergraduate degree or diploma (1 completed postgraduate, 5 present postgraduate and 
4 completed undergraduate). By the second interview, 15 people (16.0% of those 
eligible by age) had completed their undergraduate studies (two completed postgraduate, 
four present postgraduate, two discontinued postgraduate and seven completed 
undergraduate). There were a further five people at the first interview, and seven at the 
second, who had completed a trade or professional certificate.
These finding support Plant’s belief that some form of higher education is more 
commonly reported among drug takers than non-drug takers (1976). The figures for 
completion of tertiary studies in my sample are also comparable to some other Australian 
studies. The ANAIDUS researchers report that 8.8 per cent of respondents had 
completed tertiary education (1991). A slightly higher percentage of 14 per cent who 
had completed a university or college course, and an additional 27.2 per cent who had 
completed a trade or technical course was uncovered in the ASHIDU research (Loxley et 
al, 1995). Lenton and Tan-Quigley report that 6.8 per cent of their sample had 
completed university or college and an additional 22.4 per cent had completed a trade or 
technical course (1997). Only 16 per cent of the “recreational” cocaine users surveyed 
by Mugford and Cohen had not attended a tertiary institutional989).
At their first interview, more than a quarter of the people I interviewed who had 
completed secondary school were presently university undergraduate students (n=23, 
26.7%). This is much higher than the proportion found by Lenton and Tan-Quigley 
where 3.7 per cent of their sample were enrolled at a university or college at the time of 
interview (1997). One of my ethnographic areas is a venue frequented by tertiary 
students, which led to several introductions to students who then made interview 
appointments. This partly explains the large number of university students in my 
sample compared to other samples. In addition, a history of involvement in tertiary 
education is fairly common in the general ACT population since around 20 per cent have 
a degree or diploma and a similar proportion have a trade or other certificate (ACT 
Community and Health Service, 1988).
At the first interview, 11 people had discontinued an undergraduate degree or diploma 
and one had discontinued a trade certificate. By the second interview, the number of 
people who had discontinued their tertiary studies had increased to 15: two more people 
had discontinued a trade certificate and two a postgraduate degree or diploma. This 
attrition rate is of some concern but I did not ascertain reasons for discontinuation of 
studies and am unaware of data from the general population of tertiary “drop outs” that 
would allow for any comparisons.
3.10: Conclusion
I was looking for Canberra-based people who use illegal drugs. In spite of Canberra 
having a relatively mobile population, most people I interviewed had been Canberra 
residents for a lengthy period. This indicates residential stability in the majority of 
respondents who presented for the second interview. These people had, however, lived 
in Canberra for a significantly longer time than those who presented only for the first 
interview.
Those who presented only for the first interview were also significantly younger than 
those who were interviewed twice. In fieldwork terms, the people I had least success in 
tracking down for a follow-up interview were those who had presented from the 
snowball to the school and those, mainly teenagers, from a “squat.” Only nine of the 19 
people from the snowball into the school (47.4% of this snowball), and only 11 of the 
24 people from the “squat” (45.8% of these people) were accessible for the second 
interview. This high attrition rate from these two sources helps to explain both the 
significantly younger age of those who presented only for the first interview and their 
significantly shorter period of Canberra residency. These differences will influence the 
findings discussed in subsequent chapters in as much as the people who were 
interviewed twice would, in general, have a longer history of using drugs.
The people I interviewed were similar to other ACT residents in terms of their 
sociodemographic profile but not in terms of their religious beliefs. In this respect, they 
are similar to Mugford and Cohen’s finding (1989) that belonging to an orthodox 
religion is uncommon among people who use illegal drugs.
As with other samples of people who use illegal drugs, more men than women 
presented for interview but compared to samples drawn from treatment and corrective 
agencies, and also samples which contained a larger proportion of people with a 
treatment and incarceration history, a larger proportion of women presented for my 
interviews. Both my research and that of other largely non-treatment populations 
suggest that there are more women using illegal drugs than indicated by samples solely 
drawn from treatment settings.
Several studies, including mine, have found women to be younger than men. It is 
possible that, in the samples obtained from treatment settings, the women are younger 
because younger women are more likely to have no childcare responsibilities. This 
would facilitate their ability to enter into treatment. This does not, however, explain the 
younger age of women who were not in treatment. I suggest that there is a need for 
further research to examine more fully the relationship between gender and age among 
illegal drug users. Until there is more research, several questions remain unanswered. 
For example: if women do start using drugs at an earlier age, what sort of predisposing 
factors are at work? With regard to the findings that women in treatment are younger 
than their male counterparts, could this be because they are more likely to have problems 
earlier, or could it be that they are perceived by themselves, or others, to be having more 
problems?
Respondents at the first interview were younger than those found in other Australian 
studies, but by the second interview their median age was similar to that of several other 
studies.
There was a higher proportion of those who had completed their secondary education in 
my survey compared to other surveys of illegal drug users. Both my study and some 
other Australian studies have found that many illegal drug users spend some time 
studying in tertiary institutions. Mine also found that there was a considerable attrition 
rate. These findings suggest that in order to promote safer drug use and to also 
potentially reduce tertiary attrition rates among illegal drug users, it would be 
worthwhile to specifically target tertiary institutions with harm minimisation messages.
Because of the honorarium of $40.00 for each interview, there might have been an over- 
sampling of the unwaged, the unemployed, low income workers and students. All of 
these people are more likely to fit in the younger age brackets.
Overall, then, I found some differences when comparing the people I interviewed with 
other samples, but I also found some similarities. Based on these findings, my 
hypothesis that the people I interviewed would be different from other illegal drug users 
studied is only partially upheld. I found no significant differences in any of the 
characteristics discussed here, either when I compared all the Oswaldians with the non- 
Oswaldians, or when I compared the core-Oswaldians with the Remainder.
In addition, the sociodemographic results reported in this chapter provide no evidence to 
support my hypothesis that the Oswaldians would be different from other illegal drug 
users I studied.
41
CHAPTER 4: SETTING THE SCENE: A HISTORY OF DRUG USE IN 
AUSTRALIA, THE ACT AND AMONG RESPONDENTS
4.1: Introduction
This chapter demonstrates that, by comparison with most other Australians, the people I 
interviewed are not unique in that they use drugs, but they are unique in their range of 
experimentation with a wide range of drugs. The majority of drugs they used are 
presently illegal. Unlike the general population of Australians who use only legal 
substances, they are, therefore, likely to be prosecuted for their use. Most people 
smoked tobacco and drank alcohol. As well as the dangers associated with these drugs, 
they are at increased risk because there is no quality control on most of the other drugs 
they used. Over the years, research has demonstrated that many heroin-related deaths
are due to concurrent use of other drugs, notably alcohol (Concool et al, 1979; Kreek, 
1984; Kreek, 1987; Bammer and Sengoz, 1995; Strang et al, 1996; Zador et al, 1996). 
Klee and colleagues found that polydrug users, particularly those who used the 
benzodiazepine temazepam, had an increased likelihood of taking more health risks, in 
particular, sharing needles (1990). Similarly, Darke found polydrug users to be a more 
risky subgroup because they injected more frequently and because they borrowed and 
lent needles more frequently (1994). These findings indicate that the extensive poly drug 
use of the people I interviewed has the potential to further increase the harm associated 
with drug use.
I had hypothesised that I would find differences between Oswaldians and non- 
Oswaldians in polydrug use. In our paper on the Oswaldians (Appendix 3) Stephen 
Mugford and I described this group as “drug enthusiasts”. Although the Oswaldians in 
the present research had used significantly more classes of drugs than the non- 
Oswaldians, there was no longer a significant difference when comparing the number of 
individual drugs. The findings for this research demonstrate the large numbers of drugs 
that had been used by all respondents, and that the term “drug enthusiasts” might equally 
apply to both Oswaldians and non-Oswaldians.
Zinberg maintains that “in any valid theory of drug use [it] is necessary to understand in 
every case how the specific characteristics of the drug and the personality of the user 
interact and are modified by the social setting and its controls” (1984:15). This 
insightful theory of “drug, set and setting” influenced the way I conducted my research 
and present my findings. In this chapter, I discuss the characteristics of the drugs used 
by the people I interviewed and also the social setting and the controls on these drugs. 
In subsequent chapters, I weave in some of the qualitative findings which allow 
glimpses of some of the personalities of the people I interviewed.
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As will be shown in both this chapter and the next, the people I interviewed were 
polydrug users. When Gould and Kleber wrote about polydrug use in 1974 they 
thought that it was probably of only “recent concern” to drug treatment programs. In 
their review of research conducted in the late 1960’s and early 1970's, they showed that 
previous research had concentrated on the association between heroin and marijuana. 
Following their own study among people in treatment settings (who had used a variety 
of other drugs in addition to heroin and marijuana) they concluded that drug use in the 
USA was moving into a polydrug rather than a heroin era (1974). There is now a 
wealth of evidence from overseas (for example, Stimson and Ogbome, 1970; Flaherty et 
al, 1984; Wilkinson et al, 1987; Wiebel, 1988; De Leon, 1989; Klee et al, 1990; Kramer 
et al, 1990; Martin et al, 1993; Pivnick et al, 1994), from Australia in general (Carroll, 
1988; Mugford and Cohen, 1989; Bell, Fernandes and Batey, 1990; Moore et al, 1992; 
Howard, 1993b; Darke, 1994; Hall and Hando, 1994; Loxley et al, 1995) and from 
within the ACT (for example, Latukefu, 1987; Dance, 1991b; Dance and Mugford, 
1992; Stevens and Wardlaw, 1994) to demonstrate that poly drug use is common among 
people who use illegal drugs.
As a backdrop to both the scene changes and individual changes in drug use behaviours 
described in the following chapter, I set the scene in this chapter by giving a broad 
overview of the history of drug use in Australia, followed by a general picture of the 
drug use in the ACT. As an introduction to the histories of the use of classes of drugs, 1 
present a brief overview of their effects, largely concentrating on the perceived positive 
effects. Their harmful effects are discussed more fully in Chapter 6. Towards the end 
of this chapter, I present an overview of the respondents’ treatment histories.
Among the comparisons between my results and those from other researchers, I include 
some from the NDS household survey. As Larson and Bammer have indicated, there 
are, however, several drawbacks to general population surveys: since the use of illegal 
drugs is quite rare, even large surveys identify only a small number of users; homeless 
and institutionalised populations could be expected to contain people who use illegal 
drugs, yet both are obviously excluded from household surveys; and there is a high 
non-response rate where data on illegal activities are being sought (1996). Estimates 
based on the household survey need, therefore, to be viewed with some caution.
4.2: A brief history of drug use in Australia
Contrary to popular belief, Aborigines did use drugs prior to white settlement. The 
major difference between that long pre-settlement history and the 200 years since, is that 
the monitoring and distribution of drugs was previously in the hands of the Aborigines 
rather than in the hands of the Europeans (Brady, 1991). Prior to colonisation,
Aborigines, generally men of ritual standing, used at least four plants containing nicotine 
(Watson, 1991). Pituri, an indigenous desert plant, was used most commonly. Many 
Aboriginal peoples also made intoxicating beverages from local flora (Brady, 1991).
When the first white settlers arrived they brought with them alcohol, usually in the form 
of rum. Aborigines were sometimes forced to drink alcohol for the “amusement” of the 
settlers and white men gave it to Aboriginal women as payment for sexual favours 
(Brady, 1992). We have now reached such a tragic stage that one prominent Aboriginal 
leader was led to say: “Nothing has so thoroughly wasted potential human talent as has 
the widespread contemporary dependence on alcohol and other harmful substances 
among our indigenous population” (O'Donoghue, 1990:5).
The overall amounts of alcohol consumed in Australia, and the relative popularity of 
wine, beer and spirits, have varied greatly since colonisation (Krivanek, 1982) when 
Australia was predominantly a spirit-drinking country and it was legally permitted to 
supplement wages with spirits, usually rum (McAllister et al, 1991). In this century, 
beer became the predominant form of alcohol and a steep rise in use occurred in the latter 
half of this century (Sargent, 1979). Recently, wine has overtaken beer as the most 
popular alcoholic drink and there has also been a large increase in the consumption of 
low alcohol beer (NDS, 1994). The lowest consumption of alcohol occurred in the 
1930s, largely due to the effects of the Temperance Movement and the Great Depression 
(McAllister et al, 1991). After this time, alcohol consumption increased dramatically 
and by 1977 had spread to the extent that Australia was dubbed by a Senate Standing 
Committee into drug use “An Intoxicated Society” (Baume et al, 1977). Since that 
report, there has been a reduction in alcohol use. In recent times alcohol consumption 
dropped by 13 per cent during the period from 1988/89 to 1992/93 (NDS, 1994). 
Notwithstanding this reduction, in 1991, Australia had the second highest per capita 
alcohol consumption in the English speaking world (after New Zealand). At this time, 
it also ranked seventeenth in the world for absolute alcohol consumption (NDS, 1994).
Tobacco arrived in Australia shortly following white settlement and was used as an 
incentive to increase workers’ productivity (McAllister et al, 1991). Its use increased 
gradually in the earlier part of this century, then in the mid 1970’s started to decrease 
(Krivanek, 1982). By 1993, 21 per cent of Australian women and 29 per cent of men 
were regular smokers (NDS, 1994).
In nineteenth century Australia, opiates were used often by all sectors of the population 
in ways that were similar to other western nations. Because there was little distinction 
between opiates used as treatment and “out of need or desire”, there were no medical, 
legal or social sanctions on their use (Manderson, 1992a:508). As in other newly
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colonised countries which experienced waves of Chinese migration from the 1850s, it 
was racial discrimination against these new immigrants which was the progenitor for the 
development of sanctions, including legislative sanctions, against heroin (Manderson, 
1992a). There were also moves from within the Chinese community to prohibit its use 
(Lonie, 1979; Manderson, 1993).
The prohibition on the smoking of opium (but not other methods of use) was gradually 
introduced in every Australian State over a 13 year period beginning in 1895. But, as 
Manderson puts it, “the ardour of the moral entrepreneurs and temperance lobby was by 
no means slaked with the prohibition of opium smoking” (1992a:511). In the early 
decades of this century, Australia followed other English speaking nations, notably the 
United States, which developed laws prohibiting the use of opiates and cocaine unless 
they were prescribed by a medical practitioner. These laws arose in tandem with the 
upsurge of medical dominance (Manderson, 1992a).
Following the first World War, the League of Nations set up an Advisory Committee on 
Traffic in Opium and Other Dangerous Drugs, and in 1925 Australia signed the Geneva 
Convention which led to the adoption by State Governments1 of a legislative scheme of 
regulation, prohibition and severe penalties for non-prescribed drug use which soon 
came to include cannabis (Manderson, 1992a).
Both before and after the second World War, Australia had very high levels of legal 
heroin consumption and by 1951 it was the highest per capita user in the world. This 
led to an enquiry by the Commonwealth Department of Health which concluded that 
consideration be given to prohibiting its medical use. Prohibition was enacted by the 
Commonwealth Government in 1953 and eventually all State Governments bowed to 
Commonwealth pressure to follow suit (Manderson, 1992a).
Australian drug law has been influenced largely by international obligations. In 1967, 
the Australian Federal Government ratified the Single Convention on Narcotic Drugs of 
1961. Whilst preserving this Single Convention, in 1989 Australia signed the 1988 
United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic 
Substances (Norberry, 1991).
In the first half of this century there were some “middle class, middle aged therapeutic 
addicts” who were given their drugs on prescription (Manderson, 1992b:529). This 
practice continued until the late 1960’s when there were not only legislative changes, but
1 Australia was federated in 1900 and this ultimately led to the establishment of six State Governments, 
as well as a Federal Government. There are now also two Territory Governments, including (since 
1989) the ACT, which was previously under the jurisdiction of the Federal Government.
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a change on the profile of drug users who were “young, used drugs recreationally and 
most often smoked marijuana” (Manderson, 1992b:529).
Prohibition has brought to Australia problems which might be considered to be worse 
than the personal use of presently prohibited drugs. For example, numerous 
commissions and official enquiries in Australia (as well as elsewhere) have reported on 
the nexus between corruption and the illegal drug trade (Wodak, 1991; Fox and 
Matthews, 1992). Based on 1988 data, Collins and Lapsley estimated that the economic 
cost of drug use in Australia is $14.3 billion a year. Tobacco accounts for 47.5 per cent 
of this cost, alcohol for 41.9 per cent and illegal drugs for around 10.0 per cent. 
Because there were major unquantifiable areas, Collins and Lapsley consider these 
figures to be “minimum estimates”. They go on to document that 75 per cent of the 
tangible economic cost of illegal drugs arise solely from their illegality (1992).
From the 1960’s onward, there has been a dramatic increase in the use of illegal drugs 
throughout most western societies. Explanations for this include the dominance of 
modem day consumer culture with its emphasis on leisure and pleasure (Mugford and 
Cohen, 1989) and the need to retreat from the complexities of modem society through 
the use of drugs: an adaptation which manifests in “the rejection of cultural goals and 
institutional means” (Merton, 1963:153). Australia is no exception to the modem day 
increase in illegal drug use. In the 1960s there was, as in other Western nations, an 
upsurge of “youth rebellion” alongside a widespread increase in drug use (McAllister et 
al, 1991:203).
4.3: Drug use in the ACT
Most of the people I interviewed were longterm Canberra residents, and in this section, I 
present an overview of what is known about drug use in this city.
The Australian Bureau of Statistics (ABS) National Health Survey found that 30.3 per 
cent of people aged over 18 in the ACT were smokers. This is proportionately higher 
than elsewhere in Australia (Jacobs, 1993).
This survey also found that, compared to the rest of Australia, the ACT reported the 
highest proportion of adults who had consumed alcohol in the seven days prior to 
interview. More males (79.8%) than females (61.3%) reported drinking during this 
period. People in the ACT reported an average consumption of 24.5 millilitres of 
alcohol per day compared to a lower Australian average of 23.6 millilitres (Jacobs, 
1993).
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A random survey drawn from all but three high schools in the ACT found that 
analgesics, alcohol and tobacco were the drugs most widely used. Approximately one 
quarter of the students had used marijuana and inhalants, but the use of other illegal 
drugs was rare (ACT Alcohol and Drug Service, 1991). Results from the 1989 to 1990 
ABS National Health Survey show that the majority of people in the ACT use drugs. 
According to these findings, 66.7 per cent had used medications in the two weeks prior 
to interview. Most (49.9%) had taken pain relievers (Jacobs, 1993).
As part of the Feasibility Research into the Controlled Availability of Opioids, a review 
of illegal drug use in the city was undertaken by other researchers and myself 
(McDonald et al, 1993). This full paper is attached as Appendix 14 and I also make 
reference to it during some of the discussion on specific drugs in both this and the 
following chapter. Some of the more general findings are highlighted below.
In this publication, we remarked that whilst some heroin users fit the stereotypical image 
of “alienated individuals with lifestyles manifesting a constellation of problems”, we 
drew on qualitative data from heroin users interviewed in the ACT to demonstrate that 
many were in control of their lives. We concluded that there is no such thing as a 
“typical heroin user” (McDonald et al, 1993:130).
Our research with illegal drug users, service providers and law enforcement agencies 
demonstrated that almost all illegal drugs were brought into Canberra. Owing to the 
dilution of the drugs as they moved through more levels of the drug market to reach 
Canberra, the drug price/quality relationship was worse than in Sydney or Melbourne. 
As I indicate in the following chapter, there has subsequently been a reported increase in 
the purity of heroin.
4.4: Data collection on drug use at the first interview
The discussion moves on to focus on the drug use histories taken at the first interview I 
conducted for this research. I begin by describing how I collected these data.
Wilkinson and colleagues have demonstrated that there are variations in drug 
concentration among pharmacological classes (1987). The people I interviewed in 1989 
also educated me about the variations in effect among classes of drugs they used. The 
drug use sections of my interview guides (Appendices 6 and 7) were consequently 
designed so that data were collected on specific drugs within a pharmacological class. I 
nominated a class of drug then asked respondents what drugs within this class they had 
used. I did not read out the list of drugs because I did not want to alert respondents, 
particularly the younger ones, to illegal drugs which they had never heard of. I also 
wanted to minimise the chance that people might report use of drugs that they had not
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actually used. Consequently, particularly where I was asking about drugs ever used, 
rather than drugs being currently used, there may have been under-reporting.
Data were collected on drugs which were taken either for their psychotropic effects 
(alcohol, tobacco, some opioids, cannabis, stimulants, psychedelics and inhalants) or to 
assist with problems associated with drug use (some opioids, benzodiazepines, 
barbiturates and antidepressants). There is some overlap between the classes of drugs.
I considered cannabis, for example, as a separate class but it also has hallucinogenic 
properties. The questionnaire was designed so that people were asked about 
tranquillisers they had used. With the exception of Mandrax (which was then included in 
the miscellaneous drugs category) all the tranquillisers that had been used were 
benzodiazepines. I also asked people about their use of barbiturates. Though 
benzodiazepines and barbiturates are not, strictly speaking, classes of drugs, I termed 
them as such for the purposes of this work.
The data collection on prescribed and over the counter drugs was restricted to those that 
the respondents indicated were related to their other drug use. For example, I collected 
data on the use of codeine which was used to assist people when they were experiencing 
withdrawal symptoms from heroin, or to cure a hangover, but did not do so if it was 
used to relieve the discomfort of dysmenorrhoea.
In addition to the drugs which fell into these ten designated classes, I also asked 
respondents if any other drugs had been used for their psychotropic effects, and if, for 
any reason, any other drugs had been taken because of the drugs they consumed. That 
is, I was exploring inter-relationships between drugs consumed. A few people 
mentioned antipsychotic agents thus giving a possible total of 11 classes. Twenty one 
respondents also named “cocktails” of drugs and 18 named miscellaneous drugs which 
they said were taken for their psychotropic effect. In a few instances, people could not 
name a particular drug, only its class. There were also a few drugs mentioned that I 
could not find in any of the pharmacopoeias I consulted but whose effects people were 
usually able to describe. These are not included in the totals but are listed as unknown 
in the tables in Appendix 15.
After completing several interviews, it became apparent that many people were using 
prescription drugs, particularly Doloxene, codeine, the benzodiazepines and 
antidepressants, that had not been prescribed to them, but which had been obtained 
illegally. I then started to collect data on whether the drugs were prescribed or not. 
These findings are recorded in the tables on drug use histories (attached as Appendix 15) 
but with the exception of methadone, there are too many missing values to give an 
accurate picture of whether dmgs were legally or illegally obtained.
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4.5: Drug use histories of respondents
Before presenting the respondents’ histories of the classes of drugs used, and the 
individual drugs used within these classes, I present an overview of the total classes and 
drugs ever used at time of the first interview and the histories of involvement with illegal 
drug use.
A median of 8 drug classes (out of the possible total of 11) had been used (range 3-10, 
interquartile range 7-9). The median stayed at 8 for all the subsets (definitions of the 
subsets are included in Table 2 in Appendix 4) but the Oswaldians had used a range of 
5-10 classes (interquartile range 8-9), which was greater than the range of 3 to 10 
(interquartile range 7-9) among the non-Oswaldians (Z -2.634, p < 0.01).
One hundred and two drugs had been used by the total sample during their drug taking 
careers. A median of 17 drugs per person (range 3-45, interquartile range 13-22) had 
been used. Men had used more drugs (median, 20, range 3-45, interquartile range 13- 
24) than women (median 15, range 7-40, interquartile range 12-20) (Z -2.344, p = 
0.0192). As shown in Chapter 3, there was a tendency for the women I interviewed to 
be younger than their male counterparts and this may explain the gender difference.
Oswaldians had used more drugs (median 18, range 8-40, interquartile range 14-25) 
than non-Oswaldians (median 16, range 3-45, interquartile range 12-22) but, unlike the 
finding for classes of drugs, this difference was not significant.
There was a median period of 9 years of illegal drug use (median 9 years, range 1-30 
years, interquartile range 6-12.3 years) which was longer than that found in the subset 
who presented only for the first interview (median 6.5 years, range 1-21 years, 
interquartile range 4-10 years) (Z -2.264, p = 0.0238).
Men had used illegal drugs (median 10 years, range 1-30 years, interquartile range 6.3- 
13 years) longer than women (median 8 years, range 2-18 years, interquartile range 4- 
11 years). This may partly explain the greater number of drugs used by men.
The median age of first illegal drug use was 14 (range 11-19, interquartile range 13-15). 
Women first used illegal drugs at the age of 14 (range 11-20, interquartile range 13 -16); 
men had a slightly higher median age of 15 (range 10-29, interquartile range 13.3-16).
The following part of the chapter examines the histories of the use of individual classes 
of drugs and drugs used within those classes. These are listed in order of frequency of 
use of classes.
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4.6: Alcohol
Alcohol use is common in Australia, and it was virtually universal in my sample. There 
was only one respondent who had not drunk alcohol, and there was a young median age 
of 13.5 for first use for the majority that had (Table 1, Appendix 15).
4.7: Tobacco
All but 3 people (96.9%) had smoked tobacco (Table 2, Appendix 15). There was a 
young median age of 14 for first use. Though the NDS found that women tended to 
start smoking earlier than men (1994), I found no significant gender difference .
4.8: Cannabis
Cannabis contains the psychoactive chemical delta-9-tetrahydrocannibinol (THC). Its 
concentration varies in the three most commonly used forms: marijuana, hashish and 
hashish oil (Hall, 1995). Users experience several psychoactive effects including 
hallucinations and feelings of euphoria, relaxation and self confidence (Australian 
Bureau of Criminal Intelligence, 1996).
In 1989, the newly formed ACT Legislative Assembly instituted a Select Committee on 
HIV, Illegal Drugs and Prostitution chaired by Michael Moore. Following consultation 
with an array of interested parties, there was an amendment to the ACT Drugs of 
Dependence Act to the effect that police now have an option to issue a $100 on the spot 
fine for “cultivating or participating in the cultivation of not more than 5 cannabis plants, 
or possession of not more than 25 grams of cannabis or self use (administration) of 
cannabis” . The cultivation and possession of a larger number of plants or of cannabis 
resin or oil are treated more harshly and may lead to imprisonment (ACT Department of 
Health and Community Care, 1996). Similar legislation passed in South Australia in 
1987 does not appear to have led to an increase in the use of cannabis (Christie, 1991).
Ninety nine per cent of the people I interviewed (n=96) had used cannabis (Table 3, 
Appendix 15). Most had commenced their use before this Act was passed. Several 
respondents said they approved of this new legislation. Most people had used 
marijuana, hashish or hashish oil. One person had also used pure THC when he lived 
overseas.
4.8A: Marijuana
Marijuana is the most commonly used illegal drug in the world (McAllister and Makkai, 
1991a). The 1993 NDS found that 28 per cent of women and 41 per cent of men had 
used it. Among those aged between 14-34, the rates increased to between 46 and 47 per 
cent for women and 58 to 60 per cent for men (1994). Marijuana had been used by all
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the cannabis users in my survey (Table 4, Appendix 15). The first route for all 96 
people was inhalation and the median age at first use was 15.
4.8. H: Hashish
Most people had also used hashish (n=95, 97.9%) (Table 5, Appendix 15). The median 
age of 16 for first use was older than that for marijuana.
4.8.iii: Hashish oil
A majority of 60.8 per cent of respondents (n=59) had tried hashish oil (Table 6, 
Appendix 15). Seventy five per cent of Oswaldians (n=30) had used it compared to 
50.9 per cent of non-Oswaldians (n=29) (Chi2 at 1 df = 5.7, p = 0.0166).
The median age of 17 for first use of hashish oil was higher than for first use of both 
marijuana and hashish. This suggests that many of those who continue to use cannabis 
progress to the more potent forms as they become older and more experienced cannabis 
users.
4.9: Hallucinogens
Several drugs can induce alterations of mood and thinking in such a way that people see 
or hear things that do not exist (Goodman Gilman et al, 1990; Australian Bureau of 
Criminal Intelligence, 1996). The major sources for these drugs are natural plant 
substances, extractions from natural substances, and synthetic manufacture (Brecher, 
1972).
The 1993 NDS found that 7 per cent of women and 9 per cent of men had ever used 
hallucinogens. There was a higher rate of use among younger people: 8 to 9 per cent of 
women and 12 to 15 per cent of men in the 14-34 year age bracket reported using them 
(1994).
Ninety five of the people I interviewed (97.9%) had used hallucinogens (Table 7, 
Appendix 15), making this the second most common class of illegal drugs used. Fifteen 
different hallucinogens had been used by the total sample and there was a median of 3 
types that had used. Men had used a median of 3 (range 1-9, interquartile range 3-5) 
compared to a lower median of 2 for women (range 1-5, interquartile range 2-3) (Z 
-3.616, p < 0.001).
4.9. i: Psychedelic mushrooms
Allen and colleagues conclude that Psilocybe cubensis and/or Psilocybe subcubensis, 
Psilocybe subaerginosa and Copelandia cyanescens are the most common species of 
psychoactive mushrooms used in Australia. These are all dung inhabiting species and it
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is likely that they were introduced to Australia when livestock were brought in shortly 
following white settlement. There was an upsurge in the use of these fungi between 
1969 and 1975 which led to each Australian State and Territory enacting legislation to 
prohibit their use (Allen et al, 1991).
The ACT has a temperate climate in which psychedelic mushrooms grow readily. 
Perhaps as a consequence, these were the hallucinogens most commonly used by the 
people I interviewed (n=87, 89.7%) (Table 8, Appendix 15). The median age of first 
use was 18.
4.9.ii: “Trips”
Lysergic Acid Diethylamide (LSD) was originally synthesised in 1938. Its psychotropic 
effects became apparent in 1943 (Brecher, 1972). Subsequently, it was used for 
psychotherapy before its non-medical use spread among the young (Brecher, 1972; 
Goodman Gilman et al, 1990). LSD was “romanticised” in the 1960’s by Timothy 
Leary and other “drug gurus” of that period (Drucker, 1990:9). According to available 
intelligence, LSD is manufactured by a small number of people in the USA and then 
shipped to Australia before being diluted and impregnated into perforated blotting paper 
(Australian Bureau of Criminal Intelligence, 1996).
Though the use of pure LSD is uncommon in the ACT (McDonald et al, 1993), 31 
people I interviewed (38.8%) said they had used it at some time (Table 10, Appendix 
15). This is an underestimation because, during the piloting of the interviews, I treated 
LSD and “trips” 1 as one category. I then separated them and re-entered the values 
previously entered as “trips”. As a consequence, there are 17 missing values for LSD 
and comparative tests were not made. The terms LSD and “trips” are often used 
interchangeably, but most respondents subsequently interviewed (after the piloting), 
were able to distinguish them. “Trips” were said to be less powerful than LSD and, 
suggesting they were adulterated with amphetamine, some respondents also said that 
“trips” gave them a “speedy” rather than an hallucinogenic effect.
Eighty six people (88.7%) reported using “trips” (Table 10, Appendix 15). There was a 
low median age of 18 for first use. Those who were interviewed once had a lower 
median age of 16 for first use (Z -2.737, p < 0.01).
4.9. iii: Methylenedioxymethamphetamine
Methylenedioxymethamphetamine (MDMA, now more commonly know as ecstasy) has 
both hallucinogenic and stimulant properties (Fitzgerald, 1991). Because of the
1 “Trips” are sometimes sold as LSD and may contain a variety of hallucinogens, amphetamines or 
other substances (McDonald et al, 1993).
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combination of drugs used in its manufacture, it is also referred to as a “designer drug” 
(Buchanan and Brown, 1988; Chesher, 1990; Jerrard, 1990; NDS, 1994).
MDMA was developed in 1914 as an appetite suppressant but was never used clinically 
for this purpose. By the 1970s it was being used in psychotherapy (White et al, 1997). 
Patients who received MDMA reported euphoria, empathy and increased self esteem 
(Buchanan and Brown, 1988). It is also used to enhance sexual pleasure (Moore et al, 
1992). Although MDMA appeared in the illegal market in 1972, it was not widely used 
until the 1980s (Chesher, 1990). Its use recently attracted public attention in Australia 
because of a number of deaths among young people who have used it (White et al, 
1997). White and colleagues consider this number to be “relatively small compared with 
the likely frequency of its use” (1997:117). Only 3 per cent of respondents in the 1994 
NDS household survey, however, reported use of ecstasy or other “designer drugs”. 
There was, however, a slightly higher proportion of reports among younger than older 
people (1994).
Forty three of the people I interviewed (44.3%) had a history of ecstasy use (Table 11, 
Appendix 15). There was a median age of 21 for first use.
4.9. iv: Other hallucinogens
Eleven other hallucinogens were mentioned by a few respondents. They had taken them 
mostly by mouth on the first occasion and there was an age range of 12-33 for first use.
4.10: Stimulants
Stimulants had been used by 91 people (93.8%) (Table 13, Appendix 15). Ten different 
stimulants were mentioned, and there was a median of 1.3 different types that had been 
used.
4.10A: Amphetamine
The most frequently used stimulants were amphetamine based. Amphetamine was 
originally manufactured by a German chemist in 1887 (Australian Bureau of Criminal 
Intelligence, 1996). Its stimulant effects (which have led to the drug being colloquially 
called “speed”) and euphoric, and appetite suppressant effects were soon recognised and 
this led to its use for non-medicinal purposes (Derlet and Heischober, 1990).
Amphetamines are usually manufactured in illegal laboratories in Australia. According 
to the Australian Bureau of Criminal Intelligence, Outlaw Motor Cycle Gangs are 
“actively involved” in the production and distribution of amphetamine in the ACT 
(1996:74). Some laboratories with links to the “bikie” subculture have been closed
down by law enforcement agencies (Parliamentary Joint Committee on the National 
Crime Authority [The Cleeland Committee], 1989).
The NDS 1993 household survey found that 8 per cent of women and 9 per cent of men 
had tried amphetamine. Rather larger proportions of those in the younger age brackets 
reported its use (10-12% for women and 13-16% for men in the 14 to 34 age bracket) 
(1994). There are some indications of an increase in the number of people using 
amphetamine in the ACT (McDonald et al, 1993).
Ninety of the people I interviewed (92.8%) reported the use of “speed” (Table 14, 
Appendix 15) and there was a median age of 18 for first use. This is similar to the 
median age of 17 Hall and Hando found in their study of amphetamine users in Sydney 
(1994).
4.10.H: Cocaine
According to Mugford and Cohen, there was a perception in some (government) 
quarters in the mid 1980s that Australia might be about to experience a wave of cocaine 
use similar to that experienced by the USA (1989). In the 1993 NDS survey, however, 
only 2 percent of women and 3 per cent of men had ever tried cocaine or “crack”1 
(1994). McAllister and colleagues are, therefore, correct in their conclusion that the 
“anticipated cocaine threat to Australia has not yet materialised” (1991:138).
Over half the people I interviewed had used cocaine (56.7%, n=55) (Table 15, 
Appendix 15) and there was a median age of 19 for first use. Most had only used it 
once or on an occasional basis. This low level of use is similar to the finding reported 
from the sample surveyed by Hall and colleagues (1991). As will be shown in the 
following chapter, less than half of the people I interviewed who reported ever using 
cocaine used it during the 12 months prior to the first interview, and only 14 used it 
between interviews.
Only one person reported trying “crack” (Table 16, Appendix 15). Its use has become 
widespread in the USA, largely among inner-city communities experiencing a range of 
social problems. As with other forms of cocaine, its use in Australia is rare (McAllister 
and Makkai, 1991b).
1 This is a potent, smokeable form of cocaine (Drucker, 1990).
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4.10. iii: Other stimulants
Six other stimulants which, apart from “red speed”1 were caffeine and/or ephedrine 
based, were used by only small numbers of people (Table 16, Appendix 15). There 
was an age range of 14-24 for their first use. With the exception of Adifax (which was 
prescribed as an appetite suppressant, but which was also used as a stimulant), all the 
other drugs had been taken solely for their stimulative properties.
4.11: Opioids
Opioids are either natural compounds derived from unripe seed capsules of the Oriental 
poppy, or semi-synthetic and synthetic compounds with similar properties (Goodman 
Gilman et al, 1990; Cherubin and Sapira, 1993). The people I interviewed had used 17 
different opioids during their drug-taking careers (Table 17, Appendix 15). There was a 
median of 4 different types that had been used.
4.1 Li: Heroin
The opioid which causes most concern in the western world is heroin, which was first 
synthesised from morphine in 1874. On entering the body it is transformed into 
morphine and most users experience intense feelings of euphoria (Australian Bureau of 
Criminal Intelligence, 1996).
The 1993 NDS survey found that 2 per cent of their sample had used heroin and that 
there was little variation by age or gender (1994). There are signs of an increase in the 
number of ACT residents using heroin (McDonald et al, 1993).
Based on data collected for the ACT DIP during 1988-89, Larson and colleagues 
estimated that there are around 1250 “arrest-vulnerable and treatment/counselling 
seeking population of heroin users”, but that number did not reflect “all heroin users or 
even all dependent users” (1994:830).
Most heroin importations into Australia are made using couriers on commercial air 
flights (Parliamentary Joint Committee on the National Crime Authority [The Cleeland 
Committee], 1989). The “Golden Triangle” is the source of around 80 per cent of 
heroin importations into Australia (Australian Bureau of Criminal Intelligence, 1996). 
According to Wodak, only 5-10 per cent of the estimated 1000 kg of illegal heroin 
brought into Australia a year is intercepted (1991).
Heroin was the most common opioid used by the people I interviewed; 77.3 per cent of 
respondents reported its use (n=75) (Table 18, Appendix 15). Most people who had
1 Respondents informed me that this is a concoction of chemicals sold pre-drawn-up in syringes which 
acts as a stimulant and is red in colour. It is sometimes also referred to as "dragon's blood.”
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used it (n=59, 78.7%), had injected it the first time they had taken it, and there was a 
median age of 19 for first use. Men were slightly older (median 19, range 13-34, 
interquartile range 18-20) than women (median 18, range 14-26, interquartile range 17- 
20) at their first use.
4.11. U: Doloxene
Doloxene is “a mild analgesic structurally related to ... methadone” (Thomas, 
1988:658). It is available on prescription in tablet form in Australia. With 43.3 per cent 
of respondents reporting using it (n=42) (Table 19, Appendix 15), Doloxene was the 
second most commonly used opioid among the people I interviewed and there was a 
median age of 20 for first use. Everyone who had used Doloxene had also used heroin. 
The data from 36 respondents on prescription of Doloxene showed that 29 people had it 
prescribed. Fourteen of these people had also taken Doloxene illegally, as had the 
other 7.
4.11. Hi: Opium
The milky juice obtained from Papaver somniferum is dried and powdered to make 
opium (Goodman Gilman et al, 1990). Thirty eight respondents (39.2%) reported using 
opium in this raw form (Table 20, Appendix 15). There was a median age of 20 for 
first use.
4.11.iv: Codeine
Codeine has properties which, though less potent, are similar to morphine. It is 
available on prescription but other forms of codeine (Mersyndol, for example, which 
contains both codeine and paracetamol) (Thomas, 1988), is available over the counter in 
Australia. Codeine had been used by 38.1 per cent of respondents (n=37) (Table 21, 
Appendix 15). The median age of first use was 19 and most people had taken it orally 
the first time they had used it. All but two of the codeine users had also used heroin.
4.1 l.v: Methadone
Methadone programs were first introduced to Australia in 1970 by Dr Stella Dalton 
whose advocacy of the treatment led to a steady and gradual increase in the number of 
places (Ward et al, 1992). In the late 1970s and early 1980s there was, however, a 
reduction in availability of methadone treatment because it did not, as some had 
expected, cure heroin dependence (Burgess et al, 1990). Because of rising demand 
from heroin users, and then in response to fears of an HIV epidemic among IDUs, the 
number of places expanded again (Ward et al, 1992).
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Thirty five of the people I interviewed had a history of methadone use (Table 22, 
Appendix 15) and there was a median age of 23.5 for first use. Sixteen people had used 
non-prescribed methadone, 13 had used only prescribed methadone and 6 had used both 
prescribed and non-prescribed methadone. Only three core-Oswaldians (11.5%) had 
used methadone compared to 32 of the Remainder (45.1%) (Chi2 at 1 df = 9.3, p < 
0.01). Only one of the core-Oswaldians had it prescribed.
4.11. vi: “Homebake ”
“Homebake” was first seen in New Zealand in the early 1980’s and appeared in Western 
Australia in 1986 (Lenton et al, 1992). Except to a few illegal manufacturers, the exact 
recipe is unknown, but it has been ascertained that it is chemically modified codeine 
which is prepared for injection (McDonald et al, 1993). Towards the end of 1991, both 
drug users and treatment agency personnel in the ACT reported knowledge of its use 
(McDonald et al, 1993). There were no reports of the use of “homebake” during my 
1989 interviews (Dance, 1989), but by the 1992 interviews, 27 people (27.8%) reported 
its use (Table 23, Appendix 15). The median age of first use was 23.
4.11. vii: Poppy extract
Twenty five people (25.8%) reported using “poppies” (Table 24, Appendix 15). They 
were most commonly taken after purchasing poppy seeds or harvesting poppy parts 
from gardens and brewing them to take as a beverage. A greater proportion of women 
(39.5%, n=15) than men (17%, n=10) had used them (Chi2 at 1 df = 6.1, p =0.0133). 
There was a median age of 21 for first use.
4. ll.v iii: Morphine
Morphine had been used illegally by 24 people (24.7%) (Table 25, Appendix 15). 
There was a median age of 20.5 for first use. Most users (87.5%, n=21) had injected it 
at their first use.
4.11. ix: Other opioids
An additional 9 synthetic opioids had been used illegally by small numbers of people 
(Table 26, Appendix 15).
4.12: Inhalants
Inhalants can be grouped into four basic classes: volatile solvents, aerosols,
anaesthetics and volatile nitrites. After a review of the international literature, Kerner 
concludes that the use of inhalants is a “world-wide phenomenon”, and that their use is 
becoming more prevalent (1988:23).
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Four per cent of the 1993 Australian NDS household sample reported using inhalants 
(1994). Studies from both overseas and Australia have demonstrated they are mainly 
used by young people (Kerner, 1988; Dinwiddie et al, 1991; NDS, 1994). In Australia, 
the inhalation of petrol is unfortunately common among young people of Aboriginal and 
Torres Strait Islander origin living mostly in isolated regions where it is difficult to 
access other drugs. Petrol sniffing in these communities has escalated over the past few 
decades leading to an increased mortality and morbidity among young Aboriginal people 
(Brady, 1991).
Seventy six of the people I interviewed had used 11 different inhalants since beginning 
their illegal drug use but there was a median use of only one type (Table 27, Appendix 
15).
4.12A: Nitrous oxide
Nitrous oxide was the most common inhalant ever used (n=56, 57.7%) (Table 28, 
Appendix 15). The median age for first use was 18.
Nitrous oxide is-an anaesthetic agent (Kemer, 1988) and a few people I interviewed said 
they had found cylinders containing the gas. The most common way that the gas was 
obtained was, however, by purchasing or shoplifting containers of meringue or 
whipped cream from supermarkets. The meringue or cream is encased in a synthetic 
outer case (the “bulb”) and nitrous oxide is used to propel the contents. Bruce describes 
his first use and method of administration:
then someone said ‘Oh you know those bulbs you get in the supermarkets 
they've got nitrous oxide in them'. And I said ‘Oh really'. So one thing 
lead to another and somehow we got hold of a soda stream machine thing 
and just had a couple of packets of bulbs.
Trevor had a similar story:
we discovered that nitrous oxide ... which we knew was a dental 
anaesthetic, was in these cream-whipping bulbs that you buy in 
supermarkets ... so we said, 'Oh, well, we'll try it, see what that's like’ ... 
we got an old soda siphon and put one in and tried it and ... amazing.
Similar access has been reported from the USA where nitrous oxide is also used to 
propel some brands of whipped cream (Kemer, 1988; Wagner et al, 1992). ACT users 
have been advised by a health educator that although the most common way of 
administering nitrous oxide for non-medical use is via a soda syphon, inhaling it from 
balloons is safer (McPartlan, 1997).
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4.12.H: Amyl Nitrite
Amyl nitrite is a volatile nitrite which has been used medically since 1867 (Sigell et al, 
1978). It relaxes most smooth muscle which causes vasodilatation and increased 
bloodflow (Goodman Gilman et al, 1990). These properties have led to its non- 
medicinal use to alter consciousness, enhance meditation, stimulate dancing and 
intensify sexual experience (Sigell et al, 1978). Because of the euphoria associated with 
its inhalation, amyl nitrite is also commonly known as “rush” (Australian Bureau of 
Criminal Intelligence, 1996). In Australia, it can be purchased legally in sex shops as 
‘“ room deodorisers’” and, because of the effects reported above, its use has become 
popular with both the gay and dance “scenes” (Australian Bureau of Criminal 
Intelligence, 1996:136).
Amyl nitrite was the second most popular inhalant among the people I interviewed. 
Thirty two people (33.0%) had used it and, as with nitrous oxide, there was a median 
age of 18 for first use (Table 29, Appendix 15).
4.12AU: Other inhalants
Nine other inhalants had been used by small numbers of people (Table 30, Appendix 
15).
4.13: Benzodiazepines
Since they were first used in clinical practice in the USA in 1961, many different 
benzodiazepines have been synthesised (Goodman Gilman et al, 1990). These drugs 
largely replaced barbiturates for the relief of anxiety and depression but, like 
barbiturates, they are now known to have a variety of adverse effects, including a 
potential for dependency (McAllister et al, 1991).
Thirty four per cent of respondents in the 1993 NDS sample reported using 
tranquillisers (1994). Previous research in the ACT has shown the use of tranquillisers 
to be common among people who use illegal drugs (McDonald et al, 1993).
Seventy two people (74.2%) I interviewed had used 10 different benzodiazepines since 
beginning their illegal drug use, and there was a median of 2 that had been used (Table 
31, Appendix 15). Thirty five Oswaldians (87.5%) had used benzodiazepines 
compared to 37 non-Oswaldians (64.9%) (Chi2 at 1 df = 6.3, p = 0.0123).
The history of benzodiazepine use was very similar for men and women; 73.7 per cent 
of women (n=28) and 74.6 per cent of men (n=44) had used them. Use of prescribed 
tranquillisers has, however, previously been found to be more common among women 
than men (Cooperstock, 1978; Cooperstock and Parnell, 1982). The reason I found
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gender similarities may be due to the fact that I collected data on both non-prescribed and 
prescribed use.
Following a review of both the overseas and Australian literature, Darke concluded that 
the use of benzodiazepines is widespread among IDUs (1994). Among the people I 
interviewed, a high proportion of 81.3 per cent of those who had ever injected (n=65) 
had used benzodiazepines. Their use was not, however, significantly related to the 
period of IDU.
4.13J: Diazepam
Diazepam was the most common benzodiazepine used (68.0%, n=66) (Table 32, 
Appendix 15). This is consistent with the finding that in Australia, it is the most 
frequently prescribed drug in its class (Mant et al, 1993). The median age for first use 
among the people I interviewed was 19. There was a lower median age for women 
(median 16.5, range 14-23, interquartile range 15.5-21) than for men (median 20, range 
14-38, interquartile range 17-24.5) (Z -2.457, p = 0.0148).
Eighty two and a half per cent of Oswaldians (n=33) had used diazepam compared to 
57.9 per cent of non-Oswaldians (n=33) (Chi2 at 1 df = 6.5, p = 0.0105). This largely 
explains the difference found between these subsets in the class of benzodiazepines.
4.13. H: Flunitrazepam
Flunitrazepam was the next most commonly used benzodiazepine; 34.0 per cent of 
respondents reported its use (n=33) (Table 33, Appendix 15). There was a median age 
of 21 for first use.
4.13. Hi: Oxazepam
Oxazepam had been used by 28.9 per cent of respondents (n=28) (Table 34, Appendix 
15). There was a median age of 22 for first use.
4.13.iv: Nitrazepam
A little over a quarter of respondents had used nitrazepam (n=25) (Table 35, Appendix 
15) and there was a median age of 21 for first use.
4.13. v: Temazepam
Twenty one people (21.6%) had used temazepam (Table 36, Appendix 15). There was 
a median age of 23 for first use.
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4.13. vi: Other benzodiazepines
Another 5 benzodiazepines had been used only by small numbers of people (Table 37, 
Appendix 15).
4.14: Antidepressants
Tricyclic antidepressants were synthesised in the 1940s (Goodman Gilman et al, 1990). 
More than a quarter of the respondents (28.9%, n=28) had used them (Table 38, 
Appendix 15), but each was used by only small numbers of people. There was an age 
range of between 13-42 for first use. Seven different types had been used (Table 39, 
Appendix 15).
4.15: Barbiturates
Barbiturates were previously used extensively for their sedative-hypnotic properties 
(Goodman Gilman et al, 1990). The 1993 NDS survey found that 2-3 per cent of those 
in the 14 to 34 year age brackets had used barbiturates compared to 5-6 per cent who 
were 35 or over (1994).
Sixteen of the people I interviewed had used barbiturates during their drug using careers 
(Table 40, Appendix 15). A range of 1 to 4 had been used and there was an age range 
of 16 to 36 for first use. Six different types had been used (Table 41, Appendix 15).
4.16: Antipsychotics
Five respondents had used antipsychotics (Table 42, Appendix 15) and 3 different types 
had been used (Table 43, Appendix 15). Only one person reported using any of these 
drugs (Largactyl) other than on prescription. This low level of use may indicate a low 
incidence of psychopathology among respondents; a reluctance to seek medical help for 
problems; or a perception that these drugs do not have desirable psychoactive effects.
4.17: “Cocktails”
Eighteen people had used “cocktails” (that is, mixtures of drugs) (Table 44, Appendix 
15). Most people had injected “cocktails” containing heroin and/or amphetamine (Table 
45, Appendix 15). There was an age range of 15-37 for first use.
4.18: Miscellaneous drugs
Ten people (Table 46, Appendix 15) had used ten different miscellaneous drugs (Table 
47, Appendix 15). Those drugs which were impossible to categorise are also included 
in these tables. There was an age range of 14-16 for first use and most people had taken 
these drugs by mouth.
4.19: Respondents’ histories of treatment for drug problems
The discussion now turns to a brief overview of treatment histories. In order to conduct 
a one day census of clients of alcohol and other drug treatment services in Australia, 
Chen and colleagues identified 465 treatment agencies in 1992 (self help groups and 
agencies that provided only “information, education, ‘brief counselling and/or referral” 
were excluded from this total (1993:7). This census showed that non-residential 
services were more commonly utilised than residential services. Counselling comprised 
the main form of service on census day. At the time of the survey, the total number of 
clients of treatment services in Australia was estimated to be between 29 000 and 44 000 
(Chen et al, 1993).
Twelve of the treatment agencies identified by Chen and colleagues were in the ACT. 
These agencies include both government and non-government agencies. There are also 
a variety of self help group such as Narcotics Anonymous (NA).
At the first interview I conducted, only 7 people were then in treatment. Six were 
receiving methadone. Two of these people had recently entered their first treatment of 
any kind and the remaining four had undergone between 3 and 21 previous courses of 
methadone. Two of these people had also experienced other kinds of treatment for 
opioid dependence. The seventh person was receiving his first treatment in the form of 
drug-free counselling.
Of the 21 people with a previous history of treatment, 13 had received methadone; some 
had undergone more than one course and some also had a history of other treatment for 
opioid use. Three people had at one time entered a Detoxification Centre as their only 
mode of treatment for opioid use, and a further 3 people had once been admitted to this 
form of treatment for other drug use (one for barbiturate use, one for hashish use and 
one for both amphetamine and alcohol use). One person had received previous 
treatment only in the form of counselling and another only in the form of NA.
The gender proportions for treatment history were similar: 32.2 per cent of women 
(n=9) and 23.7 per cent of men (n=19) were either in treatment at the first interview, or 
had a history of treatment.
Of the 28 people in treatment at some time, 9 were Oswaldians (22.5%) and 19 were 
non-Oswaldians (33.3%). Only two core-Oswaldians (7.7%) had a history of treatment 
at the first interview compared to 26 of the Remainder (36.6%) (Chi2 at 1 df = 7.8 p < 
0 .01) .
4.20: Conclusion
Most people had been involved with the illegal drug scene in Canberra for several years. 
The majority had commenced both their legal and illegal drug use in their teens and early 
twenties and, as Lukoff points out, the one unambiguous association with drug use in 
western society is youth (1980).
Those who completed both interviews had used drugs significantly longer than those 
who only presented for the first interview. This is probably because these people were 
significantly older. As shown in Chapter 2, a larger proportion of those who were 
reaccessed for the second interview also had a treatment history. These factors may 
influence the findings discussed in subsequent chapters, particularly the changes in 
treatment history.
Apart from the treatment history (particularly the use of methadone), there were few 
other significant differences between the Oswaldian subsets and their opposite subsets. 
There is, therefore, little in these findings to support my hypothesis that the Oswaldians 
were different from other people who use illegal drugs in terms of extensive 
experimentation with a wide range of drugs. It is possible my hypothesis was 
stimulated by the fact that, at first contact, very few Oswaldians had been in treatment. 
As will be shown in the following chapter, even this difference had disappeared by the 
second round of interviews. In my honours research, I speculated that because the 
people I interviewed were polydrug users who were not dependent on specific drugs, 
they might be at a lower risk of requiring treatment (Dance, 1989). As will be shown in 
the following chapter, time has shown this not to be true.
CHAPTER 5: DYNAMICS OF DRUG USE: SCENE CHANGES, 
EXPERIENCED CHANGES
5.1: Introduction
One reason for the follow-up interviews was to obtain data on reasons for any changes 
in drug consumption. Apart from a study conducted by Bammer and Weekes in the 
ACT on factors associated with stopping heroin use (1994), there appear to have been 
no other Australian studies looking at transitions in drug consumption patterns; some 
Western Australian researchers are, however, presently conducting research on 
transmissions in modes of intake (Bammer, G, 1998, March, 31, pers comm). Several 
overseas longitudinal studies have investigated variations in drug use, but most have 
focused only on dependent opioid users (for example, Waldorf, 1970; Maddux, 1981; 
Jorquez, 1983; Simpson et al, 1986; Faupel and Klockars, 1987; Rounsaville et al, 
1987), whereas my data cover any drugs used. Another major difference between my 
research and other studies is that in my study, many drugs were used occasionally or 
only once.
Previous studies of variations in drug consumption patterns have developed two major 
models: “drug career” and “maturing out”. The concept of a “drug career” evolved 
from the Chicago school of sociology’s concept of occupations which referred to “the 
sequence of movement from one position to another in an occupational system by an 
individual who works in that system” (Becker, 1963:24). Becker extended the 
application of this model when he talked about the “careers” of marijuana users 
(1963:61). The concept has subsequently been employed by several other researchers 
studying drug use (for example, Maddux, 1981; Nurco et al, 1981a, 1981b, 1981c; 
Crawford et al, 1983; Jorquez, 1983; Bennett and Wright, 1986; Simpson et al, 1986; 
Anglin et al, 1987a).
Becker identified three phases in the careers of marijuana users: “beginners, occasional 
and regular users” (1963:61). He pointed out that sometimes users do not advance 
beyond the second stage or may stop altogether. As users move from one stage to 
another, social controls become progressively less effective. For some people, 
however, the controls are effective and prevent progress from one stage to the next 
(Becker, 1963). Though Becker has been criticised because his theorising was based 
only on men who use drugs (Naffine, 1987), the model has become a widely used 
theoretical explanation for changes in drug use.
The second model is “maturing out”. Until the 1980s it was commonly believed that 
few people who were opioid dependent ever recovered (Maddux and Desmond, 1986). 
Then Winick examined five years of records of opioid users who were reported to the
Federal Bureau of Narcotics in 1955, finding that around two thirds were not reported 
again during this period. This led him to conclude that they were no longer using 
opioids. He found that they became “inactive” at around 35 years of age and that the 
average period of dependence before this inactivity was 8.6 years (1962:4). He then 
proposed his theory of “maturing out” and postulated that the problems for which 
people began taking drugs had become “less salient” as they matured (1962:4).
Several other studies of “maturing out” among dependent heroin users who become 
abstinent have raised questions about Winick’s conclusions. Maddux criticised 
Winick for interpreting the status of “not reported again” as equivalent to cessation of 
use. He believes that although some people probably did cease use, others were not 
reported because they were in prison, had died, or had resumed use without being 
detected. Following his study of the long term careers of men (mostly black or 
Mexican-American) who had been discharged from treatment, Maddux pessimistically 
concluded that even abstinence of three years or more does not necessarily signify 
permanent abstinence (1981).
Waldorf found that long voluntary abstentions from heroin use were more reliably 
predicted by a longer period of using than by age (1970). Snow reported that 
“maturing out” occurred in around 23 per cent of the known “addicts” he followed up 
in New York, pointing out that this was lower than the proportion reported by Winick 
(1973:925). Snow went on to say that although the majority of his sample in the 28-37 
year age-bracket did become “inactive”, 24.6 per cent became “inactive” even 
younger.
The theory of “maturing out” has also been criticised by Yates because of its 
implication that a drug user is immature and it is this immaturity which leads to drug 
use (1990).
Whilst there has been some criticism of Winick’s assumptions, subsequent research 
showed that long-term abstinence is possible. Other research has also revealed that the 
cessation of opioid use does not necessarily require treatment (Waldorf and Biemacki, 
1979; Willie, 1983; Stall and Biemacki, 1986).
I wanted to apply these general models of “drug careers” and “maturing out” in an 
Australian context and tease out some of the underlying reasons for modifications in 
types of drugs and consumption patterns by collecting prospective data. These data 
illuminated some of the complexities of drug use behaviours over time. The major 
“scene” change was an expansion of places in the ACT Methadone Program which 
allowed several people to enter or re-enter treatment. Some modifications in drug
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consumption were due simply to altered access. Health concerns and lifestyle changes 
were also frequently reported as reasons for modifying drug use.
After briefly describing the data collection on drug use at the second interview, I 
present a largely quantitative description of the variations in consumption patterns 
which occurred between interviews before going on to describe the reasons people 
gave for the changes.
5.2: Data collection on drug use at the second interview
As with the first interview, I nominated a class of drugs. I then asked respondents 
which particular drugs within this class they had used between interviews, before 
investigating consumption patterns and the route/s used for administration. Although I 
did not collect adequate data at the first interview on whether prescription drugs were 
legally or illegally obtained, I designed the interview guides for the second interview 
so that complete data were collected on this aspect of use.
Apart from the instances of “binge use” and seasonal use, and the instances of people 
who had used a drug between interviews but who said that they had “stopped”, the 
other codes related to changes in drug use levels were ordinal scales. Since there were 
relatively few instances of nominal codes, the data from these people at both 
interviews were removed from the analysis in order to perform the Wilcoxon matched- 
pairs signed ranks test.
Previous research shows that the frequency of drug injecting varies widely, even for 
the same individual (Wodak and Des Jarlais, 1993). I found this to be true for many of 
the drugs used by the people I interviewed, regardless of their mode of consumption. 
When conducting the pilot surveys, it became apparent that the frequency of some 
respondents’ drug use had varied greatly over the period for which I was requesting 
data. The coding for levels of use was, therefore, reorganised to allow a range of drug 
use consumption levels (Table 5.1).
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Table 5.1: Codes for levels of use
L ev e l o f  use V alu e
N o t used 1
O cca s io n a lly /o n ce  o n ly 2
L ess  than w eek ly 3
E qual to or le s s  than 1-2 a w eek 4
E qual to or le ss  than 3 -6  a w eek 5
E qual to or le s s  than daily 6
A lw a y s daily 7
The few significant differences found between subsets (definitions of the subsets are 
included in Table 2 in Appendix 4) are briefly described in the relevant sections of this 
chapter.
5. 3: Changes in number of drugs used between interviews
The data collection covered 11 classes of drugs. Including “cocktails” and 
miscellaneous drugs, 77 drugs were named by respondents. Sixty nine were used 
during the 12 months prior to the first interview and 53 between interviews. A median 
of 10 drugs were used in the 12 months leading up to the first interview. Between 
interviews this median dropped to 7 (Figure 5.1) (Z -6.713, p < 0.0001). At the first 
interview, I asked about drugs used in the previous 12 months; for the majority of 
respondents, the period between interviews was longer than this (average 18.3 months) 
making the reduction in the number of drugs used even more notable.
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Figure 5.1: Number of drugs used during 12 months prior to first interview 
and number of drugs used between interviews
Number of 
drugs used
First interview
Median 10 
Range 3-27
Interquartile range 8-14
D Between interviews
Median 7 
Range 3-14 
Interquartile range 5-9
0 2 4 6 8 10 12 14 16 18 20
n people
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Not only was the reduction in the number of individual drugs used highly significant, 
there was also a highly significant change in the number of classes. In the 12 months 
prior to the first interview, there was a median of 6 classes used (range 3-10, 
interquartile range 5-7) compared to 5 between interviews (range 3-9, interquartile 
range 4-6); despite this overlap in the ranges, the fall in the median was highly 
significant (Z - 5.042, p < 0.001).
The OTI polydrug score (Appendix 10:375-380) assessed the number of categories of 
drugs used during the month prior to interview (heroin, other “opiates”, alcohol, 
cannabis, amphetamines, cocaine, tranquillisers, barbiturates, hallucinogens, inhalants, 
tobacco). At the first interview, this median score was 5 (range 2-9, interquartile range 
3.3-6), and by the second it was down to 4 (range 0-7, interquartile range 3-4) (Z 
-5.256, p < 0.001). The median polydrug use scores at both interviews were similar to 
the mean of 4.1 reported by Darke and colleagues among the 290 people interviewed 
when they compiled the OTI (1991a).
5. 4: Changes in alcohol use
People’s levels of drinking can vary quite widely over a period of time, and since I 
was asking people about periods of around a year, the estimates needed to be able to 
reflect that variation. At each interview, I asked respondents to estimate both the 
lowest and highest number of standard1 drinks they consumed a week during the 
relevant timeframes. Most people were able to quantify these amounts but some 
people either said they always “binged” on alcohol, or they gave a range from a lowest 
number to “binge.” These people were excluded from the statistical analyses.
The lowest number of standard drinks for the current non-binge drinkers at the first 
interview worked out to be a median of 7 compared to a median of 2 among the 
current drinkers at the second interview. At both interviews, the median highest 
number was 14. (Table 1, Appendix 16).
The National Health and Medical Research Council (NHMRC) guidelines on safe 
maximum number of standard drinks a day differs by gender (2 for women and 4 for 
men (1992). Consequently, I analysed the data from men and women separately. At 
the first interview, 34.2 per cent of women (n=13) currently consumed more than 14 
drinks a week at their lowest level of consumption, and 47.4 per cent (n=18) consumed 
more than this at their highest level. At the second interview, smaller proportions
1 My estimates of standard drinks were gleaned from A guide to healthier drinking. This stipulates that 
570 millilitres of low alcohol beer, 285 millilitres of normal strength beer, 120 millilitres of wine, 60 
mis of liqueur or 30 millilitres of spirits equal a standard drink (Heather et al, 1989).
currently consumed more than 14 drinks a week at both their lowest level (15.8%, 
n=6) and highest levels of consumption (36.8%, n=14).
At the first interview, a smaller proportion of men than women currently consumed 
more than the safe level recommended for their gender (28 drinks a week) at both their 
lowest (11.9%, n=7) and highest (22.0%, n=13) levels. There was still a gender 
difference at the second interview for the lowest level (8.5%, n=5), but for their 
highest level (30.5%, n=18) the proportion was similar to that of women.
Although during both timeframes some people had drunk above the highest 
recommended levels, a majority were drinking below levels deemed to be harmful. A 
major exception to this was the drinking patterns of the Oswaldians. Although both 
the lowest and highest median number of drinks was greater among Oswaldians than 
non-Oswaldians in the 12 months prior to the first interview (Table 2, Appendix 16), 
the differences at that time were not significant. In the period between interviews, 
however, the Oswaldians drank a median of 6 standard drinks a week at their lowest 
level compared to one among the non-Oswaldians (Z -2.807, p < 0.005) (Table 3, 
Appendix 16). At their highest level, the Oswaldians drank a median of 30 standard 
drinks a week compared to 10 among the non-Oswaldians (Z -2.947, p < 0.005).
When comparing the core-Oswaldians with the Remainder, the difference at the first 
interview was nearly significant for the lowest number of drinks (Z -2.565, p = 
0.0102), and highly significant for the highest (Z -3.41, p < 0.001). Although the core- 
Oswaldians then currently drank at their lowest level 5 drinks compared to 6 in the 
Remainder (Table 4, Appendix 16), their higher levels in the interquartile range 
explain the difference. The most number of drinks consumed was much greater for the 
core-Oswaldians with their median of 30 compared to a median of 13 for the 
Remainder. Between interviews, the median levels for both the lowest and highest 
number of drinks for the core-Oswaldians were fairly similar to those at the first 
interview (Table 5, Appendix 16). The Remainders’ median had dropped to 1 for their 
lowest number of drinks but their highest number of drinks remained fairly stable. 
The differences between the subsets reached significance for both the lowest (Z 
-2.961, p < 0.005) and the highest number of drinks (Z -3.441, p < 0.001).
These findings for high levels of alcohol consumption among the Oswaldians confirm 
my ethnographic work where I have observed heavy drinking among the majority of 
Oswaldians. As with many other drugs consumed by this group, alcohol is frequently 
celebrated in the “hymns” sung on “Saint Oswald’s Day.” One example is “All drinks 
alcoholic” sung to the tune of “All things bright and beautiful.” This begins:
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All drinks alcoholic,
All pills both great and small,
All illegal substances,
St Oswald took them all.
“Naughty, Naughty” is sung to the tune of “Glory, glory hallelujah” and contains these 
lines:
Naughty, Naughty, what a booner,
Johnno threw up in his schooner,
He couldn ’tfind  the door,
But he quickly found the floor 
St Oswald staggers on.
5.5: Changes in tobacco use
The vast majority of people I interviewed smoked tobacco (90.7%, n=88 at the first 
interview, 88.7%, n=86 at the second) (Table 6, Appendix 16). At both interviews, I 
asked respondents to estimate the lowest and highest number of cigarettes they 
smoked a day during the appropriate timeframe. Most people were heavy smokers; at 
both interviews there was a median number of between 20-25 cigarettes smoked a day 
at both levels. Although the median for the lowest number of cigarettes smoked was 
20 at both interviews, the smaller number in the bottom end of the interquartile range 
at the second interview led to a significant reduction (Z -2.696, p < 0.01).
I found no significant gender differences, but the NDS survey reported a tendency for 
women to smoke fewer cigarettes than men (1994).
5.6: Changes in cannabis use
Cannabis was the most frequently used drug amongst respondents in the ACT DIP 
(McDonald et al, 1993). At both interviews, the majority of people I interviewed were 
also current cannabis smokers (at the first interview, 93.8%, n=91, at the second 
88.7%, n=86) (Table 7 Appendix 16). There was a decrease from a median of 2 forms 
of cannabis currently used at the first interview to 1 between interviews (Z -6.988, p < 
0.001). There was a fairly similar wide range of consumption patterns at both 
interviews.
5.6.i: Marijuana
This wide range in consumption patterns for cannabis was largely due to the range of 
use for marijuana (Table 8, Appendix 16). At both interviews, around a quarter of 
those who had used marijuana were smoking it on a daily basis.
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5.6.U: Hashish
The significant reduction in the number of types of cannabis used between interviews 
was largely due to a significant reduction in the number of people who had used 
hashish (Table 9, Appendix 16). This dropped from 83.5 per cent of respondents 
(n=81) in the 12 months prior to the first interview to 29.9 per cent (n=29) between 
interviews (Chi2 at 1 df = 50.1, p <0.001). As a consequence, there was an equally 
significant reduction in the levels of use (Z -5.83, p <0.001). At both interviews, very 
few people used hashish more than weekly.
5.6.iii: Hashish oil
Only 10 people were current users of hashish oil at the first interview (Table 10, 
Appendix 16), and most had used it occasionally or only once. Between interviews, it 
was used by only one person.
5.7: Changes in stimulant use
Nine different stimulants were used during the 12 months prior to the first interview 
and 8 in the period prior to the second. Between interviews, 14 fewer people had used 
stimulants (Table 11, Appendix 16). In addition, there were reductions in all the other 
levels of use involving between one and 12 people (Z -2.662, p < 0.01). (As noted 
earlier (Section 5.2), the people who had “binged” (n=4) and those who said that they 
had “stopped” for more than 4 months at the second interview (n=5) were excluded 
from the analysis.) At both interviews, more than half of those who had used 
stimulants had used them occasionally or once only and no one had used them every 
day.
At the first interview, I found a significant difference between those who were 
interviewed only once and those who went on to present for the second interview in 
current routes of the administration of stimulants (Chi2 at 8 df = 24.1 p < 0.01). The 
largest difference lay in those who had used only the intravenous (IV) route; reported 
by 37.5 per cent of those who were interviewed only once (n=12) compared to 59.7 
per cent of those who went on to present for the second interview (n=46). Those in the 
latter subset tended to be older and to have been using drugs for a longer period which 
may explain why those who were interviewed only once still tended to favour other 
routes of administration. At the second interview, the majority of stimulant users also 
tended to use the IV route.
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5.7A: Amphetamine
The stimulant reported most commonly at both interviews was amphetamine. Thirteen 
fewer people currently used it at the second interview than at the first (Table 12, 
Appendix 16), when there were also 11 less people who used it always less than 
weekly. The proportions for range of use were fairly similar in the other categories.
5.7.H: Cocaine
About a quarter of respondents were current users of cocaine at the first interview 
(Table 13, Appendix 16). By the second interview, there were only 14 current users 
(Chi2 at 1 df = 6.5 p < 0.01). At both interviews, the majority of cocaine users had 
used it only occasionally and most had injected it.
5.7.iii:: Other stimulants
At both interviews, 6 other stimulants had been used. Seventeen people had used them 
at the first interview and 7 at the second (Table 14, Appendix 16). Nearly everyone 
had taken them occasionally or only once. At the first interview, most had been taken 
orally (73.9%, n=17). At the second, equal numbers had been taken orally and IV 
(n=3).
There has been concern in the USA about the use of “ice”1. Among the people I 
interviewed, only Eggplant reported its use. This was in the period between interviews 
when he had smoked it by accident in the belief that it was “mull” (marijuana). This 
report of the use of “ice” by only one respondent suggests that its use has not become 
widespread in Australia.
5.8: Changes in opioid use
Twelve different opioids were used during the 12 months prior to the first interview 
and 11 in the period between interviews. The median number used fell from 3 to 2 
between interviews (Z -4.69, p < 0.001) (Table 15, Appendix 16). There were a few 
more people at the second interview (n=77, 79.4%) than at the first (n=74, 76.3%) who 
reported current use. At the second interview, however, 8 people said they had 
“stopped” all opioid use. They all hoped this would be permanent, and 5 had good 
reason to believe this might be so since they had not used any opioids for 12 months or 
more. Two people had not used any for 8 months, and one person had not used any 
for 5 months. A further two people (not included in the “stopped” category) said they 
had not used any opioids for about 3 months and they too hoped for this to be 
permanent.
1 A smokeable form of methamphetamine (Derlet and Heischober, 1990; US Department of Health and
Human Services, 1990).
At the second interview, the number of people who said that they used opioids equal 
to, or less than, daily increased by 19. This is largely explained by the number of 
people who had entered methadone treatment between interviews and whose opioid 
use had, as a consequence, included daily use. Seven fewer people also said that they 
used opioids equal to or less than once or twice a week. The variation in levels of use 
of opioids was significant (Z -2.81, p < 0.01). (As explained above (Section 5.2), the 
person who had “binged” at the first interview and the people who said that they had 
“stopped” opioid use at the second interview (n=8) were excluded from the analysis.) 
Reflecting the range of different opioids used, most opioid users at both interviews had 
used more than one route.
5.8.i: Heroin
Six more people at the second interview than at the first reported current use of heroin 
(Table 16, Appendix 16). Five had used it for the first time, and Eggplant, who had 
used heroin very occasionally prior to the 12 months before his first interview, had 
used it once between interviews.
At the second interview, 12 people said that they had “stopped” the use of heroin 
(seven for more than 12 months, one for 10 months, two for 8 months, one for 5 
months and one for 4 months). Six of these people were in treatment at the second 
interview, one had finished a course of repeat counselling and one had been prescribed 
diazepam which had enabled her to stop her use. In addition, two people (mentioned 
in the introduction to this section, and also not included in this table) said that they had 
“stopped” all opioid use for less than 3 months.
Nearly all heroin used was by injection, this is in keeping with previous reports that 
heroin in Canberra is usually taken this way (McDonald et al, 1993). At the first 
interview, 7 people had injected heroin every day but at the second interview no one 
was using this frequently. More people had used it on an equal to, or less than daily, 
basis. As with opioids as a class, this is mainly because those people who had entered 
treatment used heroin less often, exchanging their frequent heroin use with daily 
methadone use.
5.8.U: Doloxene
The number of people who used Doloxene fell from 35 (36.1%) to 21 (21.6%) 
between interviews (Chi2 at 1 df = 9.8, p < 0.01) (Table 17, Appendix 16). The 
number who had taken it by prescription only was roughly similar at both interviews 
(15 and 14), and 3 people had taken it only illegally at both interviews. By the second 
interview, no one had taken both prescribed and unprescribed Doloxene, whereas at 
the first interview 11 people had done so.
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5.8.iii: Codeine
Similarly, a fall from 32 to 17 occurred in the number of people who used codeine 
between interviews (Chi2 at 1 df = 9.8, p < 0.01) (Table 18, Appendix 16). This led to 
there also being a significant change in levels of use (Z -2.667, p < 0.01). (As 
previously stated (Section 5.2) 3 people who had “binged” at the first interview and 
the one person at the second interview who had not used any codeine for 12 months 
were excluded from the analysis.) In the 12 months prior to the first interview, 7 IDUs 
had sometimes or always taken codeine by injection but no one reported injecting it in 
the period between interviews.
5.8. iv: “Homebake ”
The number of people currently using “homebake” also fell from 25 to 5 between 
interviews (Chi2 at 1 df = 13.3, p < 0.001) (Table 19, Appendix 16). I found a variety 
of consumption patterns at the first interview but, by the second, most people who 
used it had only done so occasionally. Only 7.1 per cent of those interviewed once 
(n=3) were current “homebake” users compared to 25.9 per cent who went on to 
present for the second interview (n=25) (Chi2 at 1 df = 6.3, p = 0.0119).
5.8. v: Methadone
I found an increase from 21 to 36 between interviews in the number of people using 
methadone (Table 20, Appendix 16) (Chi2 at 1 df = 8.3, p < 0.01). Two people had 
not used any for at least 4 months and both said they had “stopped.” The majority of 
people at both interviews had used it once a day or less but, due to the increased 
number of people who had entered treatment, the number in this category increased 
from 10 to 26 between interviews (Z -4.05, p < 0.001).
In recent years there have been increased efforts to educate IDUs about the dangers of 
injecting methadone (ACT IV League, 1995; Connexions, 1995; New South Wales 
User's and AIDS Association (NUAA), 1997) but it is obvious that the temptation to 
inject is still too great for many. Ten people I interviewed had injected methadone, 
which represents a fairly high proportion (23.8%) of the 42 people who had used 
methadone at both interviews.
At the first interview, 10 people had taken only prescribed methadone and 10 had only 
obtained it illegally. In both instances, this worked out to be 47.6 per cent of the then 
methadone users. By the second interview, the majority of methadone that was used 
had been prescribed (75.% of the then methadone users, n=27).
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5.8. vi: Poppy extract
The number of respondents reporting current use of poppy extract dropped from 20 to 
8 between interviews (Chi2 at 1 df = 7.2, p < 0.01) (Table 21, Appendix 16). Most use 
was occasional, and almost everyone had taken poppies in the form of a juice.
5.8. vii: Other opioids
Six different other opioids had been used by 34 people in the 12 months leading up to 
the first interview and 5 had been used by 25 people between interviews (Table 22, 
Appendix 16). Most had been taken on an occasional or once only basis and a range 
of different routes was used.
5.9: Changes in hallucinogen use
Nine different hallucinogens were used during both the 12 months prior to the first 
interview and the period between interviews (Table 23, Appendix 16). A median 
number of 2 different types was currently used at the first interview compared to one 
at the second (Z -5.328, p < 0.001). The results demonstrated a fall from 64 to 45 in 
the number of people who had used hallucinogens between interviews (Chi2 at 1 df = 
15.7, p < 0.001). The majority of hallucinogen users at both interviews used them 
occasionally or once only, and most people took them by mouth.
Those who were interviewed once were fairly evenly divided between using 
hallucinogens occasionally or only once, and using them always less than weekly, in 
the 12 months prior to the first interview. Both these categories constituted 46.7 per 
cent of this population (n=14 for each category) and only small proportions of people 
mentioned other patterns of use. Forty three people who went on to present for the 
second interview had used hallucinogens occasionally or once only (75.4%) while 
only 21 per cent said they used them always less than weekly. This was the only other 
significant difference (in addition to that described above in the routes used for 
stimulants) found in drug use behaviours between these two subsets (Z -2.64, p< 0.01). 
(As noted in Section 5.2, people who said that they were “binge” or seasonal users 
were excluded from the analysis (n=9)).
In the previous chapter, I reported a significant gender difference in the number of 
hallucinogens ever used. There was, however, no significant gender difference in the 
number currently used at either interview.
Although no significant difference was found between the core-Oswaldians and the 
Remainder in the number of hallucinogens ever used, a significant difference was 
found in current use at the first interview. The 18 current hallucinogen users among 
the core-Oswaldians had used a median of 1.5 drugs in this class (range 1-3,
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interquartile range 1-2) compared to a higher median of 2 (range 1-5, interquartile 
range 2-3) among the 46 current users in the Remainder subset (Z -3.43, p < 0.001). 
This difference had disappeared by the second interview.
5.9A: ‘Trips"
“Trips” were currently used by 57.7 per cent of people at the first interview and by 
36.1 per cent at the second (Table 24, Appendix 16) (Chi2 at 1 df = 17.6, p < 0.001). 
At both interviews, the majority of use had occurred occasionally or once only, and 
most “trips” had been taken by mouth.
5.9. U: Psychedelic mushrooms
Psychedelic mushrooms were the second most frequently used hallucinogen at both 
interviews; 48.5 per cent of respondents reported current use at the first interview and 
23.7 per cent used them between interviews (Chi2 at 1 df = 20.6, p < 0.001) (Table 25, 
Appendix 16). Most use occurred on an occasional or once only basis, and they were 
taken by mouth.
5.9. iii: Other hallucinogens
Seven other hallucinogens had been used by less than 20 per cent of people at the first 
interview, and six by less than 14 per cent at the second (Table 26, Appendix 16). 
There were 29 current users of other hallucinogens at the first interview and a fall to 
16 by the second interview. Very few had been used other than on an occasional or 
once only basis and the majority had been taken by mouth.
5.10: Changes in benzodiazepine use
Ten different benzodiazepines had been used during the 12 months prior to the first 
interview. Eight were used between interviews. There was a median of 2 different 
benzodiazepines used at the first interview and one at the second (Z -4.118, p < 0.001). 
The proportion of people who used them also decreased from 50.5 per cent at the first 
interview to 35.1 per cent at the second interview (Chi2 at 1 df = 8.4, p < 0.01) (Table 
27, Appendix 16). At the first interview, 91.8 per cent of benzodiazepine users 
(n=45), were IDUs and at the second interview 94.1 per cent were IDUs (n=32). This 
is consistent with other reports on the high levels of benzodiazepine use among IDUs 
(Perera et al, 1987; Darke et al, 1992b; Seivewright et al, 1993; Darke, 1994). I found 
a wide range of use patterns at both interviews. Most benzodiazepines were taken 
orally.
5.10A: Diazepam
The only benzodiazepine used by more than 17 people was diazepam. This was 
currently used by 45 people (46.4%) at the first interview and 27 (27.8%) at the second 
interview (Table 28, Appendix 16) (Chi2 at 1 df = 11.6, p < 0.001). Ten fewer people 
had used it occasionally or once only at the second interview, and the number of 
people who had used it always less than weekly had dropped from 8 to zero. The 
numbers in the other categories were fairly similar at both interviews. Most people 
had taken diazepam by mouth. Fewer people had taken unprescribed diazepam at the 
second interview than at the first, whilst the number who had taken only prescribed 
diazepam was greater. This may, however, be an artefact of the missing values 
(n=l 1).
Between interviews, a greater proportion of core-Oswaldians (50%, n=13) than the 
Remainder (19.7%, n=14) used diazepam (Chi2 at 1 df = 8.7, p < 0.01).
5.10. ii: Other benzodiazepines
Another nine benzodiazepines had been used at the first interview amongst 32 people, 
and seven amongst 21 people at the second (Table 29, Appendix 16). Most had been 
used by fewer than 10 people. At the first interview the majority of users had taken 
them on an occasional or once only basis. At the second, there were fairly similar 
numbers of people using at this level and the equal to or less than daily level. At both 
interviews, the numbers of users at the other levels were similar. Most people had 
taken these drugs orally, and a greater proportion of people at the second interview 
were having them prescribed. As with diazepam, this may be an artefact of the 
missing values (n=14).
5.11: Changes in inhalant use
Six inhalants had been used during the 12 months prior to the first interview and 3 in 
the period between interviews. At both interviews most people had used only one 
type. Thirty eight people were current inhalant users at the first interview compared to 
21 at the second (Chi2 at 1 df = 9.7, p < 0.01) (Table 30, Appendix 16).
5. ll.i:  Nitrous oxide
The only inhalant currently used by more than 14 people was nitrous oxide. At the 
first interview there were reports of nitrous oxide use from 28 people (28.9%) and a 
small fall to 21 people (21.6%) at the second interview (Table 31, Appendix 16). Very 
few users of nitrous oxide had used it on other than an occasional or once only basis.
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5.1 L ii: Other inhalants
Another 5 inhalants had been currently used at the first interview and 2 were used in 
the period between interviews (Table 32, Appendix 16). Amyl nitrite was currently 
used by 14 people at the first interview and by two at the second. The other inhalants 
had been used by only one or two people at both interviews, and only two people (who 
had always used them less than weekly) had taken them more frequently than 
occasionally or once only.
5.12: Changes in other drugs used
Only 11 people at the first interview and 6 at the second were current users of 
antidepressants (Table 33, Appendix 16). Five were used during the 12 months prior 
to the first interview, and 3 were used between interviews (Table 34, Appendix 16). 
Most people had been prescribed these drugs.
In the 1960’s, barbiturates gained a reputation both for dependence and as the drug 
most often used for suicide. As a result, restrictions were placed upon their use in 
Australia, and they are now prescribed primarily for the treatment of epilepsy 
(McAllister et al, 1991). The 6 people I interviewed who reported current use of 
barbiturates at the first interview (Table 35, Appendix 16) had either found them, or 
they had been found by friends, in discarded containers. Stephen was the only person 
who reported use between interviews. He was one of the oldest respondents who had 
previously been treated for barbiturate dependence. Between interviews, he had 
travelled interstate and “managed to get a ‘script’”. Four barbiturates were used in the 
12 months prior to the first interview, and only one between interviews.
One person had used a prescribed antipsychotic during the 12 months prior to the first 
interview, and another person had one prescribed in the period between interviews 
(Table 36, Appendix 16).
Four cocktails had been used both during the 12 months prior to the first interview and 
between interviews (Table 37, Appendix 16).
Five people had used miscellaneous drugs during the 12 months prior to the first 
interview and a different person had used one in the period between interviews (Table 
38, Appendix 16).
5.13: Personal explanations for changes in drug use
The following part of this chapter supplements these quantitative results with the 
results of the analyses of the qualitative data from the second interview on reasons 
given by respondents for changes in drug use. I compared the quantitative data from 
the two interviews and asked people to explain any changes. Most gave several
reasons. I then asked respondents to discuss both their negative and positive effects.
Apart from the effects related to the drug per se, these effects are discussed in the 
relevant subsequent chapters.
Almost half of the changes that occurred were in drugs that had been used in the 12 
months prior to the first interview but were not used between interviews (Table 5.2).
In general, people were only considered to have “not used” a particular drug if they 
had not consumed it at all between interviews. A few people who had used a drug 
between interviews insisted they had now stopped their use. In these instances, a 
shorter period of time was accepted as non-use (these timeframes are noted in the 
attached tables).
Several people had, however, commenced or recommenced use of certain drugs and 
others had increased their consumption patterns. In a few instances, drug use patterns 
had fluctuated so greatly between interviews that it was impossible to put them into 
any of these categories. Some people’s drug use had remained stable but, since I 
mainly wanted to ascertain reasons for variation, details of stable use were not 
obtained except from those people who had continued with methadone maintenance.
Table 5.2: Total changes and types of drug use 
consumption variations between interviews
79
C hange n
C om m enced 80
R ecom m enced 42
Increased 74
D ecreased 186
N ot used 433
F luctuating 25
T otal 840
On all but 26 occasions, people were able to give a reason for a transition in their 
consumption levels. Many gave a variety of reasons, and these data required multiple 
coding. Unless otherwise stipulated, several different levels of consumption (by the 
total sample) were involved in the case of most drugs. Because very few significant 
differences were found between any of the subsets in any of the quantitative results 
recorded above, and also because these changes involved a large number of drugs and 
analyses would have increased the possibility of spurious findings, I did not code these 
changes then analyse quantitative differences between the subsets. I have, however, 
recorded the findings from all the subsets separately in the attached tables which show
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that most of the variations in most of the drugs affected all of the subsets. The codes I 
used for these qualitative data are attached as Appendix 17.
5.14: Methadone treatment
In the early 1980s , there was “widespread concern about the apparent rise in illnesses, 
crime and death associated with heroin use.” In 1985, NCADA endorsed methadone 
maintenance as an “appropriate and useful method” of treatment for heroin 
dependence. During the interim, there has been a “steady and substantial growth in 
the number of individuals receiving methadone treatment in most jurisdictions1 in 
Australia” (NDS, 1997:4). In 1995, there were more than 15 000 people on 
methadone programs throughout Australia compared with 2203 in February 1985 
(Drug Offensive Bulletin, 1995).
In its third interim report, members of the recently formed ACT Government’s Select 
Committee on HIV, Illegal Drugs and Prostitution noted that they had “heard a 
number of complaints” about the ACT Methadone Program. One of the major 
complaints was that there was a limited number of places on the Program. Members 
of the Committee go on to say that this problem had now been addressed since there 
had already been an increase in the number of places and, furthermore, there was a 
proposal to further increase this number. The recent, and generally Australia-wide, 
increase in the number of methadone places is, therefore, mirrored in the increased 
number of ACT people receiving this treatment. There were 68 ACT people receiving 
treatment in 1987 compared to 323 in 1994 (NDS, 1994). During the period between 
commencing my first and second rounds of interviews, there was a more than two and 
a half fold increase: 112 at the beginning of 1992, 293 in September 1993 (Table 5.3). 
At the first interview, some people not in treatment were experiencing a range of 
problems associated with their heroin use. The increased number of places in the 
Methadone Program facilitated treatment entry for some of these people. Several 
remarked how easily and quickly, often within a day, they were able to enter treatment 
when they needed to.
1 The Northern Territory is an exception to this since methadone can only be prescribed there “in 
special circumstances following approval by the Chief Medical Officer, under strict guidelines approved 
by the Minister for Health Services” (NDS, 1997:4).
Table 5.3: ACT Methadone Program
Datea
Maintenance
n
Reduction
n
Total
n
January 1992: commenced 
first round of interviews
102 10 112
October 1992: completed 
first round of interviews
141 5 146
September 1993: commenced 
second round of interviews
293 0 293
a I wanted to correlate the increasing number of methadone places with the time of my 
interviews and obtained these figures from people in contact with the ACT 
Methadone Program. Figures for 1992 were obtained from Rod McClure, then a 
physician in the Program. The 1993 figure was obtained from a peer educator who 
was involved in the Program. The number of people receiving methadone in the 
ACT has continued to rise. In mid 1997, 405 people were in treatment, 280 through 
the public hospital system and 115 through the private sector (Battisson, L. Clinical 
Nurse Consultant, ACT Methadone Clinic. 1997, July 3, pers comm).
At the first interview, 69 people had never been in treatment, 7 were currently in 
treatment and 21 had a previous history of treatment (Table 1, Appendix 18). (As 
reported in the previous chapter, several people had been in treatment more than once 
in the past.) By the second interview, the number currently in treatment had increased 
to 29, the number with only a previous history of treatment had decreased to 17, and 
there was a corresponding decrease to 51 in the number of people who had never had 
treatment. Only 4 of the 26 people in methadone treatment at the second interview 
had been in this treatment at the first. (In efforts to control their tobacco consumption 
one woman had meditated and one had enrolled in a QUIT Program between 
interviews. Their results are not included in the table.)
The ANAIDUS data showed that women were less likely than men to be in treatment 
(Ross et al, 1993b). At the second interview I conducted, a slightly smaller proportion 
of women (42.1%, n=16) than men (50.9%, n=30) were presently in treatment, or had 
a history of treatment.
The change in treatment status was highly significant for the total population of 
respondents (Chi2 at 1 df = 21.2, p < 0.001). With the exception of the core- 
Oswaldians, there were also significant changes in all the subsets (Table 5.4).
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Table 5.4: Significance of change in treatment status 
between interviews by subset
S ubset C h i2 at 1 d f P
W om en 10.0 < 0 .0 1
M en 11.3 < 0 .0 0 1
O sw ald ians 11.0 < 0 .0 0 1
N on-O sw ald ians 10.3 < 0 .0 1
C ore-O sw ald ians 5.0 = 0 .02
R em ainder 16.2 < 0 .0 0 1
Of the 46 people who were either in treatment at the second interview, or who had a 
history of treatment, 20 were Oswaldians (50%) and 26 were non-Oswaldians (45.6%).
In addition to one core-Oswaldian who re-entered treatment and another having a 
previous history of treatment, 7 core-Oswaldians entered treatment for the first time 
between interviews. This resulted in 34 per cent of core-Oswaldians (n=9) currently 
or previously in treatment compared to 52.1 per cent of the Remainder (n=37). The 
significant difference in treatment history at the first interview between these two 
subsets (reported in the previous chapter) had disappeared by the second interview.
5. 14.i: Commencing and recommencing treatment
The results for both the commencement and recommencement of methadone treatment 
are combined in the following discussion since the reasons given were similar for both 
types of treatment entrants.
All but one person mentioned the negative effects of their increased heroin use as 
precursors to them entering treatment (Table 2, Appendix 18). These problems 
covered the impact of heroin use on lifestyle, health and relationships with significant 
others. (I considered “significant others” to be partners, children, other family and 
friends). Patrick’s comments are illustrative of the impact this increased use had:
The way it increased, i t ... just the way it does, it just comes to dominate 
your life. We got to where we were using so much we weren ’t paying rent, 
we weren't buying much food. We borrowed a thousand dollars to buy a 
truck, we sold it and we used all the money to buy heroin and we still owed 
a thousand dollars. A bit after that, I was just so distraught about it really. 
Even then, 1 think, my libido started going, with that great use it just sort 
of petered out. We got to the doctor about that time and he got us on 
methadone.
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Chris was the only person who was in methadone treatment at the second interview 
who said his heroin use had so been out of control that he had contemplated suicide. 
In addition to Patrick and Chris, another 12 people mentioned health concerns as 
forces which led them to seek treatment. Most comments referred to feeling generally 
“sick” or stressed. Two people said that their hepatitis had led to them seeking 
treatment, and Tamara talked about concerns related to a friend being HIV positive.
Eight men and one woman mentioned reasons related to criminal activities as part of 
their rationale for seeking methadone treatment. Erin said these were the only reasons 
that he had entered treatment. He and Sam were dealing partners, as well as sexual 
partners, whose home had been raided by the police who were looking for drugs. 
Although none had been found, this raid, and having their drugs and money stolen by 
other dealers who had a shotgun, had scared them so much that they had sought 
treatment. Erin had remained on methadone for only three and a half weeks, but Sam 
was still in treatment. Another three men also mentioned reasons associated with 
heroin dealing and another was on a good behaviour bond for possession of chemicals 
to manufacture amphetamine. Two other men also had direct contact with the police. 
One said that his partner had been caught for fraud and one said: “the police tracked 
me down for scams that I was doing. I was charged with eighty counts of theft, so I 
went on methadone.” Brett had a history of incarceration and his partner had recently 
had their first baby. He said: “Now I have family commitments, I can no longer break 
and enter.”
People surveyed by Anglin and colleagues gave 3 major reasons for entering 
methadone treatment: they were “tired of addiction, tired of the lifestyle and wanted 
to use less heroin” (1987b:261). Weatherburn and Lind interviewed 246 people 
entering treatment. Most reported that being tired of the lifestyle (97%) was the major 
reason for wanting to stop heroin use. Other reasons included the expense of heroin 
(67%), good family support (41%) and trouble with the police (30%) (1996). Dale and 
colleagues found that the two major reasons people gave for entering into treatment 
were because “they were experiencing drug use problems or because they wanted 
methadone” (1992:55). The people I interviewed thus have much in common with 
these other reports from people entering treatment. The primary differences among 
the people I interviewed were in the numbers who specifically reported health 
problems related to their increased heroin use and that no one said that they “wanted 
methadone.”
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5.14. U: Effects of methadone treatment
After thirty years experience of prescribing methadone, Dole (one of the physicians 
who first prescribed it for opioid-dependence) (1966), concludes that “the essential 
questions concerning (its) efficacy and safety have been decisively answered” 
(1994:3). Following an extensive review of the international literature from both 
randomised controlled trials and observational studies, Ward and colleagues found that 
methadone maintenance is an effective harm minimisation strategy. The positive 
outcomes include reductions in heroin use, crime, injection-related risk behaviours and 
premature mortality (Ward et al, 1994).
I asked everyone who had commenced, recommenced or continued methadone 
treatment, and the man who had discontinued his treatment to continue with 
counselling, to discuss its effects. Most people described ways treatment had affected 
them both positively and negatively. Only effects associated with methadone per se 
and the Methadone Program are discussed in this chapter. (The others are included in 
relevant subsequent chapters.)
5.14. Hi: Positive effects of methadone and the Methadone Program
Dale and colleagues report that the majority of people they surveyed mentioned 
positive aspects of methadone such as, it being clean and safe and that its effects last 
longer than other opioids (1992). Although no one I interviewed said that they had 
gone into treatment because they “wanted methadone”, 9 did mention positive effects 
of the drug. Alexander, who had not used any heroin since starting his first methadone 
treatment shortly after our first interview, said: “It works better than heroin because it 
lasts all day.”
Three people also mentioned positive aspects of the Program itself. Kerry said “It’s 
given me something to do, every day I’ve got to go and get the methadone ... The 
nurses are great, they’re really supportive.”
5.14.iv: Positive effects o f methadone treatment on other drug use 
In addition to methadone treatment, some people gave other reasons for their 
modification in drug consumption patterns and some variations were said to be due to 
other causes. These are reported in the appropriate sections below.
There were 71 reports that certain other drugs were not being used due to Methadone 
treatment (Table 3, Appendix 18). The classes of drugs most frequently mentioned 
were opioids (including heroin, which four people had not used for periods of 4 to 12 
months) and benzodiazepines. Everyone except Brigid and Mishima said they no 
longer needed these drugs because they were receiving methadone. Brigid had
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stopped the use of psychedelic mushrooms because they did not go well with 
methadone, and Mishima had stopped the use of both psychedelic mushrooms and 
“trips” for the same reason. (Because of the cases of imprecise data collection detailed 
in the previous chapter, “trips” and LSD were combined for the purposes of the 
analysis of these data.) One man, who had not used heroin for 12 months, and had 
also stopped use of most other drugs, attributed his success not only to methadone 
treatment, but to treatment administered by a psychiatrist and counsellor. He said this 
treatment had helped him resolve problems experienced in childhood.
There were 31 reports of a decrease in drug use attributed to methadone treatment. 
Most (n=22) involved heroin which, apart from the woman who had ceased then 
recommenced treatment, meant that everyone still in treatment at the second interview 
had stopped or reduced their heroin use between interviews. Although the majority of 
people in methadone were still using heroin, their levels of use had dropped. As other 
researchers have indicated, a goal of successful maintenance rather than abstinence can 
be considered appropriate treatment (Bianchi et al, 1992; Ward et al, 1994).
5.14. v: Negative effects of methadone and the Methadone Program
In addition to the positive comments about their methadone treatment, there was also 
several complaints from most respondents. The most common was that of disliking 
the drug itself (n=12), although this was often accompanied by a positive comment. 
This ambivalence is best summed up in Mulch’s comment: “It’s an insidious drug, but 
thank God for it.”
Five people made negative statements about the Program. Snork, who had only had 3 
months of methadone before he took himself off the Program, made comments which 
encompass many of the negative feelings expressed by the others:
having hours to remember to be there ... and they’re different times at 
weekends, and I ’d often miss my dose ‘cos I forgot, having to go all the 
way to the hospital every single day, having to go there was publicly 
showing everyone you were a junkie, someone might see you there, I didn ’t 
like that.
5.14. vi: Negative effects of methadone treatment on other drug use
Eight people either said that heroin was less effective since they had commenced 
methadone, or that it cost them more money to feel its effects. Chris, who had stopped 
his use for 10 months, plaintively said “I still get urges for heroin.”
In contrast to the 102 reports of a non-use of a drug or a reduction in drug use, there 
were only 9 reports, which came from three people, of drugs being commenced, 
recommenced or increased due to methadone treatment (Table 4, Appendix 18).
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Two came from Alexander. He had stopped injecting “speedballs” since the first 
interview but had once injected a “cocktail” of methadone and amphetamine. He 
also increased his use of marijuana between interviews (at the first interview he 
reported a range of daily use to occasional use and at the second he reported 
consistent daily use), partly because:You get a euphoric rush from heroin, and the 
painkillers, but with methadone you don’t get a euphoric feeling, you get the 
underlying painkiller but not the euphoria, and the marijuana with the methadone 
gives you the euphoric effect.
5.15: Other drug treatment
Table 5 in Appendix 18 shows the reasons given for treatment entry by those 8 people 
who had entered other forms of treatment and whose drug use had been affected by 
their treatment. Greg had ceased methadone treatment and continued with counselling 
in order to cease opioid use. Three people had entered treatment because of the 
influence of their partners: one of these people also mentioned her “Mum” not liking 
her heroin use as part of her reason for commencing prescribed diazepam. Four 
people mentioned the negative effects of their drug use on their health as a reason for 
entering treatment. Damien was the only person apart from Chris (mentioned above) 
who said that one of the reasons he went into treatment was because he felt suicidal:
Well, in the last survey I put down that I wished I was dead ... I was very 
fortunate that I found NA ... There is no doubt in my mind that I could not 
have stopped using drugs and started having a good life without the NA 
fellowship.
The remaining people who had entered these other forms of treatment also only 
mentioned their positive effects (those connected with drug use are listed in Tables 
6-7, Appendix 18).
Another man started his first heroin Detoxification Program between interviews. 
Although it had brought his use under some control, he was still using frequently at the 
time of the second interview. One woman had been in and out of a repeat NA 
treatment between interviews and had found it unsatisfactory. She was still struggling 
with her illegal drug use.
5.16: Discussion of treatment histories
Of the 51 people who had not had any treatment by the time of the second interview, 
30 had used heroin between interviews. Most were low level users but there were still 
some who were experiencing problems due to their heroin use. Those heroin users at 
the second interview with a history of treatment for opioid use had a median age of 28 
(range 22-41, interquartile range 25-30), compared to a median of 23.5 among those
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heroin users without a treatment history (range 17-38, interquartile range 20-27) (Z 
-3.547, p < 0.001). There was also a significant difference in the duration of heroin 
use. Those with the history of treatment for opioid use had a median of 9 years from 
their first use (range 2-20, interquartile range 4.3-10), compared to a median of 4 years 
(range 1-16, interquartile range 2-6) among those with no treatment history (Z -3.418, 
p < 0.001). These findings are supported by similar results from an analysis of the 
ANAIDUS data (Ross et al, 1993b).
A notable difference between my studies and other studies where the theory of 
“maturing out” has been applied to abstinence is that other researchers have estimated 
duration of use not only from first use but from first heavy use. Duration of use in my 
study is based only on age at first use. The theory of “maturing out” in terms both of 
age and period of using may, however, be applicable not only to abstinence but to 
entry into treatment.
5.17: Other reasons given by respondents for changes in drug consumption 
patterns
In this section, I relate the richness of the variety of reasons given by the respondents 
for other changes in their drug consumption patterns.
5.17. i: Experimental use
Experimental use has been found to be one of the determinants for commencing drug 
use (World Health Organisation [WHO] Expert Committee on Drug Dependence, 
1974; Bennett and Wright, 1986; Navaratnam and Foong, 1990a). I based the decision 
to code a reason for taking a drug as an experiment (Table 8, Appendix 18) on whether 
respondents indicated that they had some curiosity about a drug before it was made 
available to them. This was exemplified in the following comment from Jackie. She 
had tried her first unprescribed methadone after some of her friends had obtained take- 
home doses from the Methadone Program: “I wanted to try it and see how other 
people were feeling and stuff.”
Fourteen of the 80 instances of a drug being used for the first time between interviews 
were partly or completely explained as an experiment. Since most people had used the 
drug only once or “a few times”, my use of the terminology is largely in accordance 
with Swadi’s belief that it should be abandoned except when restricted to those who 
have only used a drug once or twice (1990). One woman who had stopped her use 
said that she had previously only tried poppy extract once as an experiment, and 
Maggie, who had taken both opium and heroin for the first few times between 
interviews then stopped (mainly because she was pregnant), said that she had tried 
them because: “I wanted to see what (they were) like.”
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5.17.U: Availability
Other researchers have found the availability of a drug to be a major reason for 
altering drug use behaviours (Lukoff, 1980; Fraser and George, 1988; George and 
Fraser, 1988; Glassner and Loughlin, 1990; Morrison, 1991; Grund, 1992). Most 
people who mentioned availability (Table 9, Appendix 18) as a reason for a change in 
consumption patterns had taken the drugs involved only once or occasionally. 
Tamara’s explanation of her recommencement of amphetamine use was one of the 
very few instances where access was connected with market forces: “A dealer 
broadened his range.” Most comments were more general, such as Patrick’s 
explanation for his commencement of occasional unprescribed Murelax use: “I just 
know someone with a ‘script’.” Many people simply said that their use was “just 
opportunistic”, that the drugs had been found, or that their use was “due to 
availability.”
Thirty eight instances of commencing the use of a drug, 12 of recommencement, and 
13 of increased use were associated by respondents with their availability. Three of 
the instances of increased use were related to heroin. Since I first met Jeff (a core- 
Oswaldian) in 1989, he had always been a very occasional user of heroin, By the time 
of our second interview for this research he had gone through episodes of using “a few 
times a week”, one of the reasons being that he was “more often aware that it’s 
around.”
Of the 186 reports of decreased drug use, 18 were related to the drug being less 
available. By way of illustration, Emma had commenced cocaine use two months 
before the first interview. She had then gone through periods of two day cocaine 
“binges.” Between interviews she had only used it very occasionally because: “At the 
previous interview I was in contact with people who were using it, and it’s only 
around erratically.”
The biggest shift in availability was in drugs that had not been used; 121 people 
reported that they had previously used the drug only because it was available. The 
drug most frequently cited was hashish, for which 27 of the 40 reports of a transition 
from use to non-use were explained simply as lack of availability. Eleven people who 
had previously reported occasional use of cocaine had not used it between interviews. 
Drew-1 said: “The circles in which it’s sold are different to mine, and I haven’t had 
anyone asking if I want to buy it.” All the other people who had stopped the use of 
drugs included in Table 9 in Appendix 18 offered similar reasons. This covered drugs 
usually available only on prescription (indicating that they had previously been 
illegally obtained).
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Ruari was one of 3 people who reported variations in availability as all or part of their 
explanation for fluctuating drug use consumption patterns. He had increased his 
marijuana use from an average of twice a week at the first interview, then had a period 
of daily use before bringing it down again to its previous level. He explained the 
reason for the increase: “The harvest came in and a friend had it and I saw them every 
day and had it.”
5.17. iii: The effects of the drug
Other researchers have indicated that the effects of the drug may in themselves be 
reason enough for people to use them (Lewis et al, 1987; Navaratnam and Foong, 
1990a, 1990b). Eleven people I interviewed had increased the use of a drug for this 
reason (Table 10, Appendix 18). Apart from Eggplant, who said his use of tobacco 
had increased because he was “addicted”, and Amelia who had increased her use of 3 
benzodiazepines because of a “pill dependency”, respondents who had a transition in 
drug use consumption gave a similar reason to Jessie. She was the only person who 
had recommenced the use of a drug between interviews because of the feelings she had 
for the drug: “I love it.” Snork, who had recommenced heroin use (after temporarily 
stopping use between interviews) also offered a similar explanation: “I like it ... I 
missed it.”
Many changes which occurred in this category were in drugs that were not used 
(n=114) and in drugs where there had been a decrease in use (n=23). Most 
respondents explained these variations by saying: “I’m not that interested in it”, or ”1 
can’t be bothered with it”, or “I don’t enjoy it any more.” According to the WHO 
Expert Committee on Drug Dependence, such reasons are often given for stopping use 
(1974).
Some people then went on to comment about the effects of the drugs. Sixteen of these 
comments were positive, and they all came from people who had commenced or 
recommenced their use of a drug (Table 11, Appendix 18). Most people said they 
“liked” or “loved” the drug.
There were also 16 negative comments related to drugs per se (Table 12, Appendix 
18). One person who had used opium for the first time, and another who had his first 
use of datura, said that the drug made them feel “touchy” (meaning irritable). Stephen, 
who at the age of 45 had inhaled glue for the first time, said “1 wouldn’t like to do it 
again.” The negative comments made by other people stemmed from the drug being 
“boring” or “not very effective.” This included Cathie’s first and only use of heroin, 
which she had smoked.
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Eggplant had re-commenced heroin use and had used only it once. He was “still not 
keen on it.” Olivia made a similar comment about her recommencement (on just one 
occasion) of poppy extract. The people who had increased their heroin use (one 
temporarily) all expressed concerns about this increase. Snork’s increased use of 
“trips” led him to say: “I got a little worried about my acid use. I was having it heaps, 
but wanting it more heaps.”
5.17. iv: Othe r drug use
In 93 instances, the explanation for a variation in drug use consumption was partly or 
completely inter-related with another drug (Table 13, Appendix 18). The “other drug” 
most commonly cited was heroin. In five of the 51 instances where heroin was 
mentioned, there had been a commencement or recommencement of use - in 9 an 
increase, in 9 a decrease, and in 28 non-use (one temporarily) of the drugs listed in 
Table 13. Twenty comments were connected with one of the other opioids listed in 
this table. One person said that they had stopped the use of poppy extract because they 
no longer needed them with increased use of heroin, but most people were trying to 
control their use of heroin and other opioids. A few comments were not directly 
related to a change in heroin use. Two people said they had previously only used non- 
prescribed methadone when they were “hanging out” for heroin and one person had 
only used “homebake” because there was “poor quality heroin around at the time.” 
Only another two variations were explained as a replacement for other drugs.
The main reason given for the remaining opioids that were decreased or not used, and 
that were correlated with heroin, was because people favoured heroin more. Sara’s 
comment typified these responses: “I don’t really like any other drugs, just heroin.”
Daryl said that because he was trying not to use heroin he was using more “speed” 
which, in turn, he connected with his increased use of alcohol. Tamara had increased 
her tobacco consumption because of periods of “hanging out” for heroin. Jeremy put 
his increased tobacco use down to stopping heroin (as well as other illegal drugs).
As other researchers have found (for example, Maddux and Desmond, 1980; Hartman 
et al, 1983; Anglin et al, 1989; Almog et al, 1993) there was an inverse relationship 
between alcohol and heroin use. Five people who had increased their alcohol use said 
this was due to either stopping, or temporarily decreasing, heroin use. Conversely, 3 
people who had decreased their alcohol consumption said this was related to increased 
heroin use.
Some of the diversifications in patterns of heroin use had affected some other drug use 
(Table 13, Appendix 18). Sara had increased her use of heroin and stopped the use of
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most other drugs because “I only like heroin now.” Two people who had stopped their 
heroin use had stopped their use of other opioids and benzodiazepines and, when 
Morgan went through a period of not using heroin, her marijuana had decreased 
because she said she tended to use it in conjunction with heroin.
There have been disparate findings on the relationship between deviations in heroin 
consumption patterns and the use of other drugs. In addition to alcohol, Anglin and 
colleagues also found that the use of other drugs is inversely related to heroin (1989). 
In one of the few studies to compare different levels of heroin use Flaherty and co­
workers, however, found that daily heroin users tended to use other drugs to a slightly 
greater extent than the occasional heroin users (defined as those who used heroin less 
frequently than daily) (1984). Rounsaville and colleagues report a reduction in 
alcohol, cocaine, and other drug use among the people they surveyed who had not 
used heroin for more than 6 months (1987). In a follow-up study of clients who had 
been admitted to methadone clinics, Fairbank and colleagues found that those who 
stopped their heroin use, or who used less than weekly, were more likely to also 
decrease their use of other drugs, compared to those who continued to use heroin more 
frequently (1993). This reduction parallels a finding from a study of 114 people 
receiving methadone maintenance in a Glasgow treatment setting who completed the 
OTI. They were also found to have significantly reduced the mean number of drugs 
(from 4 to 2.4) between an early attendance and after 6 months of treatment (Macleod 
et al, 1996).
No one said their use of alcohol had increased because of going into treatment but I 
checked through the qualitative data to see how many people who had entered or re­
entered methadone treatment had increased their alcohol use. There were only 4 such 
people among the 18 who had increased their alcohol consumption between 
interviews. James-1 and Amelia had re-entered methadone treatment. James-1 related 
his increase to him “having more of a social life” and Amelia said “I don’t know why 
[it increased].” Brigid, who had started her first methadone treatment, said she drank 
because it “always made me happy” and Sinead, who had been in and out of her first 
treatment, largely associated her increased alcohol intake to a period when she was 
trying not to use heroin.
As seen in the discussion on treatment above, most people who went into treatment 
had decreased or stopped the use of not only heroin but other drugs. In order to get a 
more complete picture of the impact that decreased or non-use of heroin had on other 
drug use, I looked at the number of drugs used at each interview by the 12 people who 
had stopped heroin and the 33 who had reduced their use. At the first interview, these 
45 people had used a median of 12 drugs (range 3-25, interquartile range 9-15) and at
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the second the median had dropped to 7 (range 3-14, interquartile range 6-10) (Z 
-4.882, p < 0.001). My findings, therefore, support those from other researchers who 
have demonstrated that there is not necessarily an inverse relationship between the use 
of heroin and other drugs.
Changes in the use of the benzodiazepines (listed in Table 13 in Appendix 18) were 
also commonly associated with heroin. Four of the people who had commenced or 
recommenced benzodiazepine use had them prescribed to control heroin use, and 3 
people who had stopped the use of a drug in this class had done so because they no 
longer needed them since they had stopped using heroin. Most of the instances of the 
non-use of a benzodiazepine involved a switch to another drug in this class.
Drew-2 said his decreased use of heroin (as well as amphetamine and his non-use of 
ecstasy) was due to him “discovering energy” (a “cocktail” of ecstasy and 
amphetamine). Part of Roger’s reasoning for his decreased heroin use was “heroin’s 
not my drug of choice, that’s alcohol and tobacco for me.” Olivia was using less 
heroin because she had “better access to marijuana.” Lisa’s heroin use had risen when 
she was trying to stop her use of Doloxene, which had been prescribed as an analgesic.
There was a miscellaneous array of other drugs mentioned in conjunction with the 
drugs listed in Table 13, including 6 mentions of marijuana, 6 of alcohol and one each 
of hashish, tobacco, “trips” and No doz1 .
Four people made positive comments about the effects of new drugs on other drugs 
they used (Table 14, Appendix 18). Both Sara and Gazoo, for example, who had 
commenced benzodiazepine use, said these drugs enhanced the effects of heroin. 
Navaratnam and Foong have reported a similar finding among the people they 
interviewed (1990a and 1990b).
A few people also made negative comments about the effects that their changes had on 
other drugs (Table 15, Appendix 18). For example, Jeff, who had increased his use of 
heroin, had starting using unprescribed codeine to assist him with periods of “slight 
withdrawal.”
5.17. v: Drug quality
In addition to Gazoo’s remark that fluctuating heroin quality had been one of the 
reasons he had entered methadone treatment, another 19 people referred to an 
alteration in drug quality when discussing their reasons for varying their drug use
1 An over the counter substance containing caffeine.
levels (Table 16, Appendix 18). Verifying the findings reported by McDonald and 
colleagues (Appendix 14), Rob was among several heroin users who, at the first 
interview, maintained that Canberra’s heroin was of a poorer quality then elsewhere. 
At the second interview, Sam was one of 7 people who commented on an increase in 
heroin purity “[There’s] heaps better heroin around. Now you can get rocks pretty 
pure. Sometimes they’re cut, but [you can get] forty to sixty per cent [purity].”
These comments are corroborated by reports from police services and analytical 
laboratories which show that purity levels of heroin rose in most States and Territories 
during 1992 from the 0-10 per cent purity range to 20-25 per cent purity (Anon, 1992). 
This trend has continued. During 1995 to 1996, samples of heroin tested ranged from 
13.2 per cent to 79.8 per cent purity with an average of 58.7 per cent purity (Australian 
Bureau of Criminal Intelligence, 1996). In spite of this increase in heroin purity, only 
Jeff and Brenda associated their increased heroin use (Brenda’s temporarily) with an 
increase in its quality.
Jeff had also recommenced the use of “trips” because he felt they were of good 
quality. The people who had stopped or decreased their use of “trips”, amphetamine, 
ecstasy and cocaine said this was because of their inferior quality.
5.17. vi: Injection-related,
Otto was one of only 4 people who referred to injecting when discussing their 
variations in drug use (Table 17, Appendix 18). He described his first opioid injection 
of dissolved morphine tablets:
we got this tablet and tried to dissolve it. It went into the consistency of 
glue, but we had some. I liked the effect, but not the process of injecting it.
Alison had increased her amphetamine use because “Half the time, it’s just to hit up” 
(to inject). One of the reasons that Annabel had used amphetamine only once between 
interviews was because “It’s a hassle when you’re out to have to find somewhere to 
inject and you have to go and get a clean fit” (needle and syringe). James-3 had 
reduced his amphetamine use because “I don’t want to use needles any more.”
5.17. vii: Age
In addition to the one person who said they had gone into methadone treatment 
because of their age, and the two people who said they had gone into methadone 
treatment because they had been using for 10 to 11 years, there were only another 
eight instances where people alluded to their age or period of using in relation to the 
drug use changes (Table 18, Appendix 18). All were associated with a decrease or a 
non-use of a drug. Some comments were along the lines of James-3’s explanation for
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not using Sudafed1 : “It’s a bit of a kiddies’ drug.” Others were similar to Rob’s 
comment that, at the age of 23, he was “too old to handle trips.”
5.17.viii: Lifestyle events
A variety of lifestyle events precipitated 89 changes in drug use consumption levels 
(Table 19, Appendix 18). Several were due to a party or particular event. One such 
scenario is “Saint Oswald’s Day.” Aidan and Rafe (two core-Oswaldians) had 
recommenced the use of “speed” as part of the celebrations involved with “Saint 
Oswald’s Day” and, although Trevor (another core-Oswaldian) had not used any 
between interviews, he said he might “just have a line [on the next] Saint Oswald’s 
Day.” Most drugs mentioned in the context of a party or particular event were used on 
an occasional or once only basis.
Snork was one of only 5 people who associated a variation in drug use consumption 
with moves to or from Canberra. One of these was his fluctuating heroin use. At the 
first interview, this ranged from occasional use to using 2 to 3 times a week. Between 
interviews, his use had increased to a period when he used 4 to 5 times a day, followed 
by a period of non-use for 3 months which was due to him “escaping from Canberra.” 
Since returning, he had recommenced use: “I actually went out to get it ... because of 
Canberra ... it’s hard not to do in Canberra .”
Alcohol was the drug most commonly cited when variability in use was related to a 
lifestyle change. The increased use was mostly because, as James-1 said, the people 
involved were having “more of a social life”, while the decreased use was often simply 
explained along the lines of “I’m staying home more.”
In addition to the 10 people who gave a general lifestyle reason for entering 
methadone treatment, there were 5 people who had decreased their heroin use, one 
woman who had decreased her alcohol use and one who had stopped using 
amphetamine who all also gave general lifestyle reasons as part of their rationale for 
the variation. Rob, for instance, who had reduced his heroin use explained: “I was 
making a mess of things, there were new things I wanted to do ... more to see about 
life.” During the twelve months prior to the first interview, Susie had consumed 6 to 
10 drinks twice a week “to get pissed.” At the second interview she still “Sometimes 
had maybe ten drinks” but went weeks without and in the “Past few months, not as 
much. I don’t want to drink or use [heroin] ... I don’t like what it does to my health or 
lifestyle.” Simpson and colleagues also found that the main reason that the people in
1 An ephedrine-based substance.
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their study (65%) stopped daily opioid was because they were tired of the lifestyle 
(1986).
Several people linked their changes with the demands of work or study. This is how 
James-1 explained his decreased marijuana use: “I’ve got to work, I’ve got to be 
alert.” Cathie, Steve and Marie, who had all completed their studies, were exceptions. 
Cathie said that having less stress due to not studying had enabled her to reduce her 
marijuana and alcohol use, and Marie had temporarily stopped smoking for the same 
reasons. Steve’s tobacco use had fluctuated. He said:
I was keen to finish Uni’ and wanted to stop smoking. When I finished 
Uni’, the guard, the reason for stopping went and I just started again.
Morgan was the only other exception in this category. Her use of heroin had 
fluctuated between interviews. It had increased when:
I was working nights and on my own in the day, so I had time to stew 
things over and go and get heroin and hassle around and scam.
5.17.ix: Financial
There were 58 instances where a modification in drug consumption levels was related 
to finances (Table 20, Appendix 18). In one of the two instances where use of a drug 
had commenced, 9 where there was as increase, and in 6 where use had temporarily 
increased, or recommenced, people said their financial situation had improved. Apart 
from Otto, who had commenced heroin use and whose increased income was due to 
selling marijuana: “[I’ve] got plenty of money, I can afford to buy heroin”; this 
increased income had been legally obtained.
Comments of a somewhat different nature came from 5 other people who attributed 
their change to the drug being “cheap” or “free.” For example, David and Maggie had 
both commenced opium use (Maggie then stopped when she was pregnant) for this 
reason.
Twenty instances of a decrease in the use of a drug, 19 of a drug not being used and 4 
where the use had temporarily stopped, or had reduced, were partly or wholly 
explained as being due to the expense of the drug, not being able to afford the drug, 
getting into debt, or wanting to spend money on other things. Jackie was one of 5 
people who had reduced their heroin use partly or completely due to financial reasons: 
“I was sick of not having food in the house and being hassled for money.” 
Blackwell’s respondents also referred to the financial drain of heroin use being a major 
disincentive for continuation of use (1983)
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5.17. x: Significant others
Several other researchers have found that significant others play a part in reducing or 
stopping drug consumption (Waldorf, 1970; Simpson et al, 1986; Stall and Biemacki, 
1986; Anglin et al, 1987b; Valiant, 1988; Morrison, 1991). In addition to 18 reports of 
significant others affecting treatment seeking, I found 62 instances where a decrease in 
use or non-use was associated with a significant other.
5.17. x.a: Partners
Only two instances of commencement of drug use were attributed to partners and both 
involved a new relationship (Table 21, Appendix 18). Seven reports of an increase in 
use were partly or wholly due to a partnership change. Alison linked several of her 
variations in drug use to her change in partners. She considered, for example, that her 
commencement of cocaine use and her increased use of amphetamine and ecstasy was 
due to her new partner “really liking” the drugs. Daryl also associated several of his 
changes in consumption patterns to his partners. His use of alcohol had increased 
from 3 drinks once a week at the first interview to “sometimes binge use” at the 
second because his new girlfriend was “an alcoholic.” He had stopped smoking 
cigarettes for a period and said he had recommenced because his new partner smoked. 
His heroin use had also fluctuated: he had stopped because his “ex-partner ripped me 
o ff’ and he had been using heavily with her, and he started again because his new 
girlfriend was a “heavy user.”
Ten reports of decreased drug use, and 5 of non-use, were connected to partners. Most 
were either because a partner did not use the drug or did not like the respondent’s use. 
Roger had a 16 year history as a non-dependent user of heroin at the first interview, 
and his reduction of heroin use (from weekly to monthly) between interviews is 
included in this category. This had “probably got something to do with Lynda who 
doesn’t use heroin, she knows I do and there’s no particular pressure - perhaps some 
subtle pressure.”
Three other people said that their decrease or non-use of a drug was due to a break-up 
of a previous relationship where the partner used the drug. Without going into 
treatment, Greta had “stopped” heroin for more than 12 months at the second 
interview. Among her reasons was the fact “I broke up with Kevin, we were using 
heroin and that kept us together.”
Amy’s reason for decreased heroin use was somewhat different. She had used heroin 
fortnightly at the first interview then had a period between interviews when she 
“started using daily when my ex-boyfriend was dealing and using a lot and giving it to 
me.” When she broke up with this boyfriend she formed a partnership with Lee and
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“stopped using heroin for a period. Lee had a nervous breakdown, I was worried 
about him and using drugs was the last thing I wanted to do.” Marsha’s reason for not 
using amphetamine for more than 12 months was also partly because: “I wasn’t 
comfortable with Tim using the drug.”
Including the cases reported above, there were 10 instances of fluctuating drug use 
patterns which respondents partly or wholly explained as due to the break-up of a 
relationship. Both Emma and Sinead, for example, had stopped using heroin for a 
period after leaving a relationship where the partner was a heavy user. Sinead then 
recommenced her use because “John was around and harassing me and my friends.”
5.17. x. b: Pregnancies
Between interviews, Deirdre had given birth to her first child and Brett’s de facto wife 
had their first child. Another three women were pregnant for the first time, Chris’s de 
facto wife was expecting their first child and Annie was trying to conceive. Among 
these seven respondents, there were 10 reports of a reduction in drug use, 21 of a drug 
not being used, and two of fluctuating patterns, which were all largely explained by a 
previous, current or hoped for pregnancy (Table 22, Appendix 18).
Deirdre’s pregnancy had led to her stopping the use of several drugs. At her first 
interview, she was injecting heroin 5 times a week, consuming an average of 12 
alcoholic drinks a day and smoking up to 50 cigarettes a day. She also currently used 
another 10 drugs. Shortly after our interview, Deirdre conceived her first child and, 
without going into treatment, she stopped all illegal drug use. By her second 
interview, when she was accompanied by her healthy and happy toddler, she had 
reduced her alcohol use to 2 to 4 drinks a week and her cigarettes to 5 a day.
5.17. x. c: Other family
In addition to those new and expectant parents and the one person who said a child 
was an influence on them entering methadone treatment, another two people, both 
women, said that their changes in drug use were related to their children (Table 23, 
Appendix 18). Julie had reduced her cigarette smoking from an average of 40 a day to 
25 because “My kids don’t let me smoke in the house.” Marsha had stopped using 
amphetamine for more than 12 months partly because one of her children was a victim 
of a criminal activity which precipitated police involvement: “[I want my children] to 
live in a safe environment and deal with the police in a non-paranoid environment.”
Only two people ascribed variations in their drug use to their parents. Greg had 
commenced prescribed Tofranil when he was depressed “to please Mum”, and one of 
the reasons that Robyn was smoking less was because her Mother didn’t like her
smoking. Only Jackie mentioned another family member in conjunction with a change 
in drug use. She had temporarily stopped smoking when one of her grandparents was 
dying of lung cancer.
5.17.x.d: Friends
Other research has indicated that friends are influential in changing drug use patterns 
(for example, Waldorf and Biernacki, 1979; Bennett and Wright, 1986; Glassner and 
Loughlin, 1990; Morrison, 1991). In contrast to the few reports of influence on drug 
use consumption patterns by family (other than partners and children), there were 46 
partially or completely due to friends (Table 24, Appendix 18).
I found no evidence for people being coerced into drug use by, as Faupel puts it, “the 
veteran addict/dealer promiscuously turning on the young and vulnerable.” As Faupel 
goes on to say, in spite of this popular image, there is no evidence to suggest that this 
happens in reality (1991:53). In their study of adolescents, Glassner and Loughlin 
found that “Drug use arises out of association with peers not so much as the result of 
pressures, but rather as part of a social context” (1990:159). I found only two 
indications of any coercion into initiation into drug use. Both were by friends. Mr X 
said that he had been completely influenced by a friend to take heroin for the first 
time:
Well, one of my friends just fully conned me into i t ... she spent about three 
hours conning me, and 1 just did. Both times [I used heroin], it was the 
same person.
Gazoo had commenced prescribed flunitrazepam because a friend had persuaded him 
to get a prescription for her in exchange for heroin. He had then used some of the 
flunitrazepam himself. There was no coercion involved in Bert’s first amphetamine 
use: “Friends brought up the idea, so I said ‘No worries.’”
Several variations were said to be due to the influence of a peer. Elke is a case in 
point, but, as an example of the multiple coding required, she also indicated this was 
partly to experiment:
there was this guy I was living with and he got me into marijuana, and he 
was a really bad influence on me. And I met up with him at this festival, 
and I ’d been curious about heroin and we injected it.
Most of the increases, non-use and fluctuation of drug use patterns explained as being 
due to friends were largely results of a change in the people that respondents were 
“hanging around” or living with. Sara’s variation in alcohol consumption typifies 
these responses. Her alcohol consumption had dropped from a third of a cask of wine
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5 times a week to “a couple of drinks a week” because “My drinking friends have left 
town.”
Rosetta was one of 16 people who had stopped or reduced a drug because of 
witnessing detrimental effects in friends: “My flatmate smokes [marijuana] and that 
annoys me - she’s always stoned and doesn’t do anything and I don’t want to be like 
that.” This had led to her reducing her marijuana use from the daily use of several 
“bongs” at the first interview to fortnightly use. Three people had not used 
amphetamine since before the first interview, and one person had not used any for 
more than 12 months. Greta and Aaron were among 4 people who had reduced or not 
used amphetamine due to seeing the effects of heavy use on a friend. They had seen 
the same friend in hospital with “speed psychosis.”
There have been several recent heroin-related deaths in Canberra, as in other States 
and Territories in Australia (Hall, 1996; Zador et al, 1996). These have often occurred 
in clusters. Bammer and Sengoz investigated one apparent cluster that occurred in 
Canberra between my two rounds of interviews. As part of this process they examined 
ACT ambulance records from the second half of 1992 to the first half of 1993. These 
showed a dramatic increase in the number of people treated for “likely or possible 
heroin overdoses” (1995:316 ).
Although I did not ask respondents if they knew anyone who had overdosed, either 
during ethnographic work or at the second interview, 7 people volunteered the 
information that they knew someone who had recently died in this way. At interview, 
Greg was one of three people who said they had decreased their heroin use for this 
reason. He was receiving methadone treatment and also having counselling at the first 
interview. He had discontinued methadone treatment 6 months prior to the second 
interview but had continued with his counselling. Recently, two of Greg’s friends had 
died of a heroin overdose and he had been the last person to see one of them alive. His 
last use of heroin had been 3 months ago, shortly following this death:
I was terribly worried when Tina OD ’d, I was worried about my own using 
... it’s easier not to use when you think you might die if you do, and 1 
basically want to live. I f Tina hadn’t died, I would still be dabbling I 
reckon ... I had a friend who shot himself a few years ago and his brother 
really cleaned himself up and I said I ’d do the same as him after Tina died.
Two of the ex-heroin users interviewed by Bammer and Weekes also said that the 
death of a significant other had been the point at which they decided to stop using 
heroin (1994). No one in my study reported increasing their use after such an 
experience, but some people in Bammer and Weekes's study did.
Steve had not used any heroin for two and a half months (and was hoping for this to be 
permanent) because he had used it with a friend who then became “clinically dead and 
was rescussed” (resuscitated). Blackwell found that several of the people she 
interviewed had reflected on their heroin consumption after witnessing adverse effects 
in friends (1983).
5.17.xi: Legal/criminal
Simpson and colleagues report that 32 per cent of the people they surveyed who 
stopped daily opioid use said that a fear of the law was a motivating factor (1986). 
Following a study of 406 men admitted to a drug treatment centre, Anglin and 
colleagues concluded that their results “support a concept of maturing out of drug 
addiction as a phenomenon conditional upon levels of drug dealing and crime” 
(1986:244). Maddux and Desmond found that a major facilitating factor for a long 
period of abstinence was a period of probation or parole for a year or more (1980).
In addition to the 9 people who had commenced methadone treatment and who 
discussed criminal activities as part of their rationale, there were another 22 instances 
where I was able to identify a link between a variation in drug use with either a 
criminal activity or a legal reason (Table 25, Appendix 18). One was related to a 
respondent’s dealer getting “busted” and 10 were related to personal dealing. Otto 
associated his commencement and continuation of heroin use with earning more 
money from increased sales of marijuana, and two people had increased their 
marijuana use because they were also selling it. One woman had decreased her 
marijuana use because she was no longer dealing it or living with people who did.
Both Erin and Snork had temporarily increased their heroin use when they were 
dealing it. One person had decreased his alcohol use and one his tobacco use because 
they had stopped selling heroin. They both believed that their use had increased 
during the stressful period when they were. Bart had been found with 0.5 gram of 
cocaine prior to the previous interview and this police involvement and its 
ramifications had led him to stop its use. Boy Wonder had decreased his amphetamine 
use after being caught in possession of chemicals to manufacture amphetamine and he 
was on a two year good behaviour bond.
There were 4 other examples of direct police involvement. Brian had prided himself 
on being a very “hidden user.” He had been through a terrible experience between 
interviews when a friend he was with had died of a heroin overdose, which had led to 
his involvement in police inquiries. He had then reduced his heroin use from often 
very heavy use to occasional use: ”1 decided to go for ‘script’ drugs [he said he was 
now “dependent” on diazepam] because of the illegality of heroin.” Jade’s non-use of
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temazepam was partly because “Last time I had them, weird things happened with a 
police case.” Forest had not used Avils1 because when he used them “I was out of 
control ... and was picked up by the cops.” Marsha had stopped using amphetamine 
for more than 12 months partly because (as related above) one of her children was a 
victim of a criminal activity which had precipitated police visiting her home.
Two people had decreased their cannabis use when they moved to New South Wales 
because of the more stringent laws related to its use in that State. Mishima said that 
one of the reasons for his decreased alcohol use was because he had been involved in a 
drunken fight and Mick had been assaulted when he was drunk and this had led him to 
drink less alcohol. Fred had reduced his amphetamine because of the “general 
secretiveness” involved, and Daryl, after committing an act of vandalism towards a 
previous girlfriend, had temporarily stopped his heroin use because he realised that 
“What I did was wrong.”
Very few people I interviewed reported a link between stopping the use of a drug and 
their criminal behaviour. In particular, only a few said that they had stopped the use of 
a drug because they had been charged with a criminal offence. The discrepancy 
between my finding and that of other researchers is probably related to several 
differences between the samples. For example, the people in my sample were 
different in variables such as gender composition and the variety and levels of drugs 
used and, as will be shown in Chapter 8, few people had committed serious crimes, 
and comparatively few had been imprisoned.
5.17.xii: Health
The WHO Expert Committee on drug dependence report that use of a drug is often 
discontinued because of concern a user has about his or her welfare (1974). Health- 
related issues were among the most common triggers for a change in drug 
consumption patterns among the people I interviewed. In addition to the 18 people 
who said that one of the reasons they sought treatment was because of the negative 
impact drug use had on their health, there were another 174 instances of a change in 
drug use patterns being juxtaposed with a health related issue (Table 26, Appendix 
18).
Ten people connected their commencement, and 11 their recommencement of the use 
of a drug (including 3 whose heroin use had fluctuated) with their health. Most drugs 
in these categories had been prescribed for symptoms including headaches, insomnia
1 Avils are a type of antihistamine available over the counter in Australia. When used as advised, the 
side-effects are minimal but when used in large doses, they can produce hallucinations (Thomas, 
1988).
102
and depression, and for the control of heroin use. A few drugs that had not been 
prescribed, where respondents had commenced or recommenced a drug, as well as a 
few increases in use, had been used to help allay a variety of health problems including 
insomnia, depression and stomach cramps.
Only two people who had increased their use of drugs due to a health problem had 
been prescribed the drug. Both had used diazepam to assist with problems related to 
their use of heroin. There were 8 instances of increased use of a drug and two of 
recommencement related to people having more stressful lives.
Fifteen of the instances of decreased drug use (including one person’s fluctuating use) 
were related to health problems following marijuana use. A wide range of health 
problems were mentioned, most by only one person. Some people reported 
diminished cognitive ability. Several problems, such as memory loss, paranoia, 
auditory hallucinations or feeling “edgy”, “scared”, “uncomfortable” or “nervous”, 
were psychological. The only person who had stopped marijuana use said that this 
was because of paranoia, and Sara had stopped hashish use for the same reason. 
Physical health problems mentioned by those that had decreased their marijuana use, 
and by two people who had stopped hashish use, included dependency, queasiness, 
sleeping problems and respiratory problems. Problems mentioned by the people I 
interviewed correspond with those discussed by Hall in a review of the health 
problems associated with cannabis use (1995).
The other health-related comments about decreased use, non-use or a temporary 
cessation of use were mostly general such as “I don’t like what it does to my health”, 
“I had a filthy habit” or “I was generally rundown.”
Some people had stopped or decreased their use of a drug because of hepatitis and 
these reasons are discussed in Chapter 7. Five people who had decreased their tobacco 
use had suffered respiratory problems, including 3 who had been ill with pneumonia.
Most of the 16 people who stopped amphetamine use for a health reason, as well as the 
7 who had reduced their use also for a health reason, referred to the negative aspects of 
the “comedown.” Although, for some, it was a matter of feeling generally unwell, 
others, such as James-2, had experienced more profound after-effects. He had been 
through a period of injecting amphetamine four times a day for 6 of the 12 months 
leading up to his first interview. In the period between interviews he had used it only 
occasionally and had usually administered it intranasally. He explained this by saying: 
“Now I feel really bad coming down. I feel shithouse and it scares me.” After a 
history of using 3 to 4 times a month at the first interview, Rob had stopped his use of
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amphetamine for more than 12 months and talked about several health problems he 
had experienced which had formed part of his rationale for stopping:
Speed made me feel edgy, angry, a bit stupid... I don ’t think it’s safe. You 
can talk to people without thinking they *re going to kill you.
Five other people mentioned negative psychological sequelae of the drug including 
paranoia and “speed psychosis.” This high prevalence of health problems associated 
with amphetamine use resonates with the finding of Hall and Hando. They report that 
around a third of the of 231 amphetamine users they surveyed in Sydney had 
experienced amphetamine-related health problems (1994).
Many people who had decreased or stopped the use of hallucinogens also mentioned 
the unpleasantness of the “comedown” or having a “bad trip,” Five people who had 
stopped the use of “trips”, one who had reduced his use, and 3 who had stopped the 
use of psychedelic mushrooms, also referred to negative psychological side-effects.
I did not ask respondents if they had ever experienced an overdose of heroin, only if 
they had one during the month prior to interview (as part of the OTI). Daryl was the 
only person who spontaneously reported an overdose affecting his drug use. He had 
gone through a “near death experience” after concurrent use of several drugs including 
heroin and hallucinogens. The reason he gave for not using any psychedelic 
mushrooms was because of this experience, saying “No psychedelics, it’s not 
practical.” He did not relate any of his other changes to this experience.
Both of the people who had reduced their nitrous oxide use, and two who had stopped 
its use, said they were worried about the effects on their lungs of the metal in the bulbs 
containing the drug.
Everyone who had stopped the use of benzodiazepines referred to the fact that they 
made them feel “sleepy” or “stupid.” Tim had stopped his use of prescribed 
Prothiaden because “I was depressed about being on methadone. I wanted to take one 
less drug. I wanted to stop being a half person.”
The theme emerging from 5 people’s variations was somewhat different to those 
covered above. One had increased the use of “trips”, two had increased their use of 
marijuana, two had decreased their marijuana use and one had temporarily stopped 
smoking because they were feeling more relaxed.
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5.18: Discussion
One of the reasons for collecting the prospective data was to tease out some of the 
reasons for changes in drug use “careers” and reasons for “maturing out” of drug use. 
In describing the reasons for stopping or decreasing their use, very few people referred 
to their age or their period of using and only one man related his stopping the use of 
drugs to having resolved traumatic childhood experiences. Many did, however, give 
reasons such as added family responsibilities, the pressures of employment, wanting to 
spend their money on other things or the deleterious effects of drugs on health. These 
reasons may be interpreted as being part of a process of “maturing out.”
The lower rate of consistent daily use for some drugs at the second interview may be 
an artefact of the longer timeframe since levels of use are more likely to fluctuate over 
the longer timeframe for which data were being sought at the second interview 
(median 18.3 months) compared to the first (12 months).
Most people I interviewed had been using illegal drugs for a shorter period than those 
surveyed by other researchers who studied the “maturing out” of opioid users. They 
also tended to be younger and, despite the significant increase in the number of people 
in treatment, there were still more people who had never experienced treatment than 
who had. It is possible that “maturing out” occurs at an early age in the case of the use 
of drugs other than opioids. It is also possible that the differences are due to 
geographical location.
I did not interview enough people who said they had “stopped” using heroin to be 
confident about any comparisons with other studies on “maturing out” of heroin 
dependence. In addition, these people had all “stopped” for a much shorter period than 
those studied by other researchers and it is possible that some will revert to heroin use.
Most people gave several reasons for the changes in their drug use. Many reductions 
were due to factors such as unavailability, treatment, and dislike of the drug. Although 
the number of people using heroin had increased by five between interviews, 12 
people said they had “stopped” their use and 33 had reduced their consumption.
Most of the people who had entered into treatment said the major reason they had 
sought treatment was the multitude of problems which accompanied their increased 
use of heroin. Fortunately, the need for treatment coincided with an expansion of 
places in the Methadone Program but, as evidenced by those 3 people who had 
commenced their first treatment only to leave it shortly afterwards, this form of 
treatment had not worked for everyone. There were, however, 26 people in methadone 
treatment at the second interview compared to 4 at the first. Although there were
mixed accounts of the efficacy of methadone treatment, most people who had 
continued with their treatment mentioned its positive effects. All those who entered 
into treatment between interviews and who were still in treatment at the time of the 
second interview had either stopped or reduced their heroin consumption. Amongst all 
respondents, including those who entered into treatment, there was a significant 
reduction in the number of drugs used between interviews.
Given the relatively young profile of the respondents in my sample, there were 
probably many people in the beginning or occasional stages of drug use when “social 
controls” (Becker, 1963:61) led them to stop their drug use at an early stage and they 
did not progress in their drug using careers. Their ability to not revert to use may, 
therefore, be greater than for those who are at later stages of their careers where social 
controls had not previously prevented their progress to higher levels of use.
Several people discussed the correspondence between their use of two or more drugs. 
The non-use or decrease in the use of heroin had also led to the reduction or decreased 
use of other drugs, particularly other opioids and benzodiazepines. Other research has 
also demonstrated that opioid users tend to use fewer non-narcotic drugs when using 
less opioids (Shaffer et al, 1985). As reported in the previous chapter, poly drug use is 
associated with heroin overdoses and BBV risk behaviours. It may be hoped that the 
reduction in polydrug use amongst the population I studied will lessen their potential 
for the mortality and morbidity associated with drug use.
Biemacki found that one quarter to one third of his sample of 101 ex-dependent opioid 
users who became abstinent without treatment, had stopped their use because of a 
“rock bottom” event which he defines as “a highly dramatic emotionally loaded life 
situation” (1986:43). There were very few examples of “rock bottom” events among 
the people I interviewed. Examples of these types of events were friends’ deaths, one 
friend’s near death from a heroin-related overdose, and perhaps some of the criminal 
behaviours which led to police involvement. Similarly, Klingemann found that among 
the people he studied who had stopped using heroin and alcohol without treatment 
“this absolute image of hitting bottom can not be empirically supported in many cases” 
(1991). Some of the reasons given by the people I interviewed can be likened to those 
Klingemann found. Some he terms “‘cross-roads cases’ [those] who want to drop out 
before reaching the subjective absolute low point.” Others he terms “‘pressure 
sensitive cases’ for whom social pressure plays a particularly important role” 
(Klingemann, 1991:734).
There were two people in my study who had felt suicidal because of their drug use. 
According to Biemacki, “The thought of taking one’s own life as an alternative to
continuing the addiction is a major factor that distinguishes the rock bottom 
phenomenon from the existential crisis. The existential crisis is felt as a sense of 
mortification where the most profound kind of self questioning occurs and where the 
individual feels that he has nowhere to turn to salvage a sense of well being” 
(1986:59).
Whilst the terms “maturing out” and “drug using careers” are useful umbrella terms, 
the prospective data collection revealed the multitude of reasons offered by 
respondents for changes in their drug using patterns.
5.18. i: Ratios of heroin users
Citing an article by Treaster in The New York Times, Winick records that in 1993 
current treatment programs catered for less than a third of the nation’s “addicts.” 
Winick associated this with the lack of available facilities and interest on the part of 
the users (1993). Previously, there were also too few treatment places for people 
experiencing problems with their heroin use in Australia. Due to calls from IDUs and 
the HIV/AIDS epidemic, there is now greater access to methadone treatment (Ward et 
al, 1992). This has led to more people entering treatment, which must have impacted 
on the ratio of treatment to non-treatment heroin users. Only one person I interviewed 
expressed a fear of contracting HIV, and only two people said that a form of hepatitis 
had led them to seek treatment. As will be shown in the following Chapter, there 
have, however, recently been huge increases in the numbers of IDUs who have a form 
of bloodborne hepatitis. Allowing these people to enter treatment will necessitate 
further increases in the number of treatment facilities.
Hartnoll and colleagues (1985), the CDCSH (1988a) and Marks (1992) have suggested 
that there are more non-dependent than dependent heroin users. The ratios, however, 
give no indication of how long a non-dependent career may last. My results, along 
with those reported from the ANAIDUS data (Ross et al, 1993b) revealed that people 
not in treatment were more likely to be younger and at an earlier stage of their drug­
taking career. If younger users hear of these ratios, and I have found that some have, 
they may be misled into thinking that they will be among a fortunate perceived 
majority who will succeed in controlling their heroin use.
It is difficult to make generalisations based on a small sample but my research, 
particularly my nine years’ contact with the Oswaldians, lead me to question the ratio 
of non-dependent to dependent heroin users. Thirty five Oswaldians had ever used 
heroin. Two had experimented with it once before the first interview and one had been 
an occasional user and stopped before the first interview. He had previously been in 
treatment for non-opioid use. Table 5.5 is based on the findings from the 32
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Oswaldians who had used heroin between interviews, and also on subsequent 
ethnographic work which has informed me that one other core-Oswaldian and one 
peripheral group member have been treated for opioid use.
This table shows that 20 Oswaldians have a history of treatment. Five had re-entered 
treatment between interviews, one had been in continuous treatment, one had not been 
in treatment since before the first interview, and the other 13 had gone into treatment 
for the first time. The 3 people who had “stopped” heroin use had done so without 
going into treatment. They had “stopped” for periods of 8 to 12 months. The 
problems experienced by the 4 people who had also not been in treatment included 
periods of dependency, contracting a bloodbome form of hepatitis, periods of dealing 
heroin and, for one person, a short period of incarceration for possession and dealing.
Of the five Oswaldians who had no problems with their heroin use, one had 
commenced shortly before the first interview and had only used it 4 times. Between 
interviews, his use ranged from a “few times a week” to a 4 month period with no use. 
Since he said he “really loved” heroin, I considered him to be at risk of increasing his 
use. Two people had used heroin for the first time between interviews. I also 
considered one of these people to be at risk of developing a dependency since he had 
continued to inject it on a fortnightly to monthly basis and had previously received 
detoxification treatment for hashish use. The other person who had used heroin for the 
first time had only smoked it once. The other two people who had experienced no 
problems had been occasional users for periods of 12 and 16 years.
Table 5.5: Summary of heroin use history for Oswaldians
Status_____________________________________________n
Treatment history opioid use 20
“Stopped” heroin use 3
No treatment but problems related to heroin use 4
No problems related to heroin use 5
Total _________32
Harding and colleagues have reported findings from a small sample which 
demonstrated that it is possible for those with a treatment history to revert to 
controlled heroin use (1980). Theresa, Sebastian and Andre, 3 Oswaldians whom I 
first met in 1989, also had a treatment history for opioid use at that time when they 
then reported “recreational” use. Sebastian subsequently told me that he did not think 
he was ever a “recreational” user. He was back in treatment at the time of both
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interviews conducted as part of this research. Theresa was back in treatment at the 
time of the second interview. Andre had not returned to treatment but had gone 
through periods of very heavy heroin use. Two Oswaldians who have subsequently 
entered methadone treatment had not used heroin at first contact. The other 
Oswaldians I met in 1989 all considered themselves “recreational” users at the time. 
This is best summed up in one of the remarks made in 1989 by a core-Oswaldian who 
had experienced problems with use by the time of our second interview for this 
research: “It's an OK drug if you use it right. Recreationally it's a right laugh. If you 
use it all the time it's no good.”
Overseas research has shown that long-term non-dependent heroin use is possible 
(Powell, 1973; Zinberg and Jacobson, 1976; Harding and Zinberg, 1977; Zinberg, 
1984). This was also shown in my long-term study of the Oswaldians, but by only two 
people. For the overwhelming majority of Oswaldian heroin users, this “recreational” 
phase of a heroin-using career was transient with its endpoint being a need for 
treatment, other problems with use, or discontinuation of use.
An up to date Australian study is needed to more accurately estimate the current ratio 
of non-dependent to dependent heroin users and to also estimate the ratio of dependent 
users not in treatment to those receiving treatment. Such a study would have to be 
longitudinal in order to ascertain the ratio who continue with long-term non­
problematic heroin use and the ratio who do not enter treatment. As Larson and 
Bammer have indicated there are, however, inherent difficulties in achieving 
meaningful estimates of people involved in illegal activities (1996).
5.19: Conclusion
These results show that drug use patterns are dynamic and influenced by a variety of 
“scene” and individual changes. In particular, the increase in the number of places 
available for methadone treatment impacted on the drug use behaviours of those 
concerned. The prospective data support other evidence which suggest that many drug 
users either stop or reduce their illegal drug use. I found a significant reduction in 
both the number of individual drugs used and in the classes of drugs used between 
interviews. There were also many examples of a decrease in the use of individual 
drugs. A decrease, or non-use of heroin, led to a significant reduction in the use of 
other drugs. There is, however, a less optimistic sub-theme since some people had 
commenced, recommenced or increased their consumption patterns.
People stop using drugs for a great variety of reasons. One of the most important 
themes to emerge from my findings was the reduction, or non-use, of a drug due to
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detrimental health effects. A secondary theme was a concern for the health of 
significant others. This shows that people who use illegal drugs can reflect on the 
impact drug use has on their own lives as well as the lives of other people. One harm 
minimisation approach may be to give drug users access to the voices of people who 
have reported problems in studies such as this. It is my intention to make this report 
available as widely as possible to the people I interviewed, as well as to other people 
who use illegal drugs.
During a period when there was an increase in heroin quality and also the potential for 
a trial for controlled availability of opioids (National Centre For Epidemiology And 
Population Health [NCEPH], 1991), many respondents had either stopped or reduced 
their heroin consumption. There were also several heroin-related overdoses in this 
period. There is a need fur future research to tease out the complicated associations 
between heroin using patterns and the changes in heroin quality and heroin-related 
overdoses.
A limitation of my study is that I did not ask people why they had continued to use 
drugs. If I had done so, there would have been more data on both the positive and 
negative aspects of drug use. When compared with those who went on to present for 
the second interview, the people who presented only for the first were younger and at 
an earlier stage of their drug using career. It is possible that the changes in this latter 
subset would have been different. In particular, there may have been fewer people 
entering treatment and the alterations in consumption patterns might have included 
fewer instances of stopping the use of a drug and more of commencing the use of a 
drug.
In the following chapters, I discuss changes in health and criminal behaviours and 
refer to the variations in drug use behaviours discussed here. I also report the effects 
that these changes in drug use behaviours had in these realms.
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CHAPTER 6: PHYSICAL, PSYCHOLOGICAL AND SOCIAL HEALTH 
6.1: Introduction
One of my major research interests was in minimising the harm associated with illegal 
drug use. This is the first of two chapters which discuss the health of the people I 
interviewed, focusing primarily on the differences found at the two interviews, and the 
relationship between drug use transitions and health. Since BBVs and sexually 
transmitted diseases (STDs) are of major concern among DDUs and their sexual partners, 
the whole of Chapter 7 is devoted to injecting and sexual behaviours.
To enable people to achieve optimum health, it is necessary to consider their physical, 
mental and social well-being (WHO, 1986). This chapter focuses on these three areas 
beginning with a brief overview of the history of the development of harm minimisation 
in Australia (some of which is also relevant to Chapter 7). A sa  prelude to my results, I 
then review previous general findings on the mortality and morbidity associated with 
drug use, before discussing the positive effects of drug use. Though they are not 
mutually exclusive realms, I have divided the chapter into sections on physical, 
psychological and social health. At the end of each section, I discuss the implications of 
the findings before uniting the major findings from these three sections in the 
conclusion.
6.2: The harm minimisation movement in Australia
Australia was quick to take measures to help prevent the spread of HIV among IDUs 
(Rumbold and Hamilton, 1998). In 1985, the Australian Federal Government of the 
day convened a Joint Federal-State Drugs Summit which formed the basis of NCADA 
(Ministerial Council on Drug Strategy, 1992). Since its inception, the “guiding 
principle” of NCADA has been that of harm minimisation (Rumbold and Hamilton, 
1998:138). Following reviews in 1988 and 1991, NCADA evolved into the NDS 
(Allsop, 1995). The NDS definition of harm minimisation is presented in Chapter 1, 
Section 1. The NDS operates at both Federal, and State and Territory Government 
levels, as well as working with non-Government organisations (Rumbold and 
Hamilton, 1998). As Rumbold and Hamilton remark, the NDS “represents a quite 
extraordinary commitment on the part of the sectors of health, education, justice (law­
making) and law enforcement agencies to work together” (Rumbold and Hamilton, 
1998:138).
The ACT Drug Strategy has been developed along the lines of the NDS, seeking to 
provide a balance between promoting safer drug use and harm minimisation (ACT 
Department of Health, 1995: foreword by Terry Connolly, then Minister for Health and 
Attorney General of the ACT).
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Although much of the concern around harm minimisation has focused on the prevention 
of HIV in the illegal drug using community, the harm minimisation movement has a 
longer history than this focus would suggest. Methadone maintenance is one important 
example of harm minimisation which occurred well before the advent of HIV/AIDS 
(Brettle, 1991; Des Jarlais and Friedman, 1993). Originally, NCADA’s main focus was 
on illegal drugs but, in 1988, recognising that most harm is caused by alcohol and 
tobacco, it placed due emphasis on problems associated with the use of these drugs 
(Crofts and Herkt, 1995). It is now apparent that more Australian heroin users die of 
overdoses than of AIDS, and that both HCV and HBV are more prevalent among 
Australian IDUs than is HIV/AIDS. The prevention of these sequelae of illegal drug use 
has emerged as an important issue for the harm minimisation movement.
6.3: Mortality and morbidity associated with drug use
I return to BBVs in Chapter 7, and in this section I present an overview of some of the 
other harms associated with drug use. These harms may “take the form of illness, 
disability, social dysfunction and, ultimately, death” (Drugs of Dependence Branch, 
Department of Health Housing and Community Services, 1992:1). In Australia, health 
problems attributed to both legal and illegal drug use lead to the premature loss of 
160 000 person years of life per year and 1.6 million bed days of hospital use per year 
(English et al, 1995). Approximately one in five of all reported deaths in Australia are 
related to drug use (Australian Bureau of Criminal Intelligence, 1996). It is estimated 
that around 23 000 Australians a year die from the use of drugs (English et al, 1995). 
Legal drugs are responsible for the vast majority of this mortality since tobacco is 
implicated in around 72 per cent of these deaths and alcohol in more than 25 per cent 
(NDS, 1994).
Deaths due to illegal drug use account, therefore, for less than 3 per cent of drug-related 
mortality. There are, however, important age differentials. Almost one in every three 
deaths recorded in people aged 15-34 can be attributed to drug use (Drugs of 
Dependence Branch, Department of Health Housing and Community Services, 1992). 
Alcohol accounts for around 62 per cent of the deaths in this age group whilst illegal 
drug use accounts for 34 per cent (NDS, 1994).
During the period from 1981 to 1990, there was an 8 per cent decrease in the drug- 
caused death rate (deaths per 100 000 population). This reduction, however, largely 
occurred in deaths due to legal drugs. Over this period, there was a 17 per cent decrease 
in the alcohol death rate and a 6 per cent decrease in the tobacco death rate. Conversely, 
there was a 170 per cent increase in the opioid death rates and a 46 per cent increase in 
the death rate from other illegal drugs. The number of people who died from opioid use 
rose from 397 in 1989 to 457 in 1990 (Drugs of Dependence Branch, Department of
Health Housing and Community Services, 1992). Most died from heroin-related 
overdoses. There was an agreement by Federal, State and Territory police and health 
ministers to set up a National Task Force to look at ways of trying to curb this tragic 
trend (Drug Offensive Bulletin, 1995). Unfortunately, there are indications that it has 
continued (Hall, 1996).
Other potentially life-threatening sequelae of illegal drug use, such as infections, 
musculo-skeletal problems and cardio-respiratory disease, are most commonly 
associated with IDU (Chiang and Goldfrank, 1990; Cherubin and Sapira, 1993). 
People who use illegal drugs are also at increased risk of suffering from a range of other 
physical health problems which are not usually life-threatening. Examples of these 
include the vomiting and constipation associated with opioid use.
Those who use non-injecting routes of administration are not immune from adverse 
side-effects. Respiratory diseases are associated with both inhalatory and intranasal 
administration, and there have been reports of gastrointestinal problems following oral 
consumption of drugs (Chiang and Goldfrank, 1990). Deaths due to inhalant use have 
been also reported (Wagner et al, 1992).
Not only are people who use drugs at increased risk of physical health problems, they 
are also at increased risk of psychopathology. Following a study of a sample of 20 291 
people interviewed in the National Institute of Mental Health Catchment Area Program in 
the USA, Regier and colleagues found that, for those with severe mental disorders, 
comorbidity with an addictive disorder was particularly high. Among those who were 
dependent on illegal drugs, more than 50 per cent had at least one pyschopathological 
symptom. Around 37 per cent of those who were dependent on alcohol had a 
pyschopathological problem (1990). In their study of 533 opioid users in treatment, and 
107 who were not, Rounsaville and colleagues found that over 70 per cent had a history 
of depressive illness (1985). According to a 1993 NDS report, only two studies of 
psychopathology among opioid users had been conducted in Australia at that time. Both 
found approximately 60 per cent of respondents had significant levels of non-psychotic 
psychiatric comorbidity (1993).
The pyschopathological diseases associated with the use of alcohol and illegal drugs 
range from anxiety and depressive or antisocial personality disorders, to more severe 
psychiatric conditions such as schizophrenia (Regier et al, 1990; Latkin and Mandell, 
1993; American Psychiatric Association, 1994; Lipsitz et al, 1994; Dinwiddie et al, 
1996). Including mental ill health associated with dependence, the fourth edition of the 
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) devotes almost a
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hundred pages to problems associated with drug use per se (American Psychiatric 
Association, 1994).
Other psychopathology may predate drug use, and some drugs may be used as self- 
medication (Edwards et al, 1981). It may be difficult to distinguish these pre-existing 
problems from those resulting from drug use (Edwards et al, 1981; Wesson et al, 1986; 
NDS, 1993). In addition, some associations between psychopathology and drug use 
are “chance associations” (Edwards et al, 1981:233). Further complicating the issue, 
users themselves may also be ambiguous about their rationale for taking drugs. In 
response to being asked “What would you say were the best things about heroin?”, Erin 
responded:
I feel that I've got schizophrenic tendencies. Heroin is a cure for that. I 
don't care what any psychologist says, or psychiatrist... I know that my 
schizophrenic tendencies are completely nullified when I take heroin. And 
that allows me to be more creative, more relaxed, and just go about my life 
in a much easier and freer manner... I f I didn't have it, I'd be jerky, I'd be 
shy, and I just wouldn't be able to be myself... and I think, because of all 
the other drugs I've done, maybe I have messed up my head a b it ... but I 
don't really think so, I think I've always had those - like - you know, 
schizophrenic kind of traits, and it just gets rid of them completely.
In addition to the physical and psychological pathology, social problems, such as poor 
housing and loss of support networks, often go hand in hand with illegal drug use and 
may also contribute to the health burden some users experience.
At our first interview, Damien talked about the physical, psychological and social costs 
of his drug use. He was then 28 and had drifted in and out of heroin dependence for ten 
years having tried several forms of treatment to assist him in controlling his drug use. 
He had also used a multitude of other drugs during his drug-using career, including 21 
in the 12 months prior to interview:
I wake up in the morning, I feel shithouse, I always do, and I'm depressed,
I'm an unhappy person ... every single day of my life, I take those pills 
[Valium and Debendox] ... if I don't take them for a day I have a really 
uncomfortable, miserable ... day, I'm very agitated, my skin crawls ... I 
sweat... when it's ho t... or when it's cold ... and shiver when it's hot and 
... get goosebumps, that sort of thing ... [heroin's] ... ruined my life, my 
job prospects, my housing prospects, my social life ... all these things - my 
financial situation they're all shot to pieces... all because of heroin, because 
I've spent every cent I've got on heroin - I'll even forget the food, forget the 
rent, forget everything ... I've lost just a lot of my youth. In the end, you 
even end up taking off your own family.
By our second interview, Damien had been going to NA meetings and, apart from a 
daily cigarette he had gradually stopped all drug use.
Much of the health burden associated with illegal drug use accompanies the sort of 
heavy prolonged use Damien had experienced. Many of the younger people I 
interviewed had been using illegal drugs for only a short time and such users are also at 
risk (Erickson, 1993). Some of the people I interviewed consumed drugs at quite low 
levels and other researchers have noted pathology associated with this level of use 
(Moore, 1993; Keene, 1995; Williamson et al, 1995). Moore, Hawks and Saunders 
mention problems such as lethargy, depression, anorexia and having periods of, or 
becoming dependent on, a drug, as potential side-effects of “recreational” drug use 
(Moore et al, 1992).
6.4: The positive effects of drug use
The emphasis on deleterious health effects can obscure the fact that, for some people, 
drug use may be advantageous to health. The intense feelings of pleasure accompanying 
the use of drugs such as heroin and cocaine have been well documented (for example, 
Siegel, 1989; Warburton, 1990). Zinberg maintains that drug users benefit from 
“regular controlled use because it brings them relaxation and a sense of freedom from 
inhibitions” (1984:192). Mugford and Cohen also argue that the pleasure obtained from 
the use of drugs is, in itself, sufficient motivation for commencing and continuing drug 
use (1989). Moore and Saunders believe that not only is it possible for users to gain 
physically and psychologically from the pleasurable effects of a drug, there is also the 
potential for such social benefits as belonging to a peer group or forging new 
friendships (1991). Following a study of the illegal drug market in Nottingham, Bean 
and Wilkinson found that “central to the drug users’ world was what they called a 
“ ‘treat’” which could be “justified” in almost any way (1988:538). Implicit in this idea 
of a “treat” is the positive effect that the user perceives the drug to have.
Several people I interviewed (reported in Chapter 6) mentioned the pleasurable effects of 
the drugs they used. Such effects are vividly described by Roger. I first met him in 
1989 when he was 29. He will be 39 in 1998 and he has used heroin for 20 years 
without ever developing a dependency. At the first interview for this research he 
described the way heroin made him feel:
it makes you feel physically very p leasant... it's having a nice warm bath 
and putting on a big fu r  coat and sitting in front o f the fire and feeling really 
good physically, like having your back rubbed.
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6.5: A mixed experience of drug use
Chris’s history demonstrates that during their drug-taking careers, many people 
experience both the pleasure and pathology which may accompany drug use. At our 
first interview, Chris was 31 and he had been using heroin since he was 18. He had 
previously been dependent and had undergone several courses of treatment. At the time 
of interview he was injecting heroin twice a week and his use was associated with 
pleasure:
with heroin ... you get such a good feeling of well-being, 'cos ...it feels like 
your nerve-ends have been cut off or they have been dampened like putting 
rubber fingers on all your hands or something ... see, you feel like you've 
got a friend with you all the time ... you don't feel lonely ... you just 
walking around and you feel like as if you've got someone with you, you're 
in a group ... it's the same sort of feeling it gives ... sort of secure.
Between interviews, Chris’s heroin use had escalated again. During this time, heroin 
was no longer associated with pleasure, but with pathology:
[It] got to a point where I didn't care, I just wanted to die. 1 bought 0.5 
gram (of heroin), which I knew was the sort of stuff that two people had 
OD’d on that week ... Everyone I knew was using, using in toilets, gutters,
I just didn 't care. I was just going to go to the cemetery and kill myself. I 
rang someone I knew [now partner] to say “goodbye.” She knew 
something was up and she said come over, so I did.
By the time of the second interview, Chris had recommenced methadone and had not 
used heroin for 10 months.
Both the positive and negative health aspects of drug use were taken into consideration 
as I looked to see if there had been any significant changes in health between interviews 
and then attempted to ascertain what factors might have led to these changes.
6.6: Overview of the presentation of the findings
The findings derived from the OTI physical, psychological and social domains are 
augmented by the results of the qualitative and quantitative data obtained from the 
questionnaire I developed. After presenting the total scores for each OTI domain, I also 
briefly discuss the individual questions. These results are interwoven with my other 
findings and are included in the tables in Appendix 19 where I indicate which questions 
were gleaned from the OTI.
No significant differences were found between those who were interviewed only once 
and their opposite subset (definitions of the subsets are included in Table 2 in Appendix 
4) in any of the OTI physical or psychological data obtained at the first interview and 
only one difference related to social health was found. Some researchers have found
gender differences in both the physical and psychological health of people who use 
illegal drugs. I also found some gender differences in these realms and there were also 
differences, some over time, between the Oswaldian subsets and their opposite subsets. 
These are discussed in the text and where differences were found between subsets, these 
results are also included with the other tables in Appendix 19.
I begin by presenting my findings on physical health before moving on to 
psychological, then social health.
6.7: General physical health
The OTI physical health section consists of a checklist of 51 symptoms within 8 
subcategories (Appendix 10:390-392) for which there range of possible scores from 0 
(best) to 51 for women and 49 for men (worst). The questions are mainly confined to 
symptoms experienced during the month prior to interview.
Figure 6.1 shows the distribution of the health scores at the two interviews. The median 
score at the first interview was 11 and at the second interview it had dropped to 10 (Z 
-2.847, p < 0.005). This indicates an improvement in health between interviews.
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Figure 6.1: Distribution of OTI health scores at first and second interview
Total health scores
First interview
Median 11 
Range 2-40
Interquartile range 7-20
Second interview
Median 10 
Range 0-30
Interquartile range 5-16
n people
Table 6.1 shows the distribution of the OTI physical health score for IDUs, treatment 
entrants and subsets. The median health score among the IDUs I interviewed was 
slightly lower at both interviews than the mean of 12.6 found by Darke and colleagues 
among the IDUs they interviewed (1991a). Following their longitudinal survey of 
clients receiving methadone maintenance, Macleod and colleagues report that the mean 
score for clients at treatment entry was 19. After 6 six months of treatment, there was a 
significant reduction to 10 (1996). I found no significant difference between interviews 
in the people who had entered methadone treatment. Whilst women’s health had 
improved more than men’s there was no significant difference within either subset at 
either interview. Nor did any of the differences between the other subsets approach 
significance at either interview. Between interviews, however, the changes in the non- 
Oswaldian and Remainder subsets was significant whilst that in their opposite subsets 
was not.
Table 6.1: OTI total health physical score for IDUs, treatment entrants
and subsets
Median Range Interquartile range
IDUs 1st interview 11 2-40 6-21
IDUs 2nd interview 11 0-30 5-17
Significance
Z -2.264
p = 0.0438
Median Range Interquartile range
Not in treatment 1st interview 11 2-35 8-21.8
Methadone treatment 2nd interview 10 0-27 5.3-16.5
Significance
Z -1.289
Women 1st interview 
Women 2nd interview
Men 1st interview 
Men 2nd interview
p = 0.1980
Median Range Interquartile range
14 2-40 9-22
11 0-30
Significance
6-17
Z -2.2927
Median
p = 0.0219 
Range Interquartile range
10 2-34 6-16
10 0-28 5-15
Significance
Z -2.0343 
p = 0.0419
(cont.)
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Table 6.1 continued: OTI total health physical score for IDUs, treatment
entrants and subsets
Median Range Interquartile range
Oswaldians 1st interview 10 2-40 8-15
Oswaldians 2nd interview 11 0-28
Significance
5.5-16.5
Z -0.738
p = 0.4592
Median Range Interquartile range
non-Oswaldians 1st interview 12 2-34 6.3-21
non-Oswaldians 2nd interview 9 0-30 5-16
— ~ - .
Significance
Z -3.172
p < 0.01
Median Range Interquartile range
Core-Oswaldians 1st interview 8.5 2-40 5-14
Core-Oswaldians 2nd interview 9.5 0-26
Significance
3-15
Z -0.773
p = 0.4412
Median Range Interquartile range
Remainder 1st interview 13 2-34 8-20
Remainder 2nd interview 11 0-30 5-17
Significance
Z -2.92
p < 0.01
At the first interview, 57 people (60%) had an OTI physical health score considered to 
be average or below (Table 1, Appendix 19). At the second interview, the picture was 
similar with 61 people (64.2%) having an average or below average score, but 
considerably more people had a low score than at the first interview, and fewer people 
had one that was high.
A greater proportion of women than men fell into the high level of dysfunction category 
at the first interview and there were correspondingly smaller proportions of women than 
men in the low and below average levels of dysfunction (Z -2.479, p = 0.0132) (Table 
1, Appendix 19). By the second interview, the gender proportions were fairly similar in 
all categories except for there being a greater proportion of men than women with a low 
score and the gender difference no longer approached significance. When the levels of 
dysfunction were compared over time, there was a significant improvement for the non- 
Oswaldians (Z -2.881, p < 0.01) (Table 2, Appendix 19) and the improvement
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approached significance for the Remainder (Z -2.42, p = 0.0156) (Table 3, Appendix 
19).
In order to better explore these differences, I broke the total health scores into their sub­
categories and also analysed the subsets separately. These results (apart from those 
associated with IDU, and genital and reproductive symptoms, which are included in the 
tables accompanying Chapter 7) are attached as Tables 4-18 in Appendix 19. In the text 
below, I mention the significant differences found between interviews, as well as those 
which approached significance. Table 6.2 summarises these differences, includes the 
results of the significance tests, and identifies the tables where the numerical results are 
documented.
There were reductions in most general health symptoms at the second interview for the 
total population of respondents and a corresponding reduction in the median scores. 
The change between interviews approached significance for women. There were 
significantly fewer reports of these problems from both the non-Oswaldian and 
Remainder subsets. The median score for cardio-respiratory problems was 2 at both 
interviews but the slight reductions in the ranges and interquartile ranges resulted in a 
significant difference. The reduction in these problems for the non-Oswaldian and 
Remainder subsets approached significance. The high incidence of “Forgetting things” 
(Table 15, Appendix 19) was similar at both interviews and is of some concern in this 
cohort of, mostly young, people. Cannabis use is known to lead to cognitive 
impairment (Australian Bureau of Criminal Intelligence, 1996) and since the majority of 
respondents used it, it was probably the major cause of this symptom. The reduction in 
neurological problems for the non-Oswaldians was very nearly significant.
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Table 6.2: Significant changes and those approaching significance found
between interviews in sub-categories of the OTI health domain
S am p le /su b se t Subcategory T ab le  n u m b e r  
A ppendix 19
in Significance
T o ta l sam ple General health 4 Z  -.2 ,79  p 
<  0.01
W om en G eneral health 4 Z  -2 .507
p =  0 .0120
non-O sw ald ians G eneral health 5 Z  -3 .257
p <  0.001
R em ainder General health 6 Z  -2 .729
p < 0.01
T o ta l sam ple Cardio-respiratory 7 Z  -2.45 
p =  0 .0142
non-O sw aldians Cardio-respiratory 8 Z  -2.461 
p = 0.0138
R em ainder Cardio-respiratory 9 Z  -2 .34 
p =  0 .0192
non-O sw ald ians N eurological 14 Z  -2 .552
p =  0.0108
At the first interview, women had a total median score of 2 for gastro-intestinal 
problems compared to 1 for men (Z -2.495, p 0.0124) (Table 16, Appendix 19). The 
median scores were the same for both genders at the second interview.
In the previous chapter, I reported that several people related their treatment and drug 
use consumption transition to their health. Some people also went on to talk about the 
positive and/or negative effects of these changes on their health. The effects on general 
physical health are discussed below.
6.7.i: Positive effects o f treatment on general physical health
The people interviewed by Dale and colleagues reported several positive physical health 
effects of methadone including that it “stops sickness” and “keeps me healthier” 
(1992:57). Thirteen people I interviewed also discussed the positive changes in their 
health due to their methadone treatment (Table 19, Appendix 19). Most people made 
general comments such as Jade’s: “W e’re pretty healthy and we’ve cleaned up our act”, 
or they mentioned an improvement in their diet. Boy Wonder, for example, said “We 
now have more money for food.” Four people said they were no longer suffering from 
withdrawal. Sebastian had re-entered NA and said: “My libido has increased, I’m less 
tired, I’ve started exercising and I’m fitter.”
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6.7. U: Negative effects of methadone treatment on general physical health
Eighteen physical health symptoms were attributed to methadone. Most were mentioned 
by only one or two people and none were reported by more than five (Table 20, 
Appendix 19). One of these was a loss or diminishing of libido, which was only 
reported by men. Other researchers have also found sexual dysfunction to be 
experienced frequently by men receiving methadone (Rosenbaum and Murphy, 1987). 
Like the consumers surveyed by Dale and colleagues (1992), the people I interviewed 
also reported poor dental health, increased perspiration, constipation and nausea.
Patrick was among several treatment entrants who mentioned a range of symptoms:
It slowed my body metabolism down so much, it’s incredible. I found it 
difficult to believe, it’s so radical... I ’m just so much more tired and lazy.
I t’s so much harder to exercise and harder to create an interest, or a belief 
that I can get and feel healthy, just because my body is behaving so 
differently to how it did ... I ’ve also gone, this past twelve months I ’ve 
gone to almost losing my libido completely. I t’s worse than with the heavy 
use of heroin [and] 1 ’ve lost another tooth.
According to Kreek, many of the side effects of methadone are observed only in the first 
few months of treatment (1978). Since most of the people I interviewed had been in 
treatment for a relatively short period, it may be hoped that the adverse effects will 
lessen over time.
6.7. in: Positive effects of changes in drug use on physical health
There were 26 comments about the positive effects of drug use changes on health (Table 
21, Appendix 19). Three came from people who said their recommencement or 
increased use of particular drugs had beneficial effects on their health. Brenda’s 
recommencement of marijuana use had helped relieve her stomach cramps (which she 
had attributed to her methadone treatment) and Alison said her increased use of 
amphetamine had given her the energy to work. Jacqui’s increased marijuana use had 
improved her previously poor appetite. Maggie also referred to her improved appetite 
when she stopped smoking. This was especially important for her and her expected 
baby because she had previously suffered from morning sickness which her smoking 
had exacerbated. Andre’s heroin use had fluctuated and his temporary non-use had led 
to him eating better at that time.
Erin and Brenda, two people who had decreased their tobacco consumption, Sara, who 
had stopped smoking tobacco, and Sam, who had decreased her marijuana use, all 
talked about having fewer respiratory symptoms. Erin also said he was getting fewer 
headaches because he was smoking less tobacco and Katie said she was now “less
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addicted” to tobacco. Rob made a similar comment when he said of his decreased 
heroin use “I like not being addicted ... I feel stronger.”
Most of the other comments about decreased or non-use of a drug were general. For 
example, as Boy Wonder, who had decreased his amphetamine use, said: “I feel a little 
bit healthier.” James-2 was pleased that he was getting into fewer fights because he was 
drinking less and Rosetta, who had also reduced her alcohol consumption, was happy 
that she was ”not putting on as much weight.”
6.7.iv: Negative effects of changes in drug use on physical health 
There were 32 comments related to the negative physical health aspects of changes in 
drug use (Table 22, Appendix 19). Thirteen were made by people who had 
commenced use of a drug. Three very different health complaints were related to 
opium use. Lorelei said she got constipated when she used it frequently, Mr X did 
not like the nausea associated with his two uses, and David’s heavier use led him to 
say: “When I was using a lot I got achey and couldn’t sleep for two and a half 
nights, and I don’t want to go through that again.”
Bert, who had only used amphetamine twice, said: “I felt terrible the next day, 
headache, tired, brain dead. Neither time has made me want to take it again -  at least 
not in the near future.”
Rosetta had also only used amphetamine once. She said “I don’t really like the thought 
of having it healthwise, all the stuff in it.” Annabel and Jessie had used their first 
ecstasy. Annabel said that it had given her a headache and Jessie complained about the 
“comedown.” Alison had a similar comment about her new cocaine use. Greg’s use of 
Tofranil had given him palpitations and he had only taken it a couple of times, and 
Eggplant said the “ice” he had taken by accident “made me very ill.” Mr X (who had 
used heroin only twice) was concerned about becoming dependent. Although Jacqui 
acknowledged that her newly prescribed Stelazine was beneficial, she also said that it 
made her “very sleepy.”
Jeff had enjoyed his recommencement of “trips”, but he also said “I find myself worn 
out by trips these days,” and of his increased heroin use he said:
There were one or two nights at the peak of the binge, when I was using 
every second day, if I stopped for a few days Td have a bit of trouble 
sleeping.
Phil (whose use of heroin had increased), Morgan (whose use of heroin had 
fluctuated) and Alison’s increased use of amphetamine had also led to feelings of
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withdrawal. Snork said his increased use of “trips” had led to him: “ ... getting lots 
of headaches.”
Two people (one of whom had increased then decreased his use) said they had more 
respiratory symptoms due to their increased use of marijuana and Marcus said his 
temporary increased amphetamine use had not only made him “more susceptible to 
colds” but he had also lost a lot of weight because he was not “eating properly.” 
Georges made a similar comment about his increased alcohol use: “My digestive system 
isn’t functioning, I often sacrifice food for alcohol.”
The other comments about increased use were of a disparate nature. Brigid simply said 
of her increased alcohol use: “It’s become detrimental to my health.” Lisa said that 
when her heroin use increased “My skin got bad.” Following a period of heavy use 
Jessie’s “veins just dropped and I couldn’t do it” and Boy W onder’s increased 
marijuana use had made him “lethargic.”
Although Marsha was generally pleased about her non-use of amphetamine she 
laughingly mentioned her weight gain as a negative side-effect. Tim had not used 
Prothiaden for 4 months and he said he had been generally physically ill when he 
discontinued it.
6.7.v; Discussion of physical health
There were fewer reports of most physical health symptoms at the second interview than 
at the first, which led to a significant reduction in the total OTI health score.
Women were in poorer physical health than men at the first interview, but fewer gender 
differences were found at the second. Based on a review of the literature, Mondanaro 
reports findings from several studies which show that women who use illegal drugs 
have worse physical health than their male counterparts (1981). She later identified 
several cofactors that increase a woman heroin user’s health risks; anorexia, bulimia, 
anaemia, and STDs are more common in women and she believes this may exacerbate 
the poor nutrition associated with heroin use. Mondanaro maintains that, even during 
treatment, women continue to experience more problems than men (1987). When 
investigating a sample of 1668 (mostly Hispanic) IDUs in the USA who had not 
received formal drug treatment for at least 6 months, Singh and colleagues found that the 
average self-report for health within the past 6 months was “closer to ‘fair’” for women 
whilst men’s was “closer to ‘good’” (1994:279).
Results such as these are not restricted to women who use drugs. Several general 
population studies have demonstrated that women report more illnesses than men
126
(Wadsworth et al, 1971; Wingard, 1984). Broom examined findings from the 1983 
Australian Health Survey and found that in 17 of the 24 most frequently reported 
illnesses (which excluded disorders of female reproduction), women’s rates exceeded 
those of men’s (1990).
Given these findings, it was not surprising that the women in my sample were in poorer 
health than men at the first interview. Schneider, Laury and Hughes found the women 
college students they surveyed reported more willingness to talk about psychopathology 
than male students (1980). Comey has suggested that women find it easier than men to 
divulge personal information (1990). This hypothesis might account for the gender 
difference found at the first interview but does not account for the findings at the 
second, where the frequency of men and women’s reports of physical health symptoms 
were not significantly different.
6.8: Psychological health
This section begins with changes gleaned from the GHQ (included in the OTI, Appendix 
10:393-395) before going on to discuss the findings from the qualitative data on effects 
of changes in drug use on psychological health. Goldberg and Hillier advise that scores 
of 0 to 4 should be regarded as low scores and those between 5 to 28 should be 
regarded as high scores (1979).
At the first interview, the median GHQ score was 5; at the second it was down to 3 
(Figure 6.2). The change was very nearly significant (Z -2.754, p = 0.0104) and 
indicates a general improvement between interviews.
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Figure 6.2: Distribution of GHQ scores at first and second interview
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The GHQ findings from both interviews for IDUs, methadone treatment entrants and 
subsets are shown in Table 6.3 which also records the significance of changes between 
interviews. At the first interview, the subset of IDUs had the same median score as the 
total sample and at the second they had a similar fall in the median score. Darke and 
colleagues found a rather higher mean GHQ score of 8.6 among the IDUs they 
interviewed for the OTI (1991a). The lower score in my sample may be due to the fact 
that some IDUs I interviewed were not in treatment, and higher rates of current 
depression have been found among methadone clients than among opioid users not in 
treatment (Rounsaville and Kleber, 1985). In addition, some of the IDUs I interviewed 
were injecting at quite low levels. Other research has found more psychological 
problems in people with greater levels of drug use (Robbins, 1989).
Macleod and colleagues report that the 114 methadone maintenance clients they studied 
had a mean GHQ score of 12 at their first assessment. There was a highly significant 
fall to 4 following 6 months of treatment (1996). The people I interviewed who entered 
or re-entered methadone treatment between interviews had no significant change, nor 
was any significant difference found at either interview between these people and the 
non-treatment entrants.
At the first interview, women had a higher median score than men. Both men’s and 
women’s median scores had dropped to 3 at the second interview. Darke and colleagues 
found that the GHQ scores among the women they surveyed during the formulation of 
the OTI were significantly higher than those of men (1992c). Similarly, Comey found 
higher GHQ scores among women than men in a sample of general practitioner clients 
(1990).
The fall in the non-Oswaldians score was almost significant whilst that in the Remainder 
subset was significant.
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Table 6.3: GHQ score at each interview for IDUs, treatment entrants and subsets
S am ple /subse t F irst in terv iew Second interview Significance
ID U s M edian 5 M edian  2.5 Z  -2 .443
R ange 0-27 R ange 0-26 P
Interquartile range 1-10 Interquartile range 0-7 0 .0 3 5 0
M ethadone treatm ent entry M edian 7 M edian 6 Z  -1 .128
b e tw e en  in te rv iew s, s till R ange 0-27 R ange 0-27 P
in trea tm en t Interquartile range 1-10 In te rq u a r tile  ran g e  0.3 
15.3
0 .2 5 6 4
W om en
M edian 7 M edian 3
R ange 0-27 R ange 0-22 Z  -2 .187
Interquartile range 2-13 Interquartile range 0-8 P
0 .0 2 8 6
M en
M edian 4 M edian 3
Z  -1 .597R ange 0-27 R ange 0-26
Interquartile range 0-9 Interquartile range 1-6 P
0 .1 0 9 6
O sw aldians
M edian 5 M edian 5
R ange 0-27 R ange 0-26 Z -1 .007
Interquartile range 0 .5-10 Interquartile range 1-7.5 P -
0 .3 1 2 4
non-O sw aldians M edian 5 M edian 2 Z  -2. 543
R ange 0-25 R ange 0-16 P =
Interquartile range 1.3-10 Interquartile range 0-6 0 .0 1 1 0
core-O sw aldians M edian 3.5 M edian 3 Z  -.0 .244
R ange 0-27 R ange 0-26 P =
Interquartile range 0-8 Interquartile range 0-7 0 .8 1 0 4
R em ainder M edian 5 M edian 3 Z  -2 .822
R ange 0-25 R ange 0-22 p <  0 .005
Interquartile range 2-10.5 Interquartile  range 0.75-6.3
Table 23 in Appendix 19 shows the levels of psychological dysfunction as determined 
by Darke and colleagues (Darke et al, 1991a). At both interviews, most people had a 
score considered to be average or below, and there were more people in these categories 
at the second interview than at the first (Z -2.754, p < 0.01); much of this change 
occurred in women for whom the difference approached significance (Z -2.491, p 
0.0128).
There was a significant difference over time for the non-Oswaldians, more of whom had 
a lower score at the second than at the first interview (Z -2.967, p < 0.01) (Table 24, 
Appendix 19); there was also a significant improvement in the Remainder subset (Z 
-2.945, p < 0.005) (Table 25, Appendix 19).
As explained more fully in Chapter 2, Section 4, items in the GHQ-28 are divided into a 
somatic symptoms area, an anxiety area, a social dysfunctional area and a depression 
area. I found reductions in the median scores in the somatic symptoms, anxiety and 
social dysfunctional areas for the total sample (Table 26, Appendix 19). The reduction 
in the somatic symptoms approached significance (Z -2.36, p = 0.0192). There was a 
median depression subscale of 0 at both interviews, but reductions in the ranges and
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interquartile ranges between interviews led to a significant improvement (Z -3.4, p < 
0.005).
Most of the reduction in the depression subscale was due to women’s scores (Z -2.781, 
p < 0.01) (Table 26, Appendix 19). At both interviews, there was a median score of 0 
in the depression subscale for the Oswaldians (Table 27, Appendix 19) but the 
reductions in the ranges, as well as a reduction in the interquartile range, led to this 
change approaching significance (Z -2.518, p = 0.0120). At the first interview, there 
was a median score of 1 in the somatic symptom subscale for the non-Oswaldians and at 
the second the median score had dropped to 0 (Z -3.14, p < 0.01). The Remainder 
subset had a median somatic symptoms score of 1 at the first interview which had fallen 
to 0 at the second interview (Z 2.963, p < 0.005) (Table 28, Appendix 19). There was 
a median score of 1 for this subset in the depression subscale at the first interview and a 
drop to 0 by the second (Z 2.949, p < 0.005).
I also tabulated my scores to compare them with those compiled by Goldberg and Hillier 
from 200 patients during their formulation of the GHQ-28 (1979). My sample was 
fairly evenly divided at the first interview, since there were 45 people (47.4%) with a 
low score and 50 people (52.6%) with a high score (Table 29, Appendix 19). The 
number with a low score had increased to 56 (58.9%) at the second interview, and those 
with high score had decreased to 39 (41.0%). The number of people with the highest 
score (12-28) fell from 21 (22.1%) at the first interview to 9 (9.5%) at the second. The 
findings at the second interview were similar to Mugford and Cohen’s results from their 
study of “recreational” cocaine users where 64 per cent were found to have a low score 
(1989).
At the first interview 15 women (40.5%) and 30 men (51.7%) had a low score (Table 
29, Appendix 19). The scores for men approximated the group determined by Goldberg 
and Hillier to be subclinical whilst that for women fell between subclinical and mild 
cases. By the second interview, 23 women (62.2%) and 33 men (56.9%) had a low 
score. The picture for both genders was similar to the group determined to be 
subclinical by Goldberg and Hillier (1979).
Table 30 in Appendix 19 compares the Oswaldians with non-Oswaldians and Table 31 
compares the core-Oswaldians and Remainder. There were only marginal differences 
between subsets.
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6.8.i: Positive effects o f treatment on psychological health
This section on psychological health continues with some of the findings from the 
qualitative data, beginning with those from treatment entrants. The people interviewed 
by Dale and colleagues reported several positive physiological health effects of 
methadone, including that it helped them to relax (1992). Four of the people I 
interviewed made comments of a similar nature (Table 32, Appendix 19). Boy Wonder, 
for example, said: “Life is a lot more relaxed, it’s just about right now.” Amelia and 
Alexander simply said they were “happier”, Kerry said her self-esteem had improved 
and Brett said, “I feel reasonably better off mentally, I have stresses and depression, 
but I ’m optimistic most of the time.”
Damien made a similar comment about his NA treatment:
I ’ve turned the fu ll circle from  being a pessimist to being an optimist 
Basically, while I  was using drugs I was always very unkind to m yself 
And now I always make an effort to be good to myself And I no longer 
feel like a worthless person and the thought o f living with absolutely no 
hope or faith I  find  terrifying.
Greg’s counselling had enabled him to stop his methadone treatment. He said: “It was 
probably the most empowering thing I’ve ever done in my life.”
6.8.U: Negative effects o f methadone treatment on psychological health 
There were also 12 negative comments about the effects methadone treatment on 
psychological health (Table 33, Appendix 19). Most people referred to diminished 
cognitive ability, or the way treatment had negatively affected their self-esteem.
6.8.iii: Positive effects o f changes in drug use on psychological health 
There were 20 comments about the positive effects of changes in drug use on 
psychological health (Table 34, Appendix 19). Although Mr X was concerned about his 
two uses of heroin, he also said he found the drug “pretty relaxing.” Otto had no 
qualms about his commencement of heroin use: “it was the best -  great fun.” Jacqui 
was pleased to be no longer “hearing voices” after commencing prescribed Stelazine and 
Barry’s recommencement of Surmontil meant: “Things are fine.”
Brenda’s recommencement of marijuana use had cheered her since it made her laugh a 
lot. Greg’s increased marijuana use had an unusual effect which he found beneficial, 
but, as he often did, he added a proviso:
Now if  I have a smoke in the morning I ’ll have a cry, which is good, but 
having a smoke to bring it on is not necessarily good.
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Jessie said her recommencement of opium was “good” since it put her in a “dreamlike 
state”, and Boy Wonder reported that his increased marijuana use had made him “a bit 
more relaxed.” Seven people who had decreased or stopped the use of drugs also said 
they felt more relaxed or less stressed because of these transitions.
Most of the other comments were related to better self-esteem. Greta is a case in point. 
She had not used heroin for more than 12 months and had stopped without treatment. 
She said: “I’ve got more motivation ... I love myself again, I’m really happy.”
6.8.iv: Negative effects o f changes in drug use on psychological health 
Fifteen people talked about the negative aspects of the changes they had made on their 
psychological health (Table 35, Appendix 19). The two women who had injected 
heroin for the first time found the experience frightening. Maggie (who later stopped 
her use) said: “I blacked out twice, I was really scared.” In spite of having a bad 
experience Elke still had an open mind about using it again:
one o f the guys dropped and needed mouth to mouth, and I can remember 
feeling nothing. And it really spun me out later that this guy who ’d had the 
same amount as me had dropped and it could have been me. I reckon I ’d 
prefer really good heads [o f marijuana] to that, I might and might not use 
again, but can’t really see the right situation coming.
Two people whose use of heroin had fluctuated mentioned negative psychological 
aspects associated with their period of heavy use. Drew-1 said “I was quite depressed” 
and Sinead talked about her poor self-esteem. James-l’s increased alcohol use had also 
negatively affected his self image.
As well as mentioning a positive psychological aspect of her recommenced opium use 
(described above), Jessie also felt the drug was “bad because it can cut out feelings.” 
Alison was very concerned about her increased amphetamine use:
There’s been a couple o f times when you have more than three hits in a day, 
and we ’ve had really bad arguments. We both went mad and I got really 
scared. I  was convinced I  was going to be killed . . .  I  can really plot my 
feelings. I  know that i f  I  have some, the next day I ’m going to be feeling 
depressed.
Four people who had increased their marijuana use (one temporarily) talked about being 
“less in control”, and feeling vague and paranoid. In addition to mentioning several 
negative physical side-effects of stopping Prothiaden, Tim also said that when he 
stopped he felt anxious, teary, short tempered, depressed, irrational and he suffered 
from amnesia and loss of confidence.
6..8. v: Discussion on psychological health
As with physical health, the findings for psychological health show an overall 
improvement between interviews. It has long been known that there is a link between 
physical and psychological health (Phillips and Segal, 1969:63). The similarity of my 
findings in these two domains is not, therefore, remarkable. Much of the improvement 
over time had occurred among women and the non-Oswaldian subsets.
At the first interview, women were in poorer psychological health than men, but by the 
second there were fewer differences. This mirrors the findings for general physical 
health. Similarly, women’s psychological health has been found to be worse than that 
of m en’s; following a study of a US sample of 1282 women and 749 men Mirowsky 
and Ross concluded that women “genuinely suffer more distress than men” (1995).
Studies of people who use illegal drugs have found women report significantly higher 
levels of psychopathology than their male counterparts (Reed, 1981; Lipsitz et al, 1994; 
Booth et al, 1995). Mondanaro postulates several reasons for this difference such as 
women having responsibility for childcare, living alone, having lower incomes, lower 
levels of education, having partners who are most likely to use drugs, more dysfunction 
and pathology in the family of origin, higher levels of depression and anxiety, and lower 
levels of self-esteem (1987).
6.9: Social health
Other researchers have noted the social costs of drug use: the expense involved may lead 
to the user not spending money on everyday essentials such as rent, food and other 
living expenses: “a situation that often exacerbates relationship problems” (Lintzeris and 
Spry-Bailey, 1998:236). This section looks at some of the dimensions of social health 
related to employment status, income, living situations and relationships with significant 
others. I first outline the changes in the total results of the OTI Social Functioning 
Scale, then amplify the findings from the individual questions within the domain. 
Interspersed with these latter are the additional findings from the questions developed in 
my own interview guide.
6.9A: OTI Social Functioning Scale
The OTI Social Functioning domain contains 12 questions which measure employment, 
residential stability, interpersonal conflict and the involvement of the respondent in the 
drug-use subculture (Appendix 10:384-386). The 5 possible responses to each question 
are scored from 0 to 4 giving a possible total score of 0 (best) to 48 (worst) for this 
domain. Figure 6.3 shows that the median score at both interviews was 14.
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Figure 6.3: Distribution of OTI social functioning scores at first 
and second interview
Social
functioning
score
First interview
Median 14 
Range 1-33
Interquartile range 9-18
Second interview
Median 14 
Range 2-30
Interquartile range 9.3-18.8
n people
These median scores were lower than the mean of 20.5 reported by Darke and 
colleagues from their research with IDUs during the development of the OTI (Darke 
1991a). At their first interview, the 74 current IDUs I interviewed had the same social 
functioning median score and range as the total population interviewed and only a minor 
difference in the interquartile range (10-18). At the second interview the median score 
for the then 77 current IDUs was 16 (range 3-30, interquartile range 10-19). This was 
only marginally higher than that found in the total population I interviewed.
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Macleod and colleagues also used the OTI in a longitudinal study in Scotland, reporting 
a Social Functioning score of 21 at their first assessment. Following 6 months of 
treatment there was a significant reduction in the mean score to 17 (1996). The people I 
interviewed who entered or re-entered treatment between interviews (and who were still 
in treatment) had a median Social Functioning score of 16 at both interviews, and there 
was no significant difference at either interview between these people and those who 
were not in treatment.
At both interviews, the majority of people had an OTI social score considered to be 
either low or below average and very few people had a high score (Table 36, Appendix 
19). The number of people with an above average score increased between interviews.
6.9.U: Employment
The only significant difference in either physical, psychological or social health found at 
the first interview between those who were interviewed only once and their opposite 
subset was in employment status. There were 33 tertiary students among those who 
went on to present for the second interview (34.0%) compared to 3 among those 
interviewed only once (7.1%) (Chi2 at 1 df = 11.0, p < 0.001). The subset of people 
who went on to present for the second interview included 9 secondary students (9.3%) 
whilst the subset of those who were only interviewed once contained 12 (26.6%) (Chi2 
at 1 df = 8.5, p < 0.005). These differences are interrelated and can be largely attributed 
to the fact that those who were interviewed twice were significantly older at the first 
interview than those who were interviewed once. This, in turn, can be attributed to my 
lack of success in relocating the people from secondary school and the young people 
from the “squat.”
At the first interview, 29.2 per cent of respondents were unemployed (n=26). This 
proportion had increased to an even higher 42.7 per cent at the second interview (n=41) 
(Table 37, Appendix 19) (Chi2 at 1 df = 9, p < 0.01). Two of the OTI questions were 
related to employment and the responses validate these findings (Tables 38 and 39). 
Much of the increase in unemployment was due to people transferring from another 
form of Government benefit to unemployment benefits.
These unemployment rates are considerably higher than the overall ACT rate for the year 
1991-92 which, at 7.1 per cent, was lower than elsewhere in Australia (Jacobs, 1993). 
For younger age groups the ACT rate was, however, somewhat higher. Those aged 20 
to 24 had an unemployment rate of 9.9 per cent and those aged 15 to 19 had an even 
higher rate of 20 per cent (Jacobs, 1993).
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The high rate of unemployment among the people I interviewed is comparable to that 
found in some other studies of Australian people who use illegal drugs. Among the 
ANAIDUS respondents, 24.2 per cent were unemployed (1991). A Western Australian 
survey of IDUs found 30.3 per cent were unemployed (Lenton and Tan-Quigley, 1997) 
At 74.1 per cent, unemployment among the ASHIDU respondents (Loxley et al, 1995). 
was notably higher than that at either of the interviews I conducted.
Nine women (28.1%) and 17 men (30.3%) were unemployed at the first interview; by 
the second interview the number of unemployed women increased to 16 (43.2 %) and 
the number of men to 25 (42.4%). The gender proportions at both interviews were thus 
very similar. This finding adds to the divergent results of other Australian studies of 
people who use illegal drugs where occupational gender differences have also been 
examined. The ANAIDUS researchers found that women were more likely to be 
employed than men (1991) and Loxley and colleagues found this difference to be 
significant among ASHIDU respondents (1995). Stevens and Wardlaw reported the 
reverse to be true for their ACT DIP study where a greater proportion of men than 
women were in paid employment (1994). Because the questions from these surveys 
were each approached in different ways from mine, drawing conclusions from these 
comparisons is not possible.
Five people at the first interview and seven at the second said that they were receiving a 
Social Security benefit because of problems associated with illegal drug use. As seen in 
the previous chapter, a few people, including tertiary students, tied their changes in drug 
use to their employment. The wide range of occupations for those who did have paid 
employment included artist, computing professional, educator, labourer and public 
servant.
Although there was a significant reduction in the numbers of drugs used between 
interviews, more people were unemployed at the second interview than at the first. 
Several researchers have looked at the complicated association between drug use and 
unemployment. A study of school-leavers in Scotland found more involvement in 
illegal drug use amongst those who were unemployed than among those who were 
working or full-time students (Plant et al, 1985). Pearson’s study of heroin users in 
England led him to suggest that a close relationship existed between heroin misuse and 
environmental levels of social problems (1987). Young asserts that drug use is 
appealing to those who are unemployed (1971). A study conducted among young 
unemployed people in Sydney gives support to this belief since it found that there was a 
relationship between long-term unemployment and an increase in both legal and illegal 
drug use (Turtle and Ridley, 1984). Waldorf found that “the single most interesting 
finding” in his study of abstentions in heroin users was the high percentage who worked
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while abstaining (1970:233). Maddux found full-time employment in heroin abstainers 
to be more than double that of daily users (1981).
6.9. iii: Income
The high levels of unemployment resulted in a low median annual income of $8000 at 
the first interview and a slightly increased $9000 at the second interview (Z -2.646, p < 
0.01) (Table 40, Appendix 19). By comparison, in 1992 when the first interviews took 
place, average weekly earnings for the ACT were around $562 (Jacobs, 1993). Judging 
from the median incomes and from the numbers of people within each of the 
employment categories listed in Table 40, it appears that much of the difference seen at 
the second interview was due to the increased number of people who received 
unemployment benefits during the previous 12 months. This was a contributory factor 
to the finding of a higher median income.
At the first interview the non-Oswaldians had a median income of $7000 (range 
$0-45 000, interquartile range $5-13 000) compared to a median of $9000 at the second 
interview (range $3-45 000, interquartile range $7-13 000) (Z 2.523, p = 0.0118). The 
difference for the Remainder was significant. Their results were the same as the non- 
Oswaldians at the first interview. At the second interview, their median and range were 
also the same, but there was an increase in the lower end of the interquartile range to $8- 
14 000 (Z -2.964, p < 0.0005). There were no significant differences over time in any 
individual income category.
The low level of income begs the question of how the people I interviewed were able to 
pay for their drugs but, as reported in the previous chapter, many people used illegal 
drugs only occasionally. At the time of first interview, several of those experiencing 
heroin dependency were going without food in order to pay for their drugs. Twelve 
people said that poor finances had led to them seeking methadone treatment and there 
were a further 43 instances of a decrease in use or non-use of a drug partly or wholly 
explained as being due to lack of finance (also reported in the previous chapter). 
Goldstein also found that the opioid users he studied had very little income and he 
pointed out that it is part of the ‘“ dope fiend’ myth” that narcotic users have high 
incomes (1981:67).
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Fourteen people whose drug use behaviours had changed talked about the positive 
effects this had wrought on their finances (Table 41, Appendix 19). Most comments 
came from eleven of the people who had entered into methadone treatment. Gazoo, for 
example, who had commenced his first treatment, said that it meant that he and his 
partner were:
better off, we’ve worked out our finances and we can catch up ... we’ve 
got a spare twenty dollars to buy things. It’s amazing what you can buy for 
twenty dollars, we’ve bought books, seen a few movies and gone out to 
dinner. That’s made a hell of a lot of difference to us. In general, we’re 
having a better time.
One man who had decreased his alcohol use and the two people who had decreased their 
heroin use said they now had “more money” (Table 41, Appendix 19). Five people 
who had either commenced or increased the use of a drug, or whose drug use had 
fluctuated, discussed the negative effects these transitions had on their finances (Table 
42, Appendix 19). Marcus was typical of these people. His amphetamine use had 
fluctuated and when he had been using heavily he had “spent the rent money on drugs 
and I didn’t have money for food.”
6.9.iv: Living situations
In this section, I examine findings related to residential stability, changes in those whom 
respondents were living with, and the proportion of time spent living with IDUs during 
the 6 months prior to each interview.
A majority of 68 people (70.1%) had lived in the ACT all the time between interviews 
(Table 43, Appendix 19). Thirteen had lived in one other place, 13 in two to five other 
places, and 3 in six or more places. This finding of residential stability was validated by 
the OTI findings (Table 44, Appendix 19) and accords with the finding (reported in 
Chapter 3) that this was a fairly stable population in terms of residential mobility. At the 
second interview, people tended to have even more residential stability than at the first 
interview (Z -2.903, p < 0.01). As will be shown below, significantly more people 
were in a relationship at the second interview. This may have impacted on residential 
stability.
At both interviews, most people reported living with friends or a partner (Table 45, 
Appendix 19). In general, many young people choose to live with their friends which 
ties in with the finding (described in the previous chapter) that friends often influenced 
changes in drug use. Ten more people at the second interview were living with a partner 
and 9 fewer were living with a parent. Given the passing of time between interviews, 
and the tendency for young people to leave home as they mature, this change is not 
unexpected. At both interviews, only a small proportion of people lived alone.
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At the first interview, 76.9 per cent of core-Oswaldians lived with friends (n=20) 
compared to 33.8 per cent of the Remainder (n=24) (Chi2 at 1 df = 14.3, p < 0.001). 
At the second interview, there were only minor changes in these proportions: 69.2 per 
cent of core-Oswaldians lived with friends (n= 18) compared to 32.4 per cent of the 
Remainder (n=23) (Chi2 at 1 df = 10.6, p < 0.005). These results confirm my 
ethnographic work where I observed that most of the core-Oswaldians were living with 
fellow Oswaldians.
The only significant differences in any of these responses over time was that a greater 
proportion of men lived with other family at the first interview (16.9%, n=10) than at 
the second (5.1%, n=3) (Chi2 at 1 df = 7, p < 0.01).
At both interviews, a minority of people had lived all the time with heroin users (Table 
46, Appendix 19). Respondents in the ASHIDU survey were asked a similar question 
and approximately 40 per cent responded “All of the time” and approximately 32 per 
cent responded “None of the time” leaving only small proportions in the other 3 
categories (Loxley et al, 1995:106). Because the differences found in my survey may 
have been due to some people I interviewed being non-IDUs and/or non-heroin users, I 
analysed the responses from these people separately: the findings were similar to those 
for the total population.
6.9. v: Relationships with significant others
I turn now to a discussion of respondents’ relationships with their partners, children, 
other family and friends. The discussion includes the effects of their transitions in drug 
use on these significant others.
6.9. v.a: Partners
At the first interview, a small majority of 52 respondents (53.6%) were not in a 
relationship (Table 47, Appendix 19). Excluding 4 people who said they had never 
been in a relationship, there was a short median period of 3 months (range 1 month-10 
years, interquartile range 2-12 months) for being single. Of the 45 people (46.4%) who 
were in a relationship, 38 (39.2%) had a partner, or a boy/girl friend, and a further 7 
(9.4%) were either married or in a de facto relationship. There was a median duration of 
12 months (range 1 month-10 years, interquartile range 3-38 months) for these 
relationships.
By the second interview, the number of people in a relationship had increased to 60 
(61.9%) (Chi2 at 1 df = 7.3, p < 0.01). There is a tendency for people to have more 
stable relationships as they mature and the increased number of people in relationships at 
the second interview may simply be another effect of the passage of time.
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Nineteen women (50%) and 26 men (44.1%) were in a relationship at the first 
interview. At the second interview the number of women in a relationship had increased 
to 29 (76.3%) (Chi2 at 1 df = 7.1, p < 0.01) and there was a smaller increase to 31 in 
the number of men (52.5%) in a relationship. The gender difference at this time 
approached significance (Chi2 at 1 df = 5.5, p = 0.0186).
It is known that being in a relationship is a positive predictor of health (Hu and 
Goldman, 1990; Goldman et al, 1991; Umberson, 1992). As reported above, women’s 
health had improved even more than men’s between interviews. It is, therefore, 
possible that the improvement in health and relationship status were inter-related.
My finding for the second interview is similar to that of Loxley and colleagues who 
found that among respondents interviewed for the ASHIDU project, significantly more 
men than women were single (1995). The overall finding at the first interview is 
comparable to some other Australian studies. Mugford and Cohen found that 45 per 
cent of their sample were in a de facto relationship (1989). Lenton and Tan-Quigley 
found a similar rate of 44.3 per cent who were living with a sexual partner (1997). The 
ASHIDU researchers found a lower proportion of 32.6 per cent who were “married or 
cohabiting” (Loxley et al, 1995:20). The proportion of people in a relationship at the 
second interview I conducted was higher than that found in any of these studies, but this 
may be due to the fact that I also considered those with boy/girlfriends as being in a 
relationship whereas other studies may not have done so.
There were 13 core-Oswaldians in a relationship at both interviews, but the number in a 
relationship in the Remainder subset increased from 32 to 47 between interviews (Chi2 
at 1 df = 9.8, p < 0.01) (Table 48, Appendix 19). The changes in this subset occurred 
in the cases of 10 women (38.5%) and 5 men (11.1%).
The median length for relationships at the second interview was 14 months (range 1 
month - 11.5 years, interquartile range 7-23 months). This was longer than that found 
at the first interview, but for some people this increase was due to the continuation of a 
relationship from the first interview. Consequently, I did not perform a comparative test 
on these results. One man had still never been in a relationship, two of the remaining 
single people were separated or divorced. At the time of the second interview 37 people 
were single. The median length of time that they had been single was 10.5 months 
(range 1 month to 20 years, interquartile range 3.5 months to 1.9 years). Most people 
had functional relationships with their partners (Table 49, Appendix 19). At both 
interviews, only a few people reported conflict “Often” or “Very often.”
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I looked to see what effects either being in a relationship or entering a relationship 
between interviews might have had on the number of drugs used. There were no 
significant differences between people either in a relationship, or who had entered a 
relationship, and those either not in a relationship, or who had no change in relationship 
status between interviews. As seen in the previous chapter, however, the qualitative 
data showed that 9 people had entered treatment because of the influence of a partner and 
there were 34 instances of a change in drug use behaviour which were also due to a 
partner. Most of these changes were a decrease in use or non-use of a drug.
Seven people commented on the positive effects their drug use transitions had brought to 
their relationships (Table 50, Appendix 19). Five comments came from people 
receiving methadone, one from someone who had decreased their heroin use, and one 
from someone who had stopped using heroin. Everyone said their partners were happy 
with these changes.
There were also three comments about the negative effects of increases in drug use on 
relationships with partners (Table 51, Appendix 19). Two came from Alison, who had 
commenced cocaine use and increased her amphetamine use. She said these changes 
had led to “bad arguments.” She was also concerned about her partner’s heavy use of 
these drugs. James-1 had re-entered methadone treatment and said:
But my partner still wanted to use, she wasn’t on methadone and I didn’t 
want to use, so all these new things came into play when I went on 
methadone ... When I first got on methadone /  got really unreasonable, I 
just didn ’t want to deal with stoned people, it wasn ’t rational, but my using 
it isn ’t rational anyway.
6.9.v.b: Children
Eighteen people (18.6%) at the first interview were parents. The gender proportions 
were almost identical (18.4% of women, n=7; 18.6% of men, n= l l ) .  Seven 
Oswaldians (5.7%) and 11 non-Oswaldians (19.4%) were parents. Only one core- 
Oswaldian was a parent (3.8%). Eleven people had one child, five had two children and 
two had three children. All but one of the children was under 16.
A slight majority of 11 parents (61.1% of parents, 11.3 per cent of the total sample) said 
that their children were partially or totally dependent on them. Six were women and five 
were men. Eight people shared the child care with their child’s biological parent, who in 
most cases was also their partner. Two women had sole responsibility for parenthood. 
Two men did not know the whereabouts of their children. One woman’s child was in 
foster care.
By the second interview, the number of parents had increased by 2 to 20 (20.6%) (as 
reported in Chapter 5, another 3 women were pregnant for the first time and one man’s 
wife was expecting their first baby). There were only a few other parenthood changes at 
the second interview. One woman who had previously had total responsibility for her 
two children had entered a de facto relationship with another respondent. He assumed 
shared responsibility for her children’s care and also continued shared responsibility 
with the other biological parent (also a respondent) of his son.
The percentages of parents at the interviews I conducted are smaller than the 33.4 per 
cent found among ANAIDUS respondents (1991). They are also smaller than the ACT 
DIP where “about 40 per cent” of the sample had children under the age of 18 (Stevens 
and Wardlaw, 1994:26). At their first interview, the people I interviewed were 
relatively younger than those in some other samples and this may explain some of the 
difference. Given a little more time, the difference between my sample and others may 
diminish.
The proportion of those with dependent children in my sample (11.3%) is similar to the 
13.3 per cent found by the ANAIDUS researchers. The ANAIDUS project differed 
from mine in its finding that slightly fewer women (7.4%) than men (8.3%) had 
children who were financially dependent on them (1991). My finding is more consistent 
with of the ACT DIP which found significantly more women (37%) than men (25%) 
had children living with them. As Stevens and Wardlaw go on to point out, this is a 
reflection of what occurs in the wider community (1994).
As seen in the previous chapter, all the new and expectant parents had modified their 
drug use between interviews. Three women who had re-entered methadone treatment 
mentioned the positive effects of this on their relationships with their children (Table 52, 
Appendix 19). Julie and Theresa both said that their relationships with their children 
had improved and Jacqui (who was the only parent with a child in foster care) said: 
“I’m seeing a lot more of my son. I now see him three times a week instead of two.” 
Lisa discussed the negative impact of her increased heroin use on her relationship with 
her son:
I  realised I had a lot o f friends who were very concerned about me. They 
told me it was affecting my relationship with my son, and I hadn ’t taken any 
notice ofthat myself
6.9.v.c: Other family
At both interviews, very few people reported no contact with their family and only small 
numbers reported conflict with their relatives “Often” or “Very often.” This indicates 
that most people had functional family relationships (Table 53, Appendix 19).
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Only a few people mentioned other family when they discussed their reasons for 
changing their drug use behaviours (reported in the previous chapter). Similarly, only a 
few people talked about the effects the changes had on their relationships with other 
family (Table 54, Appendix 19). Two men who had entered methadone treatment said 
that their relationships with their family had improved and Deirdre, who had stopped 
heroin use, had previously seen her parents infrequently but was now seeing them every 
week. This change was also related to her parents wanting contact with their new 
grandchild.
6.9.v.d: Friends
At both interviews, the majority of respondents reported that they “Never” or “Rarely” 
had conflict with their friends and only a few reported they had no friends (Table 55 , 
Appendix 19). Most people had good friendship support since almost three quarters had 
“Four or more” close friends (Table 56, Appendix 19). A variation of this question was 
included in the ASHIDU study and the results are comparable since these people 
reported a median number of 5 close friends (Loxley et al, 1995:105).
The majority of respondents at both interviews were either “Very satisfied”, or 
“Satisfied” with the support that they got from their friends when they were having 
problems (Table 57, Appendix 19). This finding is also similar to the ASHIDU survey 
where respondents were asked an almost identical question and three quarters responded 
that they were “at least reasonably satisfied” (Loxley et al, 1995:106).
At both interviews, only small numbers of people saw their friends only “Rarely” and 
no one reported “Never” seeing their friends (Table 58, Appendix 19). By the second 
interview, a markedly smaller proportion of people saw their friends “Very often” (Z 
-2.683, p < 0.01).
At the first interview, 42.1 per cent of the people the respondents had “hung around 
with” had been known to them for more than 6 months (Table 59, Appendix 19). By 
the second interview, this proportion had increased to 52.6 per cent. Some of the 
increase may simply be due to the passage of time between interviews when those 
already known at the first interview and still “hung around with” at the second would 
have been known for a longer period. The ASHIDU survey had a similar question but 
respondents were asked to quantify rather than apportion the number of close friends 
known for more than six months. These respondents gave a median number of 5 people 
(Loxley et al, 1995:105).
Most respondents spent at least some of the time with “users” (Table 60, Appendix 19). 
Very few reported these were the only people they spent time with. Only 5.3 per cent of
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people at the first interview said that they did not spend any time with “users” This 
proportion had increased to 18.9 per cent by the second interview. The proportion of 
people at the second interview who said that less than half the people with whom they 
spent time were “users” had also decreased. A similar question asked of respondents in 
the ASHIDU survey carried the proviso that those whom respondents lived with should 
be excluded (Loxley et al, 1995:21). The findings from this sample were comparable to 
mine.
As reported in the previous chapter, friends were often influential in changing drug use 
behaviours. Only a few people, however, discussed the effects that these changes had 
brought to their friendships. Three people who had entered methadone treatment and 
one man who had increased his alcohol use all said they were now seeing more of their 
friends (Table 61, Appendix 19).
James-1 had recommenced methadone treatment and was trying not to use heroin. He 
said: “A friend I’ve made in the past six months is always asking me to score with him 
and it really gives me the shits” (Table 62, Appendix 19). Two of the other seven 
negative comments about the effect of a change in drug use were related to worries about 
a friend’s use of the same drug, and one was related to friends being worried about the 
respondent’s use. Annabel’s decreased alcohol intake had led to her friends thinking 
she was “weird” and 3 people said that the changes they had made meant they saw less 
of their friends.
6.9.vi: General lifestyle effects o f changes in drug use and treatment 
In addition to the one man who said he had gone into methadone treatment because of 
the general detrimental effects of his heroin use on his relationships with other people, 3 
people talked about the general positive effects of the changes on their relationships 
(Table 63, Appendix 19). Damien (who had recommenced NA) said: “... now I always 
make an effort to be good to other people.” Otto’s commencement of heroin use led him 
to say: “Before, I just didn’t like heroin users, now I don’t mind heroin users, it’s just 
junkie scumbags I don’t like.” Andre’s heroin use had fluctuated and he said of his 
period of non-use: “I was thinking more of other people.”
In addition to comments made by the 7 people who had entered methadone treatment and 
the 89 instances of other changes in drug use behaviour due to lifestyle, some people 
commented about the effects their changes in drug use had brought to their lifestyle: 24 
were positive (Table 64, Appendix 19). Seven of these were made by people who had 
received methadone treatment and one was made by Damien (who had recommenced 
NA). All the comments were of a general nature indicating an overall lifestyle
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improvement, such as Damien’s: “I’m happy to be alive now and I appreciate life. ... 
it’s a much nicer way to live.”
Steve had increased his alcohol consumption and Jeff had increased both his alcohol and 
heroin use. Both found these changes positive since they helped relieve tension 
associated with their new jobs. Cliff had decreased his alcohol consumption and said he 
was now “able to get more done” and Marcus was pleased that his decreased alcohol 
consumption enabled him to drive more. James-2 said of his reduced alcohol 
consumption:
Now 1 stay home and play cards and backgammon and s tu ff... staying 
home calms me down. I ’ve been a right goodie two shoes lately - 1 stay at 
home so then I don’t go out and fight.
Rob had decreased his heroin use and said:
I now see people running around [after heroin] and I ’m glad I ’m not like 
that. I like not being addicted, not having to run around chasing drugs, just 
using occasionally is less hassle ... [I’ve got] more time, I ’m able to do 
casual work.
Similar comments were made by people who had stopped their heroin, amphetamine and 
alcohol use, from one person who had temporarily stopped the use of heroin and from 
one person who decreased his marijuana use after a period of heavy use.
Eight people made negative comments about the lifestyle effects of their changes in drug 
use (Table 65, Appendix 19): 3 comments came from people who were in methadone 
treatment and they were of a general nature, as Brigid’s statement: “the lifestyle is no 
good.” For Deirdre, “the loss of lifestyle was difficult” when she stopped her heroin 
use, and Andre (who had stopped using heroin for a while) made a similar comment, 
which was also reminiscent of those made by heroin users interviewed by Preble and 
Casey (1969):
The first few months of stopping felt terrible, taking it every day is very life- 
affirming, you get up every day and you ’re a businessman, getting heroin.
The other comments were very mixed. Jeff believed his work had suffered because of 
his increased alcohol intake, Lisa did not like “having to deal with the people that I was 
dealing with” when her heroin use increased, and Ruari’s temporary increase of 
marijuana led to him being unable to “participate in discussions.”
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6.9.vii: Discussion o f social health
Most people’s scores on the OTI Social Functioning Scores were average or below at 
both interviews indicating a low incidence of social pathology. Although there was no 
significant difference in the total OTI Social Functioning Scores at the two interviews, 
there were a few significant differences between the two interviews in some of the 
individual variables in this domain. Much of this difference was due to the time lapse 
between interviews.
Whilst there is a perception that people who use illegal drugs have unstable lives, 
including residential mobility, most of the people I interviewed were fairly stable in this 
respect. The results from both the ASHIDU project and my study also challenge the 
stereotypically held view that people who use illegal drugs have poor social support 
networks since both studies found that respondents had contact with their family and 
friends and also had quite good relationships with their significant others. In addition, 
significantly more of the people I interviewed were with partners by the second 
interview.
Given the high unemployment among the people I interviewed, as well as those found in 
other samples of people who use illegal drugs, it would obviously be a worthwhile harm 
minimisation strategy to put efforts in to finding paid employment for both current drug 
users and those who wish to abstain from drug use. I return to this point in Chapter 9.
6.10: Conclusion
A mixed image of the people I interviewed emerges from these results. There were 
many positive findings which challenge stereotypical notions of people who use illegal 
drugs, but there were also negative factors such as the high level of unemployment and 
low income. For some people, their drug use was associated with pathology, for others 
only with pleasure. Some respondents weighed up both the costs and benefits of their 
changes in drug use on their physical, social and psychological health. By the second 
interview, there had been an improvement in health for the total sample. Many previous 
studies (some of which are reviewed above in Section 6.3) have indicated that people 
who use illegal drugs are at increased risk of physical, psychological and social 
morbidity. As documented in Chapter 5, there had been a significant reduction in the 
number of drugs used, reductions in the levels of consumption of several drugs and a 
significant increase in the number of people with a history of treatment. Many of the 
reductions in drug use were due to people entering methadone treatment (also reported in 
Chapter 5). Other authors have demonstrated a link between entering methadone 
treatment and improved health (also reported in Chapter 5). I suggest the positive 
changes in drug use consumption patterns and treatment entry had a bearing on the 
improvement in health between interviews.
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There were very few other differences between either of the Oswaldian subsets when 
compared to their opposite subsets. My original hypothesis was that there would be 
health differences between Oswaldians and non-Oswaldians. This hypothesis is not 
supported by the majority of the findings discussed in this chapter. Between interviews, 
the health of the non-Oswaldians and Remainder had improved more than that of, 
respectively, the Oswaldians and the core-Oswaldians (the definitions of these subsets 
are included as Appendix 4). I can offer no plausible explanation for these differentials.
Judging from the total health score and the levels of dysfunction at the first interview, it 
appears that at that time women were in poorer health than men. Fewer gender 
differences were found in the second interview than at the first, indicating that the 
women’s health had improved more than that of their male counterparts. Dorothy 
Broom deconstructs the question of which gender suffers more from drug and alcohol 
use noting that the kinds of suffering may be qualitatively different. She gives as an 
example the fact that though more men drink, women are damaged more quickly by 
excessive alcohol consumption (1994). According to a report from the NDS, studies 
from people who are dependent on opioids indicate gender differences in the types of 
psychopathology suffered: women are more likely to be diagnosed with an anxiety 
disorder and men are more likely to be diagnosed with an antisocial disorder (1993). 
Conclusions such as these indicate that gender specific needs should be taken into 
account when developing harm minimisation strategies for people who use illegal drugs.
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CHAPTER 7: BEHAVIOURS RELATED TO INJECTING DRUG USE AND 
SEXUAL AND GENITAL HEALTH
7.1: Introduction
The advent of HIV/AIDS and the spread BBVs and STDs among the illegal drug using 
community has led to efforts to prevent further spread of these diseases. I wanted to 
ascertain how prevalent these diseases were among the people I interviewed and see 
what changes in injecting and sexual behaviours occurred over time. In addition, I 
hoped to be able to evaluate existing harm minimisation strategies and possibly make 
further recommendations.
I begin the chapter with an overview of the way the findings are presented. As general 
background information, I then present an overview of the prevalence of IDU in 
Australia and the ACT. I move on to a presentation of the brief histories of 
HIV/AIDS, HBV and HCV as they apply to people who use illegal drugs. These 
histories include some of the Australian harm minimisation strategies which have been 
implemented to try' and curb the spread of these diseases. Each of these histories is 
followed by a discussion of the way each virus affected the people I interviewed. I 
then report the findings on the relationship between changes in drug use and BBVs 
before discussing the implications of the findings related to BBVs. The results of the 
analyses of respondents’ current injecting behaviours are then described and discussed. 
This section includes some information on reports of accidental needle sharing. The 
chapter continues with a discussion of findings relevant to sexual and genital health.
7.2: Presentation of the findings
Some findings are derived from the HRBS section of the OTI and they are indicated as 
such in Appendix 20. These results are supplemented with both quantitative and 
qualitative findings from the questionnaire I developed. I restricted the analyses on 
needle use to people who had injected during the 12 months prior to the first interview 
and to those who had commenced or recommenced injecting between interviews. 
When collecting qualitative data on needle use behaviours at the second interview, I 
did not ask these questions of people who said they had “stopped” their needle use 
because I had found at the first interview that the process of talking about injecting 
often prompted people to feel a need to inject. I did not want to instil this feeling in 
people who were trying to stop their needle use.
No significant differences were found at the first interview between those who were 
interviewed only once and their opposite subset (definitions of the subsets are included 
in Table 2 in Appendix 4). I did find some gender differences and a few significant
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differences were found between the other subsets. I also found some changes in IDU 
and sexual health between interviews.
7.3: Prevalence of injecting in Australia
As long as IDU remains an illegal activity, it will never be possible to calculate 
accurately how many people are involved in this behaviour. According to the 1994 
NDS general population household survey, two per cent of Australians over the age of 
14 had ever injected illegal drugs; about one third of them had injected in the 12 
months prior to the NDS interview. Among males aged 14 to 24, 4 per cent had ever 
injected. For both women and men aged 25 to 34, 4 per cent had ever injected (1994). 
There were approximately 14 709 000 Australians over the age of 14 in the middle of 
1992 (Jacobs, 1993). Two per cent of this number gives us around 294 180 
Australians who had ever injected and about 98 000 people who had injected in the 
previous 12 months. The 1994 NDS survey percentages were based on only 62 people 
who admitted to injecting (1994). The same caveats documented in Chapter 4 
regarding the problems of household surveys also apply here.
A somewhat larger estimate of Australians who had ever injected was given by The 
Panel on Intravenous Drug Use and HIV. According to that report “Witnesses at 
almost every meeting told the Panel that up to 500 000 Australians have at some stage 
in their life used drugs intravenously” (Baume et al, 1989:2). The CDCSH estimates 
that there are between 90 and 130 000 people presently injecting (1990). The lower 
end of the range is, therefore, similar to the estimate based on the NDS household 
survey.
7.4: Prevalence of injecting in the ACT
I also made extrapolations from the NDS percentages against the 227 792 ACT 
residents who were over 14 in 1992 (Jacobs, 1993) and arrived at figures of around 
4556 people in the ACT who had ever injected and 1500 who had injected in the 12 
months prior to interview.
Larson and colleagues calculated there were around 1250 heroin users who could be 
candidates for a heroin trial in the ACT (1994). Since this calculation was derived 
from data collected for the ACT DIP during 1988-89 where “Over 90 per cent of 
heroin users reported injecting it” (Stevens and Wardlaw, 1994:33), it would be safe to 
assume that this population consists largely of IDUs. In making their calculation, 
Larson and colleagues were interested only in “the arrest-vulnerable and 
treatment/counselling seeking population of heroin users ... [but] certainly not all 
heroin users or even all dependent users” (1994:830). Their estimate is only a little 
smaller than the estimate for all present IDUs calculated from the NDS results, and
considered only some heroin users. The number could be expected to be much greater 
if all heroin users and amphetamine users were also included. Apart from an 
assessment presented in a report prepared by DRIC, where a figure of 5000 to 7000 
current IDUs was presented (Whyte et al, 1987), there has been no documented 
calculation of the number of IDUs in the ACT. If we allow for those other IDUs not 
accounted for by Larson and colleagues, the DRIC estimate may well be reasonable 
and the calculation based on the 1994 NDS would seem to be too low.
7.5: Injecting histories of respondents
In this section, I present the injecting histories of the people I interviewed, including 
their age at first injection, some discussion of gender differences, and transitions in 
injecting frequency between interviews. At the end of the section I discuss the 
implications of the findings.
Eighty participants in the study (82.5%) had a history of IDU. Equal numbers had first 
injected heroin and amphetamine (Table 1, Appendix 20). Similarly, the ASHIDU 
study found almost equal numbers of IDUs had first injected these drugs (Loxley et al, 
1995).
There was a median age of 18 for first IDU for the people I interviewed (Figure 7.1). 
This is similar to the mean age of 18.4 reported in the ANAIDUS sample (1991) and 
also to an international survey where the mean age of first IDU ranged from 17.5 to 
21.7 across the 13 cities which participated in the research (WHO Collaborative Study 
Group, 1993).
Figure 7.1: Age first IDU
Median age 18 
Range 12-34 
Interquartile range 17-20 
(n = 78, 2 missing values)
n people
For women, the median age of first IDU was 17.5 (range 12-26, interquartile range 16- 
19.5) and for men 18.0 (range 13-34, interquartile range 17-20). This difference was 
not statistically significant and there is some age approximation for first injection since 
age was rounded off to the nearest year. There may, in addition, be some recall bias. 
The finding does, however, correspond with the finding that women were younger 
than men when they commenced illegal drug use and also with the finding of a Milan 
study where the researchers found a “tendency” for women to start injecting earlier 
than men (Nicolosi et al, 1991:98).
There was a median period of 5 years of injecting (range 1-30, interquartile range 3-8, 
n=74: 2 missing values) for current IDUs at the first interview: 83.7% of women 
(n=28) and 81.4% of men (n=48) were current IDUs. Between interviews, the number 
of current IDUs increased slightly from 76 to 79 (Table 2, Appendix 20).
The data obtained from the interview guide I developed showed that no one had 
injected every day during the period between interviews, whereas at the first interview
there were 7 people who had injected every day in the preceding 12 months (Table 3, 
Appendix 20). Nine people at the second interview said they had “stopped” injecting. 
The reasons given for stopping IDU corresponded with the reasons given for stopping 
amphetamine and heroin use (reported in the previous chapter).
The results for changes in injecting frequency for the month prior to interview (Table 
4, Appendix 20) were obtained from the HRBS. The median total HRBS score fell 
from 2 to 1 between interviews. The number of IDUs who had not injected in the 
month prior to the second interview increased from 14 to 25 and the number who had 
injected at least once a day decreased during this period from 23 to 5 (Z -3.543,
p<  0.001).
7.5 A: Discussion of findings related to injecting histories
Although the findings were not statistically significant, reports from the two very 
different environments of the ACT and Milan indicate women are younger than men 
when they start IDU. These findings may be especially important in the light of 
studies showing that the first few years of injecting are a time of high-risk for the 
transmission of BBVs (Crofts, 1993; Fennema et al, 1997). It is known that adolescent 
women mature earlier, both physically and socially, than their male counterparts 
(Tanner, 1978). This earlier maturity may include a younger age of initiation into 
IDU. In addition, as part of this earlier maturing, young women’s male partners are 
often older than they are. In a rare study which examined gender differences in 
initiation into IDU, Crofts and colleagues found that women were significantly more 
likely to have received their first injection from a partner or a lover than were men 
(1996).
I suggest that there is a need for more research to further examine gender differences 
into initiation into IDU so that appropriate gender specific harm minimisation 
strategies may be implemented for young people who may commence IDU.
The findings for injecting frequency at both interviews are quite different from the 
WHO Collaborative Study Group’s research which found that over 80 per cent of the 
IDUs in their samples had injected daily in the 6 months prior to interview (1993). 
The ANAIDUS researchers found that the median number of times their respondents 
had injected in “the most recent typical drug using month was 28” (1991:23).
The IDUs I studied injected less frequently than the IDUs in these other samples. The 
difference in my finding may indicate that I had some partial success in accessing 
“hidden” users. There was less injecting at the second interview than at the first. 
Though this could be an artefact of the longer timeframe (since levels of use are more
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likely to fluctuate over the generally longer period covered at the second interview) 
this change is a reflection of decreases in drug consumption patterns reported in 
Chapter 5. Some of this was brought about by treatment entry. As Ward and 
colleagues conclude, there is abundant evidence to suggest that IDUs in methadone 
treatment reduce their frequency of IDU (1992).
7.6: Human Immuno-deficiency Virus/Acquired Immuno-Deficiency Syndrome
In 1983, French researchers announced that in the search for the cause of a recently 
recognised immuno-deficiency disease they had discovered a new human retrovirus 
(CDCSH, 1988b). It was soon established that this virus, now known as HIV, is the 
causative organism for AIDS. This syndrome was first observed between 1979 and 
1981 in the United States of America when 11 cases of Pneumocystis carinii 
pneumonia (PCP)1 occurred among previously healthy young men who were either 
drug users or homosexuals (Masur et al, 1981 [1987 edition]). A later review showed 
that the first evidence for HIV/AIDS in IDUs occurred in New York in 1977 among 
babies bom of mothers who injected drugs (Des Jarlais et al, 1989).
Soon after the first cases of AIDS were reported, it became apparent that the sharing of 
injecting equipment was a very efficient method of transmitting HIV. After men who 
have sex with men, IDUs now account for the second largest transmission category in 
the western world (WHO and the Center for Disease Control, 1991 [CDC]; National 
Centre in HIV Epidemiology and Clinical Research, 1993). Des Jarlais and colleagues 
cite Ball and colleagues (1994)2 who report that HIV infection among IDUs has now 
been reported in 80 of the 118 countries where IDU is known to occur (1996).
In 1985, the first case of HIV in a heterosexual IDU was detected in Australia (Blacker 
et al, 1986). At the end of June, 1997, 20 706 Australians had been diagnosed as being 
HIV-positive and 5370 of these people had died of AIDS (National Centre in HIV 
Epidemiology and Clinical Research, 1997).
There was an HIV prevalence of 50 per cent among IDUs in New York in the early 
1980’s (Des Jarlais and Friedman, 1990). Soon after the first cases were reported 
among IDUs in this city, there was recognition of how vast the personal, 
epidemiological, economic and social costs were going to be (Drucker, 1986).
Concerns about preventing another “New York” occurring in Australia were often 
expressed when “responses to the threat of an IDU ... epidemic were being developed” 
(Wodak, 1995:46). In 1984, the Australian Government instituted The National AIDS
1 Pneumocystis carinii is the major opportunistic infection associated with AIDS (Schoub, 1994).
2 Not seen: this book appears to be unavailable in Australian public libraries.
Task Force. This has evolved into the Australian National Council on AIDS 
(Feachem, 1995). The first National AIDS Strategy was developed in 1989 and its 
community based programs facilitated the formation of drug user groups (Crofts and 
Herkt, 1995). The ACT IV League was originally formed as a humanitarian charity by 
a religious group. Its development to a peer-based organisation began with the advent 
of HIV/AIDS (Crofts and Herkt, 1995). In 1988, a national umbrella user 
organisation, the Australian IV League (AIVL), had its first meeting (Crofts and 
Herkt, 1995).
NEPs were set up in Australia in 1987 (Feachem, 1995). Feachem cites an 
unpublished document by Byers who has calculated that at least 10.3 million needles 
and syringes were distributed in Australia during 1993-1994 (1995). During the 
financial year 1995-1996, 360 595 needles and syringes were distributed through the 
ACT NEP’s 18 outlets (an unknown quantity were also distributed through some of 
the ACT’s pharmacies) (Fletcher, P. NEP Program manager, ADDInc, ACT. 1996, 
December 2, pers comm).
In a report prepared for the CDC (in the USA), Lurie and colleagues concluded that 
NEPs do not increase the level of drug use and do decrease rates of HIV drug risk 
behaviour (1993). In a cost effective analysis comparing cities around the world 
which had introduced needle and syringe exchange programs with those that had not, 
Hurley, Jolley and Kaldor found that the average HIV seroprevalence in locations 
where there were NEPs was 6 per cent compared to 21 per cent in locations where 
there were none. Based on the 6.3 million syringes which were believed to have been 
distributed in Australia in 1991, they conclude that the operation of NEPs prevented 
almost 3000 IUDs from contracting HIV during that year (1997).
Though any diagnosis of HIV is a personal tragedy, from an epidemiological 
standpoint the measures taken by Australia to prevent an epidemic of HIV among 
IDUs have been successful: in mid 1992, 8.0 per cent of diagnoses of HIV infection 
for which an exposure category was available were in IDUs. Over one-third of these 
people were men who also reported homosexual contact (Kaldor et al, 1993). It is now 
believed that HIV/AIDS among IDUs will not reach the epidemic proportions of New 
York (Wodak, 1995).
7.6. i: Respondents’ histories of HIV testing
Sixty eight respondents (70.1%) had ever been tested for HIV at the time of their first 
interview (Table 5, Appendix 20). Fifty nine (60.8%) were tested between interviews. 
Considering the two interviews, 31 women (81.6%) and 47 men (79.7%) had ever 
been tested. Seventy one of those who had been tested (91.0%) were current or ex-
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IDUs. This leaves 10 current IDUs and 2 ex-IDUs who had never been tested. Most 
who had been tested at all had been tested more than once. At both interviews, the 
majority of tests had taken place within 12 months prior to interview (Table 6, 
Appendix 20).
At the first interview, 29 people (43.3% of those tested), had their last test because of 
unsafe sex (Table 7, Appendix 20). Twenty four of these tests had occurred in the 12 
months prior to interview. At the second interview, the number who had a test for this 
reason was down to 11 (18.6% of those tested) (Chi2 at 1 df = 14.4, p < 0.001). The 
change largely occurred in women since their change was significant (Chi2 at 1 df = 
9.0, p < 0.01) whilst the change among men was not. The Oswaldian (Chi2 at 1 df = 
8.3, p < 0.01) and Remainder subsets (Chi2 at 1 df = 8.9, p < 0.01) also showed a 
significant change whilst their opposite subsets did not.
At the first interview, 19 people (28.4% of those tested) had their last test because of 
unsafe needle use (16 during the 12 months prior to interview). Between interviews, 
only 5 people (8.5% of those tested) had a test done because of unsafe needle use 
(Chi2 at 1 df = 10.9, p < 0.001). Much of the difference occurred in men since their 
change was significant (Chi2 at 1 df = 9.0, p < 0.01) whilst the change in women was 
not. The change in the Oswaldian subset was also significant (Chi2 at 1 df = 8.0, p < 
0.01) whilst that in the Remainder subset approached significance (Chi2 at 1 df = 6.2, p 
< 0.02 > 0.01). Some of the differences found between interviews may, however, be 
an artefact of the timeframe since, , for 17 people at the first interview, the latest test 
was performed more than 12 months prior to interview whilst, for the second 
interview, the data collection was restricted to the period between interviews, which 
for some respondents may have been shorter.
Some respondents were tested even though they had not engaged in these risk 
behaviours. There were 9 people at the first interview, and 6 at the second, who 
reported neither unsafe sex or unsafe needle use, but who said that they had the test 
done because they were worried. Most said something along the lines of “I just 
wanted to know.” Some went on to elaborate the reasons for their concern. Rob said: 
“This guy was going to kill me ‘cos I was sleeping with his girlfriend, he told me to 
have the test. He had a gun.” Theresa had the test because “I’d been whoring and 
using, both safely, but I was worried.” James-1 decided to be tested “For peace of 
mind, before (my baby) was born .” One woman’s concern was related to having an 
abnormal Pap smear which required extensive treatment, and she was aware that 
invasive cervical cancer is an AIDS defining condition for women who are HIV 
positive (Kaldor and Hall, 1993).
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At the first interview, two people had their last test when they had entered a 
Detoxification Program, and three had the test when they entered methadone 
treatment. Reflecting the increase in the number of people in methadone treatment, 10 
people had the test done for this reason between interviews.
At the first interview, one IDU knew he was HIV positive (Table 8, Appendix 20). He 
was a gay man and was adamant that he had never shared needles. Two IDUs who 
presented only for the first interview were also HIV positive. No one was aware of 
contracting HIV between interviews.
Based on the percentage of 8.0 per cent of the diagnoses of HIV infection occurring in 
IDUs (reported above), and given that at the end of 1991, 128 people in the ACT had 
been diagnosed with HIV (National Centre in HIV Epidemiology and Clinical 
Research, 1992), at the time of my first round of interviews there would have been 
fewer than 111 IDUs (some of whom who might also have been men who have sex 
with men) diagnosed with HIV in Canberra. It is, therefore, not surprising that few 
people who were HIV positive presented for my interviews.
7.7: Hepatitis B virus
A virus now known as HBV was discovered in the serum of an Australian Aborigine 
in 1965 and for this reason the virus was first known as the Australia antigen. It was 
soon recognised that the virus is transferred efficiently via sexual and blood contact, as 
well as by maternal-foetal transmission (Batey and Bollipo, 1996). Although the 
incidence of HBV in Australia has increased over the past few decades (an estimated 
3000 new cases notified each year), Australia is considered to be a low prevalence 
country since less than one per cent of the population are chronic carriers of the virus. 
Around 150 000 to 180 000 Australians are infected, of whom about 1200 die each 
year from sequelae such as cirrhosis and hepatocellular carcinoma (Gust, 1992). It has 
been estimated that, in Australia, around 5 per cent of deaths from cirrhosis of the 
liver, and 80 per cent of deaths from primary hepatocellular carcinoma, are secondary 
to HBV (Antioch et al, 1993).
IDUs are known to have a much higher prevalence of HBV than the general 
population. Batey and colleagues found evidence of HBV infection in 80 per cent of 
356 clients in a Sydney drug and alcohol unit (1987). In a study of 767 people being 
assessed for entry into methadone programs in New South Wales, Bell Fernandes and 
Batey found that 87 per cent tested positive for HBV (1990). In a 1995 national 
survey of 1 005 clients of NEPs, 30 per cent reported a diagnosis of HBV (MacDonald
1 This figure should be viewed with some caution since it is possible that there has been some mobility 
of the population.
et al, 1997). Stevens and colleagues cite a personal communication from Dr Keith 
Powell (at that time Senior Physician of the then Royal Canberra Hospital South, 
Alcohol and Drug Service) who reported that two recent studies of clients at the ACT 
Methadone Program showed that between 50 and 70 per cent tested positive for HBV 
(1992).
A safe vaccine against HBV has been available in most developed countries since the 
early 1980s (Gust, 1992). In accord with WHO guidelines, the NHMRC has recently 
recommended universal vaccination (Batey and Bollipo, 1996). Given, that only one 
third of Australian children aged between 3 months and 6 years have been fully 
immunised (McLean, 1997), and also taking account of the low rate of HBV 
immunisation among high risk groups reported above, there is little reason to believe 
that a new universal immunisation program will be widely accepted by the Australian 
public.
Earlier, the NHMRC had recommended that the HBV vaccine be offered only to at 
risk groups, including IDUs (Gust, 1992). As Gust goes on to point out, 
implementation of this recommendation was problematic for some groups, and he 
outlines impediments associated particularly with IDUs, such as a possible lack of 
motivation and problems in attending clinics for the 3 appropriately spaced doses of 
the vaccine. In a 1991-1992 study of prison inmates, Crofts and colleagues found that 
only 5.5 per cent of the 1561 known IDUs in the sample had been immunised against 
HBV (1995). A higher rate of 45 per cent was, however, found by MacDonald and 
colleagues among the 682 respondents with no history of HBV infection in their 
national sample of 1005 clients of NEPs (1997).
7.7.i: Respondents’ histories of HBV seropositivity
The majority of people I interviewed had been tested for HBV: 11 had tested positive 
prior to the first interview and a further 3 were diagnosed between interviews (Table 9, 
Appendix 20). These 14 people were all current IDUs and represent 16.9 per cent of 
the 83 people who had ever injected.
I did not ask respondents about their HBV immunisation status at the first interview 
but did so at the second when 19 reported full immunisation, including a post­
immunisation blood titre (taken to assure that their immunisation had been successful) 
(Table 10, Appendix 20). Seventeen of these people were current or ex-IDUs. Both 
people who had 3 immunisations but no titre were current IDUs, as were two people 
who had one or two injections. Forty one of the other 53 people who had no 
immunisation were current IDUs.
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7.8: Hepatitis C virus
HCV has been present in IDU populations since “at least the early 1970’s” (Crofts, 
1994:235) but it was only in 1990 that the viral RNA (Ribose Nucleic Acid) was 
identified. This demonstrated that the newly termed HCV was the major causative 
agent for non-A-non-B hepatitis (Choo et al, 1990). It is now known that there are 
serious ramifications for many people who contract the virus. Follow up studies have 
found 70 to 83 per cent of people who were HCV-positive were chronic carriers 
(Esteban et al, 1991; van der Poel et al, 1991). Alter and colleagues report that chronic 
hepatitis developed in 62 per cent of their patients with HCV (1992). Pooled data 
from people who were subsequently diagnosed with HCV showed that 20 to 30 per 
cent developed cirrhosis (van der Poel et al, 1994). HCV is also associated with 
hepatocellular carcinoma (Tsukuma et al, 1993; Okuda and Ohnishi, 1995).
The virus is predominantly transmitted via exposure to infected blood (Alter et al, 
1992; Sladden et al, 1997). In Australia and other developed countries the most 
common route of transmission is through unsafe needle use (Wodak, 1997). Shortly 
after a serological test for HCV became available, Australia was alerted to the 
seriousness of the HCV epidemic among IDUs (Bell et al, 1990). These authors 
reported results from sera tested from 172 IDUs in methadone treatment in Sydney. 
Anti-HCV was found in 86 per cent of the population and there was a significant 
correlation with years of injecting, since two thirds of people who had been injecting 
for 2 years were seropositive for HCV and 100 per cent who had been injecting for 
more than 8 years were seropositive. Subsequent research has also demonstrated an 
association between years of injecting and HCV status (Crofts et al, 1997).
In Australia, the incidence and prevalence of HCV has reached the stage where it has 
been called “arguably the commonest life-threatening infection” (Wodak, 1997:284). 
Estimates of the number of IDUs who will be newly infected each year range from 
3000 (Locarinini and McAnulty, 1996) to 6000 (Crofts et al, 1997). Crofts and 
colleagues estimate that around 130 000 current and former IDUs are HCV carriers. 
After reviewing the available data sources, these authors found that HCV prevalence 
among Australian IDUs ranges from 60 to 70 per cent (1997). International studies 
also show that 30 to 90 per cent of both treatment and non-treatment samples of IDUs 
are HCV positive (Crofts, 1994).
In May 1997, there was a cumulative total of 1391 notified cases of HCV in the ACT 
(Passaris I. Communicable Diseases Control Program, ACT Department of Health. 
1997, May 8, pers comm). Risk factor information was available for 154 cases (76.6% 
of reported cases) notified over a 6 month period during 1994. IDU accounted for 81 
per cent of these cases (Selvey et al, 1996). Notifications should, however, be viewed
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with some caution. Andrews and Curran identify a range of problems with HCV 
surveillance data in Australia including variability in the methodology of data 
collection by States and Territories, response bias, the presence of duplicates, and the 
difficulties associated with distinguishing incident cases from prevalent cases (1996).
In Australia, Interferon alpha is the only drug available for treatment of HCV. People 
who have injected illegal drugs within the previous 12 months are presently excluded 
from this treatment but the NHMRC recommends that they should be included (1997).
7.8. i: Respondents’ histories of HCV seropositivity
I was first aware of an increase in the prevalence of HCV among the people I 
interviewed during ethnographic work when some Oswaldians asked me for 
information since they had recently been diagnosed. At the second interview, I found 
that 14 people in the total sample had tested positive for HCV between interviews 
(Table 11, Appendix 20). Another 19 had been diagnosed prior to the first interview. 
These people were all IDUs and represent 39.8 per cent of the 83 people who had ever 
injected. Eleven of these people were also HBV positive.
7.9: Effects of bloodborne viruses on drug use
Some people who had been diagnosed with HBV or HCV had modified their drug use 
behaviours. Consumption of alcohol is known to exacerbate the course of both HBV 
(Okuda and Ohnishi, 1995) and HCV (Wodak and Crofts, 1994b; Okuda and Ohnishi, 
1995). Although 4 of the people I interviewed who were HBV and/or HCV positive at 
the second interview described themselves as having had binges of drinking between 
interviews, and 7 people with some form of hepatitis were heavy drinkers (consuming 
between 30-150 alcoholic beverages a week), some people recently diagnosed had 
reduced their alcohol intake and consumed no more than 20 drinks a week. Many had 
periods when they did not drink at all. One person had stopped drinking altogether 
and 5 people who had been diagnosed with a BBV said they had reduced their alcohol 
consumption because of their diagnosis. Sam, for example, said she had reduced her 
alcohol intake from an average of 20 drinks a week to one a week because “It really 
hurts me, the next day I really feel sick.”
Mishima was one of two people who had entered methadone treatment between 
interviews because of his newly diagnosed HCV. He said “My hep’ C was worsening 
and I was losing weight.” Mishima had also reduced the number of drugs he 
consumed from an average of 15 in the 12 months prior to the first interview to an 
average of 7 between interviews. Three people had stopped their codeine use, one 
person both amphetamine and heroin use, and another person had temporarily stopped 
using heroin because of a diagnosis of hepatitis. James-3 had been using heroin 1 to
10 times a day at the first interview and had dropped his use to monthly use because “I 
was sick with hep’ C.” He had also stopped the use of all other opioids “because they 
all make me feel sick.”
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Five people with a BBV had not injected for 4 months or more at the second interview, 
and said they had “stopped.” The other 43 people with a BBV were all current IDUs. 
Eighteen people with a BBV were presently in treatment at the second interview, and 
they had all reduced or stopped their IDU. Chris was the only person with HCV who 
expressed a desire to commence Interferon.. He had recommenced methadone 
treatment between interviews and had not injected for 10 months. He had also reduced 
his alcohol consumption, from 10 drinks three times a week, to a very occasional drink 
because:
Nine months ago I was told I had hep’ C, so I have to stabilise for 12 
months to get on Interferon. With the baby coming ... I ’ve got bad liver 
problems. I want to stabilise and get rid of my hep’ C, that’s part of the 
bad mistake that’s all in the past.
7.10: Discussion and implications of findings on bloodborne viruses
Most people I interviewed were concerned about BBVs since many had recently been 
tested for HIV and other BBVs. A small number (of the total population I interviewed 
at the first interview) were HIV positive. This is in keeping with other studies of HIV 
in Australian IDUs. By comparison, several people were HBV and/or HCV positive. 
The increase in reports of HCV at the second interview is partly explained by the fact 
that 9 people diagnosed between interviews had entered treatment and had 
consequently been tested. Several people had contracted HBV or HCV and, for some, 
there may be serious health ramifications.
There has been some speculation about the differential spread of BBVs in Australia. 
Referring to a Commonwealth Serum Laboratories and Merck Sharp and Donne report 
of 1990, Antioch and colleagues recount that HBV is “ ... over 100 times more 
infectious than the AIDS virus. Unlike the AIDS virus, its relative stability allows it to 
survive for several days on environmental surfaces” (1993:2).
According to the NHMRC, the variance between the spread of HIV and HCV may be 
explained by much higher carriage rates of HCV than of HIV in IDU populations. The 
authors of this report also point out that “in most situations” smaller amounts of blood 
are necessary to transmit HCV than HIV: “ ... the possibility of transmission by means 
other than the sharing of needles and syringes, such as sharing other equipment or 
environmental contamination is greater” (1997). Crofts believes that part of the reason 
for the dissimilarity of the prevalence of HIV and HCV in Australian IDUs may be
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that much less behaviour change is necessary to control the spread of a low prevalence 
virus (HIV) than a high prevalence virus (HCV) (1994). The increasing rate of HCV 
indicates that hygiene recommendations (such as careful hand washing, particularly if 
injecting others and use of a personal tourniquet) are still not being adhered to and 
even greater effort is required to further educate IDUs about ways of minimising the 
harm associated with their drug use.
As in other surveys of people who use illegal drugs, there was a low rate of 
immunisation for HBV in the people I interviewed, demonstrating a need for more 
rigorous efforts to implement the NHMRC recommendation that all IDUs should be 
fully immunised against this virus.
Until the implementation of the NHMRC recommendation that current IDUs not be 
excluded from Interferon treatment, more treatment options, including supportive 
counselling, are needed to assist IDUs with HCV to stop injecting.
There were fewer reports of HBV and HCV among the people I interviewed than in 
other populations studied. This may be attributed to several factors. Some people 
may have had these viruses but were unaware of them since they had never been 
tested. Forty six people (35 of whom were IDUs) had no history of either drug 
treatment or imprisonment. Both of these interventions are likely to lead to screening 
tests for BBVs. As a consequence of their young age, many people had a short 
duration of injecting. As reported above, there is a correlation between duration of 
IDU and HCV status. Furthermore, by comparison with other samples of IDUs, some 
respondents had low levels of IDU frequency.
Several people had contracted HBV or HCV and, for some, there may be serious 
health ramifications. In response to their diagnosis of a BBV some people had stopped 
injecting and others had reduced their use. The increase in reports of HCV at the 
second interview is partly explained by the fact that 9 people diagnosed between 
interviews had entered treatment and had consequently been tested.
In response to their diagnosis of a BBV, some people had stopped injecting and others 
had reduced their use adding weight to the evidence (reported in Chapter 5) that IDUs 
do demonstrate a concern for their health.
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7.11: Other health problems associated with IDU
In addition to BBVs, there are other health problems associated with IDU. The health 
domain of the OTI included questions on some of these other problems (Appendix 
10:381-382). At the first interview, there was a median score of 1 for these problems 
and at the second interview it was 0 (Z -3.36, p < 0. 005) (Table 12, Appendix 20). 
The reduced frequency of injecting during the month prior to the second interview 
would largely explain this difference.
At the first interview, 16 female IDUs (53.3%) and 10 male IDUs (20.8%) reported 
difficulty with injecting (Table 12, Appendix 20) (Chi2 at 1 df = 8.8, p < 0.005). 
There was also a gender difference with scarring and bruising associated with 
injecting: 10 men (20.8% of male IDUs) and 14 women IDUs (46.7% of female IDUs) 
reported this symptom. These differences led to an overall significant gender 
difference in the total score (Z -3.695, p < 0.001).
The number of people who reported individual problems listed in the OTI (“Overdose; 
Abscesses/Infections; Dirty hit; Prominent scarring/bruising (and) Difficulty 
injecting”) at the second interview was too small to look for significant differences 
between the subsets. Men had a median score of 0 at both interviews whilst women 
had a median score of 1 at the first interview and 0 at the second. Most of the 
improvement in these symptoms, was, therefore, due to changes in women (Z -3.355, 
p = 0.0005). Among women, there were reductions in both difficulty with injecting (Z 
-3.162, p < 0.05) and scarring and bruising (Z -2.496, p = 0.0124). There was no 
significant gender difference at either interview in the number who had injected during 
the month prior to interview, or in their frequency of injecting. These positive health 
changes in women mirror the other health improvements reported in Chapter 6.
The reduction in injection related problems (Table 13, Appendix 20) approached 
significance in both the Oswaldian (Z -2.43, p = 0.0150) and non-Oswaldian (Z 
-2.352, p = 0.0192) subsets and reached significance in the core-Oswaldian subset (Z 
-2.912, p < 0.01) (Table 14, Appendix 20).
7.12: HIV Risk Behaviour Score
Before going on to discuss changes in individual questions related to needle use and 
sexual behaviours, I first present the total HRBS (Appendix 10:381-383) for the 78 
IDUs for whom scores were available. The HRBS consists of 11 items, each with a 
possible score of 5 (0 equals best and 55 equals worst). Each item is concerned with 
risk behaviours in the month prior to interview. There was a median of 7 at the first 
interview and 6 at the second (Figure 7.2). Both medians are lower than the mean
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score of 9 found in the 290 IDUs interviewed by Darke and colleagues during the 
development of the OTI (1991a).
Figure 7.2: HRBS at first and second interview for IDUs
HRBS
First interview
Median 7 
Range 0-24 
Interquartile range 4-9 
(n = 78, 2 missing values)
□  Second interview
Median 6 
Range 0-24
Interquartile range 2-10 
(n = 78,2 missing values)
n people
In their longitudinal survey of 114 clients receiving methadone maintenance, Macleod 
and colleagues found a mean HRBS of 11 at treatment entry. After 6 months of 
treatment, there was a significant reduction in the score to 4 (1996). The subset of 
IDUs I interviewed who entered treatment between interviews had a median HRBS of 
8 (range 3-24, interquartile range 5.3-10.8) at the first interview and 7 at the second 
(range 0-19, interquartile range 3.3-12.8).
At both interviews, most IDUs had an HRBS considered average or below (Table 15, 
Appendix 20). There were more IDUs with a below average HRBS at the second 
interview.
7.13: Needle use risk behaviours
Until the introduction of NEPs in 1987, the sharing of injecting equipment was 
common in the ACT (Whyte et al, 1987; Jardine, 1988). In this section, I look at 
changes in needle use risk behaviours between interviews using results from individual 
questions in the HRBS. As reported by Grund and colleagues, in order to properly 
understand risky needle use behaviours, it is necessary to be aware of the social 
situations in which these behaviours occur (1992). The quantitative findings are 
supplemented by those from the qualitative data, including some accounts of 
accidental needle sharing. I then outline the few reports of the relationship between 
changes in treatment and drug use on injecting behaviours before describing the few 
cases of injecting transitions between interviews.
At the first interview the median HRBS score was 2 for IDUs (range 0-18, 
interquartile range 1-5) out of a possible score of 0 (best) to 30 (worst) for needle use 
behaviours. At the second interview, the median score had dropped to 1 (range 0-17, 
interquartile range 0-4.0). In order to further analyse changes between interviews, I 
looked separately at the score for each question (frequency of injecting is reported in 
Section 7.5). The incidence of using a needle after someone else in the month prior to 
interview remained fairly stable: 11 IDUs (13.6%) at the first interview and 9 (11.4%) 
at the second (Table 16, Appendix 20). These two subsets are, however, largely 
composed of different individuals. Looking at the findings from both interviews, there 
were 19 IDUs (24.1%) with a history of using a needle after someone else in the 
month prior to the two interviews.
Nine of the 11 people who knew that someone had used a needle before them in the 
month prior to the first interview, had used after one other person (Table 17, Appendix 
20). At the second interview, all 9 people had again shared a needle after one other 
person.
Sara had reduced the number of people she shared needles with between interviews. 
At the first interview, she was 16 and had left home because of her father’s violence. 
She and others with whom she shared a “squat” with would sometimes also share their 
needles. Sara explains why she did this:
it doesn ’t really seem to worry me. I know it should, but it doesn ’t. I don’t 
think I would get anything, I dunno why I think that, but even if I did, if I 
got AIDS or something by the time it was full-on, I don’t think it would 
matter by then, anyway. It takes a few years for AIDS to become full-on.
It can lie dormant for years ... I don’t see myself living that long ... I ’ve 
always felt that... just can’t see myself living... to a very old age.
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Sara was fortunate. By the second interview, she had tested negative for HCV, HBV 
and HIV, she had moved out of the “squat” and now confined her needle sharing to her 
boyfriend. Other homeless young people may not have such fortunate outcomes. 
Referring to a 1991 NCADA national household survey, the NDS reports that 62 per 
cent of “street kids” had injected drugs (1994:78). A Sydney study showed an 
association between people who inject drugs in “squats” and high risk behaviours 
(Caplehom and Saunders, 1993). Howard’s research in Sydney demonstrated that 
many homeless young people have, like Sara, escaped from abusive homes and also 
use illegal drugs (1993a and 1993b). Until successful longer-term interventions are 
devised, the prospects are grim for thousands of homeless young people. I return to 
this point in the harm minimisation recommendations in Chapter 9.
Twelve people knew that someone had used their needle after them in the month prior 
to the first interview (Table 18, Appendix 20). Eight had also used a needle after 
someone else within the same period. Eight people knew that someone had used their 
needle after them in the month prior to the second interview. Five of these people had 
also used a needle after someone else within the same period.
Five people who, at the first interview, reported they had used a needle after someone 
else, knew that they were either HBV or HCV positive and, in the month prior to the 
second interview, 3 people with one of these BBVs had used a needle after someone 
else. I have heard anecdotal evidence that, in circumstances where there is only one 
syringe, and more than one person wishing to inject, people with BBVs believe they 
should inject last. Although this is altruistic, many people with existing BBVs 
obviously do not realise that they are susceptible to other strains of the viruses, as well 
as other blood-borne infections.
At the first interview, James-3 was 18 and was estranged from his family. He had 
already been diagnosed with HCV and was injecting up to 10 times a day. In the 
month prior to the first interview he had used a needle after one other person 6-10 
times. Between interviews he had been hospitalised because of his hepatitis and had 
reduced his frequency of injecting. At the second interview, he was no longer 
estranged from his family and had “Stopped sharing ... I gave up getting heroin with 
other people and keep it more of a personal affair and just have my own fit.”
At the first interview, 3 people who had either HBV or HCV knew that someone had 
used a needle after them. A further 5 people diagnosed with HCV between interviews 
had someone use a needle after them in the month prior to the first interview. At the 
second interview, 6 people who knew they had HCV or HBV knew someone had 
shared a needle after them.
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In addition to the 16 people who knew that someone had shared injecting equipment 
before or after them in the month prior to interview, another 21 people had shared in 
the 12 months prior to the first interview. At the second interview, 12 people, in 
addition to the 11 who had shared in the previous month, had shared between 
interviews. Eleven people who had shared between interviews had also shared in the 
12 months prior to the first interview. As evidence of the validity of these data, 
everyone who said they had shared a needle when filling in the OTI also discussed 
their unsafe needle use during the collection of the qualitative data. Other research has 
demonstrated the consistency of self reported HIV risk behaviour among IDUs 
(McElrath et al, 1994), and the validity and reliability of such reports (Gibson and 
Young, 1994).
At both interviews, almost half the sharing had occurred with sexual partners (Table 
19, Appendix 20). Most said something along the lines of Sara: “I know he hasn’t got 
anything.” At the first interview, Aaron described a rare instance of sharing with his 
partner:
About three months ago I shared one. 1 didn ’t have any needles and it was 
about six o ’clock in the morning. It was on my way to work. [And who 
did you share with?] My girlfriend. [And who went first?] She did.
Lyn and Mary were tertiary students in their mid 20’s who had been living together 
for 4 years at their first interviews. At the first interview Lyn said that the last time he 
had shared a syringe was with Mary:
about twelve months ago ...we went to a friend’s place for dinner. I ’d had 
some drugs, and I was taking Mary some, which I took made up in a f i t ...
She went into the toilets at the friend’s house ... and had hers. Then later 
on in the evening I decided I wanted some more, and so I only had that fit 
there, so I just flushed it with water and used it again.
In response to a question about his HCV status, Lyn said he had probably got it 
because “My girlfriend was diagnosed this week.” By the second interview, he too 
had been diagnosed with HCV.
Several people had shared with a friend, as Patrick had done. His is an example of the 
desperate circumstances which lead people to share:
I shared because I ’d gone out and hassled round and got enough fuckin' 
picks, and even got an extra one and there was a lot offuckin ’ round, and 
by the time ... you know, I was hanging out and hadn’t had anything for  
two days. And we got back there and someone had walked off with the 
extra syringes. And I was just, “My God, fuck it” you know, “Give me 
some bleach. ” [So who did you share with?]. Urn, a friend I hadn ’t seen 
for five years. She’s been living (elsewhere), been using for ten years ... 
swears she ’s clean. [So who went first?] She did.
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Other researchers have also found that sharing injecting equipment is rarely random 
but is done with someone known to the respondent (for example, Barnard, 1993; 
Gossop et al, 1994; Loxley et al, 1995; Burt and Stimson, nd).
Some people I interviewed did not, however, know whose syringe they had used. 
Most of these people had done as Snork had done: “I fished them out of the [disposal] 
bin.” Mulch had also taken a syringe out of a disposal bin:
1 think it was about ...a  month-and- a-half ago . . .  but - it wasn't sharing so 
much as . . .  umn V . .  as kind of like . . .  there's a box . . .  of used ones . . .  and 
umn . . .  just - you take one out and . . .  bleach it basically, so I don't know 
who I used with -  who shared it - I shared with . . . .  but umn . . .  I - must 
have shared with someone.
These respondents discussed the ease with which they were able to extract the 
syringes. It would be impossible to design a disposal bin that could not be opened. It 
is obvious that there needs to be greater access to injecting equipment. This could be 
achieved by providing vending machines.
I asked respondents about the frequency of cleaning needles before re-using them in 
the month prior to interview (Table 20, Appendix 20). Most had cleaned their 
syringes before re-using them. At the first interview, 8 of the 19 people who re-used 
did so with their own injecting equipment and, at the second interview, 13 of the 20 
people re-used their own injecting equipment.
Most people who had re-used a needle had cleaned it with bleach every time (Table 
21, Appendix 20). Alison was one who had not. At the first interview she was 17, 
still at school and living at home. She had used several non-injectable drugs before 
starting to inject amphetamine shortly prior to interview. At this time, Alison had 
never shared a needle but said she would even if she could not clean her equipment, if 
the sharing was “with my boyfriend, [or] with someone that I knew really well.” At 
her second interview, Alison had injected the previous night and had shared a syringe 
with her boyfriend (a different boyfriend from the first interview) and cleaned the 
syringe only with water: “Never bleach, never had it there, or placed that much 
importance on it.” Alison had never been tested for any bloodbome viruses.
Marshall Becker has argued that one of the problems of the health promotion 
movement is frequent reversals of advice (1993). This criticism is relevant to the 
health promotion message regarding the 2x2x2 method of cleaning. This involved 
flushing out the syringe twice with cold water, twice with good quality bleach and 
twice again with clean cold water. In 1988, Australia instituted a national education 
program to educate IDUs about this procedure if clean equipment was not available
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(Wolk et al, 1990). Subsequent experiments by Shapsack and colleagues revealed that 
it takes 30 seconds or longer to inactivate HIV-1 by undiluted household bleach 
(1993). According to Wodak, evidence from the USA indicates that those who use 
bleach are just as likely to become infected as those who do not and he speculates that 
even if bleach was effective against HIV it is unlikely to be effective against HBC and 
HCV (1993a).
It is now advocated that if a syringe has to be used again, in an “emergency”, it should 
be first rinsed several times in cold water then filled with fresh high strength bleach 
and shaken for at least 30 seconds. After repeating this procedure, the syringe should 
then be finally rinsed with clean water a few times until all the bleach has gone 
(McPartlan, 1996).
At the second round of interviews, I asked 66 current IDUs if they knew of this new 
method of cleaning. (In addition to excluding the 12 IDUs who said they had 
“stopped” injecting, I excluded the man who was HIV positive and who had never 
shared needles). Twenty three IDUs (34.8%) said they did, indicating only partial 
dissemination of the information at this time.
The incidence of needle sharing among the people I interviewed is lower than in 
samples studied earlier. The ANAIDUS findings show that a third of the 2482 IDUs 
interviewed during 1989 and 1990 had injected with previously used needles and 
syringes in the past day or week (1991). A later study also showed a higher frequency 
of sharing than I found. Thirty one per cent of the 1005 clients of NEPs surveyed by 
MacDonald and colleagues in 1995 reported using a syringe after someone else in the 
month prior to interview. Those who injected more frequently (defined as “once a day 
or more, or more than once a week”) were significantly more likely to report sharing 
than those who injected once a week or less (1997:239). One of the differences 
between my samples and others is that mine included several infrequent injectors.
7.13. i: Accidental needle sharing
The reports of accidental needle sharing from several of the IDUs I interviewed are 
outlined below and they give some impression of the scenarios which place IDUs in 
danger of contracting bloodbome infections.
I first became aware of the possibility of accidental needle sharing when Des, one of 
the first respondents in the first round of interviews, said:
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I ’m in the window period at the moment because of what happened - 1 had 
a disaster and 1 actually used a syringe that I thought was mine - it had 
blood in it - there was a fifty per cent chance that it wasn’t mine and fifty 
per cent chance that the person who I - could have - used it [with was] 
seropositive.
(Des did not present for the second interview but I maintained contact with him for 
several months and his HIV result was negative.)
Des’s comment led me to include the following question in the interview guide: 
“Have you ever been in a situation where you might have accidentally shared a fit?” 
Among all IDUs at the first interview (including those who did not present for the 
second interview), there were 9 definite reports of accidental needle sharing ever 
occurring. At the second interview, 10 people remembered instances when this 
occurred between interviews. I could only find two other reports of accidental needle 
sharing in the literature. McKeganey and Barnard document that “accidental or 
inadvertent” needle sharing occurred “as a result of confusion arising over the 
ownership of injection equipment” among some of the IDUs they interviewed in 
Glasgow (1993:36). Respondents interviewed by Burt and Stimson reported instances 
when “sharing had occurred without their knowledge” (nd:50). Because of these few 
reports I make some mention of the possible importance of accidental needle sharing 
here. (Because questions on accidental needle sharing were included during the 
piloting, there are 5 missing responses for the first interview.)
Kate-2 vividly described the scenario which had led to her picking up the wrong 
injecting equipment:
Urn, well, in a group situation it’s kind of hard if everybody has kind o f ... 
everything’s on the table sort ofthing, and scattered around. I mean, it’s 
a mess.
Brian remembered a recent instance:
a very careless person left her fit near where I had just taken mine out of 
its plastic, I picked up the wrong one and used it. ... that was well over six 
months ago, I got an AIDS test as a consequence ... and I ’ve since been 
informed that person is suffering from ... almost every infectious disease 
known to the human race.
Patrick recalled two recent occasions at the first interview:
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I know two occasions in the last year, once was two weeks ago, where I 
had a shot... he had a shot... I put my needle down in front of me. He 
said, “I'm going to do up the wash. ” He mixed up the wash and shot it 
and then said, “Hey, I just used your needle. ” “Oh, yeah, you did. ” ... and 
then there was another time, you know, nine months ago, where I ’d 
marked my fuckin ’ pick, because we had a pick each, three of us, and 1 
said, “Look, bastard, this is my syringe. Don ’t you use it. ” And he did.
Julie was a very experienced and educated IDU. During my ethnographic work I had 
also alerted her to the possibility of accidental needle sharing. At the second interview 
she said that she might have accidentally shared a syringe with:
someone who was HIV-positive. His mother came into the room ... I didn ’t 
know whose [syringe] was whose. I went into the toilet to inject. I may 
have picked up the wrong fit, didn’t cross my mind until after I ’d hit up.
Other people made statements such as Mishima’s: “I think there’s only once that it’s 
been - like - ‘Oh my God, whose is it?”’ and Steve’s:
Well, that has happened and it has been realised that it’s happened, 
accidentally, yeah ... but you don’t seem to think about... where you’re 
gonna put it in, ‘cos the main thing on your mind is the drug itself.
At the first interview, a further 18 people thought they might have accidentally shared 
needles at some time and at the second interview 3 people said this might have 
occurred between interviews. These people made comments such as: “Yeah, it’s 
possible”; “Yeah ... just thinking of it now, fits everywhere [you’d] maybe pick up ... 
somebody else’s rather than yours”; “maybe ... being a bit ... pissed, I’ve got mixed 
up.
I also asked IDUs: “Do you ever use a fit more than once when other people around 
you are also using?” Some IDUs said they only used alone and some insisted they 
never would re-use . If the response was “Yes”, I then asked: “And how do you know 
which is your fit?” Sixty of all the IDUs interviewed at the first interview, and 33 at 
the second, made responses such as: “I just hang on to my fit” (by, for example, 
putting it in their pocket or handbag). Others used strategies such as marking their 
syringe with their initials, burning the end of the syringe or biting it. Marking 
syringes has also been reported among IDUs in the United Kingdom (McKeganey and 
Barnard, 1993; Burt and Stimson, nd).
I informed respondents that each syringe in brands distributed in the ACT is numbered 
on the hilt from 1-100 and that this might be another way of ensuring they were not 
using someone else’s syringe. I also wrote a brief report of my findings from the first 
interview for the ACT IV League Newsletter (Appendix 21).
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7.13. U: Changes in treatment and drug use and effects on injecting behaviours
The reduction in the use of injectable drugs between interviews obviously led to a 
reduced frequency of injecting. Only Mishima said that a positive effect of his 
methadone treatment was that he was injecting less. One man and one woman who 
had commenced methadone treatment were injecting just methadone and Alexander, 
who had also commenced methadone treatment, had once injected a “cocktail” of 
methadone and amphetamine. Sinead and Snork (who entered treatment for the first 
time between interviews before taking themselves off the Program) said that 
methadone did not “satisfy the craving to inject.”
7.13. Ui: Inje ding transitions
Only 11 people had transitions in modes of administering their drugs between 
interviews and for all 11 this involved injecting (one of these people had also changed 
from smoking cannabis to taking it by mouth). Some began injecting while others 
stopped. Annie had commenced occasional injections of non-prescribed methadone. 
Katie’s amphetamine use had increased between interviews and she had also 
commenced IDU. One of the reasons she stopped again was because she was 
concerned about the “power stuff’ involved with a male workmate injecting her.
Susie, Robin and Annabel had all occasionally used IV amphetamine at the first 
interview, and at the second they had used all it only once and had taken it 
intranasally. Susie was trying to reduce her frequency of use and Robin and Annabel 
had “stopped” injecting. Annabel said: “It’s a hassle when you’re out to find 
somewhere to inject and have to go and get a clean fit.” James-2 had reduced his 
amphetamine use because he felt “really bad coming down” and now usually “snorted” 
it because he was “trying not to inject.” Amelia had stopped injecting codeine at the 
second interview. Since re-entering methadone treatment, she was, however, one of 
the people who was injecting methadone. Drew-2 occasionally used “trips” at both 
interviews. He had injected them once in the 12 months prior to the first interview but 
now only took them by mouth: “It’s a waste of a trip to inject it.”
Emma had recently started occasional IV cocaine use at the first interview. At the 
second interview she had taken it only once and had taken it intranasally because 
“that’s what the others were doing ... I prefer to IV it.” She had also injected “trips” 
for the first time because “I just wanted to try it IV”, and Snork had done the same 
because “I never heard of it before, and someone else was planning to do it that way, 
so I thought I’d just try it.” Alison had previously taken ecstasy only once, by mouth. 
At the second interview she was having “binges” on it and had occasionally taken it 
IV:
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The first time 1 really injected a small amount, but it made me really off 
and 1 discovered that taking them by mouth is better... Shooting was really 
scary ... the hit was such a different thing and you’re not ready for it. I 
took it, and I knew that wasn’t normal, and I fought to stay awake. Taking 
it by mouth just gets rid ofthat awful first bit.
My findings on risky needle use behaviours are in keeping with research from several 
countries which have demonstrated that IDUs have made substantial risk behaviour 
changes in response to the threat of HIV (Stimson, 1992; WHO Collaborative Study 
Group, 1993). The following section summarises the risky behaviours that were still 
occurring in the people I interviewed.
7.13.iv: Discussion of needle use behaviours.
Most people I interviewed did not share syringes and most who had remembered 
specific and rare instances when this had occurred. They then usually followed the 
harm minimisation message of the time by cleaning their injecting equipment with 
bleach. Any reports of needle sharing, are, however, of concern; of particular concern 
were the instances of people using syringes taken from a disposal bin and the reports 
of accidental needle sharing. It is obvious that the battle to encourage IDUs always to 
use new injecting equipment has not yet been won. More IDUs need to be aware of 
the possibility of accidental needle sharing. Some IDUs do re-use their injecting 
equipment and they need to be educated to always have plenty of equipment available 
so they do not have to re-use. They should also be educated not to rely on the efficacy 
of bleach.
7.14: Sexual behaviours
1 begin this section on sexual behaviours with an overview of the sexual orientation of 
the people I interviewed. The results which follow are largely gleaned from the OTI 
questions on sexual risk behaviours. These are part of the HRBS and there is a 
possible total score of 25 for these questions (0 equals best and 25 equals worst) 
(Appendix 10:382-383). Some gender differences were found and these are 
highlighted in the discussion.
At the first interview, 6 women identified themselves as bisexual, one man as gay and
2 men as bisexual. The only change between interviews was that one young woman 
who described herself as heterosexual at the first interview now identified as bisexual. 
When discussing protected sex with respondents, I contextualised it, mainly referring 
to the use of condoms. In the few instances where it was appropriate, I referred to 
dental dams1.
1 Dental dams, also called “lollyes”, were originally developed for use during dental work. They are 
small latex sheets which may be used to cover the genito-anal area during oral and digital sex.
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There was a median sexual risk behaviour score of 3 (range 0-13, interquartile range 0- 
6) at the first interview. At the second interview it had increased to 4 (range 0-12, 
interquartile range 2-6). In order to investigate which particular behaviours had 
contributed to this increase I went on to separately analyse the individual questions in 
this domain.
Much of the increase was due to more people being sexually active. At the second 
interview, 9 more people had a sexual partner than at the first (Table 22, Appendix 
20). In the month prior to their interviews, identical proportions of heroin users and 
non-heroin users reported they had sex with other people. The WHO Collaborative 
Study Group findings also challenge the stereotypically held view that drug users who 
take depressants (such as opioids) are less sexually active than other people, since their 
respondents “were at least as sexually active as their peers in the general population of 
Great Britain and Northern Ireland” (1993:30).
Following a review of the available literature, the US Department of Health and 
Human Services concludes that “ ... latex condoms are highly effective for preventing 
HIV infection and other STDs when used consistently and correctly” (1993:590). In 
the month prior to both interviews, very few people of the people I interviewed used a 
condom every time they had sex with a regular partner. (Table 23, Appendix 20). At 
the second interview, more people reported having a regular partner, and more 
reported never using a condom. There was an increase in women’s median sexual risk 
score from 1 at the first interview to 3 at the second (Z -3.502, p < 0.001). The 
increase in the number of people who did not use a condom during the month prior to 
the second interview is associated with more people being sexually active. This is 
compatible with the findings (reported in Chapter 6) that more people were in a 
relationship at this time, and that more women than men had entered into new 
relationships. At the second interview, 39.5 per cent of women (n=15) compared to 22 
per cent of men (n=13) never used condoms with their regular sexual partners (Z 
-2.705, p < 0.01). These women were, therefore, more at risk from their sexual 
behaviours than the men. Though the proportion of women not using condoms had 
significantly increased between interviews, significantly fewer women had an HIV test 
between interviews (reported in Section 7.6.i) because of risky sexual behaviours.
The Oswaldians (Table 24, Appendix 20) tended to use condoms less frequently at the 
second interview than at the first (Z -2.892, p < 0.005).
Eighteen people at the first interview and 17 at the second had sex with a casual 
partner in the month prior to interview (Table 25, Appendix 20). Only 8 people at the
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first interview, and 10 at the second, used condoms all the time with these partners. 
Few people reported anal sex in the month prior to either interview (Table 26, 
Appendix 20).
7.14J: Discussion of sexual behaviours
Several previous studies have shown that unprotected sex remains common among 
drug users (for example, Darke et al, 1990; ANAIDUS, 1991; Liebman et al, 1992; 
Howard, 1993b; McKeganey and Barnard, 1993; WHO Collaborative Study Group, 
1993; Loxley et al, 1995; Rhodes and Quirk, 1995; Dinwiddie et al, 1996; Quirk and 
Rhodes, 1996). According to Rhodes and colleagues, most studies of IDUs show 
levels of condom use to be comparable to the general heterosexual population (1996). 
Quirk and Rhodes maintain that unprotected sex is still generally seen to be “normal 
heterosexual behaviour” (italics original) especially in long term relationships. These 
authors’ findings also shed some light on why condoms are not used among IDUs. 
Half their sample of a 1988 survey of 325 “street” IDUs believed that condoms are not 
completely effective and therefore not worth using (1996:227). Barnard and Frisher 
also investigated condom use among IDUs. Their respondents saw condoms as a 
temporary measure associated with one-off sexual encounters, rather than with stable 
long term relationships (1995).
The number of women infected with HIV through heterosexual intercourse in most 
Western countries is much greater than the number of men so infected (Gold et al, 
1989; Henderson, 1990; Booth and Watters, 1992; Richters, 1993). This may, in part, 
be attributed to anatomical features, since women’s genitalia are more likely than 
men’s to be abraded during heterosexual intercourse. In addition, there are much 
larger concentrations of HIV in semen than in vaginal and cervical secretions (Segal, 
1987). Data from the USA show a much larger proportion of women than men who 
have contracted HIV via sex with an IDU (WHO and CDC, 1991). There are also 
important social structural factors to consider. In its White Paper on HIV/AIDS, the 
CDCSH recognised that there are specific issues affecting women, such as the gender 
power differential and social stereotyping that impede negotiations for safer sex and 
safer drug taking (1989).
The low incidence of condom use among the women I interviewed is, therefore, of 
particular concern. Not only are they at risk of sexually acquiring HIV, they are at risk 
of other STDs, some of which, if untreated, may lead to infertility; and, if no other 
contraception is used, women also carry the burden of unplanned pregnancies. Wyn 
reports a low level of knowledge about STDs and their ramifications as well as poor 
knowledge about safer sex practices among the 95 young women she surveyed in 
Melbourne (1994). A society which generally allocates responsibility for
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contraception to women, yet labels them if they are seen as being sexually available 
(in this context, by carrying condoms) places them in a difficult position (McKeganey 
and Barnard, 1993; Abbott, nd). A woman may resolve this difficulty by using the 
less obvious contraceptive pill, thus obeying the first part of society’s dictum. This 
contraceptive pill may prevent her from conceiving, and also help protect her from 
society’s approbation, but it will not protect her from HIV and other STDs.
7.15: Commercial sex
The proportion of people who were either paid for sex, or who had paid for sex, was 
low in my sample. The OTI sexual risk score included a question on condom use for 
respondents who had been paid for sex in the preceding month. At the first interview, 
no one had been paid for sex during this timespan, and at the second two women had. 
Both had always used condoms. The interview guide I developed also included 
questions, which covered a longer timespan, on whether people had either paid for sex 
or been paid for sex. Four women (10.5%) had been paid for sex during the 12 months 
prior to the first interview. One woman had worked legally, and three illegally, as 
prostitutes. One man described 4 of his sexual partners as people who “pay me 
regularly with drugs”, but at the second interview he did not describe any sexual 
partners in this way. All 5 of these people were current IDUs (6.6% of current IDUs, 
5.2% of the total sample).
Three of these women did not do any sex work between interviews. Another had 
returned to sex work and another had commenced sex work. Between interviews, one 
young man had once been coerced into performing oral sex on an older man for 
money.
In the ANAIDUS research, 8.4 per cent of men and 15.0 per cent of women reported 
that “these days” they were paid for sex (including “not only money, but “food, drugs 
or shelter etc”) (1991:77). Other researchers have also noted that female IDUs are 
more likely to be involved in sex work than males (for example, Gossop et al, 1993; 
Booth et al, 1995).
Six of the men I interviewed (7.5%) had been sex industry clients in the 12 months 
prior to the first interview. Another man had paid for sex once between interviews. 
The ANAIDUS survey found that 11.7 per cent of male respondents and 2.7 per cent 
of female respondents had paid for sex (including payments other than money) (1991).
Both the ANAIDUS study and my study were looking at recent involvement in sex 
work. Some overseas studies have shown rather higher rates of ever being paid for
sex. Drucker, for example, reports that 50 per cent of women IDUs in New York have 
at some time been paid for sex (1986).
7.16: Genital health
Before concluding the chapter, I present a brief discussion on the genital health of the 
people I interviewed. The OTI health domain has 4 questions about genitourinary 
symptoms experienced by women or men in the month prior to interview (Appendix 
10:391). There were an additional two questions for women, related to a history of 
irregular periods and miscarriages “in the last few months” (Appendix 10:391). The 
questionnaire I developed included questions on STDs. Both questionnaires yielded 
information on genital health revealing fairly high numbers of people experiencing 
some problems.
At the first interview, 26 people (27.4%) had experienced a loss of libido and 21 
(22.1%) reported this problem at the second interview (Table 27, Appendix 20). The 
gender proportions were similar at both interviews. Only small numbers of people had 
recently experienced any other genitourinary problems.
There is an elevated risk of gynaecological problems for women who use drugs 
(Mondanoro, 1987), including women in methadone treatment (Rosenbaum and 
Murphy, 1987). At the first interview, more than half the women (n=20, 54.1%) said 
they had irregular periods and two (5.4%) had experienced a miscarriage. There was 
no improvement at the second interview when 18 women (48.6%) reported irregular 
periods and three women (8.1%) had experienced a miscarriage.
STDs are commonly reported by IDUs (Morlet et al, 1990; Trapido et al, 1990; Ross et 
al, 1991; Chetwynd et al, 1993; Ross et al, 1993c). If untreated, the ramifications of 
STDs and genital erosions are damaging enough, but they are also important cofactors 
in the transmission of HIV (Sparling and Aral, 1991). Twenty two of the people 
(22.7%) I interviewed believed they had contracted an STD during the 12 months prior 
to the first interview (15 women, 39.5 per cent; 7 men, 11.9%). At the second 
interview, 13 people (13.4%) believed they had contracted an STD since the previous 
interview, (3 men, 5.1%; 10 women, 26.3%). There are, however, reasons to question 
some of these self reports (see Table 28 in Appendix 20). As a consequence, it is not 
possible to give a definitive picture of the prevalence of STDs among the people I 
interviewed. If all questionable reports are discarded, there may have been as few as 6 
people (6.2%) who had contracted an STD in the 12 months prior to the first interview 
and as few as 5 (5.2%) between interviews.
Other Australian researchers have noted that self reports of STDs “must be interpreted 
cautiously” (Ross et al, 1991:34). Following a later study, however, Ross, Wodak, and 
Gold reported that their analyses suggest that “Self reports of STDs in IDUs are likely 
to be relatively reliable” (1993c: 148). My experience suggests that self reports of 
STDs do require careful interpretation1.
Making comparisons between the reports of STDs in my sample and the national 
population also posed difficulties since the collection of data on many STDs is not 
standardised in Australia (Garland et al, 1993; Hargreaves et al, 1995).
Eight women (21.0%) reported an abnormal Pap smear during the 12 months prior to 
the first interview. Three of these abnormal results resulted in the women needing 
laser treatment. At the first interview, I asked women only if they had an abnormal 
Pap smear but at the second interview I also asked if they had had a Pap smear taken. 
Between interviews, a majority of 31 women (81.6%) had a Pap smear. This is a 
much higher proportion than in the general ACT population for the financial year 
1989-90, when just 44 per cent had the test (Kavanagh, 1994). In addition, as 
Kavanagh points out, this was a time when the ACT was running a Pap smear 
campaign which may have led to a higher than usual number of women being tested. 
Looking only at the age bracket for those ACT women whose ages paralleled those of 
the women in my sample (17-35) who had a Pap smear, the percentage was somewhat 
lower for women aged 15-24 (33.%) but higher for those aged 25-34 (54.1%) 
(Kavanagh, 1994). Some of the women in my sample may have had their Pap smears 
taken outside of the ACT, but since ACT Pap smear rates appear to be slightly higher 
than in other States and Territories in Australia (Kavanagh, 1994), this should not 
influence the finding that the rate of Pap smears among the women in my sample is 
higher than that in the general population of women.
Most of the women in my sample who had Pap smears between interviews said they 
were normal, but 8 reported abnormal findings and 3 had also had abnormal results at 
the first interview. One had required laser treatment, as well as a biopsy and a cone 
biopsy, between interviews. The other women were advised by their physician to have 
a repeat test.
According to Shah, “most studies have shown that the Human Papilloma Virus (HPV) 
is recovered from a majority but not all cases of cervical cancer.” Shah goes on to 
point out that only a small number of women diagnosed with HPV go on to develop 
invasive carcinoma of the cervix (1992). Three women at the first interview and one
1 I am grateful to Dr David Plummer (a venereologist) for checking these self reports of STDs and 
indicating which were questionable.
at the second named HPV as the causative organism for their abnormal result. 
Although this virus is known to be a common cause of abnormal cervical cells 
(Franco, 1992), there are other organisms which may also lead to cervicitis (NHMRC, 
1990). There may also be idiosyncratic causes such as that reported by one woman I 
interviewed who was told her abnormal Pap smear was due to an “hormonal cyst.” An 
“Abnormal Pap smear” is not, therefore, necessarily a diagnosis of HPV.
Despite these qualifications, the incidence of abnormal Pap smears in such a young 
cohort of women is of concern. As reported in Section 7.14, many women were not 
practising safe sex. The abnormal Pap smears may also be linked with the high 
prevalence of tobacco smoking. Many women had been concerned enough about their 
genital health to have a Pap smear. Health professionals in contact with women at this 
time might feel it useful to build on this existing concern and spend some time 
discussing the need to use condoms and strategies of negotiating safe sex.
7.17: Conclusion
Australia has been very successful in preventing an epidemic of HIV among IDUs. As 
Wodak noted as early as 1990, a major problem of such success, for both IDUs and 
policymakers, is complacency. We have now reached the situation where both HBV 
and HCV have become serious public health problems in the IDU community. Future 
education programs aimed at people who use illegal drugs in particular, and also the 
wider community, should incorporate the complete armoury of potential hazards of 
unsafe behaviours. Generally, the potential consequences of HBV and HCV and 
STDs such as chlamydia and HPV are poorly understood. Educating everyone about 
these consequences and, therefore, the need to protect themselves against the 
transmission of such diseases, as well as the transmission of HIV and unplanned 
pregnancies, may help overcome future problems of complacency.
Several other commentators (for example, Dorus et al, 1991; Wodak, 1993b; Power, 
1994; Crofts and Herkt, 1995) have emphasised the importance of education and the 
ways in which peer groups have been involved in disseminating the information. In 
order to continue these initiatives, it is essential that peer groups be provided with 
sufficient funding to continue their work.
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CHAPTER 8: CRIMINAL BEHAVIOURS
8.1: Introduction
In contrast to at least 4000 years of people using drugs, legal restrictions have occurred 
relatively recently, largely during this century (Whitlock, 1975; Carney, 1987). Since 
these restrictions have been in place, it has been documented clearly from research 
both overseas (for example, Shaffer et al, 1985; Faupel and Klockars, 1987; 
Hammersley and Morrison, 1987; Inciardi et al, 1993), and from Australia (for 
example, Wardlaw, 1978; Lee et al, 1988; Dobinson and Poletti), that a link exists 
between illegal drug use and other criminal activities. As Wardlaw notes, the problem 
with many of these studies is that they were based on people who were either in 
treatment for their drug use, or already incarcerated for their criminal behaviours 
(1983). Some researchers have found that the people they studied who use illegal 
drugs were either only marginally involved in other crime. For example, in a study 
conducted of 223 people who use illegal drugs in an “open drug scene” in Zurich, 
Fuchs and Grob found that 66 per cent of these people were not involved in any type 
of other criminal behaviour (1995). Likewise, Zinberg and Jacobson found that none 
of the “controlled” heroin users they studied were involved with other illegal activities 
(1976).
The purpose of this chapter is to describe the criminal histories of the people I 
interviewed and to see how they compared with these other studies. Initially, I had set 
out to access as many people as possible without a prior history of treatment or 
imprisonment. To assess if I had been successful, I wanted to examine the criminal 
careers of the people I interviewed and then ascertain whether any changes occurred 
between interviews. In addition, when I conducted the 1989 interviews for my 
Honours Thesis (Dance, 1989), I found that the Oswaldians had a history of non-drug 
as well as drug-related criminal activity. Both drug and non-drug crime had resulted 
in a very low penalty rate and I wanted to investigate what happened with the 
Oswaldians’ criminal behaviours over time and see how they compared with other 
Canberra-based people who use illegal drugs. I also wanted to assess the 
stereotypic ally held view that people who use illegal drugs are dangerous and violent.
I begin this penultimate chapter by presenting a brief description of the data collection 
on criminal behaviours (when I use the terms “crime/criminal behaviours/activities” 
this means in addition to the crime of using illegal drugs). I then give an overview of 
the total number of crimes ever committed before discussing individual crimes. I deal 
briefly with the findings for apprehensions for particular crimes in their relevant 
sections. At the end of the criminal histories, I also summarise all the findings on 
apprehensions according to their outcomes. When asking people about their sources
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of income, I also asked about illegal income; and I present a brief description of this 
income before going on to discuss the relationship between criminal behaviours and 
changes in treatment and drug use.
8.2: Data collection on criminal behaviours
The results for crimes committed in the month prior to interview were obtained from 
the Criminal Domain in the OTI which contains questions related to property crimes, 
drug dealing, fraud and crimes involving violence (Appendix 10:387-389). There is a 
possible range of scores from 0 (best) to 16 (worst). The OTI does not seek to find the 
raw number of crimes committed but seeks to ascertain a coded frequency and then a 
total score is obtained for criminal behaviours. These findings are augmented by a 
fuller history gleaned from the questionnaire I developed. This contained questions on 
crimes ever committed and current criminal behaviours. I also asked participants if 
they had ever been apprehended and, if so, what the outcome was. I did not request 
qualitative data on criminal activities, but a few people volunteered some information 
and their quotes are interspersed with the quantitative findings.
When asking about drug dealing at the first interview, I asked respondents how many 
days they had dealt drugs in the previous 12 months and, if they replied “every day”, I 
recorded this as 365. At the second interview, I asked how many days drugs had been 
dealt between interviews and, if there was a response of “every day”, I calculated how 
many days there had been between interviews and recorded this number. For all other 
crimes committed, I asked for a raw number. When asked about crimes ever 
committed, some people said they had perpetrated a particular crime a thousand or 
more times and I recorded this as >1 000. Some of the numbers are, therefore, fairly 
rough approximations of the numbers of crimes committed. They do, however, give 
some indication of the criminal behaviours of the people I interviewed.
8.3: OTI score and summary of all criminal behaviours
There was a low median OTI score of 1 at both interviews (Figure 8.1). These 
medians are the same as the mean of 1 which Darke and colleagues found among the 
opioid users they interviewed during the development of the OTI (1991a).
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Figure 8.1: Distribution of OTI scores for criminal behaviours at first 
and second interview
Scores for 
criminal 
behaviour
I  First interview
Median 1 
Range 0-7
Interquartile range 0-3
□  Second interview
Median 1 
Range 0-6
Interquartile range 0-2
n people
I looked separately at the IDUs I interviewed and found they also had a median score 
of 1 at both interviews with very little deviation in the ranges (0-7 at the first interview 
and 0-6 at the second interview) and interquartile ranges (0-2.8 at the first interview 
and 0-2 at the second interview).
Most people had an OTI level of dysfunction score considered to be low or below 
average in the month prior to both interviews (Table 1, Appendix 22). At the first 
interview, 38 people (41.8%) had committed no crime in the month prior to interview. 
Twenty (21.9%) had a high OTI level of dysfunction. At the second interview the 
number of people who had committed no crime had increased to 45 (49.5%). The 
number of people with a high score had decreased to 11 (12.1%).
Nearly everyone had, at some time, perpetrated some criminal act (at the first 
interview n=85, 93.4%, at the second interview n=88, 96.7%) (Table 2, Appendix 22). 
A median number of 200 other crimes had ever been committed at the first interview. 
This had increased to 300 by the time of the second interview. In the 12 months 
before the first interview, 71 people (78.0%) had been involved in crime and a median 
number of 50 crimes had been perpetrated. Eight fewer people had committed a crime 
during the period between interviews. This timespan was generally longer (median
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18.3 months, range 11-21 months) than the 12 month timespan for which data were 
collected at the first interview. In addition, a lower median of 38 crimes had been 
committed between interviews than in the 12 months before the first interview.
8.4: Drug-related crimes
In this section on drug-related crime, I also briefly mention the number of people who 
had been apprehended for using illegal drugs. Apart from asking about prescription 
pad fraud in the month prior to interview (as part of the OTI), I did not specifically ask 
people about other offences related to drug use. Some people did, however, offer 
information about alcohol-related and miscellaneous drug crimes. Several people who 
mentioned these crimes had been apprehended. They would probably have had a more 
vivid recall of their offences than people who had not. I, therefore, only briefly 
describe them since they are almost certainly underestimations.
8.4.i: Illegal drug dealing
At the first interview, most people (n=70, 76.9%) had ever dealt illegal drugs. (Table 
3, Appendix 22). (This includes a few people who had dealt prescription drugs in the 
month prior to interview but for the sake of convenience I use the term “illegal drugs” 
rather than “dealing drugs illegally.”) Four people had sold illegal drugs for the first 
time by the second interview, when there were then 74 people who had ever dealt 
(81.3%). At the first interview, there was a median number of at least 100 days of ever 
selling illegal drugs. This number had increased to 200 by the second interview.
Fewer people had sold illegal drugs between interviews (n=42, 46.2%) than in the 12 
months preceding the first interview (n=55, 60.4%). At both interviews, there were a 
median of 50 days when people had perpetrated this crime. The majority of 
respondents had not dealt in the month prior to either interview, and most who had, did 
so on a less than daily basis.
The OTI contained questions on types of illegal drugs sold during the month prior to 
interview (Table 4, Appendix 22). At the first interview, heroin was the drug most 
commonly sold during this timespan (n=20, 22.0%). In the month prior to the second 
interview, 20 people had sold marijuana and 6 fewer people had sold heroin. At both 
interviews, only a few people had sold any other illegal drugs.
Among the people they interviewed receiving opioid treatment, Anglin and colleagues 
found that more men than women had dealt drugs (1987b). My study found a similar 
gender difference. Twenty five women (69.4%) and 45 men (81.8%) had ever dealt 
drugs at the first interview. Between interviews, 2 men and 2 women had dealt for the 
first time resulting in a similar gender differential at the second interview (75% of
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women and 85.5% of men) but these differences were not significant. The gender 
differential for more recent dealing was similar. In the 12 months prior to the first 
interview 20 women (55.6%) and 35 men (64.8%) had dealt drugs. Between 
interviews 14 women (38.9%) and 28 men (50.9%) had dealt drugs. There were also 
no significant gender differences either in the frequency of dealing, or in the types of 
drugs dealt during the month prior to either interview.
Ten people at the first interview (14.3% of those who had ever dealt) had a history of 
being apprehended for dealing drugs illegally and 12 people (12.5% of the total 
sample) had ever been apprehended for illegal drug use. Four apprehensions had 
resulted in a period of incarceration. Between interviews, two people had once been 
apprehended for dealing illegal drugs.
8.4. ii: Other drug-related offences
Twelve people at the first interview and 15 at the second said they had ever engaged in 
an alcohol-related offence (Table 5, Appendix 22; the figures in Table 5 total more 
than 12 and 15 respectively, because some people committed more than one alcohol- 
related offence). Most crimes remembered were driving under the influence (DUI) of 
alcohol: 7 people at the first interview, and 2 different people between interviews had 
been apprehended for this offence. Trevor and Rafe, two core-Oswaldians, had each 
been placed in a police cell for a short period of time for being drunk and disorderly. 
Most of the other people who recalled other alcohol-related offences had also been 
apprehended.
A few people mentioned miscellaneous drug crimes, mostly related to marijuana, or 
prescription pad crimes (such as theft or forgery) (Table 6, Appendix 22). As with 
alcohol-related offences, many of the other people who remembered these crimes had 
also been apprehended.
8.5: Property crime
Most people had a history of perpetrating property crime (n=69, 72.6% at the first 
interview; n=71, 74.7% at the second interview) (Table 7, Appendix 22). The median 
number of property crimes ever committed at the first interview was 20. This slightly 
increased to 22 with the passing of time between interviews. Fewer people had 
committed a property crime between interviews (n=31, 32.6%) than in the 12 months 
prior to the first interview (n=45, 47.4%). A median number of 10 crimes was 
committed both in the 12 months leading up to the first interview and during the 
period between interviews.
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James-2, who had committed 12 property crimes during the 12 months prior to the first 
interview, but none between interviews, offered some insight into why he had stopped: 
“When you’ve got your own place you realise people have worked hard for their TV. 
And I didn’t want to go to prison.”
8.5.i: Shop stealing
Most people who had been involved in property crime had stolen from shops. At the 
first interview, 51 people (54.3%) reported ever committing this crime and by the 
second interview this number had increased to 56 (59.6%) (Table 8, Appendix 22). 
Fourteen fewer people had stolen from shops between interviews than in the 12 
months preceding the first interview. This explains much of the reduced overall 
incidence of property crime at the second interview. Only Theresa commented on why 
she stole from shops when she said “My children wouldn’t have clothes otherwise.”
Fifteen people at the first interview had ever been apprehended for stealing from shops 
and another two people were apprehended between interviews. These charges were all 
dealt with leniently.
8.5.ii: Breaking, entering and stealing
At both interviews, 19 people (20.2%) had ever been involved with breaking, entering 
and stealing (BES) and they had committed 1-12 of these crimes (Table 9, Appendix 
22). In the 12 months prior to the first interview, 5 people, 3 of whom had been 
involved with BES during the month prior to interview, had committed between 1 to 3 
of these crimes. In the period between interviews, no one had done any BES.
8.5.Hi: Robbery
Fifteen people (16.6%) at the first interview and 18 (19.1%) at the second had ever 
committed an act of robbery (Table 9, Appendix 22). Most had committed 1-50 of 
these offences. Eight people (8.5%) had robbed in the 12 months prior to the first 
interview and 3 (4.2%) had robbed in the period between interviews.
8.5.iv: Receiving stolen goods
At the first interview, 17 people (18.1%) had a history of receiving stolen goods 
(Table 9, Appendix 22). The number had increased to 19 (20.2%) by the time of the 
second interview. At both interviews, most people gave a history of receiving stolen 
goods on 10 or less occasions. Nine people had received stolen goods in the 12 
months leading up to the first interview. In the period between interviews, the only 
people who had received stolen goods were the two people who had never done so 
before.
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Eight people at the first interview gave a history of being apprehended for these 
property crimes (other than stealing from shops) and the sentences ranged from fines 
to police warnings. No one was apprehended for these crimes between interviews.
8.6: Fraud
The discussion on fraud is brief because I am not confident of the numbers of people 
involved for types of fraud. This is a fault of my data collection since with 4 people at 
the first interview, and 7 at the second, I documented only “fraud” rather than the type 
perpetrated. At the first interview, a minority of 29 people (30.5%) had ever engaged 
in an act of fraud (Table 10, Appendix 22). By the second interview, 8 people had 
been involved in fraud for the first time. At both interviews, most people had a history 
of committing 10 or less frauds. Both in the 12 months preceding the first interview, 
and in the period between interviews, 19 people (20.0%) had perpetrated an act of 
fraud. The fraud most frequently reported was Social Security fraud. Twelve people 
at the first interview (11 of them in the 12 months prior to interview), and 14 at the 
second, said they had ever committed this type of fraud (Table 11, Appendix 22). The 
numbers are smaller at the second interview but this may be a fault of my data 
collection. Three people had ever been apprehended for fraud at the time of the first 
interview. Another 3 were apprehended between interviews. Everyone had received 
minor penalties.
8.7: Assaults
Only 8 people (8.4%) (all of whom were men) had a history of committing an assault 
(Table 12, Appendix 22). At the first interview, 2 men said they had ever committed a 
“violent crime” and at the second 2 men said they had assaulted someone between 
interviews. I chose not to pursue what type of violence this involved. At the first 
interview, another man had been involved in fights, and one had assaulted police at a 
demonstration. At the second interview, Daryl, who did not want to talk about his 
history of violent crime at the first interview (and whose history is not included in 
Table 12) said that he had been involved in “two way domestic violence about 20 
times” between interviews. Because he had “been up all night speeding” at the second 
interview, Daryl was extremely garrulous. This may have led him to be more 
forthcoming about the assaults he had perpetrated.
Two men, both in the period before the first interview, had been apprehended for 
assault. One man had been imprisoned and the other man had received a good 
behaviour bond. It is possible that the numbers of reported assaults is small because 
people did not wish to talk about such events. I also confess to feeling rather uneasy 
about asking people, particularly men, about violent crimes when I was alone with 
them, often in a secluded place late at night. Many of the drugs used by the people I
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interviewed, such as opioids and cannabis, have tranquillising properties and research 
on drugs and violence suggests that there is no pharmacological reason for such drugs 
to precipitate violence (National Committee on Violence, 1990). Alcohol (Brady, 
1983; Miller, 1990; National Committee on Violence, 1990; Homel et al, 1992), 
amphetamine (Wardlaw, 1978; National Committee on Violence, 1990; Hall and 
Hando, 1994), volatile substances (National Committee on Violence, 1990) and, 
particularly in the USA, cocaine (Brody, 1990) and “crack” cocaine (De La Rosa et al, 
1990) are, however, known to stimulate acts of violence.
Little has changed since 1978 when Wardlaw wrote: “Reports frequently appear in the 
media suggesting that drug users are responsible for many crimes of violence.” He 
went on to point out that this belief is not supported by most studies. It is probable, 
therefore, that the low incidence of assault reported among the people I interviewed is 
a reality rather than due to them not wishing to disclose this type of crime.
8.8: Miscellaneous crimes
A variety of miscellaneous crimes were reported (Table 13, Appendix 22). Other than 
requests for information about sex work, I gave no prompts for these crimes. No more 
than 5 people said they had committed any of these acts. It is probable that this is an 
under-estimation of the number of people involved. As with the miscellaneous drug 
crimes listed above, these offences were most often remembered by people who had 
been apprehended for them. Six people at the first interview and one person between 
interviews had such a history. Most crimes were dealt with leniently but the traffic 
offence committed by James-3, who was driving an unregistered car, and who said he 
was also “really wasted” (that is, on drugs and therefore guilty of dangerous or 
culpable driving), had resulted in a two day period of detention in a police cell.
8.9: Apprehensions for illegal activities
At the first interview, 46 people (48.9%) had ever been apprehended for illegal 
activities (Table 14, Appendix 22). Twelve people (12.8%) were apprehended 
between interviews, 6 for the first time. This is a lower proportion than found in the 
ACT DIP where in the quarter from July to September 1988, for example, 71.2 per 
cent of the drug treatment and welfare clients had a prior criminal record. It is, 
however, a higher proportion than the drug arrestees surveyed in the ACT DIP study 
where 39.7 per cent had a prior criminal record (Lee et al, 1988).
A greater proportion of men (63.2%, n=36) than women (43.2%, n=16) I interviewed 
had ever been apprehended by the second interview. Although this difference was not 
significant, I make some comment in the light of the fact that women had committed 
similar numbers of crime (median 300, range 3->l 000, interquartile range 71.8->-
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737.5) to men (median 280, range 1->1 000, interquartile range 69->l 000). Other 
Australian research has found a similar discrepancy in arrest rates (Stevens and 
Wardlaw, 1994). Stevens and Wardlaw go on to discuss possible reasons for this 
discrepancy including the “chivalry hypothesis.” According to this hypothesis, law 
enforcement officers are reluctant to report and punish women for their crimes 
(1994:34). As Stevens and Wardlaw go on to point out, this does not work in favour 
of all women since:
Punishment for women is influenced by the behaviour and characteristics 
of the woman and by the type of misdemeanour or crime. Women who 
conform to a supposedly feminine stereotype (quiet, cooperative, 
respectable) are less likely to be charged and punished than women who 
are loud argumentative, aggressive and violate the standards of  *good ’ 
womanhood (1994:35).
It is possible that the “chivalry hypothesis” may account for the gender differential in 
the apprehension rates of the people I interviewed but this issue requires further 
investigation.
Of the 52 people ever apprehended by the time of the second interview, 23 were 
Oswaldians (57.5% of Oswaldians) and 29 were non-Oswaldians (50.9%). Among the 
core-Oswaldians, 53.8 per cent (n=14) had been apprehended compared to 53.5% of 
the Remainder subset (n=38) (definitions of the subsets are included in Table 2 in 
Appendix 4). Most people who had been apprehended had received minor sentences 
(Table 15, Appendix 22).
Of major concern is the evidence from other researchers that many IDUs continue to 
inject in prison and since they do not have access to clean injecting equipment, this 
environment provides optimal circumstances for the spread of BBVs (for example, 
Douglas, 1990; Dwyer, 1990; Gaughwin, 1990; Crofts et al, 1995).
Only 9 participants in my study had a history of imprisonment: 8 men and one 
woman1 (Table 16, Appendix 22), and this may explain their relatively low rate of 
HBV and HCV relative to other studies. In addition, most people had been 
incarcerated for only a short period of time. Six men been incarcerated for 10 days or 
less. Apart from acknowledging that he had been in prison five times, once for 6 
months for a “violent crime”, one man did not want to give further details of his
1 It is possible that the man who chose not to discuss his history of violent crime at the first interview 
had been imprisoned but, given his professional career at the time, I consider this to be unlikely. 
There were also 6 missing values (due to inadequate information about whether or not these people 
had ever been apprehended ) and it is possible that some of these people had been imprisoned. Given 
the outcomes for the other apprehensions for the offences these people had committed (3 illegal drug 
use, 2 shop stealing, one BES), I also think this is improbable.
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incarceration. Six people with a history of incarceration were current IDUs. Four had 
also spent some time in drug treatment. The woman was one of 4 core-Oswaldians 
who had been incarcerated. She had been remanded in custody and was obviously 
embarrassed and concerned about this remand, especially since her partner was still in 
prison, and she was in the middle of a three year suspended jail sentence. I did not 
press her for further details.
Only one person had sex with another person whilst imprisoned and they did not have 
access to condoms. This person was also the only respondent to have injected whilst 
in prison. No needle sharing had occurred1.
No one who was reinterviewed had been imprisoned between interviews. It is 
possible, but not, I believe likely, that the woman who did not want to talk about her 
criminal history at the second interview had been imprisoned. For some people the 
reason for non-attendance at the second interview may have been that they were in 
prison. Only 5 of these people had a history of incarceration. A further 2 were facing 
charges. I followed the local press but can not confirm that these people, or any of the 
other people who did not present for the second interview, had been imprisoned. 
Given the few people who did have such a history, and also given their significantly 
younger age (in comparison to those who did go on to present for the second 
interview), it is unlikely that imprisonment offers much of the explanation for the 
attrition rate at the second interview.
Only 10 per cent of the 80 people who had ever injected at the first interview had a 
history of incarceration. Other Australian research has shown that between 35.6 to 
55.9 per cent of IDUs have a history of incarceration (ANAIDUS, 1991; Dyer et al, 
1992; Loxley et al, 1995; Dobinson and Poletti, nd). Crofts and colleagues found that 
in a 12 month period during 1991-1992, 46 per cent of 3627 prison entrants in Victoria 
(Australia) had a history of IDU (1995). According to Wodak and Des Jarlais, such 
high proportions are not restricted to Australia. They believe that “Almost 50 per cent 
of IDUs in most countries are likely to have spent some time in prison” (1993:48). In 
an analysis of the ANAIDUS data which examined differences between IDUs never in 
treatment, presently in treatment and previously in treatment, Ross and colleagues 
found that those who were never in treatment were less likely to have been imprisoned 
(1993b). There were several IDUs in my sample without a treatment history and this 
may explain their low incidence of incarceration.
1 Another 2 people who were interviewed only once had also used needles in prison. One woman, who 
knew she was HIV-positive at that time, had shared a needle with 15 other women and she said “I got 
bleach from a friendly nurse.”
8.10: Illegal income
Previous research has demonstrated a link between the use of illegal drugs and 
illegally acquired income (Nurco et al, 1981b; Collins et al, 1985). Comparatively few 
people at either interview said they had obtained money though illegal means. Twenty 
nine people (29.8%) said they had obtained illegal incomes in the 12 months prior to 
the first interview (Table 17, Appendix 22). Twenty seven were willing to give details 
of the sources and amounts of this income. The median illegal income was only 
$2000. Most people (n=20, 74.1% of people willing to discuss their sources of illegal 
income) had acquired this illegal income through the selling of illegal drugs. Because 
people found it difficult to estimate their gross income (that is including the profit they 
had made which then went on their drug use), I only recorded the net profit, that is the 
profit made over and above personal drug use. The other incomes recorded are gross 
profits.
At the second interview, fewer people (n=18, 18.6%) said they had obtained illegal 
income. Seventeen gave an estimate of the amount. Most people had earned 
$1-2000. Only Otto, who had substantially increased his marijuana sales since the first 
interview, had earned a substantial amount ($40 000). As with the first interview, 
most of the other people had also generated this income by selling illegal drugs.
The only significant difference between any of the subsets in any of the variables 
discussed in this chapter was found at the second interview when 14 Oswaldians 
(35.9%) compared to 6 non-Oswaldians had obtained illegal income (Chi2 at 1 df = 9.0 
p < 0.005).
8.11: Effects of changes in treatment status and drug use on criminal activities
As reported in Chapter 5, nine people who had entered or re-entered treatment between 
interviews mentioned a reason related to their criminal activities for doing so. Five of 
those who had commenced methadone treatment also said they had stopped dealing. 
Ward and colleagues conclude that people who receive methadone treatment generally 
reduce their criminal activities (1992). A mean OTI criminal score of 2.7 was found at 
entry into methadone treatment among the opioid users Macleod and colleagues 
studied. After 6 months of treatment, there was a significant drop to 0.24 (1996). 
There was no change among the people I interviewed who had entered or re-entered 
treatment between interviews. At both interviews, this subset had the same low 
median score of 1. There was a range of 0-6 at both interviews and only a minor 
differential in the interquartile range (0-4 at the first interview, 0-3 at the second 
interview).
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Nor was there any significant change in the OTI scores of the 45 people who had 
stopped or reduced their heroin use at the second interview. Other research has, 
however, shown a reduction in criminal activities during periods of heroin abstinence 
(Rounsaville et al, 1987).
There was a generally low OTI score at the first interview for the total sample of 
people I interviewed and also among the subsets discussed immediately above. 
Consequently, little improvement could be anticipated.
I also used the OTI to compare criminal behaviours of the heroin users who had gone 
into treatment (and who were still in treatment) with those who had not. The only 
significant difference found was at the second interview when, inexplicably, a greater 
proportion of people who had entered or re-entered methadone treatment (66.7%, 
n=14) had dealt illegal drugs by comparison with the heroin users who had not 
(26.0%, n=27) (Z -3.0, p < 0.001) (Table 18, Appendix 22). I also used the OTI to 
compare the criminal activities at the two interviews between those who had entered or 
re-entered treatment (and who were still in treatment) with those who had not. No 
significant differences were found.
As reported in Chapter 5, some treatment entrants linked their commencement or 
recommencement of treatment with their criminal behaviours, and some people also 
associated their drug use transitions with crime. Usually, these changes were linked 
with dealing illegal drugs. This accords with the finding that dealing was the most 
prevalent crime. Only 4 people mentioned the effects of their drug use changes on 
criminal activity. Rob, for example, who had decreased his heroin use, said he was 
happy not to be “selling any more” and Sara, who had increased her heroin use, had 
also started dealing it.
8.12: Discussion
The low OTI crime score at both interviews indicate that the people I interviewed were 
only minimally involved in criminal behaviours in the month prior to the two 
interviews. A more detailed history revealed, however, that most people had, at some 
time, engaged in criminal activities. Only small numbers of people had perpetrated 
illegal acts other than drug dealing, stealing from shops and fraud. The high incidence 
of stealing from shops may have had more to do with the low incomes earned by most 
people (a median of $8000 in the 12 months prior to the first interview and a median 
of $9000 in the 12 months prior to the second interview) than with their illegal drug
use.
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Particularly among older respondents, there may have been recall bias for crimes ever 
committed (such as stealing from shops as adolescents). There may also have been 
intentional under-reporting of some crimes, particularly those involving violence. My 
findings of such low rates of assault and high rates of stealing from shops do, however, 
support an earlier review of the literature where McBride concluded that “illicit drug 
users, particularly narcotic users, are more likely to commit property crimes than 
crimes against person” (1981:119). The findings also support an Australian-based 
study which found that 61 per cent of 378 apprehended heroin users had committed a 
property crime compared to 7 per cent who had committed an assault (Wardlaw, 
1978). Reuband recently conducted a study of the connection between illegal drug use 
and crime in Germany and found that acts of robbery and burglary were uncommon in 
people who used illegal drugs. He concluded that “The imputation of a strong drug- 
crime relationship seems more to reflect a dramatisation of evil than a real-world 
phenomenon” (1992:342).
Although more than half of the people I studied had been apprehended, these were 
usually for minor crimes that were dealt with leniently. Compared to other studies of 
IDUs, very few IDUs I interviewed had been imprisoned. The different results from 
my research could indicate that I was successful in accessing some people who were 
different from IDUs usually studied. Most apprehensions occurred in the ACT and it 
may also be that the ACT law enforcement agencies and courts deal with people who 
use illegal drugs more leniently than other jurisdictions. According to Terry Buddin, 
the ACT’s former Director of Public Prosecutions, this is how the ACT law 
enforcement agencies and courts are perceived. In an interview reported in The 
Canberra Times, shortly after departing his role as Director of Public Prosecutions, he 
is paraphrased as saying:
The ACT has been left vulnerable to targeting by organised crime 
networks because of the widespread perception that its courts were the 
most lenient in Australia ... there was ... a view outside Canberra that 
sentences imposed by its courts were the lowest in the country ... this was 
how some criminals, particularly drug traffickers from Sydney perceived 
the situation” (Campbell, 1998:12).
8.13: Conclusion
As in other findings reported in the previous chapters, there was little evidence to 
support my original hypothesis that the Oswaldians would be different from other 
people I studied who used illegal drugs.
My findings are in accord with those of other researchers who have found a connection 
between illegal drug use and other criminal activities. Most crimes committed by the
people I interviewed were either associated with the illegality of the drug (mostly drug 
dealing) or were minor in nature (mostly stealing from shops). Very few people I 
interviewed had been involved in more serious crime, bringing into question the 
stereotypical image of people who use illegal drugs. There is a possibility of under­
reporting, and it may also be that those who were involved in criminal activities of a 
more serious nature would not have presented for interview because of a fear of their 
crimes being uncovered. My findings do, however, support those of other researchers 
who have found that most crimes perpetrated by people who use illegal drugs were 
generally not serious.
Fewer people were involved in criminal activities between interviews than in the 12 
months leading up to the first interview. Though none of the differences were 
statistically significant the changes reported in this chapter support findings previously 
reported which indicate an overall improvement in respondents’ well-being between 
interviews.
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CHAPTER 9: SUMMARY, CONCLUSIONS, AND 
RECOMMENDATIONS
9.1: Introduction
I had hypothesised that I would find differences between Oswaldians and non- 
Oswaldians (definitions of the subsets are included in Table 2 in Appendix 4) and had 
also hypothesised that the Oswaldians who used heroin would be able to maintain their 
heroin use at a non-dependent level. As the research evolved, I began to question 
official ratios of dependent and non-dependent heroin users and also ratios of treatment 
and non treatment ratios of heroin users. The central philosophy guiding my research 
and writing has been a commitment to harm minimisation. In addition to my interest in 
comparing Oswaldians with non-Oswaldians, I was interested in gender differences and 
questioning stereotypes of people who use illegal drugs.
I used both quantitative and qualitative data, including ethnography, to obtain the 
findings discussed in this thesis. I begin this concluding chapter by summarising the 
main findings from the total sample of people who were interviewed twice. I then go on 
to highlight the differences found between this subset and those who presented for only 
the first interview before describing the differences found over time and the differences 
found between the subsets. I then make some suggestions for further research and 
further harm minimisation strategies. In the penultimate section, I discuss the limitations 
of my findings before drawing the thesis to a close. In the context of talking about 
research on AIDS, Drucker makes a salient point which is relevant for other researchers 
in the health field. He notes how researchers “disaggregate data” by separating variables 
such as age and gender. In so doing they lose sight not only of the bigger picture in 
which health risk behaviours occur but also the everyday lives of the people concerned. 
Drucker goes on to say that it is necessary to “reaggregate” the data to get a complete 
picture back (1990:9). As I conclude the thesis, I “reaggregate” the data by returning to 
the people who first inspired me to conduct this research as I present an up-to-date 
picture of the Oswaldians who have continued to privilege me by allowing me into their 
everyday lives.
9.2: Findings from the total sample
At the first interview, most respondents were long term Canberra residents, and the 
majority also lived in the ACT all the time between interviews. As with other studies of 
people who use illegal drugs, more men than women presented for interview but there 
was a slightly higher proportion of women in my sample than has been found in most 
other samples. At the first interview, this was a younger sample than most other 
studies, but there was less difference as these people matured between interviews.
A majority of respondents had completed their secondary education by attaining their 
HSC. This finding was different from most other samples studied. Many people also 
had some tertiary education. This higher level of education did not, however, lead to a 
greater proportion of people being in the workforce and there was, as in other studies of 
people who use illegal drugs, a high unemployment rate. The median income was low 
at both interviews.
Around one fifth of respondents were parents, fewer than in other samples. At both 
interviews, the majority of people had an OTI social score considered to be either low or 
below average which demonstrated that most people had functional relationships with 
their partners, other family and friends.
The data collection revealed extensive polydrug use. Considering their young median 
age, respondents had been involved with illegal drug use for a long period (median 8 
years at the first interview) and there was a low median age (14) for first use of illegal 
drugs. I had attempted to access as many people as possible who were not in treatment 
and was partially successful in this; around two thirds of the sample had no such 
history. Although some people had drunk alcohol at above the highest safe level, most 
people at both interviews were drinking below levels deemed to be harmful. Most 
people, however, were heavy smokers.
At the first interview, 80 participants reported that they had injected at some time. The 
average age of first injection (18) was similar to that reported in other studies. The 76 
current IDUs at the first interview had been injecting for an average of 5 years. The 
frequency of injecting at both interviews was lower than that found in other samples.
The majority of respondents had an OTI health and GHQ score considered to be average 
or below indicating that they were in fairly good health. In keeping with the low rate of 
HIV among Australian IDUs, none of the IDUs who presented for both interviews were 
known to have contracted HIV through unsafe needle use. Only about one fifth of 
respondents had been fully immunised against HBV; 11 IDUs had been diagnosed as 
being positive for this virus before the first interview, and 3 were diagnosed positive 
between interviews. Nineteen IDUs were diagnosed with HCV before the first 
interview and a further 14 tested positive between interviews; which is also consistent 
with findings that the rate of HCV is increasing among IDUs. The proportions of 
people with either HBV or HCV were, however, lower than in most other IDU 
populations that have been studied.
The OTI HRBS scores for IDUs were low at both interviews indicating a general low 
level of risky behaviours. Some people were, however, still sharing injecting
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equipment. Most of this sharing occurred with sexual partners or with friends, but 
some people did not know who had used a syringe before them since they had taken 
used syringes out of disposal bins. In addition, there were several reports of accidental 
needle sharing.
Most participants were heterosexual. Consistent with other reports, both from the 
general population and studies of people who use illegal drugs, unprotected sex was 
common. Only a few people were involved in commercial sex. A majority of women 
had Pap smears taken between interviews and there was a high incidence of abnormal 
results for such a young sample.
Most people had an OTI crime level of dysfunction score considered to be low or below 
average. But nearly everyone had at some time committed a crime (in addition to using 
illegal drugs). Most people had been involved in selling illegal drugs, and most had also 
committed minor property crime, generally shop stealing. During their criminal careers 
around one fifth of respondents had perpetrated BES and/or robbery and/or receiving 
stolen goods. Approximately one third of respondents had engaged in an act of fraud. 
The fraud most frequently reported was Social Security fraud. Eight men said they had 
committed a violent crime.
A small majority of people had been apprehended by law enforcement agencies for their 
criminal activities. Most of these apprehensions had been dealt with leniently, and very 
few people (n=9) had ever been incarcerated, most for only a short period. These 
findings support those of other researchers who have reported a connection between 
illegal drug use and other criminal activities. Previous research has likewise 
demonstrated that most crimes perpetrated by people who use illegal drugs were those of 
a less serious nature. Other studies have, however, found much larger proportions of 
people with a history of incarceration.
9.3: Differences between the people who presented only for the first
interview and those who presented for both
Those interviewed twice had lived in Canberra for a significantly longer period than the
42 people who presented only for the first interview. They were also significantly
older, and significantly more had completed a HSC. There were also significantly more
tertiary students and fewer secondary students among those interviewed twice.
Those who went on to present for the second interview tended to have used illegal drugs 
for a longer period than those interviewed only once. There were few other differences 
related to drug use: those who were interviewed once were using hallucinogens 
significantly more; they were significantly younger when they first used “trips”; and
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they injected stimulants significantly less frequently. A smaller proportion of those 
interviewed only once were current “homebake” users than those interviewed twice. A 
greater proportion of people who went on to present for the second interview had a 
history of treatment.
These differences are mostly related to the significant age difference found between the 
two subsets. This can largely be attributed to my lack of success with re-contacting the 
people from the snowball into a secondary school and the young people from a “squat.”
I found a significant relationship between treatment status and both age and duration of 
heroin use. Such relationships have also been found by researchers who analysed some 
of the ANAIDUS data (Ross et al, 1993b). These findings lead me to suggest that the 
younger subset of people who did not present for the second interview may, as their 
drug using careers mature, encounter similar problems to those found in that older 
subset of people who presented for both interviews.
9.4: Changes between interviews
The data collection at the second interview was largely concerned with documenting 
changes that had occurred between interviews, particularly reasons for change in 
drug consumption patterns. In this section, I discuss the major changes that occurred 
between interviews. I was also interested in applying the prospective data from an 
Australian drug using population to the models of “maturing out” and “drug using 
careers”. Below, I also synthesise some of the reasons given by respondents for 
modifications in their drug use behaviour.
There was a highly significant reduction in the number of drugs used, in the number of 
classes used, and in the OTI polydrug score. Stopping the use of one drug often led to a 
cascade effect of stopping or reducing other drugs. There were significant reductions in 
the number of types of drugs used in the cannabis, opioids, and benzodiazepine classes 
and marked reductions in the number of people using hallucinogens, benzodiazepine and 
inhalants. Stimulants were being used less frequently. In terms of individual drugs, 
there were significantly fewer people using hashish, cocaine, Doloxene, codeine, 
“homebake”, poppies, “trips”, psychedelic mushrooms and diazepam. There were 
fairly substantial reductions in the number of people who had used hashish oil, 
amphetam ine, amyl nitrite and “other” stimulants, opioids, hallucinogens, 
benzodiazepines, and inhalants. The number of current heroin users slightly increased 
between interviews but several people (n=12) said they had “stopped” their use, and 
many had reduced their consumption (n=33).
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I asked people to explain the changes in their drug use consumption. Almost half of the 
840 changes occurred in drugs that were not used between interviews. Methadone was 
the only drug used by significantly more people at the second interview. Most 
methadone was prescribed. One of the biggest “scene” changes which impacted on drug 
use behaviours between interviews was the increase in the number of people receiving 
methadone in the ACT; only 4 of the 26 people in methadone treatment at the second 
interview had been in this treatment at the first. This was related to an expansion of 
places in the ACT Methadone Program, which in turn was related to calls from NCADA 
for an Australian-wide increase in the number of methadone places.
Some people had also experienced other forms of treatment between interviews. The 
change in treatment status was highly significant for the total population of respondents 
and, with the exception of the core-Oswaldians (where it approached significance), there 
were also significant changes among all the subsets.
The qualitative data shed some light on why the people I interviewed “matured out” of 
drug use, or made changes to their drug using “careers”. The multitude of reasons 
given by respondents for changes in their drug use consumption patterns lead me to 
suggest that whilst these terms are useful umbrella terms, the rationale for changes are 
more complex than suggested by the terminology. All but one person mentioned the 
negative effects of their increased heroin use as a reason for entering treatment. These 
reasons were similar to those cited by other researchers except that a majority of people 1 
interviewed mentioned health concerns. Everyone who had gone into treatment between 
interviews, and who was still in treatment at the time of their second interview, had 
stopped or reduced their heroin use. There were 71 reports of a drug not being used and 
31 reports of a decrease in drug use attributed to methadone treatment. Other opioids 
were most frequently mentioned in this context.
Of the 51 people who had not had any treatment by the time of the second interview, 30 
had used heroin between interviews. Most were low level users but there were still 
some who were experiencing problems due to their heroin use. Those heroin users who 
had a history of treatment for opioid use at the second interview were significantly older 
and had been using heroin for significantly longer than heroin users without a treatment 
history. This demonstrates a correlation between treatment seeking and both older age 
and longer duration of heroin use. The theory of “maturing out” in terms both of age 
and period of using may be appropriate to both abstinence and to treatment entry.
Apart from the effect of treatment on drug use, several other themes for changes in drug 
uses emerged from the qualitative data. Drug availability constituted the largest category 
of all the changes (n=212). Health emerged as the second major theme (n=192).
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Individual users may experience either desirable or undesirable effects of a drug and for 
many people, the effect of a drug per se (either positive or negative) provided sufficient 
reason to change consumption patterns. Other drugs were frequently cited in 
conjunction with a change; those mentioned most were heroin and one of the 
benzodiazepines. The influence of significant others, particularly friends, was also 
important. Lifestyle events and finances were mentioned by several people. Only a few 
people mentioned experimental use, drug quality and criminal or legal reasons as being 
influential.
My study uncovered no evidence of coercion into drug use by people who sold drugs 
and only two people said they had been coerced by friends to try a drug for the first 
time. I did not ask respondents if they knew anyone who had overdosed but, either 
during ethnographic work or at the second interview, a few people volunteered the 
information that they knew someone who had recently died due to a heroin overdose and 
most talked about the impact this had on reducing their drug use.
As other researchers have found, there was an inverse relationship between alcohol and 
heroin use but I found this to be so in only a small number of people. In addition, only 
a few people (n=4) who went into methadone treatment between interviews had 
increased their alcohol use. When examining the people who had decreased or stopped 
their heroin use, I found a significant reduction in the number of drugs used. This 
supports findings from other researchers who have demonstrated that there is not 
necessarily an inverse relationship between the use of heroin and other drugs.
No one had injected every day between interviews whereas at the first interview 7 
people had done so at least once a day in the preceding year. Several people (n=9) at the 
second interview also said they had “stopped” injecting. The frequency of IDU was 
significantly less in the month prior to the second interview than in the month prior to 
the first interview. There were also significantly fewer reports of problems associated 
with injecting at that time. Between interviews, there was a significant reduction in the 
number of people who had an HIV test because of unsafe needle use.
I found an improvement in health between interviews as measured by the OTI and 
GHQ. Significantly fewer people had their latest HIV test because of unsafe sex. The 
average sexual risk score increased, mainly due to a significant increase in the number of 
people in a relationship. These people were not only having sex more frequently, they 
tended not to use condoms with people perceived as longterm partners.
There were quite solid reductions in the number of people who reported having sold 
illegal drugs, stolen from shops and obtained income by illegal means.
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Legal income had significantly increased, but it would seem that much of the difference 
lay in the increased number of people who received unemployment benefits, since more 
people were unemployed at the second interview than at the first. In other domains, 
however, the findings demonstrate that, between interviews, there were improvements 
for the majority of respondents in many aspects of their lives. There is a vast literature 
(some of which I reviewed at the beginning of Chapter 5) demonstrating that people 
who use illegal drugs are at increased risk of physical, psychological and social harms.
I suggest that the improvements among the people I interviewed are connected with the 
highly significant reduction in the number of drugs used between interviews.
9.5: Differences between Oswaldians and non-Oswaldians
I compared the Oswaldians with other people who used illegal drugs, who were similar 
in terms of the proportions of IDUs and the proportions of people with a history of 
treatment for drug problems. I had hypothesised that I would find differences between 
the Oswaldians and non-Oswaldians in other variables but generally found the subsets 
were similar. In this section, I draw together the few differences I detected.
At the first interview, the Oswaldians had a history of using significantly more classes 
of drugs than the non-Oswaldians. Also, more Oswaldians had used hashish oil and 
more had a history of benzodiazepine use. By the second interview there was only one 
significant difference found: the Oswaldians were greater alcohol consumers than non- 
Oswaldians.
There were a few differences over time in health. Between interviews the non- 
Oswaldians experienced a significant improvement in physical health as measured by the 
OTI; their overall improvement in the GHQ score approached significance. The 
improvement in the somatic symptom GHQ subscale was significant. The Oswaldians 
scored similarly at each interview on the total OTI physical and GHQ scores but there 
was an improvement in the GHQ depression subscale at the second interview.
A few other disparate differences were found over time. The non-Oswaldians had an 
almost significant increase in legal income; the Oswaldians tended to use condoms less 
frequently at the second interview than at the first; significantly more Oswaldians than 
non-Oswaldians obtained illegal income between interviews; and the reduction in the 
proportion of Oswaldians who had an HIV test because of unsafe needle use or unsafe 
sex was significant whilst that for non-Oswaldians was not.
There is, therefore, little evidence to support my hypothesis that the Oswaldians would 
be different from other people I studied who used illegal drugs.
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9.6: Differences between core-Oswaldians and the Remainder
Because the Oswaldian group also contains transient and peripheral members, I had 
originally expected to see even greater differences between the core-Oswaldians and the 
Remainder.
At the first interview fewer core-Oswaldians than the Remainder had used methadone 
and there was a similar significant difference in treatment history. These differences had 
disappeared by the second interview.
At both interviews, the core-Oswaldians were currently significantly heavier drinkers 
than the Remainder. Current hallucinogen users among the core-Oswaldians had used 
fewer types than the Remainder at the first interview; this difference had also 
disappeared by the second interview. Between interviews, a significantly greater 
proportion of core-Oswaldians than the Remainder had used diazepam.
Much of the increase in income between interviews occurred in the Remainder subset. 
Their increase was significant while the core-Oswaldians’ was not. Most of the increase 
in the number of people in a relationship was also due to the Remainder subset. Their 
change in relationship status was significant whilst the proportion of core-Oswaldians in 
a relationship was the same at both interviews. In tandem with this finding, at both 
interviews, significantly more core-Oswaldians lived with friends.
There was little change in the OTI health or GHQ score for the core-Oswaldians at the 
second interview but there was a significant improvement in the Remainder in both 
domains. Most of the improvement in health between interviews, therefore, occurred in 
non-Oswaldians and the Remainder.
There was a reduction in the proportion of the Remainder who had an HIV test because 
of unsafe needle use or unsafe sex between interviews, but not in the core-Oswaldians. 
There was also a reduction in injection related problems among the core-Oswaldians but 
not among the Remainder.
Although there were a few more differences between the core-Oswaldians and the 
Remainder than found between the Oswaldian and non-Oswaldians, some of these 
differences had dissipated over time. I have to conclude again that there is very little 
evidence to substantiate my hypothesis.
9.7: Gender differences
Women tended to be younger than men which accords with findings from several other 
studies. Based on the data obtained at the first interview, men had used more drugs 
over their drug-taking careers than women. They also had a longer history of illegal 
drug use. This could be associated with the younger age of women, but women tended 
to have been younger than men when they started both illegal drug use and IDU.
Men were slightly older than women when they first used heroin and diazepam. At the 
time of the first interview, men had used more hallucinogens than women, although 
there was no significant difference in the number currently used at either interview. A 
greater proportion of women had ingested poppy extract. At both interviews, there were 
proportionately more men than women in treatment.
The change in relationship status between interviews occurred significantly more 
frequently in women than men. A greater proportion of men lived with other family at 
the first interview than at the second. The significant improvement in physical health 
between interviews was also largely due to an improvement in women’s health. As 
measured by the OTI, their health was worse than men’s at the first interview; at the 
second interview, the women’s median score had improved significantly whilst men’s 
had not. Much of the improvement in the GHQ score also occurred among women. 
Their psychological health was worse than men’s at the first interview, but their median 
scores were the same at the second interview. Much of the reduction in the number of 
people who had an HIV test for unsafe sex also occurred in women; their change was 
significant whilst men’s was not. Despite this finding, more women than men were 
practising unsafe sex since women’s sexual risk score worsened significantly between 
interviews. This was due to more of an increase among women with partners and also 
to them using condoms significantly less frequently.
Similar proportions of men and women reported illegal activities but the apprehension 
rate was higher for men.
These findings demonstrate a few differences between men and women. Some indicate 
directions for future research and these are included in the discussion below.
9.8: Suggestions for future research
The significant changes in treatment status between interviews, and particularly the 
changes among the Oswaldians who described themselves as “recreational” users when 
I first met them, leads me to question whether there are, over time, more dependent than 
non-dependent heroin users. In addition, I found a significant relationship between 
treatment status and both age and duration of heroin use. My study sample was small.
As there is bound to be in any longitudinal study, there was also some attrition of 
respondents by the time of the second interview. In order to obtain a clearer picture of 
what happens to heroin use patterns over time, I suggest that a longitudinal study of a 
larger sample of heroin users is required. This would provide a fuller understanding of 
the present ratios of dependent and non-dependent heroin use. The Australia-wide 
increase in the number of people in methadone treatment may also have affected the 
ratios of dependent heroin users in and out of treatment. A longitudinal study containing 
larger numbers of heroin users would also have the ability to better determine ratios of 
treatment and non-treatment samples. In addition, such a study would be able to help 
determine how generalisable my findings were.
I found some gender differences in age at first use of drugs and also age and IDU. As 
indicated in Chapter 7, the early years of injecting are associated with increased risk 
behaviours. In order to better implement appropriate harm minimisation strategies for 
young people, there is a need for further research to examine more fully the relationship 
between gender and initiation into illegal drug use.
Several people reported accidental needle sharing but it is not known how prevalent this 
is. Since it is very likely to be a way of people contracting BBVs, I would like to see 
future research on IDU risk behaviours include questions and education on this aspect of 
risky needle use.
During a period when heroin quality improved, and also when there was discussion of a 
possibility of the controlled availability of heroin (NCEPH, 1991), more than half of the 
heroin users had either “stopped” or reduced their heroin consumption. Some of this 
change was due to people entering treatment but several other reasons also emerged. 
There were also several heroin-related overdoses during this period. Future research 
could tease out the complicated nexus between heroin using patterns and changes in both 
heroin quality and heroin-related overdoses.
9.9: Suggestions for further harm minimisation
This section draws upon both my research and that of other researchers to make some 
suggestions for possible further harm minimisation strategies.
9.9. i: Minimising the harm o f the interview
I would have been better equipped to assist people who talked about their physical, 
sexual and emotional abuse if I had undergone a short course on relevant counselling 
and referral prior to commencing the interviews. Research which has found a 
connection between childhood abuse and suicidal tendencies (Bayatpour et al, 1992), 
and between childhood abuse and HIV risk behaviours (Allers et al, 1993), further
demonstrates the importance of including these sorts of questions. But asking can create 
problems for the interviewer and fail to mobilise an opportunity for constructive 
intervention if interviewers are poorly equipped to respond to disclosure.
Harm minimisation recommendation 1
That attendance by prospective interviewers at a course which covers issues 
o f sexual and physical abuse be a pre-requisite fo r  any funding o f projects 
which involve interviewing people who use illegal drugs.
To minimise the danger of prosecution for respondents who are asked to discuss their 
illegal activities either at interview or during ethnographic work, it would be helpful if 
these data were protected by a Confidentiality Act such as the Commonwealth 
Epidemiological Studies (Confidentiality) Act of 1981 or the ACT’S Epidemiological 
Studies (Confidentiality) Act of 1992 (Appendix 10). Having prior protection would 
have greatly facilitated my research process. In addition, I believe researchers would 
have better access to a greater variety of people who use illegal drugs if it was known 
that their data were better protected.
Harm minimisation recommendation 2
That relevant institutions take measures to ensure that all work which 
involves collecting data o f a sensitive nature is protected by a Confidentiality 
Act and that they make approaches to the Commonwealth and State 
Governments to expedite this process.
9.9.iii: Harm minimisation related to IDU
A  minority of IDUs I interviewed were still sharing injecting equipment. Much of this 
sharing was with sexual partners, or people known to the respondent. Some people 
were, however, using syringes after taking them out of a disposal bin.
Harm minimisation recommendation 3
IDUs need even better access to sterile needles and syringes. As other 
researchers have indicated (Wodak and Crofts, 1994a; Dodding and 
Gaughwin, 1995), this could be accomplished through vending machines.
Other research has shown an association between homeless young people and high risk 
behaviours (Caplehom and Saunders, 1993). Some Australian research has shown that 
many homeless young people have escaped from abusive homes (Howard, 1993a and 
1993b).
Harm minimisation recommendation 4
Peer outreach workers could attempt to access those not currently in contact 
with service providers. Special efforts should be made to access homeless 
youth.
My research made me concerned about the potential harm of accidental needle sharing. 
This led me to write a small article for the ACT IDU population (Appendix 21).
Harm minimisation recommendation 5
Education about ways o f  avoiding accidental needle sharing could be 
included in programs which educate IDUs about safer drug use and it could 
also be included in peer magazines.
There is a high prevalence of HBV among Australian IDUs and some people I 
interviewed were diagnosed with this virus between interviews.
Harm minimisation recommendation 6
More stringent efforts are required to persuade IDUs and their sexual 
partners to be immunised against HBV.
Some of the people I interviewed reported that friends had died of a heroin-related 
overdose. There is an increasing number of young Australians dying in this way.
Harm minimisation recommendation 7.1
As indicated by other researchers (Strang et al, 1996; Zador et al, 1996), 
some heroin-related overdoses might be prevented if users were given 
access to Narcan. Consideration should be given to this proposal.
Harm minimisation recommendation 7.2
Consideration should also be given to the suggestion made by Bammer and Sengoz that 
people working in organisations which operate as advocates fo r  people who use illegal 
drugs could be trained (and given appropriate back-up) to investigate and disseminate to 
their clients the causes o f clusters o f heroin-related deaths (Bammer and Sengoz, 1995).
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Several of the people I interviewed had tested positive for HBV and HCV. Other 
researchers have noted that it is imperative to educate IDUs about the need to be taught 
that all equipment used for preparing and administering injectable drugs is a potential 
source of transmitting BBVs (Wodak and Des Jarlais, 1993). Research has 
demonstrated that it takes bleach at least 30 seconds to inactivate HIV-1 (Shapsack et al, 
1993) and Wodak believes that bleach is unlikely to be effective against HBC and HCV 
(Wodak, 1993a). Not only is it necessary for IDUs to always use sterile injecting 
equipment it is, therefore, also necessary for them to take the following precautions:
° Careful hand washing, particularly if injecting others 
° Ensuring surfaces used for preparation of injectable drugs are clean 
° Using a personal tourniquet
° Taking greater care with the solution and the equipment used to mix drugs. 
Harm minimisation recommendation 8
The increasing rate o f HCV indicates that hygiene recommendations are still 
not being followed and even greater effort needs to be put into IDU  
education.
At present, current IDUs are excluded from Interferon treatment12. Greater access to 
services is required to enable these people to stop injecting and to also ensure they have 
supportive counselling.
Harm minimisation recommendation 9
The exclusion o f IDUs from Interferon treatment is inequitable. More effort 
needs to be made to attend to the physical and psychological health needs o f 
IDUs with HCV, including non-judgmental ways to help them stop 
injecting.
9.9.iii: Safer drug use
Several commentators have noted how damaging current prohibition is for the health of 
people who use illegal drugs (for example, Nadelmann, 1988; Drucker, 1991). Until 
there is quality control of currently illegal drugs the people who use them will continue 
to die at rates above those of non-users. The IDUs I have contact with have all 
expressed their great disappointment that the Federal Government did not allow the ACT 
“heroin trial” to proceed.
1
2 Addendum, February 1999: the NHMRC recommendation that IDUs should not be excluded from 
Interferon treatment has recently been implemented.
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Harm minimisation recommendation 10
Consideration should be given to reinstating a Feasibility Study into the 
Controlled Availability o f Opioids.
Many respondents had some involvement in tertiary education. A similar finding has 
been observed in other studies.
Harm minimisation recommendation 11
That tertiary institutions be targeted as venues for teaching safer drug use.
9.9.iv: Sexual health
Few respondents were aware of the potential ramifications of STDs, such as HPV and 
chlamydia, or of the possibility that HCV and HBV are often precursors for liver cancer. 
The low rate of condom use with regular partners in my sample is similar to other 
studies. A smaller proportion of women than men used condoms. Clearly, innovative 
campaigns are needed to increase the rate of condom use, particularly among women. A 
majority of women had Pap smears, which indicates a concern on their part.
Harm minimisation recommendation 12
There is a need fo r  gender specific educational strategies regarding genital 
and sexual health. This education must cover the complete armoury o f the 
potential hazards o f unsafe sexual behaviours. Since so many women had 
been concerned enough about their genital health to have a Pap smear, this 
concern could be utilised by health professionals who, at the time o f testing, 
could spend some time educating women about the need to use condoms 
and to also teach them ways o f negotiating safe sex.
9.9.v: Social health
My study and other studies of illegal drug users have consistently reported high 
unemployment rates. Overseas studies have found employment to be positively 
associated with periods of prolonged abstinence from heroin (Waldorf, 1970; Maddux, 
1981; Simpson and Marsh, 1986). As a harm minimisation strategy, a program in The 
Netherlands offers people who use illegal drugs paid work on a daily basis (de Groot, 
1995). It would be worthwhile to examine the feasibility of implementing similar 
programs in Australia.
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Harm minimisation recommendation 13
In order to bring about periods o f prolonged or total abstinence for those 
who wish to maintain the reduction in their drug use consumption, and to 
also assist those who choose to continue to use drugs, more stringent efforts 
should be put into providing people who use illegal drugs with worthwhile 
paid employment.
9.9.vi. Peer education
Several other researchers have remarked upon the importance of continuing with peer 
education to disseminate harm minimisation strategies (Dorus et al, 1991; Wodak, 
1993b; Power, 1994; Crofts and Herkt, 1995). Australian user organisations have been 
especially recognised: “They have been a key element in Australian efforts” (Friedman 
and Ward, 1993:186). In recognition of this vital role, AIVL was awarded the national 
Rolleston award at the 1996 7th International Conference on the Reduction of Drug 
Related Harm, in Hobart. Programs which provided education to young IDUs about 
safer drug use have been run in the ACT by the ACT IV League (Byrne, 1996). Similar 
programs could be implemented for IDUs of all ages throughout Australia. ADDInc has 
recently called for urgent measures to be taken to assist the increasing numbers of young 
people accessing their treatment settings and needle exchange outlets (1996). For 
example, during 1995-1996, 48 per cent of the clients of the ACT’s NEP were below 
the age of 25 (Fletcher, P. NEP Program manager, ADDINC, ACT. 1996, December 
2, pers comm).
Harm minimisation recommendation 14
In order to best implement most of the suggestions I have made, those made 
by other people which I have endorsed, and to also continue with existing 
harm minimisation strategies, there needs to be increased funding to user 
organisations.
9.10: Limitations of the findings
The people with whom I conducted ethnographic work became friends. There are 
negative implications of this. I did not have the same magnitude of rapport with 
everyone I interviewed. This may be reflected in my research findings.
No sample of people who engage in illegal activities can be representative and this study 
is no exception. I had attempted to access as many people as possible who did not have 
a history of treatment or incarceration. Some of my findings, particularly those which 
are different from other studies, may be attributed to my sampling.
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Respondents were provided with an honorarium of $40.00 for each interview. This, 
perhaps, biased my sampling since it might have led to an oversampling of the 
unwaged, the unemployed, low income workers and students. All such people are more 
likely to fit in younger age brackets.
My major concern was investigating what happened to the Oswaldians over time. As 
shown in Table 2.2 (Page 14), only four Oswaldians (2 core-Oswaldians and 2 
peripheral group members) interviewed at the first interview did not present for the 
second interview. This small attrition is unlikely to have affected the findings reported 
from this subset. Thirty eight people from their opposite subset were lost to attrition and 
this may have had an impact on the findings from the non-Oswaldians.
9.11: Conclusion
Whilst there were some similarities between the total population I interviewed and 
samples of other people who use illegal drugs, there were also some differences such as 
a high proportion of people with their HSC and a low rate of incarceration. Most people 
were in reasonably good physical and psychological health and most had functional 
relationships with their significant others. Findings such as these may indicate that I had 
some partial success in reaching “hidden users.” They may also help change 
stereotypical images of illegal drug users which are portrayed so frequently in the media.
Profound changes in drug use consumption patterns occurred between interviews. 
Some, such as the increase in the number of people in methadone, and changes in 
availability of drugs were due to “scene” changes. Other were due to a variety of life 
experiences. This prospective data collection demonstrated the complexity and 
dynamics of drug use behaviours over time and illuminated some of the reasons for 
changing consumption patterns.
On the sort of information I obtained in 1989, I could not predict which of the 
Oswaldians were going to have problems with their heroin use. Much of my reasoning 
for hypothesising that they would be different from other drug users I studied was based 
on my close contact with a group of people who were mostly in the early stage of their 
drug using careers and also on their idiosyncratic invention of a “Patron Saint” of drug 
use. When comparing the Oswaldians with other people who use illegal drugs over 
time, and at later stages in their careers, there was little evidence to support my 
hypothesis.
My research with the Oswaldians began at a time when they associated drug use with 
pleasure. I would like to have been able to report no changes in this but, as I have 
shown throughout the thesis, a variety of transitions in drug use have occurred since my
first contact with the group. Very few Oswaldians were able to maintain all their drug 
use, particularly their heroin use, at a non-dependent level. For some Oswaldians, the 
problems associated with their increase in heroin use led them to seek their first 
treatment. Oswaldian group-members who stopped their heroin use, the few who 
managed to maintain their use at a non-dependent level, and those who reduced their 
illegal drug consumption demonstrate a concern for friends who have experienced 
problems with their heroin use.
Many Oswaldians have entered into longterm relationships, have become parents for the 
first time or re-entered tertiary education. Despite the substantial changes in these realms 
most Oswaldians, whatever their level of drug use, still interact at social occasions. The 
last “Saint Oswald’s Day” ceremony was held in 1995 and, from conversations held in 
1998 with some core-Oswaldians, I gather that it is unlikely that this celebration will be 
resurrected. Increasingly, Oswaldian gatherings are becoming more mainstream, being 
occasions such as dinner parties, weddings, engagement or birthday parties. Thus, 
though the reasons for celebrations have changed, the friendship links within the group 
have largely been maintained during the ten years since I first made contact with these 
people, who invited me into their everyday lives.
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